<SEC-DOCUMENT>0001193125-25-004935.txt : 20250113
<SEC-HEADER>0001193125-25-004935.hdr.sgml : 20250113
<ACCEPTANCE-DATETIME>20250113064528
ACCESSION NUMBER:		0001193125-25-004935
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250110
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250113
DATE AS OF CHANGE:		20250113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Clearwater Analytics Holdings, Inc.
		CENTRAL INDEX KEY:			0001866368
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40838
		FILM NUMBER:		25524710

	BUSINESS ADDRESS:	
		STREET 1:		777 W. MAIN STREET, SUITE 900
		CITY:			BOISE
		STATE:			ID
		ZIP:			83702
		BUSINESS PHONE:		208-918-2400

	MAIL ADDRESS:	
		STREET 1:		777 W. MAIN STREET, SUITE 900
		CITY:			BOISE
		STATE:			ID
		ZIP:			83702
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d921635d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cwan="http://clearwater-analytics.com/20250110" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-375">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-01-10_to_2025-01-10">0001866368</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cwan-20250110.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-01-10_to_2025-01-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001866368</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-10</xbrli:startDate> <xbrli:endDate>2025-01-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-386">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt:datemonthdayyearen" id="ixv-387">January 10, 2025</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-388">Clearwater Analytics Holdings, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:stateprovnameen" id="ixv-389">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-390">001-40838</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-391">87-1043711</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:33%"/>
<td style="vertical-align:bottom"/>
<td style="width:31%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-392">777 W. Main Street</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-393">Suite 900</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-394">Boise</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:stateprovnameen" id="ixv-395">Idaho</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-396">83702</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-397">208</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-398">433-1200</ix:nonNumeric></span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-399">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-400">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-401">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-402">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-403">Class&#160;A common stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-404">CWAN</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:exchnameen" id="ixv-405">New York Stock Exchange LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#160;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-01-10_to_2025-01-10" format="ixt-sec:boolballotbox" id="ixv-406">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Agreement and Plan of Merger </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January 10, 2025, Clearwater Analytics Holdings, Inc. (the &#8220;Company&#8221; or &#8220;Clearwater&#8221;) entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with Poseidon Acquirer, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (&#8220;Acquirer&#8221;), Poseidon Merger Sub I, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (&#8220;Merger Sub&#8221;), Poseidon Merger Sub II, LLC, a Delaware limited liability company and an indirect subsidiary of the Company (&#8220;Merger Sub II&#8221;), Enfusion, Inc., a Delaware corporation (&#8220;Enfusion&#8221;), and Enfusion Ltd. LLC, a Delaware limited liability company and subsidiary of Enfusion (&#8220;Enfusion Operating Company&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement provides, among other things and on the terms and subject to the conditions of the Merger Agreement, that (i)&#160;Merger Sub II will merge with and into the Enfusion Operating Company (the &#8220;LLC Merger&#8221;), with the Enfusion Operating Company surviving the LLC Merger as a wholly-owned subsidiary of the Company; (ii)&#160;Merger Sub will merge with and into Enfusion (the &#8220;Merger&#8221;), with Enfusion surviving the Merger as an indirectly wholly-owned subsidiary of the Company (the &#8220;Surviving Corporation&#8221;); and (iii)&#160;subject to the satisfaction of each of the Second Merger Conditions (as defined in the Merger Agreement) as of the Closing Date but before the effective time of the Merger, the Surviving Corporation will merge with and into the Acquirer (the &#8220;Second Merger&#8221;, and together with the Merger, the &#8220;Corporate Mergers&#8221;, and the Corporate Mergers together with the LLC Merger, the &#8220;Mergers&#8221;), with Acquirer surviving the Second Merger as a wholly-owned subsidiary of the Company. If the Second Merger does not occur, references to the &#8220;Mergers&#8221; shall mean the Merger and the LLC Merger. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the respective effective times of each Merger: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">i.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">each share of the Class&#160;A common stock of Enfusion outstanding as of immediately prior the effective time of the Merger (except as otherwise provided in the Merger Agreement) will be converted into the right, at the election of the holder of such share pursuant to the procedures set forth in the Merger Agreement, to receive either (i)&#160;the Per Share Mixed Consideration, (ii)&#160;the Per Share Stock Consideration or (iii)&#160;the Per Share Cash Consideration (each as defined in the Merger Agreement); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">ii.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">each common unit of Enfusion Operating Company outstanding as of immediately prior to the effective time of the LLC Merger (except as otherwise provided in the Merger Agreement) will be converted into the right, at the election of the holder of such unit pursuant to the procedures set forth in the Merger Agreement, to receive either (i)&#160;the Per Share Mixed Consideration, (ii)&#160;the Per Share Stock Consideration or (iii)&#160;the Per Share Cash Consideration (each as defined in the Merger Agreement). </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Conditions to the Mergers </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The completion of the Mergers is subject to the satisfaction or waiver of certain customary mutual closing conditions, including (a)&#160;the adoption of the Merger Agreement by the holders of a majority of the voting power of the outstanding shares of capital stock of Enfusion entitled to vote thereon, voting as a single class (the &#8220;Stockholder Approval&#8221;), (b) the absence of any order or other action that is in effect (whether temporary, preliminary or permanent) by a governmental authority restraining, enjoining or otherwise prohibiting the consummation of the Mergers or applicable law that is in effect that makes consummation of the Mergers illegal or otherwise prohibited, (c)&#160;the expiration or termination of the applicable waiting period (and any extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and any agreement with any governmental authority not to consummate the Mergers and (d)&#160;the effectiveness of the registration statement on Form <span style="white-space:nowrap">S-4</span> to be filed by the Company in connection with the Mergers. The obligation of each party to consummate the Mergers is also conditioned on the other party&#8217;s representations and warranties being true and correct (subject to certain customary materiality exceptions) and the other party having performed in all material respects its obligations under the Merger Agreement. In addition, (i)&#160;the Company, Acquirer, Merger Sub and Merger Sub II&#8217;s obligation to consummate the Mergers is conditioned upon there not having occurred a Company Material Adverse Effect (as defined in the Merger Agreement) and the absence of certain Burdensome Conditions (as defined in the Merger Agreement) specified in the Merger Agreement and (ii)&#160;Enfusion&#8217;s obligation to consummate the Mergers is conditioned upon there not having occurred a Parent Material Adverse Effect (as defined in the Merger Agreement). </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Termination </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement contains termination rights for each of the Company and Enfusion, including, among others, (a)&#160;if the consummation of the Mergers does not occur on or before July&#160;9, 2025, (b) if any order prohibiting the Mergers has become final and <span style="white-space:nowrap">non-appealable,</span> (c)&#160;if the Stockholder Approval is not obtained following the meeting of Enfusion&#8217;s stockholders for purposes of obtaining such Stockholder Approval, and (d)&#160;subject to certain conditions, (i)&#160;by the Company, prior to the receipt of the Stockholder Approval, if (x)&#160;the Board of Directors of Enfusion (the &#8220;Enfusion Board&#8221;), acting upon the recommendation of the Special Committee of the Enfusion Board, changes its recommendation in favor of the Mergers or (y)&#160;Enfusion has materially breached its <span style="white-space:nowrap">non-solicitation</span> obligations with respect to alternative acquisition proposals from third parties under the Merger Agreement or (ii)&#160;by Enfusion, prior to the receipt of the Stockholder Approval, if Enfusion wishes to terminate the Merger Agreement to enter into a definitive agreement providing for a Superior Proposal (as defined in the Merger Agreement). The Company and Enfusion may also terminate the Merger Agreement by mutual written consent. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Enfusion is required to pay the Company a termination fee of $52,325,000 in cash on termination of the Merger Agreement under specified circumstances, including, among others, termination by the Company in the event that the Enfusion Board, acting upon the recommendation of the Special Committee, changes its recommendation in favor of the Merger or termination by Enfusion to enter into a definitive agreement providing for a Superior Proposal. The Merger Agreement also provides that, in certain circumstances, each party may seek to compel the other parties to specifically perform their obligations under the Merger Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Financing of the Merger </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has obtained commitments of $1.0&#160;billion in new debt financing, subject to customary conditions, to fund, together with cash on hand, the cash portion of the aggregate merger consideration payable under the Merger Agreement and fees and expenses related to the Mergers. The receipt of financing by the Company is not a condition to the Company&#8217;s obligation to complete the Mergers. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Other Terms of the Merger Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement contains customary representations and warranties of the Company, Acquirer, Merger Sub, Merger Sub II and Enfusion, in each case generally subject to customary materiality qualifiers. Additionally, the Merger Agreement provides for customary <span style="white-space:nowrap">pre-closing</span> covenants of the Company, Acquirer, Merger Sub, Merger Sub II and Enfusion, including covenants relating to Enfusion conducting its and its subsidiaries&#8217; business in the ordinary course, preserving its business organizations substantially intact, preserving existing material business relationships substantially intact and refraining from taking certain actions without the Company&#8217;s consent, subject to certain exceptions. The Company and Enfusion also agreed to use their respective reasonable best efforts to cause the Mergers to be consummated. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement provides that, during the period from the date of the Merger Agreement until the effective time of the Merger (the &#8220;Interim Period&#8221;), the Company will be subject to certain restrictions on its ability to (a)&#160;amend its certificate of incorporation or <span style="white-space:nowrap">by-laws,</span> subject to customary exceptions, (b)&#160;declare, set aside or pay any dividends or distributions, or enter into any agreement with respect to the voting of, any capital stock of the Company, (c)&#160;split, combine, adjust, subdivide or reclassify any capital stock or equity interest of the Company or (d)&#160;adopt a plan of liquidation, dissolution, merger, restructuring, capitalization or other reorganization. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement also provides that, during the Interim Period, Enfusion will be subject to certain restrictions on its ability to solicit certain alternative acquisition proposals from third parties, provide <span style="white-space:nowrap">non-public</span> information to third parties and engage in discussions or enter into agreements with third parties regarding certain alternative acquisition proposals, subject to customary exceptions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which is filed hereto as Exhibit 2.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference herein. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement and the above description have been included to provide investors with information regarding its terms. They are not intended to provide any other factual information about the Company, Acquirer, Merger Sub, Merger Sub II, Enfusion, Enfusion Operating Company or their respective affiliates. The representations, warranties and covenants contained in the Merger Agreement were made only for purposes of the Merger Agreement as of the specific dates therein, were solely for the benefit of the parties to the Merger Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the parties thereto or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the Company&#8217;s or Enfusion&#8217;s public disclosures. Accordingly, the Merger Agreement should not be read alone, but should instead be read in conjunction with the other information regarding the Company, Acquirer, Merger Sub, Merger Sub II, Enfusion and Enfusion Operating Company and the transactions contemplated by the Merger Agreement contained in or incorporated by reference into the filings that the Company and Enfusion have made or will make with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), including the Annual Reports on Form <span style="white-space:nowrap">10-K</span> of each of the Company and Enfusion, the Registration Statement on Form <span style="white-space:nowrap">S-4</span> (the &#8220;Registration Statement&#8221;) to be filed by the Company to register the shares of the Company&#8217;s common stock to be issued pursuant to the Mergers, which will include a prospectus of the Company and a proxy statement of Enfusion (the &#8220;proxy statement/prospectus&#8221;), and other documents that the Company and Enfusion have filed or will file with the SEC. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Support Agreements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the Merger Agreement, on January&#160;10, 2025, the Company entered into support agreements with each of FTV IV, L.P., a Delaware limited partnership, FTV Investment Holdings, L.P., a Delaware limited partnership, ISP <span style="white-space:nowrap">V-B</span> EF LP, a Delaware limited partnership, ISP V Main Fund EF LLC, a Delaware limited liability company, ICONIQ Strategic Partners V, L.P., a Cayman Islands exempted limited partnership, ICONIQ Strategic Partners <span style="white-space:nowrap">V-B,</span> L.P., a Cayman Islands exempted limited partnership, Oleg Movchan and CSL Tech Holdings, LLC, a Nevada limited liability company, each a stockholder of Enfusion (collectively, the &#8220;Significant Stockholders&#8221;, and such agreements, the &#8220;Support Agreements&#8221;). The Support Agreements generally require that the Significant Stockholders vote their Subject Shares (as defined in each Support Agreement), which represent, in the aggregate approximately 45% of the total voting power of Enfusion outstanding as of January&#160;7, 2025, in favor of the adoption of the Merger Agreement and against any competing acquisition proposals, and take certain other actions in furtherance of the transactions contemplated by the Merger Agreement, in each case, subject to the limitations set forth in each Support Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions, the Support Agreements prohibit transfers by the Significant Stockholders of any of their Subject Shares prior to the termination of the Support Agreements and other actions that would impair their ability to fulfill their obligations under the Support Agreements. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Support Agreements does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the form of the Support Agreement filed hereto as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;7.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January 13, 2025, the Company and Enfusion issued a joint press release announcing the entry into the Merger Agreement. A copy of the press release is attached hereto as Exhibit 99.2 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated into this Item 7.01 by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01, including Exhibit 99.2, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), except as shall be expressly set forth by specific reference in such a filing. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cautionary Statement Regarding Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This current report on Form <span style="white-space:nowrap">8-K</span> contains &#8220;forward-looking statements&#8221; within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the beliefs and assumptions of management of the Company and Enfusion and on information currently available to their management. Forward-looking statements include information concerning the timing of the consummation of the Mergers and the Company&#8217;s ability to satisfy the closing conditions thereof, the Company&#8217;s and Enfusion&#8217;s possible or assumed future results of operations, business strategies, technology developments, financing and investment plans, competitive position, industry, economic and regulatory environment, potential growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or similar expressions and the negatives of those terms, but are not the exclusive means of identifying such statements. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company&#8217;s and Enfusion&#8217;s control, that may cause actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties may cause actual results to differ materially from the Company&#8217;s and Enfusion&#8217;s current expectations and include, but are not limited to, the Company&#8217;s and Enfusion&#8217;s ability to successfully close the Mergers, the Company&#8217;s ability to successfully integrate the operations and technology of Enfusion with those of the Company, retain and incentivize the employees of Enfusion following the close of the acquisition, retain Enfusion&#8217;s clients, repay debt to be incurred in connection with the Enfusion acquisition and meet financial covenants to be imposed in connection with such debt, risks that cost savings, synergies and growth from the acquisition may not be fully realized or may take longer to realize than expected, as well as other risks and uncertainties discussed under &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2023 filed with the SEC on February&#160;29, 2024, and in other periodic reports filed by the Company with the SEC, which are available on the Company&#8217;s website at https://investors.clearwateranalytics.com and on the website of the Securities and Exchange Commission at www.sec.gov. All forward-looking statements are based on assumptions that the Company believes to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and the Company does not undertake any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NO OFFER OR SOLICITATION </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This report is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section&#160;10 of the Securities Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Additional Information and Where to Find It </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Mergers, the Company will file with the SEC a Registration Statement on Form <span style="white-space:nowrap">S-4</span> (the &#8220;Registration Statement&#8221;) to register the shares of the Company&#8217;s common stock to be issued pursuant to the Mergers, which will include a prospectus of the Company and a proxy statement of Enfusion (the &#8220;proxy statement/prospectus&#8221;). Each of the Company and Enfusion may also file other documents with the SEC regarding the Mergers. This document is not a substitute for the Registration Statement, proxy statement/prospectus or any other document which the Company or Enfusion may file with the SEC in connection with the Mergers. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TRANSACTION, THE RISKS RELATED THERETO, AND RELATED MATTERS. After the Registration Statement has been declared effective, the definitive proxy statement/prospectus (if and when available) will be mailed to Enfusion&#8217;s security holders. Investors and security holders will be able to obtain free copies of the Registration Statement and proxy statement/prospectus, as each may be amended or supplemented from time to time, and other relevant documents filed by the Company and Enfusion with the SEC (if and when available) through the website maintained by the SEC at www.sec.gov. Copies of documents filed with the SEC by the Company, including the proxy statement/prospectus (when available), will be available free of charge from the Company&#8217;s website at https://investors.clearwateranalytics.com. Copies of documents filed with the SEC by Enfusion, including the proxy statement/prospectus (when available), will be available free of charge from Enfusion&#8217;s website at http://ir.enfusion.com. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Participants in the Solicitation </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company, Enfusion and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the Mergers. Information about the Company&#8217;s directors and executive officers is available in the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2023 filed with the SEC on February&#160;29, 2024, its definitive proxy statement for its 2024 annual meeting of stockholders, which was filed with the SEC on April&#160;29, 2024, and in the proxy statement/prospectus (when available). Information about the directors and executive officers of Enfusion is available in its Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2023 filed with the SEC on March&#160;12, 2024, its definitive proxy statement for its 2024 annual meeting of stockholders, which was filed with the SEC on April&#160;26, 2024, and in the proxy statement/prospectus (when available). Other information regarding the participants in the solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the Registration Statement, the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the Mergers when they become available. Investors should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. Copies of the documents filed with the SEC by the Company and Enfusion will be available free of charge through the website maintained by the SEC at www.sec.gov. Additionally, copies of documents filed with the SEC by the Company, including the proxy statement/prospectus (when available) will be available free of charge from the Company&#8217;s website at https://investors.clearwateranalytics.com and copies of documents filed with the SEC by Enfusion, including the proxy statement/prospectus (when available), will be available free of charge from Enfusion&#8217;s website at http://ir.enfusion.com. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:94%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d921635dex21.htm">Agreement and Plan of Merger, dated as of January&#160;10, 2025, by and among Clearwater Analytics Holdings, Inc., Enfusion, Inc., Enfusion Ltd LLC, Poseidon Merger Sub I, Inc. and Poseidon Merger Sub II, LLC.* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d921635dex991.htm">Form of Support Agreement. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d921635dex992.htm">Press Release, dated January&#160;13, 2025, issued by the Company and Enfusion, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">All schedules to the Merger Agreement have been omitted pursuant to Item 601(a)(5) of Regulation <span style="white-space:nowrap">S-K.</span> The Company hereby agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Clearwater Analytics Holdings, Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: January 13, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Alphonse Valbrune</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Alphonse Valbrune, Chief Legal Officer and Corporate Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d921635dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION COPY </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>by and among </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ENFUSION,
INC., </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ENFUSION LTD. LLC, </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CLEARWATER ANALYTICS HOLDINGS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POSEIDON ACQUIRER, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POSEIDON MERGER SUB I, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POSEIDON MERGER
SUB II, LLC </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JANUARY&nbsp;10,&nbsp;2025 </B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Other Defined Terms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Other Definitional and Interpretative Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II THE MERGERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Mergers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conversion of Shares and Units</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Election Procedures; Allocation of Merger Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exchange of Eligible Shares and Delivery of Merger Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Company Equity Awards; ESPP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Adjustments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Withholding Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payoff</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III THE SURVIVING CORPORATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certificate of Formation; Certificate of Incorporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>LLC Agreement; <FONT STYLE="white-space:nowrap">By-laws</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Directors and Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Existence and Power</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Authorization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governmental Authorization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-contravention</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Capitalization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SEC Filings and the Sarbanes-Oxley Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financial Statements; Internal Controls</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Certain Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Undisclosed Material Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance with Applicable Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Business Practices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Labor and Employment Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>AI Systems</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Properties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Data Privacy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.24</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Brokers&#146; Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Opinion of Financial Advisor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.26</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Anti-Takeover Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.27</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stock Ownership</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT, ACQUIRER, MERGER SUB AND MERGER
SUB II</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Existence and Power</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Authorization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governmental Authorization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-contravention</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Capitalization and Operation of Parent, Acquirer, Merger Sub and Merger Sub II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Vote of Parent Stockholders; Required Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance with Applicable Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Available Funds; Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Solvency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Certain Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stock Ownership</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Brokers&#146; Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Foreign Person</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SEC Filings and the Sarbanes-Oxley Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financial Statements; Internal Controls</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Certain Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Undisclosed Material Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Anti-Takeover Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Tax-Free</FONT> Reorganization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ownership and Tax Classification of Acquirer, Merger Sub, and Merger Sub II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Acquisition Proposals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Company Recommendation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Approval of Merger Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Access to Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>State Takeover Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Obligations of Acquirer, Merger Sub and Merger Sub II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director and Officer Liability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reasonable Best Efforts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Transaction Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Public Announcements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;16 Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Listing Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Parent Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financing Cooperation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of Parent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notice of Certain Events</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII CONDITIONS TO THE MERGERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to the Obligations of Each Party</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to the Obligations of Parent, Acquirer, Merger Sub and Merger Sub II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to the Obligations of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII TERMINATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Survival of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendments and Waivers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Fees and Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assignment; Benefit</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver of Jury Trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Parent Guarantee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement; No Reliance; Access to Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rules of Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Disclosure Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts; Effectiveness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-Recourse</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Debt Financing Related Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS AGREEMENT AND PLAN OF MERGER (this &#147;<B>Agreement</B>&#148;), dated January&nbsp;10,&nbsp;2025, is entered into by and among
Enfusion, Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), Enfusion Ltd. LLC, a Delaware limited liability company (the &#147;<B>Operating Company</B>&#148;), Clearwater Analytics Holdings, Inc., a Delaware corporation
(&#147;<B>Parent</B>&#148;), Poseidon Acquirer, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent (&#147;<B>Acquirer</B>&#148;), Poseidon Merger Sub I, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent
(&#147;<B>Merger Sub</B>&#148;), and Poseidon Merger Sub II, LLC, a Delaware limited liability company and an indirect subsidiary of Parent (&#147;<B>Merger Sub II</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company Board has established a special committee of independent and disinterested members of the Company Board (the
&#147;<B>Special Committee</B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Special Committee has unanimously (i)&nbsp;determined that this Agreement, providing
for the merger of Merger Sub with and into the Company (the &#147;<B>Merger</B>&#148;), with the Company surviving the Merger as a wholly-owned Subsidiary of Parent in accordance with the DGCL, the Merger and the other transactions contemplated by
this Agreement are advisable, fair to and in the best interests of the Company and the Company&#146;s stockholders, (ii)&nbsp;recommended that the Company Board determine that this Agreement, the Merger and the other transactions contemplated by
this Agreement are advisable, fair to and in the best interests of the Company and the Company&#146;s stockholders and that the Company Board adopt and approve this Agreement, the Merger and the other transactions contemplated by this Agreement,
(iii)&nbsp;recommended that the Company Board adopt and approve this Agreement, the Merger and the other transactions contemplated by this Agreement and (iv)&nbsp;recommended that, subject to approval by the Company Board, the Company Board submit
this Agreement to the Company&#146;s stockholders entitled to vote thereon for adoption thereby and resolve to recommend that such stockholders adopt this Agreement and approve the transactions contemplated by this Agreement, including the Merger;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the parties hereto intend that, subject to <U>Section</U><U></U><U>&nbsp;6.16(b)(ii)</U>, the Corporate Mergers, taken together,
constitute a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code that is subject to the Intended Tax Treatment, and that this Agreement constitutes and be adopted as a &#147;plan of reorganization&#148; within the
meaning of Section&nbsp;368 of the Code and Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-2(g);</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company Board, upon the unanimous recommendation of the Special Committee, has unanimously (i)&nbsp;determined that this
Agreement, the Merger and the other transactions contemplated by this Agreement are advisable, fair to and in the best interests of the Company and the Company&#146;s stockholders, (ii)&nbsp;adopted and approved this Agreement, the Merger and the
other transactions contemplated by this Agreement, and (iii)&nbsp;directed that this Agreement be submitted to the Company&#146;s stockholders entitled to vote thereon for adoption thereby and resolved to recommend that such stockholders adopt this
Agreement and approve the transactions contemplated by this Agreement, including the Merger; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Enfusion US 1, Inc., in its capacity as the managing member of the Operating
Company, has (i)&nbsp;determined that it is in the best interests of the Operating Company and its members, declared it advisable to enter into this Agreement providing for the merger of Merger Sub II with and into the Operating Company (the
&#147;<B>LLC Merger</B>&#148; and, together with the Corporate Mergers, the &#147;<B>Mergers</B>&#148;) in accordance with the DLLCA upon the terms and subject to the conditions set forth herein; and (ii)&nbsp;approved the execution and delivery of
this Agreement by the Operating Company and the consummation of the LLC Merger upon the terms and subject to the conditions set forth herein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Boards of Directors of each of Merger Sub, Merger Sub II, Acquirer and Parent have each (i)&nbsp;determined that this Agreement
and the Mergers are advisable and in the best interests of their respective stockholders, (ii)&nbsp;approved the Mergers on the terms and subject to the conditions set forth herein, and (iii)&nbsp;adopted and approved this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, each of the sole stockholder of Acquirer, the sole stockholder of Merger Sub and the sole member of Merger Sub II has approved the
Mergers on the terms and subject to the conditions set forth herein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as a condition and inducement to Parent&#146;s willingness
to enter into this Agreement, certain holders of the Company Common Stock have entered into a voting and support agreement (a &#147;<B>Support Agreement</B>&#148;) in connection with the transactions contemplated hereby; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution and delivery of this Agreement, the Company and certain members of the Operating Company entitled to
benefits under the Tax Receivable Agreement are entering into that certain Amendment No.&nbsp;1 to the Tax Receivable Agreement (the &#147;<B>TRA Amendment</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below,
the parties hereto agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01 <I><U>Definitions</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As used herein, the following terms have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acceptable Confidentiality Agreement</B>&#148; means a confidentiality agreement containing confidentiality and use terms not
materially less restrictive in the aggregate to the counterparty thereto than the confidentiality and use terms of the Confidentiality Agreement (it being agreed that such confidentiality agreement need not contain any &#147;<B>standstill</B>&#148;
or similar provisions or otherwise prohibit the making, or amendment, of any Acquisition Proposal); <U>provided</U>, <U>however</U>, that such confidentiality agreement shall contain provisions that permit the Company to comply with the provisions
of <U>ARTICLE VI</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquisition Proposal</B>&#148; means any inquiry, offer or proposal from any Third
Party relating to any transaction or series of related transactions involving (i)&nbsp;any acquisition or purchase by any Third Party, directly or indirectly, of 20% or more of the voting power of the capital stock of the Company and its
Subsidiaries (including securities convertible into or exercisable or exchangeable for equity or voting securities), or any tender offer, exchange offer, share issuance or other similar transaction that, if consummated, would result in any Third
Party beneficially owning 20% or more of the voting power of the capital stock of the Company and its Subsidiaries (including securities convertible into or exercisable or exchangeable for equity or voting securities), (ii) any merger, amalgamation,
consolidation, share exchange, business combination, joint venture or other similar transaction involving the Company or any of its Subsidiaries, pursuant to which a Third Party would (x)&nbsp;acquire, directly or indirectly, 20% or more of the
consolidated revenues or income or fair market value of the consolidated assets of the Company and its Subsidiaries, taken as a whole or (y)&nbsp;beneficially own 20% of the voting power of the capital stock of the Company (including securities
convertible into or exercisable or exchangeable for equity or voting securities), (iii) any liquidation, dissolution, recapitalization, extraordinary dividend or other significant corporate reorganization of the Company or any of its Subsidiaries,
the business of which constitutes 20% or more of the consolidated revenues or income or fair market value of the consolidated assets of the Company and its Subsidiaries, taken as a whole, (iv)&nbsp;any direct or indirect merger, consolidation, share
exchange, business combination, joint venture, partnership, recapitalization, reorganization or other similar transaction involving the Company or any of its Subsidiaries, or the surviving entity in such transaction, or resulting direct or indirect
parent entity of the Company, any of its Subsidiaries or the surviving entity in such transaction, pursuant to which the stockholders of the Company immediately preceding such transaction hold less than 80% of the equity interests in the surviving
or resulting entity of such transaction or (v)&nbsp;any combination of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means, with respect to
any Person, any other Person directly or indirectly controlling, controlled by, or under common control with such Person. As used in this definition, the term &#147;control&#148; (including the terms &#147;controlling,&#148; &#147;controlled
by&#148; and &#147;under common control with&#148;) means possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ownership of voting securities, by contract or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Aggregate Merger Consideration</B>&#148; means, collectively, (i)&nbsp;the aggregate per share Merger Consideration,
(ii)&nbsp;the aggregate per unit Merger Consideration, and (iii)&nbsp;the aggregate Vested Equity Award Consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>AI
Systems</B>&#148; means any artificial intelligence or machine-based system that, for explicit or implicit objectives, infers, from the input it receives, how to generate outputs such as predictions, content, recommendations, or decisions that may
influence physical or virtual environments, in each case used by the Company or any of its Subsidiaries, whether proprietary to the Company or any of its Subsidiaries or provided by third parties, and including: (i)&nbsp;any learning and predictive
analysis; (ii)&nbsp;algorithmic, rule-based expressions; (iii)&nbsp;generative artificial intelligence; and (iv)&nbsp;any other definition provided by Applicable Law or the Company or any of its Subsidiaries in any of its or their written policies,
procedures and contracts, for &#147;artificial intelligence,&#148; &#147;generative artificial intelligence,&#148; &#147;artificial general intelligence,&#148; &#147;large language model,&#148; &#147;foundation model,&#148; &#147;machine
learning,&#148; &#147;algorithm,&#148; and any similar term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Anti-Corruption Laws</B>&#148; means laws related to bribery,
corruption, kickbacks, racketeering, fraud, or other improper payments including the U.S. Foreign Corrupt Practices Act of 1977, the UK Bribery Act of 2010, and Applicable Laws implementing the OECD Convention on Combating Bribery of Foreign Public
Officials in International Business Transactions, 1997. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Anti-Money Laundering Laws</B>&#148; means laws related to money laundering,
anti-terrorism, proceeds of crime, or financial record keeping, including the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001
(USA PATRIOT Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Antitrust Laws</B>&#148; means the Sherman Antitrust Act of 1890, the Clayton Antitrust Act, the HSR Act, the
Federal Trade Commission Act of 1914 and all other applicable federal, state, local or foreign antitrust, competition, premerger notification or trade regulation laws, regulations or Orders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Law</B>&#148; means, with respect to any Person, any supranational, international, national, federal, state or local law
(statutory, common or otherwise), statute, act, stipulation, constitution, treaty, convention, ordinance, code, rule, regulation, Order or other similar requirement enacted, adopted, promulgated or applied by a Governmental Authority that is legally
binding upon and applicable to such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Burdensome Condition</B>&#148; means (i)&nbsp;any restrictions, conditions,
restraints or concessions (including any Specified Actions) with respect to the assets, properties or businesses of the Company or its Subsidiaries which would, individually or in the aggregate, result in, or be reasonably likely to result in, a
material adverse effect on the Company and its Subsidiaries, taken as a whole, (ii)&nbsp;any restrictions, conditions, restraints or concessions (including any Specified Actions) with respect to the assets, properties or businesses of any
stockholder of Parent or any of its Affiliates (other than, for purposes of this clause (ii), Parent or any of its Subsidiaries (which shall be subject to clause (iii)&nbsp;of this definition) or, following the Closing, the Company or any of its
Subsidiaries (which shall be subject to clause (i)&nbsp;of this definition)) or (iii)&nbsp;any restrictions, conditions, restraints or concessions (including any Specified Actions) with respect to the assets, properties or businesses of Parent or
any of its Subsidiaries (other than, following the Closing, the Company or any of its Subsidiaries, which shall be subject to clause (i)&nbsp;of this definition) that would result in a loss, in the aggregate, of more than $20,000,000 of revenue
generated by Parent and its Subsidiaries (taken as a whole) between (and inclusive of) January&nbsp;1, 2024 and December&nbsp;31, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means a day, other than Saturday, Sunday or other day on which commercial banks in New York, New York or
Chicago, Illinois are authorized or required by Applicable Law to close. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate</B>&#148; means each certificate formerly
representing any Eligible Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Class</B><B></B><B>&nbsp;A Common Stock</B>&#148; means Class&nbsp;A common stock of the
Company, par value $0.001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Class</B><B></B><B>&nbsp;B Common Stock</B>&#148; means Class&nbsp;B common stock of the
Company, par value $0.001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Closing Date</B>&#148; means the date of the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Code</B>&#148; means the Internal Revenue Code of 1986. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Common Unit</B>&#148; means the common limited liability company membership interests described in Section&nbsp;3.1(a)(i) of the
Operating Agreement, and having the rights and preferences specified herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Balance Sheet</B>&#148; means the
consolidated balance sheet of the Company and its Subsidiaries as of the Company Balance Sheet Date and the footnotes thereto set forth in the Company SEC Documents for the period ended on the Company Balance Sheet Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Balance Sheet Date</B>&#148; means September&nbsp;30, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Blockers</B>&#148; means, collectively, Enfusion US 1, Inc., Enfusion US 2, Inc. and Enfusion US 3, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Board</B>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Common Stock</B>&#148; means the Class&nbsp;A Common Stock and the Class&nbsp;B Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Credit Agreement</B>&#148; means that certain Credit Agreement, dated as of September&nbsp;15, 2023, among the Operating
Company, the Company, the guarantors party thereto, Bank of America, N.A. as administrative agent, swing line lender and L/C issuer and the lenders thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Disclosure Schedule</B>&#148; means the disclosure schedule that has been prepared by the Company and delivered to Parent,
Acquirer, Merger Sub and Merger Sub II prior to or simultaneously with the execution of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Employee
Plan</B>&#148; means (i)&nbsp;each &#147;employee benefit plan,&#148; within the meaning of Section&nbsp;3(3) of ERISA, whether or not subject to ERISA, (ii)&nbsp;each employment, severance or similar contract, plan, arrangement, or policy and
(iii)&nbsp;each other plan or arrangement providing for compensation or benefits (including variable cash compensation and sales commissions), incentive, bonuses, profit-sharing, stock, stock option or other equity-related rights (including
restricted stock units and stock purchase rights) or other forms of incentive or deferred compensation, health or medical care and benefits, employee assistance program, education or tuition assistance programs, disability, hospitalization, death or
sick leave benefits, supplemental unemployment benefits, severance benefits, post-employment or retirement benefits, termination, change in control, retention, pension, savings, vacation, cafeteria, dependent care, and other similar fringe or
similar employee benefit contract, plan, arrangement, agreement or policy (whether or not written and whether or not funded), that, in each case, is maintained, administered, contributed to or required to be contributed to by the Company or any
Subsidiary of the Company for the benefit of any current or former employees, officers or directors of the Company or any Subsidiary of the Company or with respect to which any current or potential liability is borne by the Company or any Subsidiary
of the Company, excluding (i)&nbsp;any benefit plan maintained by a Governmental Authority, and (ii)&nbsp;any statutory benefits (or related benefit plan) mandated by Applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Equity Awards</B>&#148; means the Company Stock Options, the Company RSUs
and the Company PSUs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Intellectual Property</B>&#148; means, individually or collectively, the Company Owned
Intellectual Property and the Company Licensed Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Licensed Intellectual Property</B>&#148; means all
Intellectual Property that is used, practiced or held for use or practice by the Company or any of its Subsidiaries or that is otherwise incorporated or embodied in any Company products or services (including the Proprietary Software Product),
except for any Company Owned Intellectual Property. For clarity, Company Licensed Intellectual Property includes Domain Names controlled by the Company or any of its Subsidiaries pursuant to the terms of service of the applicable domain registrar or
social media company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Material Adverse Effect</B>&#148; means any change, effect, event, occurrence, development,
condition or fact (collectively, &#147;<B>Effects</B>&#148;) that, individually or in the aggregate with all other Effects, that (i)&nbsp;would reasonably be expected materially impede, materially delay or prevent the Company&#146;s ability to
consummate the transactions contemplated by this Agreement or (ii)&nbsp;has had, or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and
its Subsidiaries, taken as a whole; <U>provided</U>, <U>however</U>, that none of the following (alone or in combination) shall constitute or be taken into account in determining whether a Company Material Adverse Effect has occurred or would
reasonably be expected to occur pursuant to the foregoing clause (ii): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) the negotiation, execution, announcement or performance of
this Agreement or the pendency or consummation of the Mergers or the other transactions contemplated by this Agreement (including, solely to the extent it relates to the foregoing, any loss of or adverse change in the relationship of the Company and
its Subsidiaries with their respective employees, investors, contractors, lenders, customers, technology and other partners, suppliers, vendors or Governmental Authorities or other Third Parties related thereto); <U>provided</U>, that no effect
shall be given to this clause (A)&nbsp;for purposes of any representation or warranty in <U>Section</U><U></U><U>&nbsp;4.04</U> or the condition to Closing in <U>Section</U><U></U><U>&nbsp;7.02(a)</U> to the extent relating to any such
representation or warranty; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) the identity of Parent or any of its Affiliates as the acquiror of the Company, or any facts or
circumstances concerning Parent or any of its Affiliates, including any communication by any of them regarding plans, proposals or projections with respect to the Company, its Subsidiaries or their employees; <U>provided</U>, that no effect shall be
given to this clause (B)&nbsp;or the foregoing clause (A)&nbsp;for purposes of any representation or warranty in <U>Section</U><U></U><U>&nbsp;4.04</U> or the condition to Closing in <U>Section</U><U></U><U>&nbsp;7.02(a)</U> to the extent relating
to any such representation or warranty; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) general business, economic or political conditions, or the capital, credit, banking, debt,
financial or currency markets, in the United States or elsewhere in the world, or changes therein, including changes in interest or exchange rates or any suspension of trading in securities on the NYSE; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) general conditions in any industry in which the Company and its Subsidiaries operate or
in any specific jurisdiction or geographic area in the United States or elsewhere in the world in which the Company and its Subsidiaries operate, or changes therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) any changes in GAAP or other accounting standards (or the enforcement or interpretation thereof) enacted after the date hereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) any changes in Applicable Law (or the enforcement or interpretation thereof), including the adoption, implementation, repeal,
modification, reinterpretation or proposal of any Applicable Law (or the enforcement or interpretation thereof) by any Governmental Authority, or any panel or advisory body empowered or appointed thereby, in each case, enacted after the date hereof;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) the taking of any action, or refraining from taking any action, in each case at the express written direction of Parent, Acquirer,
Merger Sub or Merger Sub II or as expressly required by this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) any Transaction Litigation or any demand or Proceeding for
appraisal or the fair value of any shares of Company Common Stock pursuant to the DGCL in connection herewith; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) any outbreak,
continuation or escalation of acts of terrorism, hostilities, sabotage or war (whether or not declared, including the Russian-Ukrainian and Israeli-Palestinian conflicts, and escalations and effects thereof), hurricanes, volcanoes, tornados, floods,
earthquakes, tsunamis, mudslides, weather-related events, epidemics, pandemics (including <FONT STYLE="white-space:nowrap">COVID-19),</FONT> plagues, other outbreaks of illness or public health events, fires or natural or <FONT
STYLE="white-space:nowrap">man-made</FONT> disaster or act of God, including any worsening of such conditions existing as of the date hereof; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) any failure by the Company to meet, or changes to, internal or analysts&#146; estimates, projections, expectations, budgets or forecasts
of operating statistics, revenue, earnings, cash flow or any other financial or performance measures (whether made by the Company or any Third Parties), any change in the Company&#146;s credit ratings, or any change in the price or trading volume of
shares of the Class&nbsp;A Common Stock (it being understood that the underlying causes of such failures or changes in this clause (J)&nbsp;may be taken into account in determining whether a Company Material Adverse Effect has occurred, unless such
underlying cause would otherwise be excepted by this definition); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U> that in the case of clauses (C), (D), (E), (F) and (I), such any Effect
may be taken into account in determining whether or not there has been a Company Material Adverse Effect, but only to the extent such any Effect has had or would reasonably be expected to have, individually or in the aggregate, a disproportionate
adverse effect on the Company and its Subsidiaries, taken as a whole, as compared to other similarly situated participants in the industry in which the Company and its Subsidiaries operate, in which case only the incremental disproportionate impact
or impacts may be taken into account in determining whether or not there has been a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Owned Intellectual Property</B>&#148; means all Intellectual Property owned
or purported to be owned by the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company PSUs</B>&#148; means each restricted stock unit
covering shares of Company Common Stock outstanding immediately prior to the Effective Time that is subject in whole or in part to performance-based vesting conditions, including performance goals or metrics, that was granted under the Company Stock
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Return</B>&#148; means any Tax Return of the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company RSU</B>&#148; means each restricted stock unit covering shares of Company Common Stock outstanding immediately prior to the
Effective Time that is subject to vesting conditions based solely on continued employment or service that was granted under the Company Stock Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Stock Option</B>&#148; means each option to purchase shares of Company Common Stock granted under the Company Stock Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Stock Plan</B>&#148; means the 2021 Stock Options and Incentive Plan, as amended, restated, supplemented or otherwise
modified from time to time in accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Termination Fee</B>&#148; means an amount equal to $52,325,000.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Contract</B>&#148; means any legally binding contract, agreement, note, bond, indenture, mortgage, guarantee, option, lease (or
sublease), license, sales or purchase order, warranty, commitment, or other instrument, obligation, arrangement or understanding of any kind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Corporate Mergers</B>&#148; means, collectively, the Merger and the Second Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">COVID-19</FONT></B>&#148; means the coronavirus (or
<FONT STYLE="white-space:nowrap">COVID-19)</FONT> pandemic, including any evolutions or mutations of the coronavirus <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> disease, and any further epidemics or pandemics arising therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Debt Financing Related Parties</B>&#148; means the Debt Financing Sources, their respective Affiliates and their and their respective
Affiliates&#146; respective directors, officers, employees, agents, advisors and other Representatives, and their successors and permitted assigns, in each case, solely in their capacities as such. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Debt Financing Sources</B>&#148; means, at any time, the agents, arrangers, lenders, initial purchasers and other entities that have
committed to provide or arrange, or have otherwise entered into agreements in connection with, all or any part of the Debt Financing (including the parties to any debt commitment letter and any agreements, joinder agreements, engagement letters,
underwriting agreements, indentures, loan agreements or credit agreements or other documentation entered into in connection therewith). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>DGCL</B>&#148; means the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>DLLCA</B>&#148; means Delaware Limited Liability Company Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Environmental Law</B>&#148; means any Applicable Law or Order concerning pollution, public or worker health or safety, or protection
of natural resources or the environment, including any such Applicable Law or Order relating to the manufacture, handling, transport, use, treatment, storage, disposal or release of, or exposure to, any Hazardous Substance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA</B>&#148; means the Employee Retirement Income Security Act of 1974 and the
rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA Affiliate</B>&#148; of any entity means any other entity that, together with
such entity, would be treated as a single employer within the meaning of Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code or Section&nbsp;4001(b)(1) of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ESPP</B>&#148; means the Company&#146;s 2021 Employee Stock Purchase Plan, as amended, restated, supplemented or otherwise modified
from time to time in accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934 and the rules
and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Agent Agreement</B>&#148; means the Contract pursuant to which Parent shall
appoint the Exchange Agent, which shall be in form and substance reasonably acceptable to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Final Judgment</B>&#148;
means a final <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment by a Governmental Authority with lawful jurisdiction over a Proceeding pursuant to <U>Section</U><U></U><U>&nbsp;9.07</U> of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Foreign Employee Plan</B>&#148; means any Company Employee Plan that is maintained pursuant to or is subject to the laws of a country
other than the United States, or provides compensation or benefits to participants providing services primarily outside of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Foreign Investment Laws</B>&#148; means all Applicable Laws relating to foreign investment or that provide for the review of national
security or defense matters or the national interest in connection with the acquisition of any interest in or assets of a business under the jurisdiction of a Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>GAAP</B>&#148; means generally accepted accounting principles in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148; means (i)&nbsp;any government or any nation, state, supra-national body, department, local authority
or other political subdivision thereof, (ii)&nbsp;any governmental or quasi-governmental body, agency, authority, self-regulatory organization (including the NYSE) or other instrumentality legally entitled to exercise executive, legislative,
judicial, regulatory or administrative functions of or pertaining to government or (iii)&nbsp;any public or private arbitral tribunal or body of competent jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authorizations</B>&#148; means, with respect to any Person, all licenses, permits, certificates, waivers, consents,
franchises (including similar authorizations or permits), exemptions, variances, expirations and terminations of any waiting period requirements and other authorizations and approvals issued to such Person by or obtained by such Person from any
Governmental Authority, or of which such Person has the benefit under any Applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Hazardous Substance</B>&#148; means any pollutant, contaminant, toxic substance,
hazardous waste, hazardous material, hazardous substance, petroleum or petroleum-containing product, asbestos-containing material, <FONT STYLE="white-space:nowrap">per-</FONT> or polyfluoroalkyl substance, or polychlorinated biphenyl, as listed,
defined or regulated (or any other substance, material or waste for which liability or standards of conduct may be imposed) under any Environmental Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HSR Act</B>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the rules and regulations promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Stock
Option</B>&#148; means a Company Stock Option with an exercise price per share that is less than the Per Share Cash Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Information Privacy and Security Laws</B>&#148; means any and all Applicable Laws (including any legally binding directive or
guidance) issued by a Governmental Authority and any applicable self- regulatory guidelines that the Company or a Subsidiary is obligated to comply with under any Applicable Law or Contract, in each case governing: (i)&nbsp;the privacy, protection,
security or Processing of Personal Information, (ii)&nbsp;online behavioral advertising, tracking technologies, call or electronic monitoring or recording, or any outbound calling and text messaging, telemarketing and email marketing,
(iii)&nbsp;breach notification, (iv)&nbsp;the use of biometric identifiers, (v)&nbsp;cybersecurity or (vi)&nbsp;data security. Without limiting the foregoing, &#147;<B>Information Privacy and Security Laws</B>&#148; includes the following, in each
case, to the extent applicable to the Company or any of its Subsidiaries: the Federal Trade Commission Act, the Telephone Consumer Protection Act, the Telemarketing and Consumer Fraud and Abuse Prevention Act, the Controlling the Assault of <FONT
STYLE="white-space:nowrap">Non-Solicited</FONT> Pornography and Marketing Act of 2003, the Computer Fraud and Abuse Act, the Electronic Communications Privacy Act, the Fair Credit Reporting Act, PCI DSS, the Fair and Accurate Credit Transactions
Act, the Health Insurance Portability and Accountability Act of 1996, as amended, including as amended by the Health Information Technology for Economic and Clinical Health Act of the American Recovery and Reinvestment Act of 2009, the applicable
provisions of the 21st Century Cures Act, and Public Law <FONT STYLE="white-space:nowrap">116-321,</FONT> and implementing regulations, including 45 C.F.R. Parts 160, 162, and 164, the Gramm-Leach-Bliley Act, the California Consumer Privacy Act, as
amended by the California Privacy Rights Act, state privacy laws, state data security laws, state social security number protection laws, state data breach notification laws, state consumer protection laws, the EU General Data Protection Regulation
2016/679 (&#147;<B>GDPR</B>&#148;) (and any applicable European Union member states&#146; laws and regulations implementing it), the GDPR it forms part of the law of the UK by virtue of section 3 of the European Union (Withdrawal) Act 2018, the UK
Data Protection Act 2018, the European Directive 2002/58/EC including as implemented into the law of the UK by the Privacy and Electronic Communications Regulations, the Canadian Personal Information Protection and Electronic Documents Act,
India&#146;s Information Technology Act, Japan&#146;s Act on the Protection of Personal Information, Hong Kong&#146;s Personal Data (Privacy) Ordinance, and Australia&#146;s Privacy Amendment (Private Sector) Act 2000, as amended by the Privacy
Amendment (Enhancing Privacy Protection) Act 2012, and other applicable data protection, data privacy or data security Applicable Laws, including, to the extent applicable, consumer health data Applicable Laws and the Federal Trade Commission health
breach notification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>International Trade Laws</B>&#148; means all Applicable Laws relating to export,
import, or anti-boycott, including without limitation laws relating to the export, reexport, and transfer of products, technology, software, commodities, and other items, including the Export Administration Regulations; laws relating to customs and
imports, including those administered by U.S. Customs and Border Protection; and anti-boycott laws, including those administered by the U.S. Department of Commerce and the U.S. Department of the Treasury. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intellectual Property</B>&#148; means all right, title and interest in or relating to technology or intellectual property in any
jurisdiction throughout the world, including (i)&nbsp;patents and patent applications, together with all reissuances, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisions,
revisions, substitutions, provisionals, renewals, extensions and reexaminations thereof (collectively, &#147;<B>Patents</B>&#148;); (ii) trade names, brand names, corporate names, trade dress, trade styles, logos, slogans, and other indicators of
the commercial source or origin of a product or service, trademarks, service marks, and general intangibles of a like nature, in each case, whether or not registered, and all registrations and applications to register, and renewals and extensions
of, any of the foregoing, together with all goodwill and <FONT STYLE="white-space:nowrap">common-law</FONT> rights associated therewith (collectively, &#147;<B>Marks</B>&#148;); (iii) copyrights and copyrightable works in both published and
unpublished works, whether or not registered, including all source code, design rights, compilations, data collections, databases and computer programs, &#147;moral&#148; rights, manuals and all registrations and applications to register, and
renewals, extensions and reversions of, any of the foregoing, and corresponding rights in works of authorship (collectively, &#147;<B>Copyrights</B>&#148;); (iv) trade secret rights and corresponding rights in, confidential information and other <FONT
STYLE="white-space:nowrap">non-public</FONT> or proprietary information (whether or not patentable or copyrightable), including ideas, <FONT STYLE="white-space:nowrap">know-how,</FONT> inventions, technology, Software discoveries and invention
disclosures, research in progress, improvements, methods, procedures, algorithms, data, databases, data collections, designs, processes, techniques, formulae, drawings, schematics, blueprints, flow charts, models, plans, strategies and prototypes
(collectively, &#147;<B>Trade Secrets</B>&#148;); (v) Internet domain names and social media accounts (collectively, &#147;<B>Domain Names</B>&#148;); (vi) intellectual property rights arising from Software and technology; and (vii)&nbsp;any and all
similar, corresponding or equivalent intellectual or proprietary rights arising under the laws of any jurisdiction throughout the world or pursuant to any international convention. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intervening Event</B>&#148; means a material positive fact, event, change, development or circumstance with respect to the Company
and its Subsidiaries or the business of the Company and its Subsidiaries, taken as a whole, not known, or reasonably foreseeable or expected, by the Special Committee as of or prior to the date hereof; <U>provided</U>, that in no event shall any
Effect that results from, involves or relates to any of the following give rise to an Intervening Event: (i)&nbsp;the receipt of an Acquisition Proposal or a Superior Proposal or any inquiry or communications or matters relating thereto;
(ii)&nbsp;the announcement or performance of this Agreement or the pendency or consummation of the Mergers or the other transactions contemplated by this Agreement; or the identity of Parent or any of its Affiliates as the acquiror of the Company,
or any facts or circumstances concerning Parent or any of its Affiliates, including any communication by any of them regarding plans, proposals or projections with respect to the Company, its Subsidiaries or their respective employees;
(iii)&nbsp;any change, in and of itself, in the price or trading volume of shares of the Class&nbsp;A Common Stock (although for purposes of clarity, any underlying Effect, with respect to this clause (iii)&nbsp;relating to or causing such change
may be considered, along with the effects or consequences thereof to the extent not otherwise excluded from this definition); or (iv)&nbsp;the fact, in and of itself, that the Company has exceeded or met internal or analysts&#146; estimates,
projections, expectations, budgets or forecasts of operating </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statistics, revenue, earnings, cash flow or any other financial or performance measures (whether made by the Company or any Third Parties) for any period ending (or for which revenues or earnings
are released) on or after the date hereof (although for purposes of clarity, any underlying Effect relating to or causing such material improvement or improvements may be considered, along with the effects or consequences thereof to the extent not
otherwise excluded from this definition). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Invention Assignment Agreement</B>&#148;<B> </B>means an executed, valid and
enforceable written Contract pursuant to which a Person has assigned to the Company or its applicable Subsidiary all of such Person&#146;s rights, title and interest in and to all Intellectual Property created or developed for the Company or the
applicable Subsidiary in the course of such Person&#146;s involvement, employment or retention thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Knowledge of the
Company</B>&#148; means the actual knowledge of each of the individuals identified in <U>Section</U><U></U><U>&nbsp;1.01</U> of the Company Disclosure Schedule following reasonable inquiry of their direct reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Knowledge of Parent</B>&#148; means the actual knowledge of each of the individuals identified in
<U>Section</U><U></U><U>&nbsp;1.01</U> of the Parent Disclosure Schedule following reasonable inquiry of their direct reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lien</B>&#148; means, with respect to any property or asset, any mortgage, lien, pledge, right of first offer, right of first
refusal, matter of record, exclusive license, priority, claim, charge, security interest or encumbrance restriction in respect of such property or asset. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Made Available</B>&#148; means that such information, document or material was: (i)&nbsp;publicly available on the SEC EDGAR database
at least 12 hours prior to the execution of this Agreement; or (ii)&nbsp;delivered to Parent or Parent&#146;s Representatives via electronic mail, in hard copy form or via the virtual data room titled &#147;Project Poseidon&#148; maintained by or on
behalf of the Company on Datasite in connection with the transactions contemplated by this Agreement at least 12 hours prior to the execution of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Marketing Period</B>&#148; means the first period of seventeen (17)&nbsp;consecutive Business Days commencing on the later of
(i)&nbsp;the earlier of (a)&nbsp;March&nbsp;18, 2025 and (b)&nbsp;the date the consolidated financial statements of Parent and its Subsidiaries included in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ending
December&nbsp;31, 2024 has been filed and (ii)&nbsp;the date that Parent has been provided the Required Financial Information; <U>provided</U>, that (x)&nbsp;the Marketing Period shall end on any earlier date on which the Debt Financing is
consummated and Parent or its Affiliate shall have obtained all of the proceeds contemplated thereby; and (y)&nbsp;the Marketing Period shall be deemed not to have commenced if, prior to the completion of such seventeen (17)&nbsp;consecutive
Business Day period, the Company has issued a public statement indicating its intention to restate, or the Company&#146;s independent auditor has determined that the Company must restate, any financial statements of the Company and its Subsidiaries
included in the Required Financial Information, in which case the Marketing Period shall be deemed not to commence unless and until such restatement has been completed and the applicable Required Financial Information has been amended to reflect
such restatement or the Company or its independent auditor has, as applicable, announced or informed Parent that it has concluded that no restatement will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required. If at any time the Company shall reasonably believe that it has provided the Required Financial Information, the Company may deliver to Parent a written notice to that effect (stating
when it believes it completed such delivery), in which case the requirement to deliver the Required Financial Information will be deemed to have been satisfied on the date specified in such notice and the Marketing Period shall be deemed to have
commenced on the date specified in such notice, in each case, unless Parent in good faith reasonably believes the Company has not completed the delivery of the Required Financial Information and, within four (4)&nbsp;Business Days after the receipt
of such notice from the Company, delivers a written notice to the Company to that effect (stating with specificity which portion(s) of the Required Financial Information the Company has not delivered); <U>provided</U>, that it is hereby understood
that the delivery of such written notice by Parent or the Company&#146;s failure to deliver a written notice stating the Company&#146;s belief that the Required Financial Information have been delivered, in each case, will not prejudice the
Company&#146;s right to assert that the Required Financial Information have been delivered; <U>provided</U>, <U>further</U>, that in the event that it is determined by Parent and the Company (acting reasonably and in good faith) that the delivery of
the Required Financial Information was complete on the date stated in the initial notice from the Company, the Marketing Period shall continue to be deemed to have commenced on such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>NYSE</B>&#148; means the New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Open Source Software</B>&#148; means any software (in source or object code form) that is, or that contains or is derived in any
manner (in whole or in part) from any Software that is, subject to (i)&nbsp;a license or other agreement commonly referred to as an open source, free software, copy left, &#147;freeware&#148;, &#147;shareware&#148; or community source code license
(including any code or library licensed under the GNU General Public License, GNU Lesser General Public License, BSD License, Apache Software License, Llama license, OpenRAIL license, Affero General Public License, Mozilla Public License, Common
Development and Distribution License, Eclipse Public License, any Creative Commons &#147;sharealike&#148; license, or any other public source code license arrangement) or (ii)&nbsp;any other license or other agreement that requires, as a condition
of the use, modification or distribution of software subject to such license or agreement, that such software or other software linked with, called by, combined or distributed with such software be (A)&nbsp;disclosed, distributed, made available,
offered, licensed or delivered in source code form, (B)&nbsp;licensed for the purpose of making derivative works, (C)&nbsp;licensed under terms that allow reverse engineering, reverse assembly, or disassembly of any kind, or (D)&nbsp;redistributable
at no charge, including any license defined as an open source license by the Open Source Initiative as set forth on www.opensource.org. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Operating Agreement</B>&#148; means the Seventh Amended and Restated Operating Agreement of the Operating Company, dated as of
October&nbsp;19, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Order</B>&#148; means, with respect to any Person, any order, injunction, judgment, award or decree,
determination, ruling, writ, stipulation, assessment or other similar requirement enacted, adopted, promulgated or applied by a Governmental Authority that is binding upon or applicable to such Person or its property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Out-of-the-Money</FONT></FONT></FONT> Company
 Stock Option</B>&#148; means a Company Stock Option with an exercise price per share that is equal to or greater than the Per Share Cash Consideration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Parent Class</B><B></B><B>&nbsp;A Common Stock</B>&#148; means Class&nbsp;A common
stock, par value $0.001 per share, of Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Parent Common Stock</B>&#148; means, collectively, the Parent Class&nbsp;A Common
Stock, the Parent Class&nbsp;B Common Stock, the Parent Class&nbsp;C Common Stock and the Parent Class&nbsp;D Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Parent Disclosure Schedule</B>&#148; means the disclosure schedule that has been prepared by Parent and delivered to the Company
prior to or simultaneously with the execution of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Parent Material Adverse Effect</B>&#148; means any Effect that,
individually or in the aggregate with all other Effects, that (i)&nbsp;would reasonably be expected to materially impede, materially delay or prevent Parent&#146;s, Acquirer&#146;s, Merger Sub&#146;s or Merger Sub II&#146;s ability to consummate the
transactions contemplated by this Agreement or (ii)&nbsp;has had, or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of Parent and its Subsidiaries,
taken as a whole; <U>provided</U>, <U>however</U>, that none of the following (alone or in combination) shall constitute or be taken into account in determining whether a Parent Material Adverse Effect has occurred or would reasonably be expected to
occur pursuant to the foregoing clause (ii): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. the negotiation, execution, announcement or performance of this Agreement or the pendency
or consummation of the Mergers or the other transactions contemplated by this Agreement (including, solely to the extent it relates to the foregoing, any loss of or adverse change in the relationship of Parent and its Subsidiaries with their
respective employees, investors, contractors, lenders, customers, technology and other partners, suppliers, vendors or Governmental Authorities or other Third Parties related thereto); <U>provided</U>, that no effect shall be given to this clause
(A)&nbsp;for purposes of any representation or warranty in <U>Section</U><U></U><U>&nbsp;5.04</U> or the condition to Closing in <U>Section</U><U></U><U>&nbsp;7.03(a)</U> to the extent relating to any such representation or warranty; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. general business, economic or political conditions, or the capital, credit, banking, debt, financial or currency markets, in the United
States or elsewhere in the world, or changes therein, including changes in interest or exchange rates or any suspension of trading in securities on the NYSE; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. general conditions in any industry in which Parent and its Subsidiaries operate or in any specific jurisdiction or geographic area in the
United States or elsewhere in the world in which the Company and its Subsidiaries operate, or changes therein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. any changes in GAAP or
other accounting standards (or the enforcement or interpretation thereof) enacted after the date hereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. any changes in Applicable Law
(or the enforcement or interpretation thereof), including the adoption, implementation, repeal, modification, reinterpretation or proposal of any Applicable Law (or the enforcement or interpretation thereof) by any Governmental Authority, or any
panel or advisory body empowered or appointed thereby, in each case, enacted after the date hereof; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">F. the taking of any action, or refraining from taking any action, in each case at the
express written direction of the Company or as expressly required by this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">G. any outbreak, continuation or escalation of acts
of terrorism, hostilities, sabotage or war (whether or not declared, including the Russian-Ukrainian and Israeli-Palestinian conflicts, and escalations and effects thereof), hurricanes, volcanoes, tornados, floods, earthquakes, tsunamis, mudslides,
weather-related events, epidemics, pandemics (including <FONT STYLE="white-space:nowrap">COVID-19),</FONT> plagues, other outbreaks of illness or public health events, fires or natural or <FONT STYLE="white-space:nowrap">man-made</FONT> disaster or
act of God, including any worsening of such conditions existing as of the date hereof; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">H. any failure by Parent to meet, or changes
to, internal or analysts&#146; estimates, projections, expectations, budgets or forecasts of operating statistics, revenue, earnings, cash flow or any other financial or performance measures (whether made by the Company or any Third Parties), any
change in Parent&#146;s credit ratings, or any change in the price or trading volume of shares of the Parent Class&nbsp;A Common Stock (it being understood that the underlying causes of such failures or changes in this clause (H)&nbsp;may be taken
into account in determining whether a Parent Material Adverse Effect has occurred, unless such underlying cause would otherwise be excepted by this definition); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U> that in the case of clauses (B), (C), (D), (E) and (G), such any Effect may be taken into account in determining whether or not there has been
a Parent Material Adverse Effect, but only to the extent such any Effect has had or would reasonably be expected to have, individually or in the aggregate, a disproportionate adverse effect on the Parent and its Subsidiaries, taken as a whole, as
compared to other similarly situated participants in the industry in which Parent and its Subsidiaries operate, in which case only the incremental disproportionate impact or impacts may be taken into account in determining whether or not there has
been a Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Parent Related Parties</B>&#148; means Parent, Acquirer, Merger Sub or Merger Sub II or
Parent&#146;s, Acquirer&#146;s, Merger Sub&#146;s and Merger Sub II&#146;s respective Affiliates or <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Parties or any of their or their respective Affiliates&#146; or
<FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Parties&#146; respective former, current or future directors, officers, employees, general or limited partners, mangers, members, direct or indirect equityholders, controlling persons, attorneys,
assignees, agents or Representatives of any of the foregoing, or any former, current or future estates, heirs, executors, administrators, trustees, successors or assigns of any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Payoff Letter</B>&#148; means a customary letter agreement in form and substance reasonably satisfactory to Parent and the Debt
Financing Sources (if any), which letter agreement shall (i)&nbsp;specify the total amount required to (A)&nbsp;pay in full all obligations (including all principal, interest, fees, prepayment premiums, penalties and other obligations (other than
contingent indemnification or expense reimbursement obligations)) under or in connection with the Company Credit Agreement and (B)&nbsp;terminate, or otherwise provide for (in a manner satisfactory to the applicable agents, lenders and letter of
credit issuers), all letters of credit outstanding under the Company Credit Agreement (if any), in each case, as of the anticipated Closing Date (and the daily accruals thereafter) (the &#147;<B>Payoff Amount</B>&#148;) and (ii)&nbsp;state that,
upon receipt of the Payoff Amount by the administrative agent under the Company Credit Agreement, (A)&nbsp;the Company Credit Agreement and any related agreements, documents or instruments shall be terminated
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(except for provisions therein that, by their express terms, survive such termination), (B) all related encumbrances, security interests, liens and collateral shall be released, all related
guaranties and subordination agreements (if any) shall be terminated (except for provisions therein that, by their express terms, survive such termination), and (C)&nbsp;the applicable agent under the Company Credit Agreement shall execute and
deliver (if and as applicable), file and authorize filing of lien terminations and other instruments or evidences of discharge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Liens</B>&#148; means (i)&nbsp;Liens disclosed on the Company Balance Sheet, (ii)&nbsp;Liens for Taxes, assessments,
utilities or other governmental charges or levies that are (A)&nbsp;not yet due and payable or (B)&nbsp;being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance with GAAP,
(iii)&nbsp;the interests of lessors and sublessors in the underlying fee estate or superior leasehold interest of any Company Leased Real Properties and other statutory Liens in favor of lessors and sublessors for amounts not yet due and payable,
(iv)&nbsp;recorded easements, rights of way and other imperfections of title or encumbrances that do not materially interfere with the present use, operation or occupation of, or materially detract from the value of, the Company Leased Real
Properties, (v)&nbsp;requirements and restrictions of applicable zoning and building laws which are not violated by the current use, operation or occupancy of the Company Leased Real Properties, (vi)&nbsp;Liens incurred or deposits or pledges made
in connection with, or to secure payment of, workers&#146; compensation, unemployment insurance, pension programs and similar obligations, (vii)&nbsp;mechanics&#146;, carriers&#146;, workmen&#146;s, repairmen&#146;s or other like Liens arising in
the ordinary course of business which are (A)&nbsp;not yet due and payable or (B)&nbsp;being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance with GAAP, (viii)&nbsp;nonexclusive
licenses and sublicenses of Intellectual Property granted to customers, contractors, and other partners or suppliers of the Company and its Subsidiaries in the ordinary course of business, (ix)&nbsp;Liens permissible under any applicable loan
agreements or indentures that would be discharged or released at or prior to the Closing, (x)&nbsp;any Liens that would be discharged or released at or prior to the Closing, (xi)&nbsp;Liens provided by operation of law, and (xii)&nbsp;any Lien
securing capital lease obligations or purchase money debt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means an individual, corporation, partnership,
limited liability company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Privacy Obligations</B>&#148; means (i)&nbsp;contractual obligations of the Company or any of its Subsidiaries related to the
Processing of Personal Information, privacy and data security and, in each case, to the extent legally binding upon the Company or a Subsidiary, (ii)&nbsp;all internally or externally published policies (including privacy policies) of the Company or
its Subsidiaries relating to the creation, collection, receipt, compilation, safeguarding, protection, use, disclosure, transfer (including cross-border), transmission, storage, maintenance, retention, deletion, disposal, modification and/or
processing (collectively, &#147;<B>Processing</B>&#148;) of Personal Information, (iii)&nbsp;published (internally or externally) statements, representations, obligations, promises and commitment of the Company or its Subsidiaries relating to
privacy, security or the Processing of Personal Information, (iv)&nbsp;Information Privacy and Security Laws, and (v)&nbsp;applicable binding industry standards with respect to Personal Information, privacy and security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Proceeding</B>&#148; means any suit, claim, action, litigation, arbitration,
proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), hearing, audit, examination, investigation or similar legal proceeding commenced, brought, pending, conducted or heard by or before any court or other
Governmental Authority or any arbitrator or arbitration panel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Proprietary Software Product</B>&#148; means the Software and
Software as a service (SaaS) products and services owned or purported to be owned by, developed for or on behalf of, or that are otherwise sold, commercialized, licensed, performed, or made available by the Company or any of its Subsidiaries,
including the Enfusion platform and all solutions and modules within such platform. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Representatives</B>&#148; means, with
respect to any Person, the directors, officers, employees, advisors, financial advisors, attorneys, accountants, consultants, financing sources, agents and other authorized representatives of such Person and such Person&#146;s Affiliates, acting
solely in such capacity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Required Financial Information</B>&#148; means (i)&nbsp;consolidated financial statements of the
Company and its Subsidiaries included in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ending December&nbsp;31, 2024, and (ii)&nbsp;to the extent reasonably requested in writing by Parent and readily available
or in the possession of the Company and its Subsidiaries, such financial and related information regarding the Company and its Subsidiaries, in each case, together with Authorization Letters with respect to such information, as is necessary to
permit Parent to prepare a customary &#147;public side&#148; and &#147;private side&#148; bank book regarding the business of the Company and its Subsidiaries, in each case, to the extent required for the Debt Financing and required by the Debt
Commitment Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Sanctions</B>&#148; means economic or financial sanctions or trade embargoes imposed, administered or
enforced from time to time by the United States government, including U.S. Department of the Treasury, the U.S. Department of State, and the U.S. Department of Commerce, the United Nations Security Council, the European Union, any EU Member State,
or HM&#146;s Treasury of the United Kingdom or any other applicable Sanctions authority with jurisdiction over the Company or its subsidiaries (excluding any counter-sanctions regimes imposed by the Russian Federation or the People&#146;s Republic
of China). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Sarbanes-Oxley Act</B>&#148; means the Sarbanes-Oxley Act of 2002, and the rules and regulations promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; means the U.S. Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Second Merger</B>&#148; the merger of the Surviving Corporation with and into the Acquirer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Second Merger Conditions</B>&#148; means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent shall have received, on the Closing Date, but before the Effective Time, an opinion, in form and substance reasonably satisfactory
to the Company (the &#147;<B>First Closing Tax Opinion</B>&#148;), from Kirkland&nbsp;&amp; Ellis LLP or another nationally recognized tax counsel reasonably acceptable to the Company and Parent, dated as of the Closing Date, concluding that, on the
basis of facts, customary representations and assumptions set forth or referred to in the First Closing Tax Opinion, for U.S. federal income tax purposes, the Corporate Mergers, taken together, will qualify as a &#147;reorganization&#148; within the
meaning of Section&nbsp;368(a)&nbsp;of the Code; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company shall have received, on the Closing Date, but before the Effective Time, an
opinion, in form and substance reasonably satisfactory to Parent (the &#147;<B>Second Closing Tax Opinion</B>&#148;, and together with the First Closing Tax Opinion, the &#147;<B>Closing Tax Opinions</B>&#148;), from Dechert LLP or another
nationally recognized tax counsel reasonably acceptable to Parent and the Company, dated as of the Closing Date, concluding that, on the basis of facts, customary representations and assumptions set forth or referred to in the Second Closing Tax
Opinion, for U.S. federal income tax purposes, the Corporate Mergers, taken together, will qualify as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a)&nbsp;of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933 and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Software</B>&#148; means any and all (i)&nbsp;software, firmware, middleware and computer programs, including any and all software
implementations of algorithms, models and methodologies, whether in source code, object code, executable or binary code, and (ii)&nbsp;documentation, user manuals, training and other materials relating to any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Special Committee Financial Advisor</B>&#148; means Goldman Sachs&nbsp;&amp; Co. LLC or another independent financial advisor of
nationally recognized reputation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148; of any Person means another Person (other than an individual), of which
securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power (or, in the case of a partnership, more than 50% of the general partnership interests) are, as of such date owned,
directly or indirectly, by such Person or by one or more other Subsidiaries of such Person or by such Person and one or more other Subsidiaries of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Superior Proposal</B>&#148; means any <I>bona fide</I> written Acquisition Proposal that did not result from or involve any material
breach or violation of <U>Section</U><U></U><U>&nbsp;6.02</U> or <U>Section</U><U></U><U>&nbsp;6.03</U> and the Special Committee or any committee thereof determines in good faith (after consultation with, and upon the advice of, a Special Committee
Financial Advisor and outside legal counsel), taking into account, among other things, all legal, financial, regulatory, and other aspects of the Acquisition Proposal and the Third Party making the Acquisition Proposal (including likelihood of
consummation and certainty of closing), (i) is reasonably capable of being consummated in accordance with its terms and (ii)&nbsp;would, if consummated in accordance with its terms, result in a transaction that is more favorable to the
Company&#146;s stockholders from a financial point of view than the Mergers (after taking into account any revisions to the terms of this Agreement proposed by Parent in writing prior to the time of such determination); <U>provided</U>,
<U>however</U>, that, for purposes of this definition of &#147;Superior Proposal,&#148; references in the term &#147;<B>Acquisition Proposal</B>&#148; to &#147;20% or more&#148; or &#147;less than 80%&#148; shall be deemed to be references to
&#147;more than 50%&#148; or &#147;less than 50%&#148;, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax</B>&#148; means any U.S. federal, state, local and foreign tax, charge, fee,
levy or other like governmental assessment or charge (including withholding required by applicable tax law on amounts paid to or by any Person and any income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation,
premium, windfall profits, environmental, customs, duties, capital stock, franchise, profits, social security, unemployment, disability, real property, personal property, sales, use, transfer, registration, value added, alternative or <FONT
STYLE="white-space:nowrap">add-on</FONT> minimum, estimated, or other tax of any kind or any charge in the nature of taxes), together with any interest, penalty, addition to tax or additional amount with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Receivable Agreement</B>&#148; means that certain Tax Receivable Agreement, dated as of October&nbsp;19, 2021, by and between the
Company and the Persons identified therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Return</B>&#148; means any report, return, document, declaration or other
information filed or required to be filed with or supplied to a Taxing Authority, including any schedule or attachment thereto, information returns, any document accompanying payments of estimated Taxes, and any amendments thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Taxing Authority</B>&#148; means any Governmental Authority responsible for the assessment, determination, collection or imposition
of any Tax. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Third Party</B>&#148; means any Person or &#147;group&#148; (as defined under Section&nbsp;13(d) of the Exchange
Act) of Persons, other than Parent or any of its Affiliates or Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transaction Litigation</B>&#148; means any
claim, demand or other Proceeding (including any class action or derivative litigation) asserted, commenced or threatened by, on behalf of or in the name of, against or otherwise involving the Company, the Company Board, any committee thereof and/or
any of the Company&#146;s directors or officers relating directly or indirectly to this Agreement, the Mergers or any related transaction, prior to the Effective Time (other than any Proceeding (i)&nbsp;arising under applicable Antitrust Law (which
shall be governed by <U>Section</U><U></U><U>&nbsp;6.10</U>) or (ii)&nbsp;between Parent or any of its Subsidiaries, on the one hand, and the Company or any of its Subsidiaries, on the other hand). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Regulations</B>&#148; means the regulations promulgated under the Code by the United States Department of Treasury and the
Internal Revenue Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Unvested Company RSUs</B>&#148; means a Company RSU that is not a Vested Company RSU. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>U.S. Employee Plan</B>&#148; means any Company Employee Plan that is maintained pursuant to or is subject to the laws of the United
States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Vested Company RSUs</B>&#148; means a Company RSU that is unexpired, outstanding, and vested as of immediately prior to
the Effective Time or that vests in accordance with its terms as in effect as of the date hereof as a result of the consummation of the Mergers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>WARN Act</B>&#148; means the Worker Adjustment and Retraining Notification Act of 1988, 29 U.S.C. &#167;&nbsp;2101, et seq. or any
similar state or local Applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Willful and Material Breach</B>&#148; means a material breach that is the
consequence of an act or omission by the breaching party with the actual knowledge that the taking of such act or failure to take such act, or the failure to cure such breach, would cause or constitute such material breach. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02 <I><U>Other Defined Terms</U></I>. Each of the following terms is defined on the page set forth opposite such term: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acceptable Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquirer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition Proposal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adverse Recommendation Change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aggregate Merger Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AI Systems</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alternative Debt Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anti-Corruption Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anti-Money Laundering Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Antitrust Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Applicable Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authorization Letters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Business Day</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&nbsp;A Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&nbsp;B Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clearwater LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COBRA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Unit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company 401(k) Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Balance Sheet</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Balance Sheet Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Credit Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Schedule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Employee Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Equity Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Licensed Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Owned Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company PSUs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Real Property Lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Recommendation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Return</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company RSU</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company SEC Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stock Option</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stock Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Subsidiary Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Termination Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuing Employee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Converted RSU</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Copyrights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">COVID-19</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current Premium</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Commitment Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Fee Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing Related Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing Sources</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Definitive Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Delaware Courts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DGCL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DLLCA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DOJ</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Domain Names</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enforceability Exceptions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA Affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ESPP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Agent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Final Exercise Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign Employee Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign Investment Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FTC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GAAP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GDPR</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Authority</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Authorizations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hazardous Substance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inbound IP License</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party Proceeding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information Privacy and Security Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Infringement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intended Tax Treatment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">International Trade Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intervening Event</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Invention Assignment Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IT Systems</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Knowledge of Parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Knowledge of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Labor Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lien</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LLC Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LLC Certificate of Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LLC Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LLC Merger Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Made Available</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Malicious Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Contract</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub II</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mergers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Superior Proposal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NYSE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Officer&#146;s Certificate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Open Source Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Option Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Order</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Class&nbsp;A Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Class&nbsp;B Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Class&nbsp;C Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Class&nbsp;D Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Disclosure Schedule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Enforcement Costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Material Adverse Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Material Contract</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Related Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent SEC Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment Fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payoff Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payoff Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permitted Liens</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Person</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personal Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Privacy Obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Processing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prohibited Modifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proprietary Software Product</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representatives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Required Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rev. Proc. <FONT STYLE="white-space:nowrap">2018-12</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sanctions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sarbanes-Oxley Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second Certificate of Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Security Incident</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Special Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Special Committee Financial Advisor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specified Action</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsidiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Superior Proposal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Support Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surviving Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surviving LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Takeover Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Return</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxing Authority</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TRA Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade Secrets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transaction Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Treasury Regulations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Employee Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested Equity Award Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested PSU Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested RSU Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WARN Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Willful and Material Breach</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Withholding Person</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.03 <I><U>Other Definitional and Interpretative Provisions</U></I>. The words
&#147;<B>hereof</B>,&#148; &#147;<B>hereto</B>&#148;, &#147;<B>hereby</B>&#148;, &#147;<B>herein</B>&#148; and &#147;<B>hereunder</B>&#148; and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any
particular provision of this Agreement. The captions herein are included for convenience of reference only and shall be ignored in the construction or interpretation hereof. References to Articles, Sections, Exhibits and Schedules are to Articles,
Sections, Exhibits and Schedules of this Agreement unless otherwise specified. Any capitalized terms used in any Exhibit or Schedule but not otherwise defined therein shall have the meaning as defined in this Agreement. Any singular term in this
Agreement shall be deemed to include the plural, and any plural term the singular. Whenever the words &#147;include,&#148; &#147;<B>includes</B>&#148; or &#147;<B>including</B>&#148; are used in this Agreement, they shall be deemed to be followed by
the words &#147;without limitation,&#148; whether or not they are in fact followed by those words or words of like import. &#147;<B>Writing</B>,&#148; &#147;<B>written</B>&#148; and comparable terms refer to printing, typing and other means of
reproducing words (including electronic media) in a visible form. References to any Applicable Law are to that Applicable Law as amended, modified or supplemented from time to time and to any rules or regulations promulgated thereunder. References
to any Person include the successors and permitted assigns of that Person. References to any statute are to that statute and to the rules and regulations promulgated thereunder, in each case as amended from time to time. References to &#147;$&#148;
and &#147;<B>dollars</B>&#148; are to the currency of the United States. References from or through any date shall mean, unless otherwise specified, from and including or through and including, respectively. References to &#147;<B>days</B>&#148;
shall mean &#147;<B>calendar days</B>&#148; unless expressly stated otherwise. Accounting terms used, but not specifically defined, in this Agreement shall be construed in accordance with GAAP. The term &#147;<B>or</B>&#148; is not exclusive. The
word &#147;<B>extent</B>&#148; in the phrase &#147;<B>to the extent</B>&#148; shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply &#147;<B>if.</B>&#148; References to the &#147;<B>ordinary course of
business</B>&#148; refer to the ordinary course of business of (i)&nbsp;the Company and its Subsidiaries, taken as a whole, consistent with the Company&#146;s past practice, or (ii)&nbsp;Parent and its Subsidiaries, taken as a whole, consistent with
Parent&#146;s past practice, as applicable. All references herein to &#147;<B>parties</B>&#148; shall be to the parties hereto unless the context shall otherwise require. If the Second Merger does not occur, references to the &#147;Mergers&#148;
shall mean the Merger and the LLC Merger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE MERGERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01 <I><U>The Closing</U></I>. Upon the terms and subject to the conditions set forth herein, the closing of the Mergers (the
&#147;<B>Closing</B>&#148;) shall take place at 8:00 a.m., Eastern time, on the second Business Day after satisfaction or, to the extent permitted hereunder, waiver of all conditions to the Mergers set forth in <U>ARTICLE VII</U> (other than those
conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver (to the extent permitted hereunder) of such conditions), unless this Agreement has been validly terminated pursuant to its terms or unless
another time or date is agreed to in writing by the parties hereto; <U>provided</U> that, notwithstanding the satisfaction or, to the extent permitted hereunder, waiver of all conditions to the Mergers set forth in <U>ARTICLE VII</U>, if the
Marketing Period has not ended at the time of the satisfaction or waiver of such conditions (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver (to the extent permitted
hereunder) of such conditions), the Closing shall instead occur on the date that is the earlier to occur of (i)&nbsp;any Business Day during the Marketing Period specified by Parent to the Company on no less than two (2)&nbsp;Business Days&#146;
prior written notice to the Company and (ii)&nbsp;the second (2nd) Business Day after the final day of the Marketing Period. The Closing shall be effected, to the extent practicable, by conference call and the electronic delivery of documents to be
held in escrow by outside counsel to the recipient party pending authorization to release at the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02 <I><U>The
Mergers</U></I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Upon the terms and subject to the conditions set forth in this Agreement, as soon as practicable on the Closing
Date, Parent and the Operating Company shall cause a certificate of merger providing for the LLC Merger (the &#147;<B>LLC Certificate of Merger</B>&#148;) to be executed and delivered to the Secretary of State of the State of Delaware for filing as
provided in the DLLCA. Upon the terms and subject to the conditions set forth in this Agreement, as soon as practicable on the Closing Date, Parent and the Company shall cause a certificate of merger providing for the Merger (the
&#147;<B>Certificate of Merger</B>&#148;) to be executed and delivered to the Secretary of State of the State of Delaware for filing as provided in the DGCL. Upon the terms and subject to the conditions set forth in this Agreement, including, for
the avoidance of doubt, <U>Section</U><U></U><U>&nbsp;6.16(b)(ii)</U>, as soon as practicable on the Closing Date, Acquirer and the Surviving Corporation shall cause a certificate of merger providing for the Second Merger (the &#147;<B>Second
Certificate of Merger</B>&#148;) to be executed and delivered to the Secretary of State of the State of Delaware for filing as provided in the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The LLC Merger shall become effective on such date and at such time when the LLC Certificate of Merger has been duly filed with the
Secretary of State of the State of Delaware, or at such later time and date as may be agreed by the parties hereto in writing and specified in the LLC Certificate of Merger (the &#147;<B>LLC Merger Effective Time</B>&#148;). The Merger shall become
effective on such date and at such time when the Certificate of Merger has been duly filed with the Secretary of State of the State of Delaware, or at such later time and date as may be agreed by the parties hereto in writing and specified in the
Certificate of Merger (the &#147;<B>Effective Time</B>&#148;); <U>provided</U> that the Effective Time shall occur immediately after the LLC Merger Effective Time. The Second Merger shall become effective on such date and at such time when the
Second Certificate of Merger has been duly filed with the Secretary of State of the State of Delaware, or at such later time and date as may be agreed by the parties hereto in writing and specified in the Second Certificate of Merger, but in any
event after the Effective Time (the &#147;<B>Second Effective Time</B>&#148;); <U>provided</U> that the Second Effective Time shall not occur unless each of the Second Merger Conditions shall have been satisfied as of the Closing Date, but prior to
the Effective Time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At the LLC Merger Effective Time, Merger Sub II shall be merged with and into the
Operating Company in accordance with the DLLCA, whereupon the separate existence of Merger Sub II shall cease, and the Operating Company shall be the surviving entity in the LLC Merger (the &#147;<B>Surviving LLC</B>&#148;), and the separate
existence of the Operating Company, with all its rights, privileges, immunities, powers and franchises, shall vest in the Surviving LLC, and all debts, liabilities and duties of the Operating Company and Merger Sub II shall become the debts,
liabilities and duties of the Surviving LLC. The LLC Merger shall have the effects set forth in this Agreement and specified in the DLLCA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) At the Effective Time, Merger Sub shall be merged with and into the Company in accordance with the DGCL, whereupon the separate existence
of Merger Sub shall cease, and the Company shall be the surviving corporation in the Merger (the &#147;<B>Surviving Corporation</B>&#148;), and the separate corporate existence of the Company, with all its rights, privileges, immunities, powers and
franchises, shall vest in the Surviving Corporation, and all debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Corporation. The Merger shall have the effects set forth in this
Agreement and specified in the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) At the Second Effective Time (if the Second Effective Time shall occur in accordance with the
terms and conditions of this Agreement), the Surviving Corporation shall be merged with and into the Acquirer in accordance with the DGCL, whereupon the separate existence of Surviving Corporation shall cease, and the Acquirer shall be the surviving
corporation in the Second Merger (the &#147;<B>Second </B><B>Surviving Corporation</B>&#148;), and the separate corporate existence of the Surviving Corporation, with all its rights, privileges, immunities, powers and franchises, shall vest in the
Acquirer, and all debts, liabilities and duties of the Acquirer and the Surviving Corporation shall become the debts, liabilities and duties of the Second Surviving Corporation. The Second Merger shall have the effects set forth in this Agreement
and specified in the DGCL. Notwithstanding the foregoing, the Second Merger shall not occur unless each of the Second Merger Conditions shall have been satisfied as of the Closing Date, but prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03 <I><U>Conversion of Shares and Units</U></I><I>.</I><I> </I>At the Effective Time, as a result of the Merger and without any
action on the part of Parent, Merger Sub, the Company or the holders of any capital stock of Parent, Merger Sub or the Company and at the LLC Merger Effective Time, as a result of the LLC Merger and without any action on the part of Parent, Merger
Sub II, the Operating Company or the holders of any capital stock of Parent or units of Merger Sub II or the Operating Company: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
Except as otherwise provided in <U>Section</U><U></U><U>&nbsp;2.03(d)</U>, <U>Section</U><U></U><U>&nbsp;2.03(f)</U> or <U>Section</U><U></U><U>&nbsp;2.03(i)</U>, each (1)&nbsp;share of Class&nbsp;A Common Stock that is issued and outstanding
immediately prior to the Effective Time (it being understood and agreed that for purposes of this <U>Section</U><U></U><U>&nbsp;2.03</U>, each Vested Company RSU that is issued and outstanding immediately prior to the Effective Time shall be
included as a Class&nbsp;A Common Stock) and (2)&nbsp;Common Unit that is issued and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
outstanding immediately prior to the LLC Merger Effective Time (each, an &#147;<B>Eligible Share</B>&#148;) shall, in each case of the foregoing clauses (1)&nbsp;and (2), be converted into the
right, at the election of the holder of such share or unit pursuant to the procedures set forth in <U>Section</U><U></U><U>&nbsp;2.04</U>, to receive either (i)&nbsp;the Per Share Mixed Consideration, (ii)&nbsp;the Per Share Stock Consideration or
(iii)&nbsp;the Per Share Cash Consideration (together, the &#147;<B>Merger Consideration</B>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">As used herein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) &#147;<B>Aggregate Consideration</B>&#148; means the sum of (x)&nbsp;Total Stock Value and (y)&nbsp;Total Cash Amount. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<B>Aggregate Consideration Per Share</B>&#148; means the quotient taken to four decimal places,&nbsp;obtained by
dividing the Aggregate Consideration by the total number of Eligible Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<B>Exchange Ratio</B>&#148; means
the quotient, taken to four decimal places,&nbsp;obtained by dividing the Aggregate Consideration Per Share by the Final Parent Stock Price. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) &#147;<B>Final Parent Stock Price</B>&#148; means the volume-weighted average price of one share of the Parent
Class&nbsp;A Common Stock for the <FONT STYLE="white-space:nowrap">ten-trading</FONT> day period ending on (and including) the second to last trading day prior to (but not including) the Closing Date, as reported by Bloomberg under the function
&#147;VWAP&#148; (or, if not available, in another authoritative source mutually selected by the Company and Parent). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v)
&#147;<B>Per Share Parent Stock Amount</B>&#148; means the quotient obtained by dividing $5.40 by the Final Parent Stock Price;<U>&nbsp;provided</U>&nbsp;that (x)&nbsp;if the Final Parent Stock Price is less than or equal to $25.0133, then the Per
Share Parent Stock Amount shall be deemed to be 0.2159 and (y)&nbsp;if the Final Parent Stock Price is greater than or equal to $30.5718, then the Per Share Parent Stock Amount shall be deemed to be 0.1766. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) &#147;<B>Per Share Cash Consideration</B>&#148; means cash in an amount equal to the Aggregate Consideration Per Share.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) &#147;<B>Per Share Mixed Consideration</B>&#148; means (i)&nbsp;cash in an amount equal to $5.85 and (ii)&nbsp;a
number of shares of Parent Class&nbsp;A Common Stock (which may not need be a whole number) equal to the Per Share Parent Stock Amount. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) &#147;<B>Per Share Stock Consideration</B>&#148; means a number of shares of Parent Class&nbsp;A Common Stock (which
need not be a whole number) equal to the Exchange Ratio. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) &#147;<B>Total Cash Amount</B>&#148; means the product
obtained by multiplying (x)&nbsp;$5.85 by (y)&nbsp;the total number of Eligible Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) &#147;<B>Total Stock</B>&#148;
means a number of shares of Parent Class&nbsp;A Common Stock equal to the product obtained by multiplying (x)&nbsp;the Per Share Parent Stock Amount by (y)&nbsp;the total number of Eligible Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) &#147;<B>Total Stock Value</B>&#148; means the product obtained by
multiplying (x)&nbsp;the Total Stock by (y)&nbsp;the Final Parent Stock Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of the Effective Time, all such shares of
Class&nbsp;A Common Stock converted into the right to receive the Merger Consideration pursuant to this <U>ARTICLE II</U> shall no longer be issued and outstanding and shall automatically be canceled and shall cease to exist, and each holder of any
such shares of Class&nbsp;A Common Stock shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration and cash in lieu of fractional shares of Parent Class&nbsp;A Common Stock in accordance with this
Agreement. As of the LLC Merger Effective Time, all such Common Units converted into the right to receive the Merger Consideration pursuant to this <U>ARTICLE II</U> shall no longer be issued and outstanding and shall automatically be canceled and
shall cease to exist, and each holder of any such Common Unit shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration and cash in lieu of fractional shares of Parent Class&nbsp;A Common Stock in
accordance with this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each share of Class&nbsp;B Common Stock that is issued and outstanding immediately prior to the
Effective Time shall be automatically canceled and shall cease to exist and no consideration shall be delivered in exchange therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
Each share of Company Common Stock held in the treasury of the Company and any shares of Company Common Stock owned by Parent, Merger Sub or Merger Sub II immediately prior to the Effective Time shall automatically be canceled and shall cease to
exist and no consideration shall be delivered in exchange therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Each share of common stock of Merger Sub issued and outstanding
immediately prior to the Effective Time shall automatically be converted into and become one fully paid, nonassessable share of common stock, par value $0.001 per share, of the Surviving Corporation with the same rights, powers and privileges as the
shares so converted and shall constitute the only outstanding shares of capital stock of the Surviving Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Each Common Unit
held in the treasury of the Operating Company and any Common Units owned by the Company, Parent, the Company Blockers or any other Subsidiary of the Company shall remain outstanding, and any Common Units owned by Acquirer, Merger Sub or Merger Sub
II immediately prior to the Effective Time shall automatically be canceled and shall cease to exist and no consideration shall be delivered in exchange therefor, and each Common Unit held by another person shall, in addition to being converted into
the right to receive Merger Consideration pursuant to <U>Section</U><U></U><U>&nbsp;2.03(a)</U>, convert into the right to receive Additional Unit Consideration (as defined in the TRA Amendment) pursuant to, and in accordance with, Section&nbsp;1.2
of the TRA Amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Each unit of limited liability company interests of Merger Sub II issued and outstanding immediately prior to
the LLC Merger Effective Time shall automatically be converted into and become one unit of limited liability company interests of the Surviving LLC with the same rights, powers and privileges as the units so converted and shall constitute the only
limited liability company interests of the Surviving LLC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Exchange Ratio, and any similarly dependent item, as the case may be, shall be
equitably adjusted, without duplication, proportionately to reflect the effect of any stock split, reverse stock split, subdivision, stock dividend (including any dividend or distribution of securities convertible into the Class&nbsp;A Common Stock
or Parent Class&nbsp;A Common Stock, as applicable), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change with respect to the number of shares of the Class&nbsp;A Common Stock (including for this
purpose any securities convertible into, or exercisable for, the Class&nbsp;A Common Stock) or Parent Class&nbsp;A Common Stock having a record date occurring on or after the date of this Agreement and prior to the Effective Time to proportionately
reflect such change; <U>provided</U>, that nothing in this <U>Section</U><U></U><U>&nbsp;2.03(h)</U> shall be construed to permit any party hereto to take any action with respect to its securities that is prohibited by the terms of this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding anything to the contrary contained herein, no certificates or scrip representing fractional shares of Parent
Class&nbsp;A Common Stock shall be issued upon the surrender for exchange of Certificates pursuant to this <U>ARTICLE II</U>, no dividends or other distributions with respect to the Parent Class&nbsp;A Common Stock shall be payable on or with
respect to any fractional share, and such fractional share interests shall not entitle the owner thereof to vote or to any other rights of a stockholder of Parent. In lieu of the issuance of any such fractional share, Parent shall pay to each former
stockholder of the Company and former unitholder of the Operating Company who otherwise would be entitled to receive a fractional share of Parent Class&nbsp;A Common Stock an amount in cash (without interest) determined by multiplying (i)&nbsp;the
fraction of a share of Parent Class&nbsp;A Common Stock which such holder would otherwise be entitled to receive (taking into account all shares of Class&nbsp;A Common Stock or Common Units held at the Effective Time by such holder and rounded to
the nearest thousandth when expressed in decimal form) pursuant to <U>Section</U><U></U><U>&nbsp;2.03(a)</U> by (ii)&nbsp;the Final Parent Stock Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) At the Second Effective Time (if the Second Effective Time shall occur in accordance with the terms and conditions of this Agreement), (i)
each share of common stock of the Surviving Corporation issued and outstanding immediately prior to the Second Effective Time shall automatically be converted into and become one fully paid, nonassessable share of common stock of the Second
Surviving Corporation with the same rights, powers and privileges as the shares so converted and shall constitute the only outstanding shares of capital stock of the Second Surviving Corporation and (ii)&nbsp;each share of Common Stock of Acquirer
issued and outstanding immediately prior to the Second Effective Time shall automatically be canceled and shall cease to exist and no consideration shall be delivered in exchange therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04 <I><U>Election Procedures; Allocation of Merger Consideration</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent shall prepare and direct the Exchange Agent to mail a form of election, which form shall be subject to the reasonable approval of
the Company (the &#147;<B>Election Form</B>&#148;), with the Joint Proxy Statement/Prospectus to the record holders of Class&nbsp;A Common Stock (including any Vested Company RSUs) and Common Units as of the record date for the Stockholders Meeting,
which Election Form shall be used by each record holder of shares of Class&nbsp;A Common Stock (including any Vested Company RSUs) and Common Units who wishes to make an Election. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent shall make available as promptly as reasonably practicable one or more Election
Forms as may be reasonably requested from time to time by all Persons who become holders or beneficial owners of Class&nbsp;A Common Stock (including any Vested Company RSUs) or Common Units before the Election Deadline, and the Company shall use
reasonable best efforts to provide the Exchange Agent with all information reasonably necessary for it to perform its duties as specified herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Election Form&nbsp;shall permit the holder (or the beneficial owner through appropriate and customary documentation and
instructions), other than any holder of Dissenting Shares, to specify (an &#147;<B>Election</B>&#148;) (i)&nbsp;the number of shares of Eligible Shares of such holder with respect to which such holder elects to receive the Per Share Mixed
Consideration (&#147;<B>Mixed Election Shares</B>&#148;), (ii)&nbsp;the number of Eligible Shares of such holder with respect to which such holder elects to receive the Per Share Stock Consideration (&#147;<B>Stock</B><B></B><B>&nbsp;Election
Shares</B>&#148;), (iii)&nbsp;the number of Eligible Shares of such holder with respect to which such holder elects to receive the Per Share Cash Consideration (&#147;<B>Cash Election Shares</B>&#148;) or (iv)&nbsp;that such holder makes no election
with respect to such holder&#146;s Eligible Shares (&#147;<B><FONT STYLE="white-space:nowrap">Non-Election</FONT></B><B></B><B>&nbsp;Shares</B>&#148;). Notwithstanding the foregoing, two or more holders of Eligible Shares (such holders,
&#147;<B>Joint Electors</B>&#148;) shall be entitled to make an Election in accordance with the procedures set forth in this <U>Section</U><U></U><U>&nbsp;2.04</U> with respect to some or all of the Eligible Shares held by each such Joint Elector (a
&#147;<B>Joint Election</B>&#148;), and, with respect to the policies and procedures set forth in <U>Section</U><U></U><U>&nbsp;2.04(f)</U>, the Exchange Agent shall treat such Joint Election as if it had been made by a single holder of Eligible
Shares. Notwithstanding anything in <U>Section</U><U></U><U>&nbsp;2.04(d)</U>, holders of Eligible Shares that deliver an Election Form to the Exchange Agent prior to the Election Deadline may deliver a Joint Election with another Joint Elector to
the Exchange Agent at any time after the Election Deadline but not less than five (5)&nbsp;Business Days before the Effective Time and instruct the Exchange Agent, after giving effect to the pro rata selection process contemplated by this
<U>Section</U><U></U><U>&nbsp;2.04</U>, with respect to the allocation among such Joint Electors of the Merger Consideration payable to such Joint Electors. Parent and the Company shall use commercially reasonable efforts to ensure that the Exchange
Agent Agreement shall include provisions to permit Joint Electors to instruct the Exchange Agent, after giving effect to the pro rata selection process contemplated by this <U>Section</U><U></U><U>&nbsp;2.04</U>, with respect to the allocation among
such Joint Electors of the Merger Consideration payable to such Joint Electors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) An Election shall have been properly made only if the
Exchange Agent shall have received at its designated office, by 5:00&nbsp;p.m., Eastern time, on a date prior to the Effective Time to be mutually agreed to by the Company and Parent (the &#147;<B>Election Deadline</B>&#148;), an Election Form
properly completed and signed and accompanied by Certificates to which such Election Form relates, duly endorsed in blank or otherwise in form acceptable for transfer on the books of the Company (or an appropriate affidavit attesting to the loss,
theft, misplacement or destruction, as applicable of such Certificate(s) and a bond of indemnity, in each case in form reasonably acceptable to the Exchange Agent and Parent or by an appropriate guarantee of delivery of such Certificates as set
forth in such Election Form; <U>provided</U> that such Certificates are in fact delivered to the Exchange Agent within five (5)&nbsp;Business Days after the date of execution of such guarantee of delivery). Any holder of Class&nbsp;A Common Stock
(including any Vested Company RSUs) or Common Unit may (i)&nbsp;change his Election by written notice received by the Exchange Agent prior to the Election Deadline, accompanied by a properly completed and signed revised Election Form or
(ii)&nbsp;revoke his Election by written notice received by the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Exchange Agent prior to the Election Deadline or by withdrawal prior to the Election Deadline of his Certificates, or of the guarantee of delivery of such Certificates, previously deposited with
the Exchange Agent. All Election Forms shall automatically be revoked if the Exchange Agent is notified in writing by the Company and Parent that the Mergers have been abandoned and that this Agreement has been terminated. If an Election Form is
revoked, the Certificate(s) (or guarantees of delivery, as appropriate), if any, for the shares of Class&nbsp;A Common Stock or Common Units to which such Election Form relates shall be promptly returned to the stockholder submitting the same to the
Exchange Agent. Parent and the Company shall cooperate to issue a press release announcing the date of the Election Deadline not more than 10 nor fewer than four Business Days prior to the Election Deadline (the form and substance of such press
release to be reasonably satisfactory to Parent and the Company). Subject to the terms of this Agreement and of the Election Form, the Exchange Agent shall have reasonable discretion to determine whether any election, revocation or change has been
properly or timely made and to disregard immaterial defects in the Election Forms, and any good faith decisions of the Exchange Agent regarding such matters shall be binding and conclusive. None of Parent, Merger Sub, Merger Sub II or the Exchange
Agent shall be under any obligation to notify any Person of any defect in an Election Form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Subject to the provisions of the Exchange
Agent Agreement, the determination of the Exchange Agent shall be binding as to whether an Election shall have been properly made or revoked pursuant to this <U>Section</U><U></U><U>&nbsp;2.04</U> with respect to shares of Company Common Stock or
Common Units and when Elections and revocations were received by it. Subject to the provisions of the Exchange Agent Agreement, if the Exchange Agent determines that any Election was not properly made with respect to any shares of Company Common
Stock or Common Units, such shares of Company Common Stock or Common Units, as applicable, shall be treated by the Exchange Agent as <FONT STYLE="white-space:nowrap">Non-Election</FONT> Shares. The pro rata selection process to be used by the
Exchange Agent shall consist of such equitable pro ration processes as shall be mutually determined by Parent and the Company. Subject to the provisions of the Exchange Agent Agreement, the Exchange Agent shall make all computations as to the
allocation and the proration contemplated by this <U>Section</U><U></U><U>&nbsp;2.04</U>, and any such computation shall be conclusive and binding on Parent and the holders of shares of Class&nbsp;A Common Stock (including any Vested Company RSUs)
or Common Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Within three Business Days after the Effective Time, Parent shall cause the Exchange Agent (as defined herein) to
effect the allocation among the holders of shares of Class&nbsp;A Common Stock (including any Vested Company RSUs) and Common Units of the rights to receive the Merger Consideration as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) all Mixed Election Shares shall be converted into the right to receive the Per Share Mixed Consideration; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Cash Election Shares For More Than Total Cash Amount</U>. If the sum of (x)&nbsp;the product obtained by multiplying
(1)&nbsp;the number of Mixed Election Shares by (2)&nbsp;$5.85, plus (y)&nbsp;the product obtained by multiplying (1)&nbsp;the number of Cash Election Shares by (2)&nbsp;the Per Share Cash Consideration is greater than the Total Cash Amount, then:
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A)
<FONT STYLE="white-space:nowrap">all&nbsp;Non-Election&nbsp;Shares</FONT> and all Stock Election Shares shall be converted into the right to receive the Per Share Stock Consideration; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) the Exchange Agent shall then select from among the Cash Election Shares, pro rata to the holders of Cash Election Shares
in accordance with their respective numbers of Cash Election Shares (except as provided in the last paragraph of this<U>&nbsp;Section 2.04(f)</U>), a sufficient number of shares (&#147;<U>Stock </U><U>Designated Shares</U>&#148;) such that the
aggregate cash amount that will be paid in the Mergers equals as closely as practicable the Total Cash Amount, and all Stock Designated Shares shall be converted into the right to receive the Per Share Stock Consideration; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) the Cash Election Shares that are not Stock Designated Shares will be converted into the right to receive the Per Share
Cash Consideration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) <U>Cash Election Shares For Less Than Total Cash Amount</U>. If the sum of (x)&nbsp;the product
obtained by multiplying (1)&nbsp;the number of Mixed Election Shares by (2)&nbsp;$5.85, plus (y)&nbsp;the product obtained by multiplying (1)&nbsp;the number of Cash Election Shares by (2)&nbsp;the Per Share Cash Consideration is less than the Total
Cash Amount, then: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) all Cash Election Shares shall be converted into the right to receive the Per Share Cash
Consideration; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) the Exchange Agent shall then select first from among
<FONT STYLE="white-space:nowrap">the&nbsp;Non-Election&nbsp;Shares</FONT> and then (if necessary) from among the Stock Election Shares, in each case pro rata to the holders <FONT STYLE="white-space:nowrap">of&nbsp;Non-Election&nbsp;Shares</FONT> or
Stock Election Shares, as the case may be, in accordance with their respective numbers <FONT STYLE="white-space:nowrap">of&nbsp;Non-Election&nbsp;Shares</FONT> or Stock Election Shares, as the case may be, a sufficient number of shares
(&#147;<U>Cash Designated Shares</U>&#148;) such that the aggregate cash amount that will be paid in the Mergers equals as closely as practicable the Total Cash Amount, and all Cash Designated Shares shall be converted into the right to receive the
Per Share Cash Consideration; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) <FONT STYLE="white-space:nowrap">the&nbsp;Non-Election&nbsp;Shares</FONT> and (if
necessary) the Stock Election Shares that are not Cash Designated Shares shall be converted into the right to receive the Per Share Stock Consideration. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) <U>Cash Election Shares Equal To Total Cash Amount</U>. If the sum of (x)&nbsp;the product obtained by multiplying
(1)&nbsp;the number of Mixed Election Shares by (2)&nbsp;$5.85, plus (y)&nbsp;the product obtained by multiplying (1)&nbsp;the number of Cash Election Shares by (2)&nbsp;the Per Share Cash Consideration is equal to the Total Cash Amount, then
subparagraphs&nbsp;(ii)&nbsp;and (iii)&nbsp;above shall not apply and all Cash Election Shares shall be converted into the right to receive the Per Share Cash Consideration and all Stock Election Shares
<FONT STYLE="white-space:nowrap">and&nbsp;Non-Election&nbsp;Shares</FONT> shall be converted into the right to receive the Per Share Stock Consideration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Agreement to the contrary, to the fullest extent permitted by Applicable
Law, for purposes of determining the allocations set forth in this<U>&nbsp;Section 2.04</U>, Parent shall cause any shares of Class&nbsp;A Common Stock that constitute Dissenting Shares as of the Election Deadline to be treated as Cash Election
Shares not subject to the pro rata selection process contemplated by this<U>&nbsp;Section 2.04</U>, and any Dissenting Shares that receive the Merger Consideration to be treated as Cash Election Shares not subject to the pro rata selection process
contemplated by this<U>&nbsp;Section 2.04</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05 <I><U>Exchange of Eligible Shares and Delivery of Merger
Consideration</U></I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Effective Time, Parent shall appoint Computershare Trust Company, N.A. (or its successor) as the
exchange agent (or such other nationally recognized exchange agent selected by Parent and reasonably acceptable to the Company) (the &#147;<B>Exchange Agent</B>&#148;) for the purpose of exchanging for the Merger Consideration (and cash in lieu of
fractional shares of Parent Class&nbsp;A Common Stock pursuant to <U>Section</U><U></U><U>&nbsp;2.03(i)</U>) certificates representing shares of Company Common Stock or Common Units (the &#147;<B>Certificates</B>&#148;); <U>provided</U>,
<U>however</U>, that any references herein to &#147;<B>Certificates</B>&#148; are deemed to include references to book-entry account statements relating to the ownership of shares of Company Common Stock or Common Units. Prior to the Effective Time,
Parent shall enter into an exchange agent agreement, in form and substance reasonably acceptable to the Company, with the Exchange Agent for the payment of the Merger Consideration in accordance with this Agreement. At the Effective Time, Parent
shall deposit, or shall cause to be deposited, with the Exchange Agent, for the benefit of the holders of shares of Company Common Stock and Common Units issued and outstanding immediately prior to the Effective Time, (x)&nbsp;an aggregate number of
shares of Parent Class&nbsp;A Common Stock to be credited in the stock ledger and other appropriate books and records of Parent in book-entry form and (y)&nbsp;cash in an amount sufficient to pay the aggregate Per Share Cash Consideration (and any
cash in lieu of fractional shares of Parent Class&nbsp;A Common Stock pursuant to <U>Section</U><U></U><U>&nbsp;2.03(i)</U>) (the &#147;<B>Payment Fund</B>&#148;). To the extent, following the deposit contemplated by the preceding sentence, such
fund diminishes for any reason below the level required to make prompt payment of the Merger Consideration, Parent shall promptly replace or restore, or cause to be replaced or restored, the lost portion of such fund so as to ensure that it is, at
all times, maintained at a level sufficient to make such payments. The Payment Fund shall be invested by the Exchange Agent as directed by Parent; <U>provided</U> that (i)&nbsp;no such investment or losses thereon shall relieve Parent from making
the payments required by this <U>ARTICLE II</U> or affect the amount of Merger Consideration payable hereunder, and following any losses Parent shall (or shall cause the Surviving Corporation to) promptly provide additional funds to the Exchange
Agent in the amount of any such losses, (ii)&nbsp;no such investment shall have maturities that could prevent or delay payments to be made pursuant to this Agreement and (iii)&nbsp;such investments shall be in short-term obligations of the United
States with maturities of no more than 30 days, or guaranteed by, and backed by the full faith and credit of, the United States. Any net profit resulting from, or interest or income produced by, such investments shall be payable to the Surviving
Corporation. The Payment Fund shall not be used for any other purpose. The Surviving Corporation shall (and Parent shall cause the Surviving Corporation to) pay all charges and expenses, including those of the Exchange Agent, in connection with the
exchange of shares of Company Common Stock and the payment of the Merger Consideration in respect of such shares of Company Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As promptly as reasonably practicable after the Effective Time, and in any event no
later than four Business Days after the Effective Time, Parent shall send, or shall cause the Exchange Agent to send, to each record holder of shares of Company Common Stock or Common Units at the Effective Time or LLC Merger Effective Time,
respectively, whose shares were converted into the right to receive the Merger Consideration pursuant to <U>Section</U><U></U><U>&nbsp;2.03(a)</U>, a letter of transmittal and instructions in forms reasonably satisfactory to the Company (which shall
specify that the delivery shall be effected, and risk of loss and title shall pass, only upon proper delivery or transfer of the Certificates (or compliance with the replacement requirements specified in <U>Section</U><U></U><U>&nbsp;2.05(e)</U>) to
the Exchange Agent) for use in such exchange. Each holder of shares of Company Common Stock or Common Units that have been converted into the right to receive the Merger Consideration shall be entitled to receive the Merger Consideration in respect
of the shares of Company Common Stock represented by a Certificate, as promptly as reasonably practicable (and in any event within three Business Days), upon (i)&nbsp;surrender to the Exchange Agent of a Certificate, together with a duly completed
and validly executed letter of transmittal in accordance with the instructions thereto, or (ii)&nbsp;receipt of an &#147;agent&#146;s message&#148; by the Exchange Agent (or such other evidence, if any, of transfer as the Exchange Agent may
reasonably request) in the case of a book-entry transfer of shares of Company Common Stock or Common Units, and, in each case, delivery to the Exchange Agent of such other documents as may reasonably be requested by the Exchange Agent. Until so
surrendered or transferred, each such Certificate shall represent after the Effective Time for all purposes only the right to receive such Merger Consideration. No interest shall be paid or accrued on the cash payable upon the surrender or transfer
of such Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If any portion of the Merger Consideration is to be paid to a Person other than the Person in whose name the
surrendered Certificate is registered, it shall be a condition to such payment that (i)&nbsp;either such Certificate shall be properly endorsed or shall otherwise be in proper form for transfer and (ii)&nbsp;the Person requesting such payment shall
pay to the Exchange Agent any transfer or other Tax required as a result of such payment to a Person other than the registered holder of such Certificate or establish to the satisfaction of the Exchange Agent that such Tax has been paid or is not
payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All Merger Consideration paid upon the surrender of Certificates in accordance with the terms hereof shall be deemed to have
been paid in full satisfaction of all rights pertaining to the shares of Company Common Stock or Common Units, as applicable, formerly represented by such Certificate and from and after the Effective Time, there shall be no further registration of
transfers of shares of Company Common Stock or Common Units, as applicable, on the stock transfer books of the Surviving Corporation or the Surviving LLC, as applicable, other than transfers to reflect, in accordance with customary settlement
procedures, trades effected prior to the Effective Time or LLC Merger Effective Time, as applicable. If, after the Effective Time or LLC Merger Effective Time, as applicable, Certificates are presented to the Surviving Corporation or Surviving LLC,
as applicable, they shall be canceled and exchanged for the Merger Consideration as provided for, and in accordance with the procedures set forth, in this <U>ARTICLE II</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If any Certificate shall have been lost, stolen or destroyed, upon the holder&#146;s compliance with the replacement requirements
established by the Exchange Agent, including, if necessary, the posting by such Person of a bond, in such customary amount as the Surviving Corporation or Surviving LLC, as applicable, may direct, as indemnity against any claim that may be made
against it with respect to such Certificate, the Exchange Agent will issue, in exchange for such lost, stolen or destroyed Certificate, the Merger Consideration to be paid in respect of the shares of Company Common Stock or Common Units formerly
represented by such Certificate, as contemplated under this <U>ARTICLE II</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Any portion of the Payment Fund that remains unclaimed by the holders of shares of
Company Common Stock or Common Units one year after the Effective Time shall be delivered to the Surviving Corporation, upon demand, and any such holder who has not exchanged shares of Company Common Stock or the Common Unit for the Merger
Consideration or Common Units in accordance with this <U>Section</U><U></U><U>&nbsp;2.05</U> prior to that time shall thereafter look only to the Surviving Corporation and the Surviving LLC for payment of the Merger Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <I><U>Dissenting Shares</U></I>. Notwithstanding <U>Section</U><U></U><U>&nbsp;2.03</U>, shares of Class&nbsp;A Common Stock issued and
outstanding immediately prior to the Effective Time and owned by a holder or beneficial owner who has not voted in favor of adoption of this Agreement or consented thereto in writing, who is entitled to appraisal and who has properly exercised
appraisal rights for such shares in accordance with Section&nbsp;262 of the DGCL shall not be converted into, nor represent, a right to receive the Merger Consideration but instead shall be entitled to payment of the appraised value of such shares
in accordance with Section&nbsp;262 of the DGCL, following which such shares shall automatically be canceled and shall cease to exist (such shares, the &#147;<B>Dissenting Shares</B>&#148;); <U>provided</U>, <U>however</U>, that if, after the
Effective Time, such owner fails to perfect, effectively withdraws or validly waives or loses such owner&#146;s right to appraisal, pursuant to Section&nbsp;262 of the DGCL or if a court of competent jurisdiction shall determine that such owner is
not entitled to the relief provided by Section&nbsp;262 of the DGCL, such shares of Class&nbsp;A Common Stock shall be treated as if they had been converted as of the Effective Time into the right to receive the Merger Consideration in accordance
with <U>Section</U><U></U><U>&nbsp;2.03</U> upon surrender of such Certificate formerly representing such share. The Company shall provide Parent prompt written notice and copies of any demands received by the Company for appraisal of shares of
Company Common Stock, any withdrawal of any such demand and any other demand, notice or instrument delivered to the Company prior to the Effective Time pursuant to Section&nbsp;262 of the DGCL or that relates to a demand for an appraisal, and Parent
shall have the opportunity and right to participate in all negotiations and Proceedings with respect to such demands. Prior to the Effective Time, the Company shall not, without the prior written consent of Parent (which shall not be unreasonably
withheld, conditioned or delayed), make any payment with respect to, or settle or offer to settle, any such demands, or agree to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06 <I><U>Company Equity Awards; ESPP</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Company Stock Options</U>. Immediately prior to the Effective Time, without any action on the part of Parent, Merger Sub, the Company
or the holders thereof, each outstanding Company Stock Option shall be treated as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Stock Options</I>. Each <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Stock Option, whether vested
or unvested, shall be cancelled and converted into the right to receive an amount in cash, without interest thereon, equal to the product obtained by multiplying (1)&nbsp;the number of shares of Company Common Stock subject to such <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Stock Option as of immediately prior to the Effective Time by (2)&nbsp;the excess, if any, of the Per Share Cash Consideration over the exercise price per
share of such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Stock Option (the &#147;<B>Option Consideration</B>&#148;), subject to applicable withholding taxes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Out-of-the-Money</FONT></FONT></FONT> Company Stock Options</I>. Each <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Out-of-the-Money</FONT></FONT></FONT> Company Stock
Option shall be forfeited and cancelled for no consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Company RSUs</U>. At the Effective Time, each Company RSU
outstanding as of immediately prior to the Effective Time will automatically, without any action on the part of Parent, Merger Sub, the Company or the holders thereof, be treated as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I>Vested Company RSUs. </I>Each Vested Company RSU shall be cancelled and converted into the right to receive the per
share Merger Consideration in respect of each share of Company Common Stock subject to such Vested Company RSU as of immediately prior to the Effective Time (the &#147;<B>Vested RSU Consideration</B>&#148;), subject to applicable withholding taxes,
in the form determined at the election of the holder of such Vested Company RSUs pursuant to the procedures set forth in <U>Section</U><U></U><U>&nbsp;2.04</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <I>Unvested Company RSUs</I>. Each Unvested Company RSU shall be assumed by Parent and converted into a restricted stock
unit award (a &#147;<B>Converted RSU</B>&#148;) with respect to a number of shares of Parent Common Stock equal to the product, rounded up to the nearest whole share, obtained by multiplying (A)&nbsp;the number of shares of Company Common Stock
subject to the Unvested Company RSU immediately prior to the Effective Time by (B)&nbsp;the Exchange Ratio. Except as otherwise provided in this <U>Section</U><U></U><U>&nbsp;2.06(b)(ii)</U>, each Converted RSU assumed and converted pursuant to this
<U>Section</U><U></U><U>&nbsp;2.06(b)(ii)</U> shall continue to have, and shall be subject to, the same terms and conditions as applied to the corresponding Unvested Company RSU immediately prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Company PSUs</U>. At the Effective Time, each Company PSU outstanding as of immediately prior to the Effective Time shall
automatically, without any action on the part of Parent, Merger Sub, the Company or the holders thereof, vest to the extent set forth in the applicable award agreement relating to such Company PSU and be cancelled and converted into the right to
receive the Per Share Mixed Consideration in respect of each share of Company Common Stock subject to any such Company PSU that vests in accordance with its terms at the Effective Time (with the applicable performance conditions deemed achieved or
not achieved based on the Per Share Mixed Consideration in accordance with the applicable award agreement) (the &#147;<B>Vested PSU Consideration</B>&#148; and, together with the Option Consideration and the Vested RSU Consideration, the
&#147;<B>Vested Equity Award Consideration</B>&#148;), subject to applicable withholding taxes. Any Company PSU (or portion thereof) that does not vest at the Effective Time in accordance with its terms shall be forfeited and cancelled for no
consideration as of the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Payment Procedures</U>. As promptly as reasonably practicable following the Closing, the
holders of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Stock Options and Vested Company RSUs shall be paid by the Company or the Surviving Corporation, through its payroll system or payroll
provider, the Vested Equity Award Consideration with respect to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Stock Options and Vested Company RSUs, respectively, that are cancelled and
converted pursuant to this <U>Section</U><U></U><U>&nbsp;2.06</U>, less any required withholding pursuant to <U>Section</U><U></U><U>&nbsp;2.06</U> in the case of employees; <U>provided</U> that such payment shall be made at such other time or times
following the Effective Time consistent with the terms of the Company RSU or Company PSU, as applicable, to the extent necessary to avoid the imposition of additional income tax under Section&nbsp;409A of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Assumption of Company Stock Plan</U>. As of the Effective Time, Parent shall assume
the Company Stock Plan under which any Unvested Company RSUs were issued, except that (i)&nbsp;the shares of Company Common Stock covered by such awards will be shares of Parent Common Stock, (ii)&nbsp;all references to a number of shares of Company
Common Stock shall be amended to refer to shares of Parent Common Stock (with appropriate adjustments to the number and type of shares), and (iii)&nbsp;all references to the Company Board (or a committee thereof) shall be amended to be references to
the Board of Directors of Parent (or the applicable committee thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) As soon as reasonably practicable (and in any event no later
than 15 days) after the date hereof, the Company shall take all actions it determines are necessary to ensure that, subject to the occurrence of the Effective Time, (i)&nbsp;no new offering or purchase periods under the ESPP shall commence after the
date hereof, (ii)&nbsp;no new participants be permitted into the ESPP after the date hereof, and (iii)&nbsp;the existing participants in the ESPP may not increase their elections with respect to the offering or purchase periods in effect on the date
hereof. Further, as soon as reasonably practicable (and in any event no later than 15 days) after the date hereof, the Company shall take such other actions as may be required to provide that, with respect to the ESPP: (A)&nbsp;the exercise date for
any offering or purchase period in effect as of the date hereof shall be the earlier of the original exercise date for such offering and the date that is 60 days after the date hereof (the &#147;<B>Final Exercise Date</B>&#148;), (B) each ESPP
participant&#146;s accumulated contributions under the ESPP shall be used to purchase shares of Company Common Stock in accordance with the terms of the ESPP as of the Final Exercise Date or, to the extent not used to purchase shares of Company
Common Stock in accordance with the terms of the ESPP prior to the Effective Time, shall be refunded to such participant through the Company&#146;s payroll system no later than 10 Business Days following the Final Exercise Date, and (C)&nbsp;the
ESPP shall terminate on the date immediately prior to the date on which the Effective Time occurs and no further rights shall be granted or exercised under the ESPP thereafter. All shares of Company Common Stock purchased on the Final Exercise Date
shall be canceled at the Effective Time and converted into the right to receive the Merger Consideration in accordance with the terms and conditions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Prior to the Effective Time, the Company Board (or, if appropriate, any committee administering the Company Stock Plan or the ESPP) shall
adopt such resolutions and take any actions that are necessary to effectuate the treatment of the Company Equity Awards and the ESPP pursuant to this <U>Section</U><U></U><U>&nbsp;2.06</U> (including the satisfaction of the requirements of Rule <FONT
STYLE="white-space:nowrap">16b-3(e)</FONT> promulgated under the Exchange Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) As soon as reasonably practicable following the
Closing Date, Parent will cause the Parent Common Stock issuable upon settlement of any Converted RSUs to be registered with the SEC on Form <FONT STYLE="white-space:nowrap">S-8,</FONT> and will use commercially reasonable efforts to maintain the
effectiveness of such registration statement for so long as such Converted RSUs remain outstanding and will reserve a sufficient number of shares of Parent Common Stock for issuance upon exercise or settlement thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07 <I><U>Adjustments</U></I>. If, during the period between the date hereof
and the LLC Merger Effective Time, any change in the outstanding limited liability company interests of the Operating Company shall occur by reason of any reclassification, recapitalization, unit split (including reverse unit split) or combination,
exchange or readjustment of units, or any equity distribution, the Merger Consideration and any other amounts payable pursuant to this Agreement shall be appropriately adjusted so as to provide the same economic effect as contemplated by this
Agreement prior to such event, and such items, so adjusted shall, from and after the date of such event, be the Merger Consideration. If, during the period between the date hereof and the Effective Time, any change in the outstanding shares of
capital stock of the Company shall occur by reason of any reclassification, recapitalization, stock split (including reverse stock split) or combination, exchange or readjustment of shares, or any stock dividend, the Merger Consideration and any
other amounts payable pursuant to this Agreement shall be appropriately adjusted so as to provide the same economic effect as contemplated by this Agreement prior to such event, and such items, so adjusted shall, from and after the date of such
event, be the Merger Consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.08 <I><U>Withholding Rights</U></I>. Each of Parent, Acquirer, Merger Sub, Merger Sub
II, the Surviving Corporation and the Exchange Agent including their respective Affiliates and agents (each a &#147;<B>Withholding Person</B>&#148;) shall be entitled to deduct and withhold from the consideration otherwise payable to any Person
pursuant to this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment under any provision of any applicable Tax law or under any agreement between the Company and the Person entitled to such
payment. To the extent that amounts are so deducted and withheld and are paid to the applicable Taxing Authority by any Withholding Person, such amounts shall be treated for all purposes under this Agreement as having been paid to the Person in
respect of which the Withholding Person made such deduction and withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.09 <I><U>Payoff</U></I>. At the Closing,
Parent shall pay, or cause to be paid, the Payoff Amount; provided that the Company shall provide to Parent (a)&nbsp;at least three Business Days prior to the Closing Date a substantially final draft of the Payoff Letter and (b)&nbsp;prior to the
Effective Time an executed copy of the Payoff Letter. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE SURVIVING CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01 <I><U>Certificate of Formation; Certificate of Incorporation</U></I>. At the LLC Merger Effective Time, the certificate of
formation of the Operating Company, as in effect immediately prior to the LLC Merger Effective Time, will remain unchanged and will become the certificate of formation of the Surviving LLC until thereafter amended in accordance with the applicable
provisions of the DLLCA. At the Effective Time, by virtue of the Merger, the certificate of incorporation of the Merger Sub, as in effect immediately prior to the Effective Time, shall be the certificate of incorporation of the Surviving Corporation
until, subject to <U>Section</U><U></U><U>&nbsp;6.10</U>, amended in accordance with Applicable Law. At the Second Effective Time (if the Second Effective Time shall occur in accordance with the terms and conditions of this Agreement), by virtue of
the Second Merger, the certificate of incorporation of the Acquirer, as in effect immediately prior to the Second Effective Time, shall be the certificate of incorporation of the Second Surviving Corporation until, subject to
<U>Section</U><U></U><U>&nbsp;6.10</U>, amended in accordance with Applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02 <I><U>LLC Agreement;
<FONT STYLE="white-space:nowrap">By-laws</FONT></U></I>. At the LLC Merger Effective Time, by virtue of the LLC Merger, the limited liability company agreement of Merger Sub II, as in effect immediately prior to the LLC Merger Effective Time, shall
become the limited liability company agreement of the Surviving LLC (the &#147;<B>LLC Agreement</B>&#148;) until, subject to <U>Section</U><U></U><U>&nbsp;6.10</U>, amended in accordance with Applicable Law and the LLC Agreement. At the Effective
Time, by virtue of the Merger, the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Merger Sub, as in effect immediately prior to the Effective Time, shall be the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Surviving Corporation
until, subject to <U>Section</U><U></U><U>&nbsp;6.10</U>, amended in accordance with Applicable Law. At the Second Effective Time (if the Second Effective Time shall occur in accordance with the terms and conditions of this Agreement), by virtue of
the Second Merger, the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Acquirer, as in effect immediately prior to the Second Effective Time, shall be the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Second Surviving Corporation
until, subject to <U>Section</U><U></U><U>&nbsp;6.10</U>, amended in accordance with Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03 <I><U>Directors
and Officers</U></I>. Parent and the Company will take such actions as are reasonably necessary such that, from and after the Effective Time, until the earlier of their death, resignation, removal or until their respective successors are duly
elected and qualified in accordance with the certificate of incorporation and <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Surviving Corporation and Applicable Law, (i)&nbsp;the directors of Merger Sub immediately prior to the Effective
Time shall be the directors of the Surviving Corporation, (ii)&nbsp;the officers of the Company immediately prior to the Effective Time shall be the officers of the Surviving Corporation and (iii)&nbsp;the officers of Merger Sub II immediately prior
to the LLC Merger Effective Time shall be the officers of the Surviving LLC. Parent and the Company will take such actions as are reasonably necessary such tha, from and after the Second Effective Time, until the earlier of their death, resignation,
removal or until their respective successors are duly elected and qualified in accordance with the certificate of incorporation and <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Second Surviving Corporation and Applicable Law, (i)&nbsp;the
directors of Acquirer immediately prior to the Second Effective Time shall be the directors of the Second Surviving Corporation and (ii)&nbsp;the officers of Acquirer immediately prior to the Second Effective Time shall be the officers of the Second
Surviving Corporation, in each case, if the Second Effective Time shall occur in accordance with the terms and conditions of this Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except (a)&nbsp;as disclosed in the Company SEC Documents furnished or filed and publicly available since January&nbsp;1, 2022 through the
date hereof (other than information that is contained (i)&nbsp;solely in the risk factors sections of such Company SEC Documents, except to the extent such information consists of factual statements, and (ii)&nbsp;in any forward-looking statements
in such Company SEC Documents that are of a nature that they speculated about future developments); provided that nothing disclosed in the Company SEC Documents will be deemed to modify or qualify the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;4.05</U>, <U>Section</U><U></U><U>&nbsp;4.09(b)</U> or <U>Section</U><U></U><U>&nbsp;4.27</U> or (b)&nbsp;subject to <U>Section</U><U></U><U>&nbsp;9.14</U>, as set forth in the Company Disclosure Schedule, the Company
hereby represents and warrants to Parent, Acquirer, Merger Sub and Merger Sub II as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01 <I><U>Corporate Existence and Power</U></I>. The Company is a corporation
duly incorporated, validly existing and in good standing under the laws of the State of Delaware and has all corporate powers and authority required to carry on its business as presently conducted and to own, lease or operate its properties, rights
and assets. The Company is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction where such qualification is necessary, except for those jurisdictions where failure to be so qualified would not
reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. The Company has Made Available to Parent complete and correct copies of the certificate of incorporation and
<FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company, including all amendments thereto, as currently in effect and the Company is not in violation of any provision thereof in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02 <I><U>Corporate Authorization</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Company and the Operating Company has all requisite corporate power and authority to (i)&nbsp;enter into and deliver this
Agreement, (ii)&nbsp;subject to the Stockholder Approval, to consummate the Mergers and the other transactions contemplated by this Agreement and (iii)&nbsp;perform its obligations hereunder. The execution, delivery and performance by each of the
Company and the Operating Company of this Agreement and the consummation by the Company and the Operating Company of the Mergers and the other transactions contemplated by this Agreement, except for obtaining the Stockholder Approval, have been duly
authorized by all necessary corporate action on the part of the Company and the Operating Agreement. Assuming the due authorization, execution and delivery of this Agreement by Parent, Acquirer, Merger Sub and Merger Sub II, this Agreement
constitutes a valid and binding agreement of the Company and the Operating Company enforceable against the Company and the Operating Company in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency,
moratorium and other similar Applicable Law affecting creditors&#146; rights generally and by general principles of equity (the &#147;<B>Enforceability Exceptions</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At a meeting duly called and held, prior to the execution of this Agreement, the Special Committee unanimously adopted resolutions
(A)&nbsp;determining that this Agreement, the Merger and the other transactions contemplated by this Agreement are advisable, fair to and in the best interests of the Company and the Company&#146;s stockholders, (B)&nbsp;recommending that the
Company Board determine that this Agreement, the Merger and the other transactions contemplated by this Agreement are advisable, fair to and in the best interests of the Company and the Company&#146;s stockholders and adopt and approve this
Agreement, the Merger and the other transactions contemplated by this Agreement, and (C)&nbsp;recommending that, subject to approval by the Company Board, the Company Board submit this Agreement to the Company&#146;s stockholders entitled to vote
thereon for adoption thereby and resolve to recommend that such stockholders adopt this Agreement and approve the transactions contemplated by this Agreement, including the Merger. Thereafter, the Company Board, upon the unanimous recommendation of
the Special Committee, unanimously adopted resolutions (i)&nbsp;determining that this Agreement, the Merger and the other transactions contemplated by this Agreement are advisable, fair to and in the best interests of the Company and the
Company&#146;s stockholders, (ii)&nbsp;adopting and approving this Agreement, the Merger and the other transactions contemplated by this Agreement, and (iii)&nbsp;directing that this Agreement be submitted to the Company&#146;s stockholders entitled
to vote thereon for adoption thereby and resolving to recommend that such stockholders adopt this Agreement and approve the transactions contemplated by this Agreement, including the Merger (the &#147;<B>Company Recommendation</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Enfusion US 1, Inc., in its capacity as the managing member of the Operating Company,
has (i)&nbsp;determined that it is in the best interests of the Operating Company and its members, declared it advisable to enter into this Agreement providing for the LLC Merger in accordance with the DLLCA upon the terms and subject to the
conditions set forth herein; and (ii)&nbsp;approved the execution and delivery of this Agreement by the Operating Company and the consummation of the LLC Merger upon the terms and subject to the conditions set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The only vote or action of holders of capital stock of the Company, or any class or series of capital stock of the Company, necessary to
adopt this Agreement are the adoption of this Agreement by the holders of a majority of the voting power of the outstanding shares of capital stock of the Company entitled to vote thereon, voting as a single class (such vote, the
&#147;<B>Stockholder Approval</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03 <I><U>Governmental Authorization</U></I>. The execution, delivery and
performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated by this Agreement require no action by or in respect of, or filing with, any Governmental Authority, other than (i)&nbsp;the filing of
the Certificate of Merger with the Secretary of State of the State of Delaware and appropriate documents with the relevant authorities of other states in which the Company is qualified to do business, (ii)&nbsp;compliance with any applicable
requirements of (A)&nbsp;the HSR Act and (B)&nbsp;any other applicable Antitrust Laws or any Foreign Investment Laws, (iii)&nbsp;compliance with any applicable requirements of the Securities Act, the Exchange Act, any other applicable U.S. state or
federal or foreign securities laws, or the rules or regulations of NYSE, and (iv)&nbsp;any actions or filings the absence of which would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04 <I><U><FONT STYLE="white-space:nowrap">Non-contravention</FONT></U></I>. The execution, delivery and performance by the
Company and the Operating Company of this Agreement and the consummation by the Company and the Operating Company of the Mergers and the other transactions contemplated by this Agreement do not and will not (with or without notice or lapse of time,
or both): (i) result in any violation or breach of any provision of the certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company or the Operating Agreement of the Operating Company; (ii)&nbsp;assuming compliance
with the matters referred to in <U>Section</U><U></U><U>&nbsp;4.03</U> and that the Stockholder Approval is obtained, result in a violation, conflict with or breach of any provision of any Applicable Law or Order; (iii)&nbsp;require any consent or
approval under, violate, result in any breach of or default under (or an event that, with notice or lapse of time or both, would become a default), result in the cancellation, adverse amendment, right of payment, termination or acceleration of any
right or obligation or the loss of any benefit to which the Company or one of its Subsidiaries is entitled under, or result in termination or give to others any right of termination of, any Material Contract; or (iv)&nbsp;result in the creation or
imposition of any Lien (other than Permitted Liens) on any asset of the Company or any of its Subsidiaries, with such exceptions, in the case of each of clauses (ii), (iii) and (iv), as would not reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05 <I><U>Capitalization</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of the Company consists of (i) 1,000,000,000 shares of Class&nbsp;A Common Stock, (ii) 150,000,000 shares of
Class&nbsp;B Common Stock and (iii) 100,000,000 shares of undesignated preferred stock, par value $0.001 per share (the &#147;<B>Company Preferred Stock</B>&#148;). At the close of business on January&nbsp;7, 2025: (A) 94,769,479 shares of
Class&nbsp;A Common Stock were issued and outstanding; (B) 34,198,767 shares of Class&nbsp;B Common Stock were issued and outstanding; (C)&nbsp;Company Stock Options to purchase an aggregate of 76,056 shares of Company Common Stock were issued and
outstanding; (D)&nbsp;an aggregate of 3,197,872 shares of Company Common Stock were subject to outstanding Company RSUs; (E)&nbsp;an aggregate of 965,294 shares of Company Common Stock were subject to outstanding Company PSUs assuming the
achievement of all performance goals or metrics applicable to such Company PSU; (F)&nbsp;an aggregate of 3,696,435 shares of Company Common Stock were reserved for issuance pursuant to the ESPP and there are no outstanding offering or purchase
periods under the ESPP as of the date hereof; (G)&nbsp;zero shares of Company Common Stock were held in the treasury of the Company; (H)&nbsp;zero shares of Company Preferred Stock were issued and outstanding; (I) 128,968,246 Common Units were
issued and outstanding; (J)&nbsp;no other limited liability company interests in the Operating Company were outstanding; and (K)&nbsp;an aggregate of 25,464,398 shares of Company Common Stock were reserved for issuance pursuant to the Company Stock
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Section 4.05(b)</U> of the Company Disclosure Schedule sets forth, as of the close of business on January&nbsp;7, 2025, a
complete and correct list of (i)&nbsp;all outstanding Company Stock Options, including the number of shares subject to such award, the name of the holder, the grant date, the vesting schedule, and the exercise or purchase price per share,
(ii)&nbsp;all outstanding Company RSUs, including the name of the holder, the grant date, the vesting schedule, and the number of shares of Company Common Stock subject to each award of Company RSUs, and (iii)&nbsp;all outstanding Company PSUs,
including the name of the holder, the grant date, the vesting schedule, and the number of shares of Company Common Stock subject to each award of Company PSUs (including the applicable performance periods), assuming the achievement of all
performance goals or metrics applicable to such Company PSUs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except for changes since January&nbsp;7, 2025 resulting from the
exercise or settlement of Company Equity Awards outstanding on such date in accordance with the applicable terms of the Company Stock Plan and such Company Equity Award or granted thereafter as expressly permitted under
<U>Section</U><U></U><U>&nbsp;6.01(b)</U> or the purchase of shares of Company Common Stock pursuant to the ESPP, there are no outstanding (i)&nbsp;shares of capital stock or voting securities of the Company, (ii)&nbsp;securities of the Company
convertible into or exchangeable for shares of capital stock or voting securities of the Company, (iii)&nbsp;subscriptions, options, warrants or other rights or arrangements to acquire from the Company, or other obligations or commitments of the
Company to issue, any capital stock or other voting securities or ownership interests in, or any securities convertible into or exchangeable for capital stock or other voting securities or ownership interests in, the Company, (iv)&nbsp;restricted
shares, stock appreciation rights, performance shares, contingent value rights, profits interests, equity-based or &#147;phantom&#148; stock or similar securities or rights that are derivative of, or provide economic benefits based, directly or
indirectly, on the value or price of, any capital stock of, or other voting securities or ownership interests in, the Company (the items in clauses (i)-(iv) being referred to collectively as the &#147;<B>Company Securities</B>&#148;), (v) voting
trusts, equityholder arrangements, proxies or other similar agreements or understandings to which </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound with respect to the voting of any shares of capital stock, or other equity or voting
interest in, of the Company or any of its Subsidiaries or (vi) contractual obligations or commitments of any character (A)&nbsp;restricting the transfer of, or requiring the registration for sale of, any shares of capital stock of the Company or any
of its Subsidiaries, (B)&nbsp;granting any preemptive rights, anti-dilutive rights or rights of first refusal or other similar rights with respect to any Company Securities, (C)&nbsp;restricting the payment of any dividend or distribution on any
Company Securities, or (D)&nbsp;requiring the Company or any of its Subsidiaries to make any payment based on the price or value of any equity interests of the Company. There are no outstanding obligations or commitments of the Company or any of its
Subsidiaries to repurchase, redeem or otherwise acquire any of the Company Securities. As of the date hereof, there are no accrued and unpaid dividends with respect to any outstanding shares of Company Common Stock. Neither the Company nor any of
its Subsidiaries has any outstanding bonds, debentures, notes or other indebtedness the holders of which have the right to vote (or convertible into or exercisable for securities having the right to vote) with the holders of equity interests in the
Company on any matter. No Subsidiary of the Company owns any Company Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All of the outstanding capital stock or other voting
securities of, or ownership interests in, each Subsidiary has been duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> as applicable, and are owned by the Company, directly or indirectly, free and
clear of any Lien (other than Permitted Liens). As of the date hereof, there are no issued, reserved for issuance or outstanding (i)&nbsp;securities of the Company or any of its Subsidiaries convertible into or exchangeable for, or measured by
reference to, shares of capital stock or other voting securities of, or ownership interests in, any Subsidiary, (ii)&nbsp;subscriptions, options, warrants or other rights or arrangements to acquire from the Company or any of its Subsidiaries, or
other obligations of the Company or any of its Subsidiaries to issue, any capital stock or other voting securities of, or ownership interests in, or any securities convertible into, or exchangeable for, or measured by reference to, any capital stock
or other voting securities of, or ownership interests in, any Subsidiary of the Company or (iii)&nbsp;restricted shares, stock appreciation rights, performance shares, contingent value rights, profits interests, equity-based or &#147;phantom&#148;
stock or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any capital stock of, or other voting securities or ownership interests in, any Subsidiary of the
Company (the items in clauses (i)&nbsp;through (iii) being referred to collectively as the &#147;<B>Company Subsidiary Securities</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) There are no outstanding obligations or commitments of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire
any of the Company Securities. There are no outstanding contractual obligations or commitments of the Company or any Subsidiary of the Company requiring the registration for sale of any Company Subsidiary Securities, granting any right to subscribe
for or acquire from any Subsidiary of the Company any Company Subsidiary Securities or requiring the Company or any of its Subsidiaries (or any outstanding obligations of the Company or any of its Subsidiaries) to repurchase, redeem or otherwise
acquire any of the Company Subsidiary Securities. The Company does not own, directly or indirectly, any shares of capital or other voting securities of, or ownership interests in, any other Person, other than its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) All issued and outstanding shares of Company Common Stock have been, and all shares that
may be issued pursuant to the Company Stock Plan or the ESPP will be, when issued in accordance with the respective terms thereof, duly authorized and validly issued and are (or, in the case of shares that have not yet been issued, will be) fully
paid, nonassessable and were not issued in breach of any preemptive rights and are free and clear of restrictions on transfer (other than as provided by applicable federal and state securities Laws). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06 <I><U>Subsidiaries</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section 4.06(a)</U> of the Company Disclosure Schedule sets forth a true and complete list of the Company&#146;s Subsidiaries together
with the jurisdiction of each Subsidiary and the ownership of equity interest of each Subsidiary. Except for securities held by the Company in connection with its ordinary course treasury investment activities and investments that are fully
impaired, neither the Company nor any of its Subsidiaries owns, directly or indirectly, any capital stock or voting securities of, or other equity interests in, or has any direct or indirect equity participation or similar interest in, or any
interest convertible into or exchangeable or exercisable for, any capital stock or voting securities of, or other equity interest in, any other Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Subsidiary
of the Company: (i)&nbsp;is a corporation or other business entity duly incorporated or organized (as applicable), validly existing and in good standing (with respect to jurisdictions that recognize such concept) under the laws of its jurisdiction
of incorporation or organization and has all corporate or other organizational powers required to carry on its business as presently conducted and to own, lease and operate its properties, rights and assets and (ii)&nbsp;is duly qualified to do
business and is in good standing (with respect to jurisdictions that recognize such concept) in each jurisdiction where such qualification is necessary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07 <I><U>SEC Filings and the Sarbanes-Oxley Act</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since January&nbsp;1, 2022, through the date hereof, the Company has filed with or furnished to, as applicable, the SEC each report,
statement, schedule, form or other document or filing required by Applicable Law to be filed or furnished by the Company at or prior to the time so required (the documents referred to in this <U>Section</U><U></U><U>&nbsp;4.07(a)</U>, together with
all exhibits and other information incorporated by reference therein and all amendments and supplements thereto, are collectively referred to as the &#147;<B>Company SEC Documents</B>&#148;). No Subsidiary of the Company is required to file any
report, statement, schedule, form or other document with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of its filing date (or, if amended or superseded by a filing
prior to the date hereof, on the date of such amended or superseded filing), each Company SEC Document complied as to form in all material respects with the applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act
and the rules and regulations promulgated thereunder applicable to the Company SEC Documents, as the case may be, each as in effect on the date that such Company SEC Document was filed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of its filing date (or, if amended or superseded by a filing prior to the date
hereof, on the date of such filing), no Company SEC Document filed with or furnished pursuant to the Exchange Act contained any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements made
therein, in light of the circumstances under which they were made, not misleading. No Company SEC Document that is a registration statement, as amended or supplemented, if applicable, filed pursuant to the Securities Act, as of the date such
registration statement or amendment became effective, contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein not misleading. As of the date
hereof, (i)&nbsp;there are no outstanding or unresolved comments in any comment letters received by the Company from the SEC and (ii)&nbsp;to the Knowledge of the Company, none of the Company SEC Documents is the subject of any ongoing review by the
SEC. As of the date hereof, to the Knowledge of the Company, there are no formal SEC inquiries or investigations pending or threatened, in each case regarding any accounting practices of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.08 <I><U>Financial Statements; Internal Controls</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The consolidated financial statements of the Company included in the Company SEC Documents (i)&nbsp;complied as to form, as of their
respective filing dates with the SEC, in all material respects with the applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, (ii)&nbsp;were prepared in accordance with GAAP applied on a
consistent basis during the periods involved (except, in the case of unaudited statements, for the absence of certain information and footnotes), and (iii)&nbsp;fairly presented (except as may be indicated in the notes thereto) in all material
respects the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and their consolidated results of operations and cash flows for the periods presented therein (subject to normal recurring
adjustments in the case of any unaudited interim financial statements). Except as has been described in the Company SEC Documents, there are no unconsolidated Subsidiaries of the Company or any <FONT STYLE="white-space:nowrap">off-balance</FONT>
sheet arrangements of the type required to be disclosed pursuant to Item 303(b) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company&#146;s system of internal control over financial reporting (as defined in Rules
<FONT STYLE="white-space:nowrap">13a-15(f)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(f)</FONT> under the Exchange Act) is reasonably designed and maintained to provide reasonable assurance that (i)&nbsp;transactions are recorded as
necessary to permit preparation of financial statements in accordance with GAAP, (ii)&nbsp;receipts and expenditures are being made only in accordance with authorizations of the Company&#146;s management and directors, and (iii)&nbsp;any
unauthorized use, acquisition or disposition of the Company&#146;s assets that would materially affect the Company&#146;s financial statements would be prevented or detected in a timely manner. There were no material weaknesses, or significant
deficiencies that in the aggregate would amount to a material weakness, identified in the management of the Company&#146;s assessment of internal controls as of and for the year ended December&nbsp;31, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company&#146;s &#147;disclosure controls and procedures&#148; (as defined in Rules <FONT STYLE="white-space:nowrap">13a-</FONT> 15(e)
and <FONT STYLE="white-space:nowrap">15d-15(e)</FONT> under the Exchange Act) are reasonably designed and maintained to ensure that (i)&nbsp;material information (both financial and <FONT STYLE="white-space:nowrap">non-financial)</FONT> required to
be disclosed by the Company in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported to the individuals responsible for preparing such reports within the time periods specified in the rules and
forms of the SEC and (ii)&nbsp;such material information is accumulated and communicated to the Company&#146;s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications of the principal
executive officer and principal financial officer of the Company required under the Exchange Act with respect to such reports. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the date hereof, the Company is in compliance in all material respects with all
rules, regulations and requirements of the Sarbanes Oxley Act to the extent applicable to the Company. Since January&nbsp;1, 2022, through the date hereof, the Company has complied in all material respects with the applicable listing and other rules
and regulations of the NYSE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.09 <I><U>Absence of Certain Changes</U></I>. Since the Company Balance Sheet Date (a),
through the date hereof the Company and its Subsidiaries have conducted their business in the ordinary course (except in connection with the transactions contemplated by this Agreement), (b) there has not been any event, change, occurrence,
development or state of circumstances that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect and (c)&nbsp;none of the Company nor any of its Subsidiaries has taken any action that,
if taken after the date of this Agreement would require Parent&#146;s consent pursuant to subsection (ii), (vi), (xii), (xiii), (xv), (xviii) or (xxi)&nbsp;of <U>Section</U><U></U><U>&nbsp;6.01(b)</U> or, solely with respect to the foregoing
subsections, subsection (xxiii)&nbsp;of <U>Section</U><U></U><U>&nbsp;6.01(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10 <I><U>No Undisclosed Material
Liabilities</U></I>. There are no liabilities or obligations of any nature, whether accrued, absolute, contingent or otherwise, known or unknown, whether due or to become due, of the Company or any of its Subsidiaries that would be required by GAAP
to be reflected on a consolidated balance sheet (or disclosed in the notes thereto), other than: (a)&nbsp;liabilities or obligations disclosed or otherwise reserved against in the Company Balance Sheet or in the consolidated financial statements of
the Company and its Subsidiaries (including the notes thereto) included in the Company SEC Documents filed prior to the date of this Agreement; (b)&nbsp;liabilities or obligations incurred in the ordinary course of business since the Company Balance
Sheet Date; (c)&nbsp;executory obligations arising under Contracts to which the Company or any of its Subsidiaries is a party (other than as a result of a breach thereof or default thereunder by the Company or any of its Subsidiaries); (d)
liabilities or obligations incurred in connection with the transactions contemplated by this Agreement (including the Mergers); and (e)&nbsp;liabilities or obligations that would not reasonably be expected to have, individually or in the aggregate,
a Company Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11 <I><U>Litigation</U></I>. Except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, from January&nbsp;1, 2022, (a) there is and there has been no Proceeding pending against or threatened in writing against or, to the Knowledge of the Company, involving the Company
or any of its Subsidiaries and (b)&nbsp;neither the Company nor any of its Subsidiaries is or has been subject to any outstanding Order. As of the date hereof, there is no pending Proceeding or outstanding Order that seeks to prevent, materially
impair or materially delay consummation of the Mergers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12 <I><U>Compliance with Applicable Law</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to result, individually or in the aggregate, in the Company incurring material liabilities,
each of the Company and its Subsidiaries is, and, since January&nbsp;1, 2022, has been, in compliance with all Applicable Laws and Privacy Obligations. Neither the Company nor any of its Subsidiaries has received any written notice since
January&nbsp;1, 2022 that remains unresolved (i)&nbsp;of any administrative, civil or criminal investigation or material audit by any Governmental Authority relating to the Company or any of its Subsidiaries or (ii)&nbsp;from any Governmental
Authority alleging that the Company or any of its Subsidiaries is not in compliance with any Applicable Law, except for such notices described in clauses (i)&nbsp;and (ii) that would not reasonably be expected to result, individually or in the
aggregate, in the Company incurring material liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to result, individually or in
the aggregate, in the Company incurring material liabilities, (i)&nbsp;each of the Company and its Subsidiaries has in effect all Governmental Authorizations necessary for it to own, lease or otherwise hold and operate its properties and assets and
to carry on its businesses and operations and (ii)&nbsp;there have occurred no defaults (with or without notice or lapse of time or both) under, violations of, or events giving rise to any right of termination, amendment or cancelation of, any such
Governmental Authorizations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.13 <I><U>Certain Business Practices</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since January&nbsp;1, 2022, the Company and its Subsidiaries have been in material compliance with all Anti-Corruption Laws. Since
January&nbsp;1, 2022, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, none of the Company nor any of its Subsidiaries, nor any of their respective directors, officers, or
employees, in each case, solely in their capacities as such, nor, to the Knowledge of the Company, any of their other Representatives or any other Person acting on their behalf, in each case, solely in their capacities as such, has: (a)&nbsp;used
any funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity; (b)&nbsp;made any unlawful payment to foreign or domestic government officials or employees or to foreign or domestic political
parties or campaigns; or (c)&nbsp;offered, promised, provided, or authorized the provision of any money, property, or other thing of value, directly or indirectly, to any Person to improperly influence official action or secure an improper advantage
in violation of Anti-Corruption Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2022, except as would not reasonably be expected to have, individually or
in the aggregate, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries, is or has been in violation of, nor to the Knowledge of the Company, been under investigation by any Governmental Authority for violating, any
applicable Anti-Corruption Laws, Sanctions, International Trade Laws, or Anti-Money Laundering Laws. Neither the Company nor any of its Subsidiaries, nor any of their respective directors, officers or employees, is the subject or target of Sanctions
or located, organized, or resident in any country or region that is the subject or target of comprehensive Sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company and
its Subsidiaries have implemented and maintain in effect policies and procedures reasonably designed to promote compliance with Anti-Corruption Laws, Sanctions, International Trade Laws, and Anti-Money Laundering Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.14 <I><U>Material Contracts</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except (i)&nbsp;as filed as exhibits to the Company SEC Documents, (ii)&nbsp;for this Agreement and the other agreements entered into in
connection with the transactions contemplated hereby and (iii)&nbsp;for Company Employee Plans, as of the date hereof, neither the Company nor any Subsidiary of the Company is a party to or is bound by any Contract: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) that is a &#147;material contract&#148; (as such term is defined in Item 601(b)(10) of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> of the Exchange Act); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) that is with the 25 largest customers of the Company and
its Subsidiaries by revenue during the 9 months ended September&nbsp;30, 2024 (as defined in the Company&#146;s Press Release issued November&nbsp;4, 2024 which is filed with the Company SEC Documents) (excluding any nondisclosure agreements, data
processing agreements, purchase orders or statements of work or invoices entered into in the ordinary course of business, and other similar Contracts that are ancillary to Contracts pursuant to which revenue is paid or payable to the Company or its
Subsidiaries); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) that is with the 10 largest vendors of the Company and its Subsidiaries during the 12 months ended
September&nbsp;30, 2024 (as determined based on cost of goods and services paid to such vendors by the Company during such time period) (excluding any <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements, data processing agreements,
purchase orders or statements of work or invoices entered into in the ordinary course of business, and other similar Contracts that are ancillary to Contracts pursuant to which cost of goods and services is paid or payable by the Company); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) relating to the disposition or acquisition of any business, equity, real property or all or substantially all of the
assets of any Person for aggregate consideration in excess of by the Company or any of its Subsidiaries outside of the ordinary course of business pursuant to which the Company or its Subsidiaries have material continuing obligations; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) containing (A)&nbsp;a covenant or other provision limiting the ability of the Company or any Subsidiary of the Company to
compete or engage in any line of business or to compete with any Person in any geographic area (other than any customary employee <FONT STYLE="white-space:nowrap">non-solicitation</FONT> or <FONT STYLE="white-space:nowrap">no-hire</FONT> clauses
entered into in the ordinary course of business), (B) &#147;most favored nation&#148; or &#147;exclusivity&#148; provisions, (C)&nbsp;a right of first refusal or right of first offer or similar right that limits the ability of the Company or any of
its Subsidiaries to sell, transfer, pledge or otherwise dispose of assets, rights or properties or (D)&nbsp;a minimum purchase, minimum volume, &#147;earnout&#148; or other contingent, deferred or fixed payment obligation of the Company and its
Subsidiaries, in each case, that would be material to the Company and its Subsidiaries, taken as a whole; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) relating to
or evidencing indebtedness for borrowed money, debt securities, warrants or other rights to acquire any debt securities, of the Company or any Subsidiary of the Company (including any hedging, swap, derivative or other similar Contract), or any
guarantee by the Company or of its Subsidiaries of the obligations of any Person (in each case, excluding, intercompany loans between the Company and any of its wholly-owned Subsidiaries or between or among any wholly-owned Subsidiaries of the
Company); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) that is a license (or a sublicense, covenant, consent or other right
in or to use Intellectual Property) granted by the Company or any Subsidiary of the Company to any Company Intellectual Property (A)&nbsp;on an exclusive basis, (B)&nbsp;pursuant to which the Company or any Subsidiary of the Company received
licensing revenues for the 12 months ended December&nbsp;31, 2023 or the 2024 calendar year in excess of $550,000, other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses granted to customers in the ordinary course of business,
and/or (C)&nbsp;that is otherwise material to the Company and its Subsidiaries, taken as a whole; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) that is a license
(or a sublicense, covenant, consent or other right in or to use Intellectual Property) of Intellectual Property granted to the Company or any Subsidiary of the Company by any third Person (A)&nbsp;on an exclusive basis, (B)&nbsp;on a <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> basis, if pursuant to which the Company or any Subsidiary of the Company made payments during the 12 months ended December&nbsp;31, 2023 or the 2024 calendar year in excess of $550,000, and/or
(C)&nbsp;that is otherwise material to the Company and its Subsidiaries, taken as a whole (each such Contract that is scheduled or required to be scheduled against (A) &#150; (C) above, an &#147;<B>Inbound IP License</B>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) that (A)&nbsp;provides for any invention, creation, conception or other development of any material Intellectual Property
(1)&nbsp;by the Company or any of its Subsidiaries for any other Person, (2)&nbsp;by the Company or any of its Subsidiaries jointly with any other Person or (3)&nbsp;for the Company or any of its Subsidiaries by any other Person (excluding any
Invention Assignment Agreements) or (B)&nbsp;provides for the assignment or other transfer of any ownership interest in any material Intellectual Property (1)&nbsp;to the Company or any of its Subsidiaries by any other Person (excluding any
Invention Assignment Agreements) or (2)&nbsp;by the Company or any of its Subsidiaries to any other Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) that is a
collective bargaining agreement or other similar Contract with any labor union, labor organization, works council or other similar employee representative (&#147;<B>Labor Agreement</B>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) that is a settlement, conciliation or similar agreement with any Governmental Authority pursuant to which the Company will
have a material outstanding obligation following the execution of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xii) any stockholders&#146; agreement,
voting trust agreement or registration rights agreement or similar agreements, arrangements or commitments relating to any equity securities of the Company or any if its Subsidiaries or relating to the disposition, voting or dividends with respect
to any equity securities of the Company or any of its Subsidiaries; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiii) is with an affiliate or other Person that
would be required to be disclosed under Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated under the Exchange Act, other than any Contract solely among the Company and its wholly-owned Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Contract of the type described above in <U>Section</U><U></U><U>&nbsp;4.14(a)</U>
is referred to herein as a &#147;<B>Material Contract.</B>&#148; Except for Material Contracts that have expired or terminated by their terms, as of the date hereof, all of the Material Contracts are (A)&nbsp;valid and binding on the Company or the
applicable Subsidiary of the Company, as the case may be, and, to the Knowledge of the Company, each other party thereto, and (B)&nbsp;in full force and effect, except (i)&nbsp;as may be limited by bankruptcy, insolvency, moratorium and other
similar Applicable Law affecting creditors&#146; rights generally and by general principles of equity and (ii)&nbsp;as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. Neither the Company
nor any Subsidiary of the Company has, and, to the Knowledge of the Company, none of the other parties thereto have, (x)&nbsp;violated any provision of, or committed or failed to perform any act under, and no event or condition exists, which (with
or without notice, lapse of time or both) would constitute a breach of or default under, the provisions of any Material Contract, except in each case for those violations, acts (or failures to act) and defaults which, individually or in the
aggregate, would not reasonably be expected to have a Company Material Adverse Effect or (y)&nbsp;the intention to renegotiate, terminate or claim a material breach under any Material Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.15 <I><U>Taxes</U></I>. Except as would not, individually or in the aggregate, reasonably be expected to have a Company
Material Adverse Effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) all Company Returns required to be filed with any Taxing Authority have been filed when due (taking into
account valid extensions) in accordance with all Applicable Laws, (ii)&nbsp;all such Company Returns were true, correct and complete, (iii)&nbsp;the Company and each of its Subsidiaries have paid (or have had paid on their behalf) all Taxes due and
payable (whether or not shown as due and owing on such Company Return) and (iv)&nbsp;all Taxes of the Company and its Subsidiaries, if not yet due and owing, have been adequately accrued and reserved to the extent required by GAAP; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Company and each of its Subsidiaries has withheld all Taxes required to have been withheld in connection with amounts paid or owing to
any employee, independent contractor, creditor, stockholder, or other Person and such Taxes have been timely paid over to the proper Governmental Authority; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) (i) no deficiencies for Taxes of the Company or any of its Subsidiaries have been assessed by any Taxing Authority, except for deficiencies
that have been paid or otherwise resolved, (ii)&nbsp;to the Knowledge of the Company, there is no Proceeding presently in progress, pending or threatened in writing against the Company or any of its Subsidiaries in respect of any Tax, (iii)&nbsp;no
claim has been made in writing by a Taxing Authority in a jurisdiction where the Company or any of its Subsidiaries does not file a type of Tax Return that it is or may be subject to taxation by, or may be required to file such type of Tax Return
in, that jurisdiction, and (iv)&nbsp;none of the Company or any of its Subsidiaries has a permanent establishment in any country other than the country of its organization, or is or has been, subject to income Tax in a jurisdiction outside the
country of its organization, in each case, where it is required to file an income Tax Return and does not file such return; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) each of
the Company and its Subsidiaries has collected all sales and use Taxes required to be collected, and has remitted, or will remit on a timely basis, such amounts to the appropriate Governmental Authorities, or has been furnished properly completed
exemption certificates; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) there are no Liens for Taxes on any assets of the Company or any of its Subsidiaries,
other than Permitted Liens; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) neither the Company nor any of its Subsidiaries has executed any waiver, except in connection with any
ongoing Tax examination, of any statute of limitations on, or extended the period for the assessment or collection of, any Tax, in each case that has not since expired and other than waivers or extensions of time to file Tax Returns granted in the
ordinary course of business or pursuant to a routine request by a Taxing Authority; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) neither the Company nor any of its Subsidiaries
was a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; in a transaction intended to be governed by Section&nbsp;355 of the Code during the <FONT STYLE="white-space:nowrap">two-year</FONT> period ending on the date of this
Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) neither the Company nor any of its Subsidiaries has participated in any &#147;reportable transaction&#148; within the
meaning of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b);</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) (i) neither the Company nor any of
its Subsidiaries is or has been a member of an affiliated group of corporations within the meaning of Section&nbsp;1504 of the Code or any group that has filed a combined, consolidated, unitary, or similar Tax Return and (ii)&nbsp;neither the
Company nor any of its Subsidiaries has any liability for the Taxes of any Person under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of state, local or foreign law), or as a transferee
or successor, by Contract or otherwise by operation of law; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Neither the Company nor any of its Subsidiaries is (or has been during the
applicable period specified in Section&nbsp;897(c)(1)(A)(ii) of the Code) a United States real property holding corporation within the meaning of Section&nbsp;897(c)(2) of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) there are no Tax sharing, allocation or indemnification agreements (other than customary commercial or financial arrangements entered into
in the ordinary course of business the primary purpose of which is unrelated to Taxes), with respect to which the Company or any of its Subsidiaries is a party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) neither the Company nor any of its Subsidiaries will be required to include any item of income in, or exclude any item of deduction from,
taxable income for any taxable period or portion thereof beginning after the Closing Date as a result of (i)&nbsp;a change in method of, or use of an improper method of, accounting occurring prior to the Closing, (ii)&nbsp;an installment sale or
open transaction arising in a taxable period (or portion thereof) ending on or before the Closing Date, (iii)&nbsp;a prepaid amount received, or paid, or deferred revenue accrued prior to the Closing, (iv)&nbsp;a &#147;closing agreement&#148; as
described in Section&nbsp;7121 of the Code (or any corresponding or similar provision of state or local income Tax Law) executed on or prior to the Closing Date, (v)&nbsp;transactions effected or investments made on or prior to the Closing that
result in taxable income pursuant to Section&nbsp;951(a) of the Code, or (vi) &#147;global intangible <FONT STYLE="white-space:nowrap">low-taxed</FONT> income&#148; within the meaning of Section&nbsp;951A of the Code (or any similar provision of
state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law) attributable to a taxable period (or portion thereof) ending on or prior to the Closing and neither the Company nor any of its Subsidiaries will be required to pay any Taxes after
the Closing Date as a result of an election under Section&nbsp;965(h) of the Code; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) neither the Company nor any of its Subsidiaries has taken any action, or knows of any
fact, agreement, plan or other circumstance, that could reasonably be expected to prevent the Corporate Mergers, taken together, from qualifying as a reorganization within the meaning of Section&nbsp;368(a) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.16 <I><U>Employee Benefit Plans</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section 4.16(a)</U> of the Company Disclosure Schedule contains a true and complete list, as of the date of this Agreement, identifying
each material U.S. Employee Plan, other than (i)&nbsp;any individual offer letter or employment agreement for <FONT STYLE="white-space:nowrap">non-officer</FONT> employees that (A)&nbsp;does not provide for any severance or change of control
benefits and (B)&nbsp;is consistent in all material respects with a standard form (in which case only such standard form(s) and all individual agreements that do not conform in all material respects to such standard form(s) are required to be
listed) or (ii)&nbsp;any U.S. Employee Plan that is terminable &#147;at will&#148; without any contractual obligation or additional liability on the part of the Company or its Subsidiaries. Within 10 Business Days following the date of this
Agreement, the Company shall provide to Parent a true, correct and complete list, as of the date of such provision, identifying each material Foreign Employee Plan, in each case other than (A)&nbsp;any individual offer letter or employment agreement
for <FONT STYLE="white-space:nowrap">non-officer</FONT> employees that does not provide for any severance or change of control benefits and are terminable on less than thirty days&#146; notice without further obligation, or (B)&nbsp;any Foreign
Employee Plan that is terminable &#147;at will&#148; (or following a notice period imposed by Applicable Law) without any contractual obligation or additional liability on the part of the Company or its Subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to each material U.S. Employee Plan, the Company has Made Available to Parent true and correct copies of the following (as
applicable) prior to the date of this Agreement: (i)&nbsp;the current plan document, including all amendments thereto or, with respect to any unwritten plan, a summary of all material terms thereof, (ii)&nbsp;the most recent summary plan description
along with all summaries of material modifications thereto, (iii)&nbsp;all related trust instruments or other funding-related documents and insurance contracts, (iv)&nbsp;the financial statements for the most recent year for which such financial
statements are available, in audited form if required by ERISA and, where applicable, Annual Report/Returns (Forms 5500) with disclosure schedules and attachments for the most recent year for which such Annual Report/Return (Form 5500) is available,
in each case, to the extent not publicly available, (v)&nbsp;a copy of all material, <FONT STYLE="white-space:nowrap">non-routine</FONT> correspondence with any Governmental Authority relating to a Company Employee Plan received or sent within the
last three years, (vi)&nbsp;the most recent Internal Revenue Service determination or opinion letter, and (vii)&nbsp;written results of any required compliance testing for the most recent plan year. The Company has Made Available to Parent true and
correct copies of the following: (A)&nbsp;the standard agreements evidencing Company Stock Options, Company RSUs and Company PSUs; and (B)&nbsp;each agreement evidencing a Company Stock Option, Company RSU or Company PSU that does not conform in all
material respects to the standard agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Within 30 days following the date of this Agreement, the Company shall, with respect to
each material Foreign Employee Plan (other than with respect to any such Foreign Employee Plan that the Company is prohibited from making available to Parent by Applicable Law), make available to Parent for review by Parent or Parent&#146;s
representatives, either via electronic mail, in hard copy form, via Datasite or similar service or in the virtual data room maintained by or on behalf of the Company in connection with the transactions contemplated by this Agreement, true and
correct copies of the documents and materials listed in clauses (i)&nbsp;through (vi) of <U>Section</U><U></U><U>&nbsp;4.16(b)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
Neither the Company, any of its Subsidiaries nor any ERISA Affiliate of the Company or any of its Subsidiaries sponsors, maintains, participates in or contributes or is obligated to contribute to, or has in the past six years sponsored, maintained,
participated in or contributed or has been obligated to contribute to, or otherwise has any current or contingent liability or obligation with respect to, (i)&nbsp;any Company Employee Plan subject to Section&nbsp;412 of the Code, Section&nbsp;302
of ERISA or Title IV of ERISA, (ii)&nbsp;any multiemployer plan within the meaning of Section&nbsp;3(37) of ERISA, (iii)&nbsp;a multiple employer plan, within the meaning of Section&nbsp;413(c) of the Code, or Section&nbsp;4063 or Section&nbsp;4064
of ERISA, or (iv)&nbsp;a &#147;multiple employer welfare arrangement&#148; (as defined in Section&nbsp;3(40) of ERISA). Neither the Company nor any of its Subsidiaries has any outstanding or contingent liability or obligation as a consequence of at
any time being considered a single employer under Section&nbsp;414 of the Code with any other Person. No Company Employee Plan that is a &#147;welfare plan&#148; (as defined in Section&nbsp;3(1) of ERISA) provides and there is no other obligation to
provide material post-termination or retiree life insurance or health benefits to any person, except (A)&nbsp;as may be required by Section&nbsp;4980B of the Code or any similar Applicable Law (&#147;<B>COBRA</B>&#148;) or (B)&nbsp;pursuant to any
Company Employee Plan identified in <U>Section</U><U></U><U>&nbsp;4.16(a)</U> of the Company Disclosure Schedule (or, with respect to a Foreign Employee Plan, listed for Parent in accordance with <U>Section</U><U></U><U>&nbsp;4.16(a)</U>) that
provides subsidized or employer-paid premiums for group health plan continuation coverage under COBRA for a period of time that is no longer than the length of the applicable severance period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Each U.S. Employee Plan which is intended to be qualified under Section&nbsp;401(a) of the Code has received a favorable determination or
may rely upon an opinion letter, or has pending, or has time remaining to which to file, an application of such determination from the Internal Revenue Service, and, to the Knowledge of the Company, no event has occurred and no condition exists that
could reasonably be expected to adversely affect the qualified status of such U.S. Employee Plan. Each U.S. Employee Plan has been established, funded and maintained in all material respects in compliance with its terms and with the requirements
prescribed by Applicable Laws, including ERISA and the Code. No material Proceedings, claims or litigation is pending with respect to any U.S. Employee Plan (other than routine claims for benefits) and, to the Knowledge of the Company, no such
Proceeding, claim or litigation is threatened in writing, and there are no governmental audits or investigations pending or, to the Knowledge of the Company, threatened in writing in connection with any U.S. Employee Plan. Neither the Company nor
any of its Subsidiaries has incurred any material Tax or other liability (whether or not assessed) pursuant to Sections 4975, 4980B, 4980D, 4980H, 6721 or 6722 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) (i) Each Foreign Employee Plan and related trust, complies in all material respects with
and has been established, maintained and administered in compliance in all material respects with (A)&nbsp;any Applicable Laws and (B)&nbsp;their terms and the terms of any collective bargaining, collective labor or works council agreements,
(ii)&nbsp;each Foreign Employee Plan which, under any Applicable Laws, is required to be registered or approved by any Governmental Authority has been so registered or approved, (iii)&nbsp;no Foreign Employee Plan has unfunded liabilities that as of
the Effective Time will not, in all material respects, be fully accrued for in the Company&#146;s financial statements or fully offset by insurance and (iv)&nbsp;each Foreign Employee Plan that is intended to qualify for preferential Tax treatment
has been determined to qualify for such Tax treatment and, to the Knowledge of the Company, there are no existing circumstances or events that have occurred or that could reasonably be expected to adversely affect the preferential Tax treatment of
such Foreign Employee Plan. The Company and its Subsidiaries are in material compliance with all obligations applicable to them with respect to any benefit plan maintained by a Governmental Authority and any statutory benefits (or related benefit
plan) mandated by Applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as provided in this Agreement or as required under Applicable Law, the consummation of the
transactions contemplated by this Agreement will not (either alone or together with any other event): (i) entitle any current or former employee, director or independent contractor of the Company or any of its Subsidiaries to any compensation or
benefits under any Company Employee Plan or otherwise or any increase in such compensation or benefits; (ii)&nbsp;accelerate the time of payment or vesting of any compensation, payments, benefits or equity-based award; (iii)&nbsp;trigger any funding
(through a grantor trust or otherwise) of compensation or benefits under any Company Employee Plan; (iv)&nbsp;result in any forgiveness of indebtedness, trigger any payment or funding, or increase the amount payable pursuant to any Company Employee
Plan; or (v)&nbsp;impose any additional restrictions or limitations of the Company&#146;s or any of its Subsidiaries&#146; right to amend, modify or terminate any Company Employee Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated by this Agreement will (either
alone or in conjunction with any other event) result in any &#147;excess parachute payment&#148; (within the meaning of Section&nbsp;280G of the Code) becoming due to any current or former employee, director or independent contractor of the Company
or any of its Subsidiaries. No Company Employee Plan provides for a &#147;<B><FONT STYLE="white-space:nowrap">gross-up</FONT></B>&#148; or similar payment in respect of any Taxes that may become payable, including those imposed under Sections 409A
or 4999 of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Except as would not reasonably be expected to result in material liability for the Company, each Company Employee
Plan that constitutes in any part a nonqualified deferred compensation plan within the meaning of Section&nbsp;409A of the Code has been operated and maintained in operational and documentary compliance with Section&nbsp;409A of the Code and
applicable guidance thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.17 <I><U>Labor and Employment Matters</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since January&nbsp;1, 2022, the Company and its Subsidiaries have been in material compliance with all federal, state, local, and foreign
Applicable Laws respecting employment and employment practices, including terms and conditions of employment, wages, and hours, equal employment opportunity, discrimination, harassment, retaliation, disability rights or benefits, immigration
(including the completion of Forms <FONT STYLE="white-space:nowrap">I-9</FONT> for all employees and the proper confirmation and maintenance of employee visas), classification of employees and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
independent contractors, pay equity, workers&#146; compensation, government contracting and subcontracting regulations, affirmative action, <FONT STYLE="white-space:nowrap">COVID-19,</FONT> plant
closures and layoffs (including the WARN Act), employee leave issues, collective bargaining and labor relations, whistleblowing, occupational safety and health standards, workers&#146; compensation, employee trainings and notices, unemployment
insurance, and withholding of payroll Taxes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not, individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect, since January&nbsp;1, 2022, (A) the Company has not received written notice of any audits or investigations pending or scheduled by any Governmental Authority pertaining to the employment practices of the Company and
(B)&nbsp;no written complaints relating to employment practices of the Company that are reasonably likely to be material to the Company have been made to any Governmental Authority or submitted to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Neither the Company nor any Subsidiary of the Company is a party to, or otherwise bound by any Labor Agreement. Since January&nbsp;1, 2022,
(i) neither the Company nor any Subsidiary of the Company has been subject to any charge, demand, petition or representation Proceeding seeking to compel, require or demand it to bargain with any labor union, works council or labor organization, and
(ii)&nbsp;there have not been any labor strikes, material labor grievances, unfair labor practices charges, material collective bargaining or work council disputes, material concerted work stoppages, lockouts, or material concerted slowdowns pending
or, to the Knowledge of the Company, threatened against the Company or any Subsidiary of the Company. To the Knowledge of the Company, since January&nbsp;1, 2022, there have been no labor organizing activities with respect to any employees of the
Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Since January&nbsp;1, 2022, neither the Company or any of its Subsidiaries have taken any action which constituted a
&#147;plant closing&#148; or &#147;mass layoff&#148; within the meaning of the WARN Act, issued any notification of a &#147;plant closing&#148; or &#147;mass layoff&#148; required by the WARN Act, or incurred any liability or obligation under the
WARN Act that remains unsatisfied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Since January&nbsp;1, 2022, no material allegations of sexual harassment or sexual misconduct have
been made against any current or former executive of the Company or its Subsidiaries, and the Company and its Subsidiaries have not entered into or executed any settlement agreements related to allegations of sexual harassment or sexual misconduct
by an officer or executive. The Company and its Subsidiaries have reasonably and impartially investigated all sexual harassment and material misconduct allegations against any officers, executives or senior supervisory employees since
January&nbsp;1, 2022 of which the Company has Knowledge. With respect to any such allegations since January&nbsp;1, 2022, that the Company has reasonably determined has merit, the Company and its Subsidiaries have taken prompt, corrective action
that is reasonably calculated to prevent further improper conduct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.18 <I><U>Insurance</U></I>.
<U>Section</U><U></U><U>&nbsp;4.18</U> of the Company Disclosure Schedule contains an accurate and complete list, as of the date hereof, of all insurance policies issued in favor of the Company or any of its Subsidiaries. Except as would not,
individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect: (a)&nbsp;the Company and its Subsidiaries maintain or are otherwise covered by insurance in such amounts and against such risks as is sufficient to
comply with Applicable Law and Contracts to which the Company or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of its Subsidiaries is a party or is bound; (b)&nbsp;all insurance policies maintained by the Company and its Subsidiaries are in full force and effect and all premiums due and payable thereon
have been paid in full; (c)&nbsp;neither the Company nor any of its Subsidiaries is in breach of or default under (or an event that, with notice or lapse of time or both, would become a default) any of such insurance policies; and (d)&nbsp;since
January&nbsp;1, 2022, the Company has not received any written notice of termination, modification or cancelation or denial of coverage with respect to any insurance policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.19 <I><U>Environmental Matters</U></I>. Except as would not, individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Company and its Subsidiaries are, and since January&nbsp;1, 2022, have been, in compliance with
all Environmental Laws, which compliance includes obtaining, maintaining and complying with all Governmental Authorizations and other authorizations necessary under or required by Environmental Laws; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) no claim or written notice, report or information has been received or is pending, or to the Knowledge of the Company, threatened against
the Company or any of its Subsidiaries, alleging that the Company or any of its Subsidiaries is in violation of, or has liability under, any Environmental Law; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) there has been no release or disposal of, contamination by, or exposure of any Person to any Hazardous Substance, including as a result of
the operation of the business of the Company and its Subsidiaries or at any Company Leased Real Property or any real property currently or formerly owned or leased by the Company, so as to result in liability (contingent or otherwise) to the Company
or its Subsidiaries under any Environmental Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.20 <I><U>Intellectual Property</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section 4.20(a)</U> of the Company Disclosure Schedule contains an accurate and complete list, as of the date hereof, of all
(i)&nbsp;Patents, pending applications to register Patents, registered Marks, pending applications to register Marks, and registered Copyrights and pending applications to register Copyrights, in each such case that are included in the Company Owned
Intellectual Property and (ii)&nbsp;Domain Names included in the Company Intellectual Property. The Company Owned Intellectual Property and Domain Names listed on <U>Section</U><U></U><U>&nbsp;4.20(a)</U> of the Company Disclosure Schedule are
subsisting and, to the Knowledge of the Company, such Company Owned Intellectual Property is valid and enforceable. The Company or a Subsidiary (i)&nbsp;is the sole and exclusive owner of each item of the Company Owned Intellectual Property, and
(ii)&nbsp;except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, has valid and enforceable rights pursuant to a valid written Inbound IP License to use all Company Licensed
Intellectual Property as the same is used in the business of the Company and its Subsidiaries, in each case, free and clear of all Liens, other than Permitted Liens. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All (i)&nbsp;Patents, Marks and Copyrights included in the Company Owned Intellectual
Property and (ii)&nbsp;Domain Names included in the Company Licensed Intellectual Property, in either case, that are issued by, or registered or the subject of an application filed with, as applicable, the U.S. Patent and Trademark Office, the U.S.
Copyright Office, a domain name registrar, or any similar office or agency anywhere in the world have been duly maintained (including the payment of maintenance fees) and are not expired, canceled or abandoned, except for such <FONT
STYLE="white-space:nowrap">non-material</FONT> issuances, registrations or applications that the Company or any of its Subsidiaries has permitted to expire or has canceled or abandoned in its reasonable business judgment and except as would not
reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Since January&nbsp;1, 2022, there
have been no, and there are no, Proceedings pending or threatened in writing, or, to the Knowledge of the Company, otherwise threatened, alleging infringement, misappropriation, dilution or other violation (&#147;<B>Infringement</B>&#148; or
&#147;<B>Infringes</B>&#148; or &#147;<B>Infringed</B>&#148; or &#147;<B>Infringing</B>&#148;, as applicable) of any Intellectual Property of any Person (or challenges to the use, validity or enforceability of any Company Intellectual Property) by
or against the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Neither the Company or any of its Subsidiaries, nor the conduct or operation of the
business of the Company and its Subsidiaries as currently conducted (i)&nbsp;currently Infringes any Intellectual Property of any Person, and (ii)&nbsp;has, since January&nbsp;1, 2022, Infringed any Intellectual Property of any Person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To the Knowledge of the Company, since January&nbsp;1, 2022, no Person has Infringed or currently is Infringing any Company Intellectual
Property, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The
Company and each of its Subsidiaries has obtained from each of their respective current and former employees, independent contractors, or consultants or any other Persons who have or are contributing to the creation or development of any product or
service of the Company or the applicable Subsidiary (or any Intellectual Property for or on behalf of the Company or the applicable Subsidiary) an Invention Assignment Agreement, to the extent the Company or applicable Subsidiary does not already
own all right, title and interest in and to such Intellectual Property by operation of law, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company and each of its Subsidiaries has taken reasonable measures to protect the confidentiality of all Trade Secrets included in the
Company Intellectual Property. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) No Proprietary Software Product contains, incorporates, is derived from, links or calls to any Open
Source Software in a manner that requires the Company or its Subsidiaries to (i)&nbsp;disclose, make available, offer, deliver, contribute or license any portion of the source code of such Proprietary Software Product or component thereof (for
clarity, other than the applicable Open Source Software) to any third party (including any open source community) or (ii)&nbsp;license any Proprietary Software Product for making modifications or derivative works, except as would not reasonably be
expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, none of the source code or related documentation or materials for any Proprietary Software Product has been licensed or provided to, or used or accessed by, any Person (including any escrow agent) other than
employees, consultants or independent contractors of the Company or a Subsidiary of the Company who have a written confidentiality obligation to the Company or the applicable Subsidiary with respect to such source code or related materials and the
Company does not have the obligation to provide the source code to any such person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Except as would not reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse Effect, (i)&nbsp;the information technology, computer and communication systems, servers, network equipment, hardware, Software, databases and other equipment owned, operated, leased
or licensed or otherwise relied upon by the Company or any of its Subsidiaries used in connection with the business (&#147;<B>IT Systems</B>&#148;) are in good working order, and are adequate and sufficient for the operation of the business of the
Company and its Subsidiaries as currently conducted, and (ii)&nbsp;since January&nbsp;1, 2022, there has been no security breach or unauthorized access or use of any IT Systems, Security Incident or Malicious Code in, or failure or outage of any of
any IT Systems, including any such failure or outage affecting any Personal Information. The Company and each of its Subsidiaries have implemented and maintain commercially reasonable (x)&nbsp;industry standard information security program to
maintain and protect the integrity and security of the IT Systems and to mitigate against the likelihood that the Proprietary Software Product contains any Malicious Code or other Software or hardware designed or able to cause harmful effect or
unauthorized access to Software, hardware or data, and which includes policies and procedures designed to detect, prevent, correct, and/or remove any malware, viruses, or other similar corruptants or effects, and any third party software routines
designed to permit unauthorized access, disable or erase software, hardware or data, or perform any other similar actions (&#147;<B>Malicious Code</B>&#148;) and <FONT STYLE="white-space:nowrap">(y)&nbsp;back-up</FONT> and disaster recovery
arrangements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) To the Knowledge of the Company, none of the Proprietary Software Product that is distributed, conveyed or made
available by the Company or any of its Subsidiaries contains any &#147;back door&#148;, &#147;drop dead device&#148;, &#147;time bomb&#148; (as such terms are commonly understood in the software industry) or any other Malicious Code or other code
designed or able to cause harmful effect or unauthorized access to any device storing or using Proprietary Software Product, data or files. No Proprietary Software Product constitutes, contains or could reasonably be considered &#147;spyware&#148;
or &#147;trackware&#148; (as such terms are commonly understood in the software industry). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.21 <I><U>AI Systems</U></I>.
All use of AI Systems in the operation of the business of the Company and its Subsidiaries, including in the development, creation, testing, distribution, delivery, maintenance, support, or licensing of any of the Proprietary Software Products, is
in compliance with Applicable Law and all policies of the Company and its Subsidiaries. None of the Company or its Subsidiaries has used any Personal Information, customer data, publicly available datasets, or other data scraped from websites to
train, validate, test, or otherwise improve or enhance any AI Systems. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.22 <I><U>Properties</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) No real property is owned in fee by the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Section 4.22(b)</U> of the Company Disclosure Schedule sets forth a true, accurate and complete list by address of all real property
leased, subleased, licensed or otherwise occupied by the Company or any of its Subsidiaries (collectively, the &#147;<B>Company Leased Real Property</B>&#148;) as of the date of this Agreement. The Company has made available to Parent true and
complete copies of each lease, sublease, license or occupancy agreement in effect as of the date hereof granting rights in the Company Leased Real Property (each a &#147;<B>Company Real Property Lease</B>&#148;), including any guarantees, amendments
and assignments thereto. Except for the Company Real Property Leases, there are no other leases, subleases, licenses, use, occupancy or similar agreements granting to any party (other than the Company or any of its Subsidiaries) any occupancy or use
rights for any Company Leased Real Property as of the date hereof. There are no subleases or similar written agreements granting to any Person other than the Company or any of its Subsidiaries the right to use or occupy any Company Leased Real
Property. Neither the Company nor any Subsidiary (as applicable) owns or holds, or is obligated under or is a party to, any option, right of first refusal or other contractual (or other) right or obligation to purchase, acquire, sell, assign, convey
or dispose of any real estate or any portion of or interest in real property, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company and
its Subsidiaries have good and valid leasehold interest in the Company Leased Real Property free and clear of all Liens, other than Permitted Liens, and as may be necessary to permit the Company and its Subsidiaries to conduct their business in the
ordinary course as currently conducted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, each Company Real Property Lease is (A)&nbsp;a valid and binding on the Company or the applicable Subsidiary of the Company, as the case may be, and, to the Knowledge of the Company, each other party thereto, and
(B)&nbsp;in full force and effect and enforceable in accordance with its terms against the Company or any Subsidiary party thereto and, to the Knowledge of the Company, the counterparties thereto, except as may be limited by bankruptcy, insolvency,
moratorium and other similar Applicable Law affecting creditors&#146; rights generally and by general principles of equity. Neither the Company nor any Subsidiary of the Company, and, to the Knowledge of the Company, none of the other parties to any
Company Real Property Lease, is in default under any Company Real Property Lease and no event or condition exists, which (with or without notice, lapse of time or both) would reasonably be expected to constitute a default under, the provisions of
any Company Real Property Lease, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect, neither the Company nor any Subsidiary of the Company would be required to expend any material funds in causing the applicable party to comply with the surrender conditions set forth in the applicable Company Real Property
Lease. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, all buildings, structures, improvements, fixtures, buildings systems and equipment, and all components thereof, located
on the Company Leased Real Property are in good operating condition and repair (normal wear and tear excepted) for the operation of the business as currently conducted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, the Company and its Subsidiaries have title to, or a valid leasehold interest in, all material tangible personal property free and clear of all Liens, other than Permitted Liens, and as may be necessary to permit the
Company and its Subsidiaries to conduct their business in the ordinary course as currently conducted, including all such assets reflected on the Company Balance Sheet (except for assets sold or otherwise disposed of since the Company Balance Sheet
Date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.23 <I><U>Data Privacy</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company and
each of its Subsidiaries, and, to the Knowledge of the Company, any Person acting for or on behalf of the Company or any of its Subsidiaries, is, and, since January&nbsp;1, 2022, has been, in compliance with all Applicable Laws and Privacy
Obligations, including in each case in connection with the Company&#146;s and its Subsidiaries&#146; Processing of any personal data, personal information, personally identifiable information, protected health information, personal health records,
consumer health data (as each term is defined under Applicable Law and similar terms or definitions under any Applicable Law) (collectively &#147;<B>Personal Information</B>&#148;). The Company and its Subsidiaries have implemented and maintained
reasonable physical, technical, organizational and administrative security measures and policies designed to protect all Personal Information collected by or on behalf of them from and against breaches and any unauthorized access, acquisition,
destruction, use and/or disclosure (&#147;<B>Security Incident</B>&#148;), and since January&nbsp;1, 2022, there has been no such breach or Security Incident, and none of the Company or any of its Subsidiaries have provided or been legally required
to provide any notice to any Person in connection with a Security Incident. The Company and its Subsidiaries have all rights, authority, consents and authorizations required under applicable Privacy Obligations and have provided all notices required
under applicable Privacy Obligations to Process all Personal Information that the Company and its Subsidiaries have Processed in connection with the operation of their business as presently conducted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2022, no Governmental Authority or Person has (i)&nbsp;made any written claim (including any notice, enforcement
notice, letter, or complaint) against the Company or any of its Subsidiaries or (ii)&nbsp;commenced or, to the Knowledge of the Company, threatened, any Proceeding by or before any Governmental Authority against the Company or a Subsidiary (or, to
the Knowledge of the Company, a vendor of the Company or a Subsidiary or any other Person acting on behalf of the Company or any of its Subsidiaries with respect to Personal Information), in each case, with respect to Personal Information, breaches,
Security Incidents, or an actual or alleged violation of any Privacy Obligations. To the Knowledge of the Company, there are no facts or circumstances that could reasonably form the basis of any such claim or Proceeding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as would not reasonably be expected to have a Company Material Adverse Effect, none of the Company or any of its Subsidiaries
(i)&nbsp;are in breach or default of any Contracts relating to the IT Systems or to Company confidential information (including Personal Information) or (ii)&nbsp;transfer Personal Information internationally except where such transfers comply with
Privacy Obligations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.24 <I><U>Brokers</U></I><I><U>&#146;</U></I><I><U> Fees</U></I>. Except for
Goldman Sachs&nbsp;&amp; Co. LLC (pursuant to an engagement letter Made Available to Parent&#146;s outside legal counsel prior to the date hereof), there are no investment bankers, brokers or finders that have been retained by or are authorized to
act on behalf of the Company or any of its Subsidiaries who are entitled to any banking, broker&#146;s, finder&#146;s or similar fee or commission in connection with the Mergers and the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.25 <I><U>Opinion of Financial Advisor</U></I>. The Special Committee has received the oral opinion of Goldman Sachs&nbsp;&amp;
Co. LLC to be subsequently confirmed by delivery of a written opinion, that, as of the date of such written opinion, and based upon and subject to the various limitations, qualifications, assumptions and other matters set forth in such written
opinion, the aggregate Merger Consideration to be paid to the holders (other than Parent and its affiliates) of shares of Class&nbsp;A Common Stock pursuant to this Agreement is fair from a financial point of view to such holders. A written copy of
each such opinion will be provided to Parent by the Company promptly following receipt by the Company for informational purposes only. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.26 <I><U>Anti-Takeover Provisions</U></I>. Assuming the accuracy of the representations and warranties of Parent, Acquirer,
Merger Sub and Merger Sub II in <U>Section</U><U></U><U>&nbsp;5.13</U>, no (a) &#147;business combination&#148;, &#147;control share acquisition&#148;, &#147;fair price&#148;, &#147;moratorium&#148; or other anti-takeover Laws (each, a
&#147;<B>Takeover Law</B>&#148;) or (b)&nbsp;anti-takeover provision in the organizational documents of the Company or any of its Subsidiaries applies or will apply with respect to this Agreement or the transactions contemplated hereby, including
the Mergers. The Company is not party to a stockholder rights agreement, &#147;poison pill&#148; or similar anti-takeover agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.27 <I><U>Stock Ownership</U></I>. None of the Company or any of its Subsidiaries owns any shares of capital stock of Parent.
None of the Company or its Subsidiaries is an &#147;interested stockholder&#148; of Parent subject to the restrictions on &#147;business combinations&#148; under Section&nbsp;203(a) of the DGCL (as such terms are defined in Section&nbsp;203(c) of
the DGCL). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF PARENT, ACQUIRER, MERGER SUB AND MERGER SUB II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except (a)&nbsp;as disclosed in the Parent SEC Documents furnished or filed and publicly available since January&nbsp;1, 2022 through the date
hereof (other than information that is contained (i)&nbsp;solely in the risk factors sections of such Parent SEC Documents, except to the extent such information consists of factual statements, and (ii)&nbsp;in any forward-looking statements in such
Parent SEC Documents that are of a nature that they speculated about future developments); provided that nothing disclosed in the Parent SEC Documents will be deemed to modify or qualify the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;5.05</U>, <U>Section</U><U></U><U>&nbsp;5.13</U> or <U>Section</U><U></U><U>&nbsp;5.18</U>, or (b)&nbsp;subject to <U>Section</U><U></U><U>&nbsp;9.14</U>, as set forth in the Parent Disclosure Schedule, Parent,
Acquirer, Merger Sub and Merger Sub II represent and warrant to the Company that: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01 <I><U>Corporate Existence and Power</U></I>. Each of Parent, Acquirer,
Merger Sub and Merger Sub II and their respective Subsidiaries is duly organized, validly existing and in good standing under the laws of its jurisdiction of formation and has all organizational powers and authority required to carry on its business
as presently conducted and to own, lease or operate its properties, rights and assets and to consummate the transactions contemplated by this Agreement. Each of Parent, Acquirer, Merger Sub and Merger Sub II and their respective Subsidiaries is duly
qualified to do business as a foreign corporation and is in good standing in each jurisdiction where such qualification is necessary, except for those jurisdictions where failure to be so qualified would not reasonably be expected to have,
individually or in the aggregate, a Parent Material Adverse Effect. Parent has Made Available to Company complete and correct copies of (i)&nbsp;the certificate of incorporation and <FONT STYLE="white-space:nowrap">by-laws</FONT> of each of Parent,
Acquirer and Merger Sub and (ii)&nbsp;the certificate of formation and limited liability company agreement of Merger Sub II, in each of case including all amendments thereto, as in effect as of the date hereof and none of Parent, Acquirer, Merger
Sub or Merger Sub II is in violation of any provision thereof in any material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02 <I><U>Corporate
Authorization</U></I>. Each of Parent, Acquirer, Merger Sub and Merger Sub II and their respective Subsidiaries has all requisite power and authority to enter into this Agreement and to consummate the transactions contemplated by this Agreement. The
execution and delivery by Parent, Acquirer, Merger Sub and Merger Sub II of this Agreement and the consummation by Parent, Acquirer, Merger Sub and Merger Sub II of the transactions contemplated by this Agreement have been duly authorized by all
necessary organizational action on the part of Parent, Acquirer, Merger Sub and Merger Sub II. Assuming due authorization, execution and delivery of this Agreement by the Company and the Operating Company, this Agreement constitutes a valid and
binding agreement of each of Parent, Acquirer, Merger Sub and Merger Sub II, enforceable against each such Person in accordance with its terms, except as subject to the Enforceability Exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03 <I><U>Governmental Authorization</U></I>. The execution, delivery and performance by Parent, Acquirer, Merger Sub and Merger
Sub II of this Agreement and the consummation by Parent, Acquirer, Merger Sub and Merger Sub II of the transactions contemplated by this Agreement require no action by or in respect of, or filing with, any Governmental Authority, other than
(a)&nbsp;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware and appropriate documents with the relevant authorities of other states in which Parent is qualified to do business, (b)&nbsp;compliance with any
applicable requirements of (i)&nbsp;the HSR Act and (ii)&nbsp;any other applicable Antitrust Laws or any Foreign Investment Laws as set forth on <U>Section</U><U></U><U>&nbsp;5.03(b)(ii)</U> of the Parent Disclosure Schedule, (c)&nbsp;compliance
with any applicable requirements of the rules and regulations of the NYSE, the Securities Act, the Exchange Act and any other U.S. state or federal securities laws, (d)&nbsp;the filing or submission with the SEC, and in the case of this clause
(d)(ii), the effectiveness, of (i)&nbsp;the Joint Proxy Statement/Prospectus, (ii)&nbsp;the Form <FONT STYLE="white-space:nowrap">S-4</FONT> and (iii)&nbsp;such reports under Section&nbsp;13(a) or 15(d) of the Exchange Act as may be required in
connection with this Agreement and the transactions contemplated hereby, (e)&nbsp;such filings with and approvals of the NYSE to permit the Parent Class&nbsp;A Common Stock that are to be issued in the Mergers to be listed on the NYSE, and
(f)&nbsp;any actions or filings the absence of which would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04 <I><U><FONT STYLE="white-space:nowrap">Non-contravention</FONT></U></I>.
The execution, delivery and performance by Parent, Acquirer, Merger Sub and Merger Sub II of this Agreement and the consummation by Parent, Acquirer, Merger Sub and Merger Sub II of the transactions contemplated by this Agreement do not and will not
(with or without notice or lapse of time, or both)&nbsp;(a) result in any violation or breach of any provision of the certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> (or similar governing documents) of Parent or
Acquirer or the certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> of Merger Sub or Merger Sub II, (b)&nbsp;assuming compliance with the matters referred to in <U>Section</U><U></U><U>&nbsp;5.03</U>, result in a
violation or breach of any provision of any Applicable Law or Order, or (c)&nbsp;require any consent or approval under, violate, result in any breach of or default under (or an event that, with notice or lapse of time or both, would become a
default), result in the cancellation, adverse amendment, right of payment, termination or acceleration of any right or obligation or the loss of any benefit to which Parent or one of its Subsidiaries is entitled under, or result in termination or
give to others any right of termination of, any Contract to which Parent, Acquirer, Merger Sub, Merger Sub II or any other Subsidiary of Parent is a party, or by which any of their respective properties or assets are bound, with such exceptions, in
the case of each of clauses (b)&nbsp;and (c) above, as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05 <I><U>Capitalization and Operation of Parent, Acquirer, Merger Sub and Merger Sub II</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of Parent consists of (i)&nbsp;1,500,000,000 shares of Parent Class&nbsp;A Common Stock, (ii) 500,000,000
shares of Class&nbsp;B common stock, par value $0.001 per share (&#147;<B>Parent Class</B><B></B><B>&nbsp;B Common Stock</B>&#148;), (iii) 500,000,000 shares of Class&nbsp;C common stock, par value $0.001 per share (&#147;<B>Parent
Class</B><B></B><B>&nbsp;C Common Stock</B>&#148;), (iv) 500,000,000 shares of Class&nbsp;D common stock, par value $0.001 per share (&#147;<B>Parent Class</B><B></B><B>&nbsp;D Common Stock</B>&#148;), and (v) 100,000,000 shares of undesignated
preferred stock, par value $0.001 per share (the &#147;<B>Parent Preferred Stock</B>&#148;). At the close of business on January&nbsp;7,&nbsp;2025: (A)&nbsp;213,706,577 shares of Parent Class&nbsp;A Common Stock were issued and outstanding;
(B)&nbsp;zero shares of Parent Class&nbsp;B Common Stock were issued and outstanding; (C)&nbsp;12,542,110 shares of Parent Class&nbsp;C Common Stock were issued and outstanding; (D) 22,243,668 shares of Parent Class&nbsp;D Common Stock were issued
and outstanding; and (E)&nbsp;zero shares of Parent Preferred Stock were issued and outstanding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All of the outstanding shares of
Parent Common Stock and equity interests of Acquirer, Merger Sub and Merger Sub II have been duly authorized, validly issued, fully paid and nonassessable and were not issued in breach of any preemptive rights and are free and clear of any
restrictions on transfer (other than as provided by applicable federal and state securities Laws). All of the issued and outstanding capital stock of Acquirer, Merger Sub and Merger Sub II is, and immediately prior to the Effective Time will be,
owned (directly or indirectly) by Parent. Each of Acquirer, Merger Sub and Merger Sub II has been formed solely for the purpose of engaging in the transactions contemplated by this Agreement and prior to the Effective Time will have engaged in no
other business activities and will have incurred no liabilities or obligations other than as contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06 <I><U>No Vote of Parent Stockholders; Required Approval</U></I>. No vote or consent of the holders of any class or series of
capital stock of Parent or the holders of any other securities of Parent (equity or otherwise) is necessary to adopt this Agreement or to approve the Mergers or the other transactions contemplated by this Agreement. The vote or consent of Parent as
the sole </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholder of Acquirer and Merger Sub and Clearwater Analytics, LLC as the sole member of Merger Sub II are the only vote or consent of the holders of any class or series of capital stock of
Acquirer, Merger Sub and Merger Sub II necessary to approve the Mergers and adopt this Agreement, which consent shall be given immediately following the execution of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07 <I><U>Litigation</U></I>. As of the date hereof, there is no Proceeding pending, or, to the Knowledge of Parent, threatened
in writing, that would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. As of the date hereof, neither Parent nor any of its Subsidiaries is subject to any Order that would reasonably be expected to
have, individually or in the aggregate, a Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08 <I><U>Compliance with Applicable Law</U></I>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to result, individually or in the aggregate, a Parent Material Adverse Effect, each of each
of Parent, Acquirer, Merger Sub, Merger Sub II and their respective Subsidiaries is, and, since January&nbsp;1, 2022, has been, in compliance with all Applicable Laws. Neither Parent, Acquirer, Merger Sub, Merger Sub II nor any of their respective
Subsidiaries has received any written notice since January&nbsp;1, 2022 that remains unresolved (i)&nbsp;of any administrative, civil or criminal investigation or material audit by any Governmental Authority relating to Parent, Acquirer, Merger Sub,
Merger Sub II or any of their respective Subsidiaries or (ii)&nbsp;from any Governmental Authority alleging that Parent, Acquirer, Merger Sub, Merger Sub II or any of their respective Subsidiaries is not in compliance with any Applicable Law, except
for such notices described in clauses (i)&nbsp;and (ii) that would not reasonably be expected to result, individually or in the aggregate, in a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to result, individually or in the aggregate, in a Parent Material Adverse Effect, (i)&nbsp;each
of each of Parent, Acquirer, Merger Sub, Merger Sub II and their respective Subsidiaries has in effect all Governmental Authorizations necessary for it to own, lease or otherwise hold and operate its properties and assets and to carry on its
businesses and operations and (ii)&nbsp;there have occurred no defaults (with or without notice or lapse of time or both) under, violations of, or events giving rise to any right of termination, amendment or cancelation of, any such Governmental
Authorizations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09 <I><U>Material Contracts</U></I>. <U>Section</U><U></U><U>&nbsp;5.09</U> of the Parent Disclosure
Schedule lists each Contract that would be required, as of the date hereof, to be filed by Parent as a &#147;material contract&#148; pursuant to Item 601(b)(10) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act or
disclosed by Parent on a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (each, a &#147;<U>Parent Material Contract</U>&#148;). Except as, individually or in the aggregate, has not had, and would not reasonably be expected to
have, a Parent Material Adverse Effect, as of the date hereof, (i)&nbsp;each Parent Material Contract is valid and binding on Parent and any of its Subsidiaries to the extent such Subsidiary is a party thereto, as applicable, and to the Knowledge of
Parent, each other party thereto, and is in full force and effect and enforceable in accordance with its terms; (ii)&nbsp;Parent and each of its Subsidiaries, and, to the Knowledge of Parent, each other party thereto, has performed all obligations
required to be performed by it under each Parent Material Contract; and (iii)&nbsp;there is no default under any Parent Material Contract by Parent or any of its Subsidiaries or, to the Knowledge of Parent, any other party thereto, and no event or
condition has occurred that constitutes, or, after notice or lapse of time or both, would constitute, a default on the part of Parent or any of its Subsidiaries or, to the Knowledge of Parent, any other party thereto under any such Parent Material
Contract, nor has Parent or any of its Subsidiaries received any notice of any such default, event or condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <I><U>Available Funds; Financing</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent has delivered to the Company true, correct and complete copies, as of the date hereof, of the fully executed (i)&nbsp;debt
commitment letter, dated as of the date hereof (together with all exhibits, annexes, schedules and term sheets attached thereto, as the same may be amended or replaced from time to time in accordance with the terms of this Agreement, the
&#147;<B>Debt Commitment Letter </B>&#148;), pursuant to which the Debt Financing Sources party thereto have agreed, subject to the terms and conditions thereof, to provide or cause to be provided the debt amounts set forth therein (the
&#147;<B>Debt Financing</B>&#148;) for the purpose of funding amounts necessary to consummate the transactions contemplated hereby and (ii)&nbsp;any fee letters referred to in the Debt Commitment Letter, subject to redaction of pricing, fee amounts,
&#147;price flex&#148; and other customary &#147;market flex&#148; none of which redacted provisions would be reasonably expected to adversely affect the conditionality, availability, aggregate principal amount or termination of the Debt Financing
(such redacted fee letters referred to in the Debt Commitment Letter, collectively, the &#147;<B>Debt Fee Letter</B>&#148;). As of the date hereof, (x)&nbsp;the Debt Commitment Letter has not been amended, supplemented or modified in any respect and
(y)&nbsp;the commitments contained in the Debt Commitment Letter has not been withdrawn, terminated, reduced, rescinded or replaced in any respect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Assuming the satisfaction of the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.01</U> and <U>Section</U><U></U><U>&nbsp;7.02</U>,
and that the Debt Financing is funded in accordance with the Debt Commitment Letter, and after giving effect to any &#147;flex&#148; provision in the Debt Commitment Letter or the Debt Fee Letter (including with respect to fees and original issue
discount), the net cash proceeds contemplated by the Debt Commitment Letter, together with cash on hand of Parent and the Company, will, in the aggregate, be sufficient for Parent, Acquirer, Merger Sub and/or Merger Sub II, as applicable, to pay the
cash portion of the Aggregate Merger Consideration, to make any repayment, repurchase or refinancing of debt expressly required by this Agreement, to pay any other amounts required to be paid at or prior to the Closing and to pay all related fees
and expenses required to be paid in connection with the transactions contemplated by this Agreement (collectively, the &#147;<B>Required Amount</B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the date hereof, the Debt Commitment Letter is in full force and effect and constitutes a legal, valid and binding obligation of
Clearwater Analytics, LLC (&#147;<B>Clearwater LLC</B>&#148;), and to the Knowledge of Parent, all the other parties thereto, enforceable against such Persons in accordance with their terms, in each case, subject to the Enforceability Exceptions. As
of the date hereof, no event has occurred which, with or without notice, lapse of time or both, would or would reasonably be expected to constitute a material default or material breach on the part of Clearwater LLC or, to the Knowledge of Parent,
any other parties thereto under the Debt Commitment Letter. Assuming the satisfaction or waiver of the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.01</U> and <U>Section</U><U></U><U>&nbsp;7.02</U>, as of the date hereof, Parent does not
have any reason to believe that any of the conditions to the funding of the Debt Financing to be satisfied by Clearwater LLC will not be satisfied on a timely basis or that the Debt Financing will not be available to Clearwater LLC on the Closing
Date in an amount sufficient, together with cash on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hand of Parent and the Company, to pay the Required Amount. The <FONT STYLE="white-space:nowrap">non-redacted</FONT> portion of the Debt Commitment Letter contains all of the conditions precedent
and other conditions to the obligations of the parties thereunder to make the Debt Financing available to Parent (or its Affiliate party thereto) on the terms therein. As of the date hereof, other than as expressly set forth in the Debt Commitment
Letter or the Debt Fee Letter, there are no side letters or other agreements to which Parent or any of its Affiliates is a party that would reasonably be expected to reduce the aggregate amount of any portion of the Debt Financing such that the
aggregate amount of the Debt Financing, taken together with cash on hand of Parent and the Company, would be below the Required Amount or materially delay the funding thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In no event shall the receipt or availability of any funds or financing (including the Debt Financing) by Parent or any of its Affiliates
or any other financing or other transactions be a condition to any of obligations of Parent, Acquirer, Merger Sub or Merger Sub II under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <I><U>Solvency</U></I>. Assuming (a)&nbsp;the satisfaction or waiver of the conditions set forth in
<U>Section</U><U></U><U>&nbsp;7.01</U> and <U>Section</U><U></U><U>&nbsp;7.02</U> (b) the accuracy of the representations and warranties of the Company contained in <U>ARTICLE IV</U> (disregarding any references to &#147;Knowledge&#148;,
&#147;Company Material Adverse Effect,&#148; &#147;materiality&#148; or similar qualifiers), (c) compliance by the Company with the covenants applicable to the Company contained herein and (d)&nbsp;that the most recent financial forecasts of the
Company and its Subsidiaries made available to Parent have been prepared in good faith based upon assumptions that were and continue to be reasonable immediately after giving effect to the transactions contemplated by this Agreement (including the
Debt Financing), each of Parent, Acquirer, Merger Sub, Merger Sub II, the Surviving Corporation and their respective Subsidiaries will be Solvent as of the Effective Time and immediately after the consummation of the transactions contemplated by
this Agreement. No transfer of property is being made by Parent, Acquirer, Merger Sub, Merger Sub II, the Surviving Corporation or any their respective Subsidiaries (or is contemplated being made) and no obligation is being incurred (or is
contemplated being incurred) by Parent, Acquirer, Merger Sub, Merger Sub II, the Surviving Corporation or any of their respective Subsidiaries in connection with the transactions contemplated by this Agreement (or any series of related transactions
or any other transactions in close proximity with the transactions contemplated by this Agreement) with the intent to hinder, delay or defraud either present or future creditors of the Company, the Surviving Corporation, Parent, Acquirer, Merger
Sub, Merger Sub II or any of their respective Subsidiaries. For purposes of this Agreement, the term &#147;<B>Solvent</B>&#148; when used with respect to any Person, means that, as of any date of determination (x)&nbsp;the amount of the &#147;fair
saleable value&#148; of the assets and property of such Person, in each case, will, as of such date, exceed (i)&nbsp;the value of all &#147;liabilities of such Person, including contingent and other liabilities,&#148; as of such date, as such quoted
terms are generally determined in accordance with Applicable Laws governing determinations of the insolvency of debtors, and (ii)&nbsp;the amount that will be required to pay the probable liabilities of such Person on its existing debts (including
contingent and other liabilities) as such debts become absolute and mature, (y)&nbsp;such Person will not have, as of such date, an unreasonably small amount of capital for the operation of the businesses in which it is engaged or proposed to be
engaged following such date, and (z)&nbsp;such Person will be able to pay its liabilities, including contingent (it being understood that the amount of contingent liabilities at any time shall be computed as the amount that, in light of all the
facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability), subordinated and other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
liabilities, as they mature. For purposes of this definition, &#147;not have an unreasonably small amount of capital for the operation of the businesses in which it is engaged or proposed to be
engaged&#148; and &#147;able to pay its liabilities, including contingent, subordinated and other liabilities, as they mature&#148; means that such Person will be able to generate enough cash from operations, asset dispositions or refinancing, or a
combination thereof, to meet its obligations as they become due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <I><U>Absence of Certain Agreements</U></I>. As of the
date hereof, neither Parent, Acquirer, Merger Sub, Merger Sub II nor any of their respective Subsidiaries has entered into any agreement, arrangement or understanding (in each case, whether oral or written), or authorized, committed or agreed to
enter into any agreement, arrangement or understanding (in each case, whether oral or written), (i) pursuant to which any stockholder of the Company would be entitled to receive, in respect of any share of Company Common Stock, consideration of a
different amount or nature than the Merger Consideration or pursuant to which any stockholder of the Company has agreed to vote to adopt this Agreement or has agreed to vote against any Superior Proposal, (ii)&nbsp;pursuant to which any equityholder
of the Operating Company would be entitled to receive, in respect of any Common Unit, consideration of a different amount or nature than the Merger Consideration or (iii)&nbsp;pursuant to which any stockholder of the Company or any of its
Subsidiaries has agreed to make an investment in, or contribution to, Parent, Acquirer, Merger Sub or Merger Sub II in connection with the transactions contemplated by this Agreement, in each case of clauses (i)&nbsp;and (ii), except for the Support
Agreements and the TRA Amendment. As of the date hereof, except for the Support Agreements and the TRA Amendment, there are no agreements, arrangements or understandings (in each case, whether oral or written) between Parent, Acquirer, Merger Sub,
Merger Sub II or any of their respective Subsidiaries, on the one hand, and any member of the Company&#146;s management or directors, on the other hand, that relate in any way to, or are in connection with, the transactions contemplated by this
Agreement or the operations of the Company or any of its Subsidiaries or, following the Effective Time, the Surviving Corporation or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <I><U>Stock Ownership</U></I>. None of Parent, Acquirer, Merger Sub or Merger Sub II owns any shares of capital stock of the
Company or equity securities of the Operating Company. None of Parent, Acquirer, Merger Sub, Merger Sub II nor any of their respective Subsidiaries is an &#147;interested stockholder&#148; of the Company subject to the restrictions on &#147;business
combinations&#148; under Section&nbsp;203(a) of the DGCL (as such terms are defined in Section&nbsp;203(c) of the DGCL). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <I><U>Brokers</U></I><I><U>&#146;</U></I><I><U> Fees</U></I>. There is no investment banker, broker, finder or other agent
or intermediary that has been retained by or is authorized to act on behalf of Parent or any of its Subsidiaries or any of their respective officers or directors in their capacities as officers or directors, who is entitled to any advisory, banking,
broker&#146;s, finder&#146;s or similar fee or commission in connection with the Mergers and the other transactions contemplated by this Agreement that the Company may be responsible for prior to the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <I><U>Foreign Person</U></I>. None of Parent, Acquirer, Merger Sub, or Merger Sub II is a foreign person, as defined in 31
C.F.R. &#167;&nbsp;800.224, nor will the transactions contemplated by this Agreement result in foreign control (as defined in 31 C.F.R. &#167;&nbsp;800.208) of the Company or constitute direct or indirect investment in the Company by any foreign
person that affords the foreign person with any of the access, rights, or involvement contemplated under 31 C.F.R. &#167;&nbsp;800.211(b). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16 <I><U>SEC Filings and the Sarbanes-Oxley Act</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since January&nbsp;1,&nbsp;2022, Parent has filed with or furnished to, as applicable, the SEC each report, statement, schedule, form or
other document or filing required by Applicable Law to be filed or furnished by Parent at or prior to the time so required (the documents referred to in this <U>Section</U><U></U><U>&nbsp;5.16(a)</U>, together with all exhibits and other information
incorporated by reference therein and all amendments and supplements thereto, are collectively referred to as the &#147;<B>Parent SEC Documents</B>&#148;). No Subsidiary of Parent is required to file any report, statement, schedule, form or other
document with the SEC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of its filing date (or, if amended or superseded by a filing prior to the date hereof, on the date of such
amended or superseded filing), each Parent SEC Document complied as to form in all material respects with the applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act and the rules and regulations promulgated
thereunder applicable to the Parent SEC Documents, as the case may be, each as in effect on the date that such Parent SEC Document was filed. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of its filing date (or, if amended or superseded by a filing prior to the date hereof, on the date of such filing), no Parent SEC
Document filed with or furnished pursuant to the Exchange Act contained any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which
they were made, not misleading. No Parent SEC Document that is a registration statement, as amended or supplemented, if applicable, filed pursuant to the Securities Act, as of the date such registration statement or amendment became effective,
contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein not misleading. As of the date hereof, (i)&nbsp;there are no outstanding or unresolved
comments in any comment letters received by Parent from the SEC and (ii)&nbsp;to the Knowledge of Parent, none of the Parent SEC Documents is the subject of any ongoing review by the SEC. As of the date hereof, to the Knowledge of Parent, there are
no formal SEC inquiries or investigations pending or threatened, in each case regarding any accounting practices of Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17 <I><U>Financial Statements; Internal Controls</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The consolidated financial statements of Parent included in the Parent SEC Documents (i)&nbsp;complied as to form, as of their respective
filing dates with the SEC, in all material respects with the applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, (ii)&nbsp;were prepared in accordance with GAAP applied on a consistent basis
during the periods involved (except, in the case of unaudited statements, for the absence of certain information and footnotes), and (iii)&nbsp;fairly presented (except as may be indicated in the notes thereto) in all material respects the
consolidated financial position of Parent and its consolidated Subsidiaries as of the dates thereof and their consolidated results of operations and cash flows for the periods presented therein (subject to normal recurring adjustments in the case of
any unaudited interim financial statements). Except as has been described in the Parent SEC Documents, there are no unconsolidated Subsidiaries of Parent or any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements of the type
required to be disclosed pursuant to Item 303(b) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent&#146;s system of internal control over financial reporting (as defined in Rules <FONT
STYLE="white-space:nowrap">13a-15(f)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(f)</FONT> under the Exchange Act) is reasonably designed and maintained to provide reasonable assurance that (i)&nbsp;transactions are recorded as necessary to
permit preparation of financial statements in accordance with GAAP, (ii)&nbsp;receipts and expenditures are being made only in accordance with authorizations of Parent&#146;s management and directors, and (iii)&nbsp;any unauthorized use, acquisition
or disposition of Parent&#146;s assets that would materially affect Parent&#146;s financial statements would be prevented or detected in a timely manner. There were no material weaknesses, or significant deficiencies that in the aggregate would
amount to a material weakness, identified in the management of Parent&#146;s assessment of internal controls as of and for the year ended December&nbsp;31, 2023. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent&#146;s &#147;disclosure controls and procedures&#148; (as defined in Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT
STYLE="white-space:nowrap">15d-15(e)</FONT> under the Exchange Act) are reasonably designed and maintained to ensure that (i)&nbsp;material information (both financial and <FONT STYLE="white-space:nowrap">non-financial)</FONT> required to be
disclosed by Parent in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported to the individuals responsible for preparing such reports within the time periods specified in the rules and forms
of the SEC and (ii)&nbsp;such material information is accumulated and communicated to Parent&#146;s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications of the principal executive officer
and principal financial officer of Parent required under the Exchange Act with respect to such reports. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the date hereof, Parent
is in compliance in all material respects with all rules, regulations and requirements of the Sarbanes Oxley Act to the extent applicable to Parent. Since January&nbsp;1, 2022, through the date hereof, Parent has complied in all material respects
with the applicable listing and other rules and regulations of the NYSE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18 <I><U>Absence of Certain Changes</U></I>.
Since February&nbsp;29, 2024 through the date hereof, there has not been any Effect that has had or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19 <I><U>No Undisclosed Material Liabilities</U></I>. There are no liabilities or obligations of any nature, whether accrued,
absolute, contingent or otherwise, known or unknown, whether due or to become due, of Parent or any of its Subsidiaries that would be required by GAAP to be reflected on a consolidated balance sheet (or disclosed in the notes thereto), other than:
(a)&nbsp;liabilities or obligations disclosed or otherwise reserved against in Parent&#146;s consolidated balance sheet as of September&nbsp;30, 2024 included in the Parent SEC Documents filed prior to the date of this Agreement;
(b)&nbsp;liabilities or obligations incurred in the ordinary course of business since September&nbsp;30, 2024; (c) executory obligations arising under Contracts to which Parent or any of its Subsidiaries is a party (other than as a result of a
breach thereof or default thereunder by Parent or any of its Subsidiaries); (d)&nbsp;liabilities or obligations incurred in connection with the transactions contemplated by this Agreement (including the Mergers); and (e)&nbsp;liabilities or
obligations that would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20 <I><U>Anti-Takeover Provisions</U></I>. Assuming the accuracy of the
representations and warranties of the Company in <U>Section</U><U></U><U>&nbsp;4.27</U>, no (a)&nbsp;Takeover Laws or (b)&nbsp;anti-takeover provision in the organizational documents of the Parent or any of its Subsidiaries applies or will apply
with respect to this Agreement or the transactions contemplated hereby, including the Mergers. Parent is not party to a stockholder rights agreement, &#147;poison pill&#148; or similar anti-takeover agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21 <I><U><FONT STYLE="white-space:nowrap">Tax-Free</FONT> </U></I><I><U>Reorganization</U></I>. Neither Parent nor any of its
Subsidiaries has taken any action, or knows of any fact, agreement, plan or other circumstance, that could reasonably be expected to prevent the Corporate Mergers, taken together, from qualifying as a reorganization within the meaning of
Section&nbsp;368(a) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.22 <I><U>Ownership and Tax Classification of Acquirer, Merger Sub, and Merger Sub
II</U></I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Acquirer is a direct, wholly owned subsidiary of Parent, was formed solely for the purpose of engaging in the Second
Merger, as of the date hereof has engaged in no business activity other than in connection with entering into this Agreement, and as of the Second Effective Time (if the Second Effective Time shall occur in accordance with the terms and conditions
of this Agreement) will have engaged in no business activity other than those occurring in connection with the Second Merger or otherwise as provided in this Agreement. Parent is, and will be at the Effective Time and the Second Effective Time (if
the Second Effective Time shall occur in accordance with the terms and conditions of this Agreement), the sole regarded owner of Acquirer for U.S. federal income tax purposes and is, and will be at the Effective Time and the Second Effective Time,
in &#147;control&#148; of Acquirer as defined in Section&nbsp;368(c) of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Merger Sub is a direct, wholly owned subsidiary of
Parent, was formed solely for the purposes of engaging in the Mergers and has engaged in no business other than as contemplated by this Agreement. Merger Sub is, and will be at the Effective Time, treated as a transitory merger subsidiary for U.S.
federal income tax purposes. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01 <I><U>Conduct of the Company</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except for matters (i)&nbsp;required, expressly permitted or expressly contemplated by this Agreement, (ii)&nbsp;set forth in
<U>Section</U><U></U><U>&nbsp;6.01</U> of the Company Disclosure Schedule, (iii)&nbsp;required by Applicable Law or (iv)&nbsp;undertaken with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or
delayed and provided that the failure of Parent to respond to a request in writing for consent within five Business Days after receipt thereof shall be deemed to constitute consent), the Company shall, and shall cause each of its Subsidiaries to,
use commercially reasonable efforts to conduct its business in the ordinary course and use commercially reasonable efforts to preserve the present business operations, organization and goodwill of the Company and its Subsidiaries, including using
commercially reasonable efforts to retain the services of key employees of the Company and its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subsidiaries and preserve their relationships with, and the goodwill of, clients, vendors, and other Persons with whom the Company or its Subsidiaries have a material business relationship;
<U>provided</U>, <U>however</U>, that no action by the Company or any of its Subsidiaries with respect to matters to the extent expressly permitted by any provision of <U>Section</U><U></U><U>&nbsp;6.01(b)</U> shall be deemed a breach of this
<U>Section</U><U></U><U>&nbsp;6.01(a)</U> unless such action would constitute a breach of such other provision. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting the
generality of the foregoing, except for matters (i)&nbsp;required, expressly permitted or expressly contemplated by this Agreement, (ii)&nbsp;set forth in <U>Section</U><U></U><U>&nbsp;6.01</U> of the Company Disclosure Schedule, (iii)&nbsp;required
by Applicable Law or (iv)&nbsp;undertaken with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed and provided that the failure of Parent to respond to a request in writing for consent
within five Business Days after receipt thereof shall be deemed to constitute consent), the Company shall not, and shall cause each of its Subsidiaries not to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) amend (including by merger, consolidation or otherwise) the Company&#146;s certificate of incorporation or <FONT
STYLE="white-space:nowrap">by-laws</FONT> or the Operating Agreement or the organizational or governing documents of any Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) (A) declare, set aside or pay any dividends on, or make any other distributions (whether in cash, stock or equity
interests, property or otherwise) in respect of, or enter into any agreement with respect to the voting of, any capital stock of the Company or any of its Subsidiaries, other than dividends and distributions by a direct or indirect wholly-owned
Subsidiary of the Company to its parent; (B)&nbsp;modify or repeal the terms of any shares of its capital stock or other equity or voting interest; or (C)&nbsp;pledge or encumber any shares of its capital stock or other equity or voting interest or
cause or permit the same to be subjected to any other Lien; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) (A) split, combine, adjust, subdivide or reclassify any
capital stock or other equity interest or voting interest of the Company or any of its Subsidiaries, (B)&nbsp;except as otherwise provided in <U>Section</U><U></U><U>&nbsp;6.01(b)(iv)</U>, issue or authorize the issuance of any other securities in
respect of, in lieu of or in substitution for, shares of capital stock of the Company or equity interests or voting interests of any of its Subsidiaries, or (C)&nbsp;purchase, redeem or otherwise acquire any Company Securities, except for
acquisitions of shares of Company Common Stock to satisfy Tax obligations with respect to Company Equity Awards or in connection with a cashless exercise of Company Stock Options, in each case, outstanding as of the date of this Agreement and in
accordance with the terms thereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) issue, deliver, sell, dispose or grant any Company Securities, other than
(A)&nbsp;the issuance of shares of Company Common Stock upon the exercise of Company Stock Options or the settlement of Company RSUs or Company PSUs, in all cases, that are outstanding on the date hereof and in accordance with the applicable terms
of the Company Stock Plan and such Company Equity Award, (B)&nbsp;grants or awards of Company Securities required to be made pursuant to the terms of Company Employee Plans in effect as of the date of this Agreement, (C)&nbsp;the issuance of shares
of Company Common Stock pursuant to the ESPP in accordance with its terms, subject to the limitations in <U>Section</U><U></U><U>&nbsp;2.06(f)</U>, or (D)&nbsp;the issuance of shares of Company Common Stock upon the settlement of exchanges of shares
of Class&nbsp;B Common Stock and Common Units pursuant to Article XII of the Operating Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) amend or otherwise modify any of the terms of any outstanding Company
Equity Awards; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) adopt a plan or agreement of, or resolutions providing for or authorizing, complete or partial
liquidation, dissolution, restructuring, merger, consolidation, division, statutory conversion or domestication, share exchange, business combination, reorganization or recapitalization of the Company or any of its Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) (A) increase or commit to increase the salary, wages, benefits, bonuses or other compensation payable or to become
payable to the Company&#146;s or any of its Subsidiaries&#146; current and former directors, officers, employees, or other <FONT STYLE="white-space:nowrap">non-employee</FONT> service providers, except (x)&nbsp;as required to be made pursuant to the
terms of any Company Employee Plan in effect on the date hereof or (y)&nbsp;pursuant to actions taken to effectuate the treatment of the Company Equity Awards and the ESPP pursuant to <U>Section</U><U></U><U>&nbsp;2.06</U>, including any amendments
to the ESPP, (B)&nbsp;become a party to, establish, adopt, amend, commence participation in or terminate any Company Employee Plan or any arrangement that would have been a Company Employee Plan had it been entered into prior to this Agreement
(other than with respect to renewal of welfare benefit plans in the ordinary course of business), (C) take any action to accelerate the vesting or lapsing of restrictions or payment, or fund in any other way to secure the payment, of compensation or
benefits under any Company Employee Plan, (D)&nbsp;change any actuarial or other assumptions used to calculate funding obligations with respect to any Company Employee Plan that is required by Applicable Law to be funded, except for any such changes
that are required by GAAP (or, in the case of a Foreign Employee Plan, the applicable financial reporting standards) or (E)&nbsp;make any grants under the Company Stock Plan or grant or commit to grant any change in control, transaction, retention,
severance or termination pay, or similar incentive to (or amend any such existing arrangement with) any current or former directors, officers, employees, or other <FONT STYLE="white-space:nowrap">non-employee</FONT> service providers of the Company
or its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) hire, engage, or terminate (other than for cause) the employment/engagement of any employee or
independent contractor with base salary (in the case of employees) or annual compensation (in the case of independent contractors) in excess of $200,000; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) waive or release any restrictive covenant obligation of any current or former employee or independent contractor; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) (1) recognize or certify any labor union, labor organization, works council, group of employees, or similar entity as the
bargaining representative for any employees of the Company or its Subsidiaries or (2)&nbsp;enter into, terminate, modify, negotiate, or enter into any Labor Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) implement or announce any &#147;plant closings&#148;, &#147;mass
layoffs&#148; or other action which would trigger the notice requirements pursuant to the WARN Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xii) acquire any
division, properties, business, assets or capital stock of any Person or division thereof, whether in whole or in part (and whether by purchase of stock, purchase of assets, merger, consolidation, partnership, joint venture, share exchange,
division, business combination or otherwise), other than one or more acquisitions in the ordinary course of business (i)&nbsp;of inventory, supplies, Intellectual Property assets, raw materials, equipment or similar assets, or (ii)&nbsp;that,
individually or in the aggregate, involve a purchase price of not more than $750,000 individually or $3,500,000 in the aggregate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiii) sell, assign, lease, license, abandon, allow to lapse or expire pledge, transfer, subject to any Lien or otherwise
dispose of Company Leased Real Property or Company Owned Intellectual Property, including granting to any Person any rights under or with respect to any Company Owned Intellectual Property or any material assets or material properties of the Company
or its Subsidiaries except (i)&nbsp;pursuant to Contracts or commitments existing as of the date hereof, <FONT STYLE="white-space:nowrap">(ii)&nbsp;non-exclusive</FONT> licenses of Company Intellectual Property to customers, contractors, and other
partners or suppliers of the Company and its Subsidiaries in the ordinary course of business, (iii)&nbsp;sales of inventory or used equipment in the ordinary course of business, (iv)&nbsp;Permitted Liens, or
<FONT STYLE="white-space:nowrap">(v)&nbsp;non-material</FONT> Company Owned Intellectual Property or Domain Names included in the Company Licensed Intellectual Property that the Company or any of its Subsidiaries has permitted to expire or has
canceled or abandoned in its reasonable business judgment; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiv) change any of the accounting methods used by the Company
materially affecting its assets, liabilities or business, except for such changes that are required by GAAP or Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated under the Exchange Act or as otherwise specifically disclosed in the
Company&#146;s reports filed with the SEC prior to the date hereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xv) make (other than Tax elections made in the
ordinary course), change, or revoke any material Tax election, change or adopt any Tax accounting period or method, file any material amended Company Return, fail to pay Taxes when due and payable (including estimated Tax payments), enter into any
closing agreement, settle or compromise any audit or other proceeding with respect to any Tax claim or assessment, surrender any right to claim a material Tax refund, offset or other reduction in Tax liability, request any ruling with respect to
Taxes, consent to any extension or waiver of the limitation period applicable to any Taxes, or enter into a voluntary disclosure or similar agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xvi) except for borrowings under the Company&#146;s Company Credit Agreement and except for intercompany loans solely between
the Company and any of its wholly-owned Subsidiaries or between any wholly-owned Subsidiaries of the Company, in each case, made in the ordinary course of business, incur, assume, guarantee or otherwise become liable for additional indebtedness for
borrowed money or issue or sell debt securities or warrants or other rights to acquire any debt securities, or assume, guarantee or endorse any indebtedness for borrowed money of any Person (other than a wholly-owned Subsidiary of the Company) in
excess of $1,000,000 individually or $3,500,000 in the aggregate; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xvii) (A) enter into any Contract that would have been a Material Contract
if it had been entered into prior to the date of this Agreement, (B)&nbsp;renew or extend any Material Contract (or any Contract described by clause (A)), other than renewals or extensions of any expiring contracts without material adverse changes
of terms with respect to the Company or its Subsidiaries (it being understood that ordinary-course, <FONT STYLE="white-space:nowrap">non-material</FONT> changes to monetary expenditures under any such contracts shall not be deemed to be a material
adverse change of terms for this purpose) or (C)&nbsp;modify or amend in any material respect or terminate (other than any Material Contract (or Contract described by clause (A)) that has expired in accordance with its terms) any Material Contract
(or Contract described by clause (A)) or waive any material right, claim, remedy or default under any Material Contract (or Contract described by clause (A)) except, in each case of clauses (A), (B) and (C), in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xviii) settle, release, waive or compromise any pending or threatened Proceeding for an amount (net of insurance proceeds) in
excess of $625,000 individually or $2,500,000 in the aggregate (other than settlements of any Proceedings for an amount not in excess of the amount, if any, reflected or reserved in the balance sheet (or the notes thereto) of the Company), in each
case, that do not involve (A)&nbsp;the imposition of any restrictions on the business or operations of the Company or any of its Subsidiaries (or, following the Closing, Parent or any of its Subsidiaries) and (B)&nbsp;any criminal liability, any
admission of wrongdoing or any wrongful conduct by the Company or any of its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xix) make or forgive any
loans, advances or capital contributions to, any other Person, except for (i)&nbsp;advances to directors, officers and other employees for travel and other business- related expenses, in each case, in the ordinary course of business and
(ii)&nbsp;loans, advances or capital contributions to, any direct or indirect wholly owned Subsidiaries of the Company in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xx) make any capital expenditures in excess of $1,000,000 (other than the capitalization of software development incurred in
the ordinary course of business); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxi) adopt a rights plan, &#147;poison pill&#148; or similar arrangement that is, or at
the Effective Time will be, applicable to this Agreement, the Mergers or the other transactions contemplated hereby; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxii) engage in any transaction with, or enter into any agreement, arrangement or understanding with, any Affiliate of the
Company or other Person covered by Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC that would be required to be disclosed pursuant to Item 404; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxiii) (A) amend the terms of the Tax Receivable Agreement or the TRA Amendment, or (B)&nbsp;make any payment to any TRA
Holder (as defined in the Tax Receivable Agreement) under the Tax Receivable Agreement, in each case of clauses (A)&nbsp;and (B), except as set forth in the TRA Amendment; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxiv) authorize, commit or agree to take any of the foregoing actions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the foregoing, nothing contained in this Agreement shall give to Parent, Acquirer, Merger Sub or Merger Sub II, directly or
indirectly, rights to control or direct the operations of the Company and its Subsidiaries prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02
<I><U>Acquisition Proposals</U></I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to <U>Section</U><U></U><U>&nbsp;6.03(b)</U> and
<U>Section</U><U></U><U>&nbsp;6.03(c)</U> and except as expressly permitted by this <U>Section</U><U></U><U>&nbsp;6.02</U>, from the date of this Agreement until the earlier to occur of the Effective Time or the termination of this Agreement
pursuant to <U>Section</U><U></U><U>&nbsp;8.01</U>, beginning on the date hereof: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Company shall not and shall
cause each of its Subsidiaries not to, nor shall the Company authorize or permit any of its Representatives or any of its Subsidiaries&#146; Representatives to and it shall direct its Representatives and its Subsidiaries&#146; Representatives not
to, directly or indirectly (other than with respect to Parent, Acquirer, Merger Sub and Merger Sub II), (A) solicit, assist, initiate, propose, induce the making, submission or announcement of or otherwise knowingly encourage or facilitate any
inquiries, proposals or offers that constitute, or that would reasonably be expected to constitute or lead to, an Acquisition Proposal, (B)&nbsp;authorize, engage in, continue or otherwise participate in any discussions or negotiations with any
Third Party regarding any inquiries, proposals or offers that constitute, or that would reasonably be expected to constitute or lead to, an Acquisition Proposal, (C)&nbsp;furnish to any Third Party any information or provide to any Third Party
access to the businesses, properties, assets, books, records or personnel of the Company or any of its Subsidiaries, in each case for the purpose of encouraging or facilitating any inquiries, proposals or offers that constitute, or that would
reasonably be expected to lead to, an Acquisition Proposal, (D)&nbsp;approve, endorse or recommend an Acquisition Proposal, or publicly propose to accept, approve, endorse or recommend any publicly announced Acquisition Proposal, (E)&nbsp;approve,
recommend or enter into, or propose to approve, recommend or enter into, any letter of intent, memorandum of understanding, merger agreement, acquisition agreement, or other similar Contract (other than an Acceptable Confidentiality Agreement, or
such other permitted confidentiality agreement pursuant to this <U>Section</U><U></U><U>&nbsp;6.02)</U> with respect to an Acquisition Proposal; or (F)&nbsp;propose, resolve, authorize, agree or commit to do any of the foregoing; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Company shall, and shall cause its Subsidiaries to, and shall direct the Company&#146;s and its Subsidiaries&#146;
Representatives to, promptly after the execution and delivery of this Agreement: (A)&nbsp;in any event within 24 hours of the execution and delivery of this Agreement, cease and terminate any existing discussions, communications or negotiations with
any Third Party, theretofore conducted by the Company, its Subsidiaries or their respective Representatives with respect to an Acquisition Proposal and terminate all access of any Third Party to any physical or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
electronic data room (or other diligence access) maintained by the Company or its Representatives and (B)&nbsp;in any event within three Business Days after the execution and delivery of this
Agreement, distribute written demand for the return or destruction of all copies of any confidential information regarding the Company or any of its Subsidiaries provided to any Third Party other than the Parent Related Parties and their
Representatives (including prior to the date of this Agreement) in accordance with the terms of the confidentiality agreement with such Third Party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary contained in this Agreement, if, at any time on or after the date hereof, but prior to obtaining
the Stockholder Approval, (i)&nbsp;the Company receives a written Acquisition Proposal from a Third Party, (ii)&nbsp;such Acquisition Proposal did not result from a material breach of this <U>Section</U><U></U><U>&nbsp;6.02</U> or
<U>Section</U><U></U><U>&nbsp;6.03</U> and (iii)&nbsp;the Special Committee determines in good faith, after consultation with a Special Committee Financial Advisor and outside legal counsel, that such Acquisition Proposal constitutes, or would
reasonably be expected to lead to, a Superior Proposal and that the failure to take the actions contemplated by the following clauses (A)&nbsp;or (B) would be inconsistent with the Special Committee&#146;s fiduciary duties under applicable Law, then
the Company or the Special Committee, directly or indirectly through one or more of their Representatives, may, subject to applicable Law, (A)&nbsp;furnish information and data with respect to the Company and its Subsidiaries to the Third Party
making such Acquisition Proposal and afford such Third Party access to the businesses, properties, assets and personnel of the Company and its Subsidiaries and (B)&nbsp;enter into, maintain and participate in discussions or negotiations with the
Third Party making such Acquisition Proposal regarding such Acquisition Proposal or otherwise cooperate with or assist or participate in, or facilitate, any such discussions or negotiations (including by entering into an Acceptable Confidentiality
Agreement with such Third Party for the purpose of receiving <FONT STYLE="white-space:nowrap">non-public</FONT> information relating to such Third Party); <U>provided</U>, <U>however</U>, that the Company (1)&nbsp;will not, and will cause its
Subsidiaries not to and shall not permit its or their Representatives to and shall direct its and their Representatives not to, furnish any <FONT STYLE="white-space:nowrap">non-public</FONT> information except pursuant to an Acceptable
Confidentiality Agreement and (2)&nbsp;will provide to Parent any <FONT STYLE="white-space:nowrap">non-public</FONT> information concerning the Company or its Subsidiaries provided to such Third Party, which was not previously provided to Parent,
substantially concurrently with such time it is provided to such Third Party. Notwithstanding anything to the contrary contained in this Agreement, the Company or the Special Committee, directly or indirectly through one or more of their
Representatives, may (x)&nbsp;following the receipt of an Acquisition Proposal from a Third Party, contact such Third Party solely in order to clarify and understand the terms and conditions of an Acquisition Proposal made by such Third Party in
order to permit the Special Committee to determine whether such Acquisition Proposal constitutes, or would reasonably be expected to lead to, a Superior Proposal and (y)&nbsp;direct any Persons to this Agreement, including the specific provisions of
this <U>Section</U><U></U><U>&nbsp;6.02</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) From and after the date of this Agreement, the Company shall promptly (and in any event
within 24 hours) notify Parent of the Company&#146;s receipt of any Acquisition Proposal and the identity of the Person making such Acquisition Proposal. The Company shall thereafter keep Parent reasonably informed on a prompt basis (and in any
event within 24 hours) of the status of any material developments regarding any such Acquisition Proposal, and promptly provide Parent with copies of all documentation (as well as written summaries of any material oral communications relating to the
terms and conditions of such Acquisition Proposal) received </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the Company and its Subsidiaries and their Representatives relating to such Acquisition Proposal (and in any event within 24 hours of receipt thereof). For the avoidance of doubt, all
information provided to Parent pursuant to this <U>Section</U><U></U><U>&nbsp;6.02</U> will be subject to the terms of the Confidentiality Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company agrees that any action or failure to take any action by any director, officer or other Representative of the Company or any of
its Subsidiaries which would constitute a breach of this <U>Section</U><U></U><U>&nbsp;6.02</U> or <U>Section</U><U></U><U>&nbsp;6.03</U> if taken or not taken by the Company or its Subsidiaries will be deemed to be a breach of this
<U>Section</U><U></U><U>&nbsp;6.02</U> or <U>Section</U><U></U><U>&nbsp;6.03</U> by the Company. The Company will not authorize, direct or knowingly permit any director, officer or other Representative of the Company or its Subsidiaries to breach
this <U>Section</U><U></U><U>&nbsp;6.02</U> or <U>Section</U><U></U><U>&nbsp;6.03</U>, and upon becoming aware of any breach or threatened breach of this <U>Section</U><U></U><U>&nbsp;6.02</U> or <U>Section</U><U></U><U>&nbsp;6.03</U> by a director,
officer or Representative of the Company or its Subsidiaries, the Company shall use its reasonable best efforts to stop such breach or threatened breach. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03 <I><U>Company Recommendation</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to <U>Section</U><U></U><U>&nbsp;6.03(b)</U> and <U>Section</U><U></U><U>&nbsp;6.03(c)</U>, neither the Company Board nor any
committee thereof (including the Special Committee) shall (i)&nbsp;fail to make, withhold, withdraw, amend or qualify, or publicly propose to withhold, withdraw, amend or qualify, the Company Recommendation, (ii)&nbsp;authorize, adopt, approve,
endorse or recommend, or publicly propose to authorize, adopt, approve, endorse or recommend, an Acquisition Proposal, (iii)&nbsp;fail to recommend against acceptance of any Third Party tender offer or exchange offer for the shares of Company Common
Stock within 10 Business Days after commencement (within the meaning of Rule <FONT STYLE="white-space:nowrap">14d-</FONT> 2 under the Exchange Act) of such offer (or if the Stockholder Meeting is scheduled to be held within 10 Business Days from the
date of such commencement, promptly and in any event prior to the date that is one Business Day before the date on which the Stockholder Meeting is scheduled to be held), (iv) adopt, approve, endorse or recommend, or publicly propose to adopt,
approve, endorse or recommend, or cause or permit the Company or any Subsidiary of the Company to execute or enter into any letter of intent, memorandum of understanding, merger agreement, acquisition agreement, or other similar agreement with
respect to an Acquisition Proposal (other than an Acceptable Confidentiality Agreement, or such other permitted confidentiality agreement, pursuant to <U>Section</U><U></U><U>&nbsp;6.02</U>), (v) fail to publicly reaffirm the Company Recommendation
within five Business Days after Parent so requests in writing (or, if the Stockholders Meeting is scheduled to be held within five Business Days of such request, within one Business Day after such request and, in any event, prior to the date of the
Stockholders Meeting); provided that Parent may make such a request no more than one time per Acquisition Proposal (it being understood and agreed that if such Acquisition Proposal is amended or modified, Parent may make such an additional request
pursuant to this clause (v)&nbsp;with respect to such amended or modified Acquisition Proposal), (vi) fail to include the Company Recommendation in the Joint Proxy Statement/Prospectus or (vii)&nbsp;resolve or publicly propose to take any action
described in the foregoing clauses (i)&nbsp;through (vi) (each of the foregoing actions described in clauses (i)&nbsp;through (vii) being referred to as an &#147;<B>Adverse Recommendation Change</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything in this Agreement to the contrary, including
<U>Section</U><U></U><U>&nbsp;6.03(a)</U>, at any time prior to obtaining the Stockholder Approval, the Special Committee may, if it determines in good faith (after consultation with a Special Committee Financial Advisor and outside legal counsel)
that the failure to do so would be inconsistent with its fiduciary duties under Applicable Law, (A)&nbsp;make an Adverse Recommendation Change in response to either (1)&nbsp;a Superior Proposal or (2)&nbsp;an Intervening Event and/or (B)&nbsp;in the
case of a Superior Proposal, cause the Company to validly terminate this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.01(h)</U> and authorize the Company to enter into a definitive agreement concerning a transaction that constitutes a
Superior Proposal, subject in each case to prior compliance with the terms of paragraph (i)&nbsp;or (ii) below, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) In the case of a Superior Proposal, (x)&nbsp;no Adverse Recommendation Change pursuant to this
<U>Section</U><U></U><U>&nbsp;6.03(b)</U> may be made and (y)&nbsp;no termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.01(h)</U> may be made: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) until after the fifth Business Day following written notice from the Company advising Parent that the Company Board or any
committee thereof, intends to make an Adverse Recommendation Change and/or validly terminate this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.01(h)</U> (a &#147;<B>Notice of Superior Proposal</B>&#148;) and specifying the reasons therefor,
including the material terms and conditions of, and the identity of the Third Party making, such Superior Proposal, and a copy of any other relevant transaction documents as well as written summaries of any material oral communications relating to
the terms and conditions of such Superior Proposal (it being understood and agreed that any amendment, modification or change to the financial terms or any material amendments, modification or change to any other term of such Superior Proposal shall
require a new Notice of Superior Proposal, which shall require a new notice period of three Business Days, and compliance with this <U>Section</U><U></U><U>&nbsp;6.03(b)</U> with respect to such new notice); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) unless during such five-Business Day period (or three-Business Day period following an amended, modified or changed
proposal), the Company shall, and shall make its Representatives available to, to the extent requested by Parent, discuss and negotiate with Parent in good faith to make such adjustments to the terms and conditions of this Agreement as would enable
the Company Board or the Special Committee, to maintain the Company Recommendation and not make an Adverse Recommendation Change or validly terminate this Agreement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) no earlier than the end of such five-Business Day period (or three-Business Day period following an amended, modified or
changed proposal), the Special Committee determines in good faith, after consultation with a Special Committee Financial Advisor and outside legal counsel, after considering any amendments to the terms and conditions of this Agreement proposed by
Parent in a binding written offer irrevocably made by Parent during such five-Business Day period (or three-Business Day period following an amended, modified or changed proposal), that the failure to take such action would be inconsistent with its
fiduciary duties under Applicable Law and that such Acquisition Proposal continues to constitute a Superior Proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) In the case of an Intervening Event, no Adverse Recommendation Change
pursuant to this <U>Section</U><U></U><U>&nbsp;6.03(b)</U> may be made: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) until after the fifth Business Day following
written notice from the Company advising Parent that the Company Board or the Special Committee intends to take such action and specifying the material facts underlying the determination by the Company Board or the Special Committee that an
Intervening Event has occurred, and the reason for the Adverse Recommendation Change, in reasonable detail; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) unless
during such five-Business Day period, the Company shall, and shall make its Representatives available to, to the extent requested by Parent, discuss and negotiate with Parent in good faith to enable Parent to amend this Agreement in such a manner
that obviates the need for an Adverse Recommendation Change; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) unless, prior to the expiration of such five-Business
Day period, the Special Committee determines in good faith, taking into consideration any amendments to this Agreement proposed in writing by Parent (after consultation with a Special Committee Financial Advisor and outside legal counsel), that the
failure to effect an Adverse Recommendation Change would still be inconsistent with its fiduciary duties under Applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Nothing
contained in <U>Section</U><U></U><U>&nbsp;6.02</U> or this <U>Section</U><U></U><U>&nbsp;6.03</U> or elsewhere in this Agreement shall prohibit the Company from (i)&nbsp;taking and disclosing a position contemplated by Rule <FONT
STYLE="white-space:nowrap">14d-9,</FONT> Rule <FONT STYLE="white-space:nowrap">14e-2(a)</FONT> or Item 1012(a) of Regulation <FONT STYLE="white-space:nowrap">M-A</FONT> promulgated under the Exchange Act, (ii)&nbsp;making any disclosure to the
Company&#146;s stockholders if, the Company Board or any committee thereof determines in good faith, after consultation with outside legal counsel, the failure to do so would be inconsistent with its fiduciary duties under Applicable Law or any
disclosure requirements under Applicable Law, or (iii)&nbsp;making any disclosure that constitutes a &#147;stop, look and listen&#148; communication or similar communication of the type contemplated by
<FONT STYLE="white-space:nowrap">Section&nbsp;14d-</FONT> 9(f) promulgated under the Exchange Act, in each case, so long as any such disclosure complies with the terms and conditions set forth in <U>Section</U><U></U><U>&nbsp;6.02</U> and this
<U>Section</U><U></U><U>&nbsp;6.03</U> and does not include any statement that constitutes an Adverse Recommendation Change (it being understood that a customary &#147;stop, look and listen&#148; communication by the Company Board or any committee
thereof pursuant to Rule <FONT STYLE="white-space:nowrap">14d-9(f)</FONT> promulgated under the Exchange Act shall not, in and of itself, constitute an Adverse Recommendation Change). For the avoidance of doubt, nothing in this
<U>Section</U><U></U><U>&nbsp;6.03(c)</U> will (A)&nbsp;limit or otherwise affect the obligations of the Company or the Special Committee and the rights of Parent under <U>Section</U><U></U><U>&nbsp;6.02</U> or this
<U>Section</U><U></U><U>&nbsp;6.03</U> or (B)&nbsp;be deemed to permit the Special Committee to make an Adverse Recommendation Change except to the extent expressly permitted by <U>Section</U><U></U><U>&nbsp;6.03(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.04 <I><U>Approval of Merger Agreement</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Promptly following the effectiveness of the Form <FONT STYLE="white-space:nowrap">S-4</FONT> under the Securities Act, the Company shall,
in accordance with Applicable Law and the Company&#146;s governing documents, duly set a record date for, call, give notice of, convene and hold a special meeting of the Company&#146;s stockholders (including any adjournments and postponements
thereof, the &#147;<B>Stockholder Meeting</B>&#148;), within 30 days of mailing the definitive Joint Proxy Statement/Prospectus, for the purpose of considering and taking action upon the matters requiring Stockholder Approval; <U>provided</U> that
notwithstanding anything else to the contrary herein, the Company may postpone or adjourn the Stockholder Meeting (i)&nbsp;if there would be insufficient shares represented to constitute a quorum necessary for the conduct of business or to obtain
the Stockholder Approval, (ii)&nbsp;with the consent of Parent (not to be unreasonably withheld, conditioned or delayed), (iii) if the Company is required to postpone or adjourn the Stockholder Meeting by applicable Law or a request from the SEC or
its staff or (iv)&nbsp;in order to give the Company&#146;s stockholders sufficient time to evaluate any necessary supplement, amendment, information or disclosure that the Company has sent or otherwise made available to the holders of shares of
Company Common Stock if determines that, the Company Board or any committee thereof, such adjournment or postponement is consistent with its fiduciary duties under Applicable Law; <U>provided</U> that in the case of the foregoing clause (i)&nbsp;and
clause (iv), such postponement or adjournment shall not be for more than 20 Business Days in the aggregate past the originally scheduled date without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or
delayed). The Company shall use its reasonable best efforts to (A)&nbsp;mail or cause the definitive Joint Proxy Statement/Prospectus to be mailed to the Company&#146;s stockholders promptly following the filing thereof with the SEC and confirmation
from the SEC that the Form <FONT STYLE="white-space:nowrap">S-4</FONT> has been declared effective under the Securities Act and that it will not review, or that it has completed its review of, the Joint Proxy Statement/Prospectus, (B)&nbsp;solicit
from the Company&#146;s stockholders proxies in favor of the adoption of this Agreement, and (C)&nbsp;take all other action necessary or advisable to secure Stockholder Approval or any other vote of the holders of shares of Company Common Stock
required by Applicable Law to effect the Mergers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Promptly after the execution of this Agreement (and in any event within 20 Business
Days thereof), (i) the Company and Parent shall jointly prepare a registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (the &#147;<B>Form <FONT STYLE="white-space:nowrap">S-4</FONT></B>&#148;) in connection with the issuance of
Parent Class&nbsp;A Common Stock as Merger Consideration, which shall include a joint proxy statement/prospectus (such joint proxy statement/prospectus, as amended or supplemented from time to time, the &#147;<B>Joint Proxy
Statement/Prospectus</B>&#148;) in preliminary form and Parent shall file the Form <FONT STYLE="white-space:nowrap">S-4</FONT> with the SEC; and (ii)&nbsp;the Company and Parent shall jointly prepare and the Company shall file with the SEC the Joint
Proxy Statement/Prospectus. Each of the Company and Parent shall use reasonable best efforts to have the Form <FONT STYLE="white-space:nowrap">S-4</FONT> declared effective under the Securities Act as promptly as practicable after such filing and to
keep the Form <FONT STYLE="white-space:nowrap">S-4</FONT> effective for so long as necessary to consummate the transactions contemplated by this Agreement. The Company and Parent shall cooperate with each other in connection with the preparation and
filing of the foregoing, including to cause their respective Affiliates and advisors, as applicable, to cooperate with the preparation and filing of the foregoing, including promptly furnishing to the other party in writing upon request any and all
information relating to the Company or Parent, as applicable, and their respective Affiliates as may be required, or otherwise reasonably requested by the Company or Parent, as applicable, to be set forth in the Form
<FONT STYLE="white-space:nowrap">S-4</FONT> or the Joint Proxy Statement/Prospectus under Applicable Law. The Company and Parent shall cooperate with each other and use reasonable best efforts to respond as promptly as reasonably practicable to any
comments received from the SEC or its staff concerning the Form <FONT STYLE="white-space:nowrap">S-4</FONT> and the Joint Proxy Statement/Prospectus. The Company and Parent shall notify the other party promptly upon the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
receipt of any comments from the SEC or its staff or any other government officials and of any request by the SEC or its staff or any other government officials for amendments or supplements to
the Form <FONT STYLE="white-space:nowrap">S-4</FONT> or the Joint Proxy Statement/Prospectus and shall supply the other with copies of all correspondence between it or any of its Representatives, on the one hand, and the SEC, or its staff or any
other government officials, on the other hand, with respect to the Form <FONT STYLE="white-space:nowrap">S-4</FONT> or the Joint Proxy Statement/Prospectus. The Company and Parent shall cooperate and provide the other party and its counsel with a
reasonable opportunity to review and comment on any amendment or supplement to the Form <FONT STYLE="white-space:nowrap">S-4</FONT> or the Joint Proxy Statement/Prospectus or any written communications with the SEC or its staff with respect thereto
prior to filing or submitting such with the SEC. No filing of, or amendment or supplement to, the Form <FONT STYLE="white-space:nowrap">S-4,</FONT> or any written communication with the SEC or its staff with respect thereto, will be made by Parent,
and no filing of, or amendment or supplement to, the Joint Proxy Statement/Prospectus, or any written communication with the SEC or its staff with respect thereto, will be made by Parent or the Company, in each case without providing the other and
its counsel with a reasonable opportunity to review and comment (which comments shall be considered by the applicable party in good faith) thereon if reasonably practicable; <U>provided</U>, that with respect to documents filed by a party that are
incorporated by reference in the Form <FONT STYLE="white-space:nowrap">S-4</FONT> or the Joint Proxy Statement/Prospectus, this right of review and comment shall apply only with respect to information relating to the other party or its business,
financial condition or results of operations, or the combined entity or the transactions contemplated by this Agreement; and <U>provided</U>, <U>further</U>, that this review and comment right shall not apply with respect to information relating to
an Adverse Recommendation Change. Each party shall advise the other party, promptly after it receives notice thereof, of the time when the Form <FONT STYLE="white-space:nowrap">S-4</FONT> has become effective, of the time when any supplement or
amendment to the Form <FONT STYLE="white-space:nowrap">S-4</FONT> has been filed, of the issuance of any stop order with respect to the Form <FONT STYLE="white-space:nowrap">S-4,</FONT> or of any request by the SEC for amendment of the Form <FONT
STYLE="white-space:nowrap">S-4</FONT> or the Joint Proxy Statement/Prospectus or comments on the Form <FONT STYLE="white-space:nowrap">S-4</FONT> or the Joint Proxy Statement/Prospectus and responses thereto or requests by the SEC for additional
information relating thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each of Parent, Acquirer, Merger Sub, Merger Sub II and the Company further agrees that all information
supplied by such party (or such party&#146;s Affiliates) for inclusion or incorporation by reference in the Form <FONT STYLE="white-space:nowrap">S-4</FONT> and the Joint Proxy Statement/Prospectus in connection with the Merger (i)&nbsp;will not,
with regards to the Joint Proxy Statement/Prospectus, on the date it is first mailed to stockholders of the Company and at the time of the Stockholder Meeting, and with regards to the Form <FONT STYLE="white-space:nowrap">S-4,</FONT> on the date
that it becomes effective under the Securities Act, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they are made, not misleading and (ii)&nbsp;will comply as to form in all material respects with the applicable requirements of the Securities Act, the Exchange Act and the NYSE. Notwithstanding the foregoing, the Company on the one
hand, and Parent, Acquirer, Merger Sub and Merger Sub II on the other hand, each assumes no responsibility with respect to information supplied by or on behalf of, respectively, Parent, Acquirer, Merger Sub, Merger Sub II or their respective
Affiliates, or the Company or its Affiliates, for inclusion or incorporation by reference in the Form <FONT STYLE="white-space:nowrap">S-4</FONT> and the Joint Proxy Statement/Prospectus. If at any time prior to the Effective Time, any information
relating to the Company, Parent, Acquirer, Merger Sub, Merger Sub II or any of their respective Affiliates should be discovered by the Company, on the one hand, or Parent, Acquirer, Merger Sub or Merger Sub II, on the other hand, that should be set
forth in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an amendment or supplement to the Form <FONT STYLE="white-space:nowrap">S-4</FONT> or the Joint Proxy Statement/Prospectus, as the case may be, so that such filing would not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, then the party that
discovers such information shall promptly notify the other, and an appropriate amendment or supplement to such filing describing such information shall be promptly prepared and filed with the SEC by the appropriate party and, to the extent required
by applicable law or the SEC or its staff, disseminated to the holders of shares of Company Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.05 <I><U>Access
to Information</U></I>. Subject to Applicable Law and applicable contractual restrictions entered into prior to the date of this Agreement, and solely for purposes of furthering the transactions contemplated by this Agreement or transition or
integration planning related thereto, upon reasonable notice, the Company shall (and shall cause its Subsidiaries to) afford Parent&#146;s officers and Parent&#146;s other authorized Representatives reasonable access, during normal business hours
throughout the period prior to the Effective Time, to its properties, books, Contracts, records and personnel (it being understood and agreed that the preparation of any financial statements of the Company shall be governed by
<U>Section</U><U></U><U>&nbsp;6.18</U> and not this <U>Section</U><U></U><U>&nbsp;6.05</U>). The foregoing shall not require the Company or its Subsidiaries (a)&nbsp;to provide access to or otherwise make available or furnish any books, Contracts or
records to the extent such access would constitute a violation of a confidentiality, <FONT STYLE="white-space:nowrap">non-</FONT> disclosure or other similar agreement in effect as of the date hereof, (b)&nbsp;to provide access to or otherwise make
available or furnish any information if and to the extent that the provision of such information would in the good faith judgment of the Company based on advice of outside counsel jeopardize any attorney-client, work product or other legal privilege
or protection, (c)&nbsp;to provide access to the extent that such access would jeopardize the health and safety of any employee of the Company or its Subsidiaries, (d)&nbsp;to provide access to or otherwise make available or furnish any information
relating to the process conducted by the Special Committee that led to the execution of this Agreement or (e)&nbsp;to provide access to or otherwise make available or furnish any information if and to the extent that the provision of such
information could in the judgment of the Company based on advice of counsel violate any Applicable Law; <U>provided</U>, that the Company and its Subsidiaries shall use reasonable best efforts to make appropriate substitute arrangements for access
by Parent and its authorized Representatives in a manner that does not result in the issues described in the foregoing clauses (a)&nbsp;through (e). Except in the ordinary course of business of Parent, Acquirer, Merger Sub or their respective
Affiliates and unrelated to the transactions contemplated hereby, Parent, Acquirer, Merger Sub and Merger Sub II shall not, and shall cause their respective Representatives not to, contact any employee of the Company not directly involved in the
negotiation of the transactions contemplated by this Agreement or any customer, technology or other partner, vendor or supplier of the Company in connection with the Mergers or any of the other transactions contemplated by this Agreement, without
the Company&#146;s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed), and Parent, Acquirer, Merger Sub and Merger Sub II acknowledge and agree that any such contact shall be arranged and supervised by
Representatives of the Company. All requests for information made pursuant to this <U>Section</U><U></U><U>&nbsp;6.05</U> shall be directed to the Chief Legal Officer or other Person designated by the Company. All such information shall be deemed
Evaluation Material (as defined in the applicable Confidentiality Agreement) under and be governed by the terms of the applicable Confidentiality Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.06 <I><U>Employee Matters</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For a period of not less than 12 months after the Closing Date, Parent shall provide each employee of the Company or its Subsidiaries
immediately before the Effective Time for so long as such person continues employment with Parent, the Surviving Corporation or any Subsidiary of Parent or the Surviving Corporation following the Closing Date (each a &#147;<B>Continuing
Employee</B>&#148;) with (i)&nbsp;(A) base salary or base hourly rate, as applicable and (B)&nbsp;target cash incentive compensation opportunities (including commissions, but excluding retention, long-term incentive compensation, change in control,
transaction or other <FONT STYLE="white-space:nowrap">one-time</FONT> or special bonus opportunities and equity or equity-based incentive compensation), in each case, in an amount that is no less favorable than that was provided to each such
Continuing Employee immediately prior to the Closing Date and (ii)&nbsp;employee benefits (including severance benefits that would have been provided to such Continuing Employee under the applicable severance benefit plans, programs, policies,
agreements and arrangements set forth in <U>Section</U><U></U><U>&nbsp;6.06(a)</U> of the Company Disclosure Schedule, defined contribution retirement, health and welfare, vacation and sick or other paid leave and remote working options, but
excluding defined benefit pension, equity or equity-based, nonqualified deferred compensation, change in control, retention or retiree health or welfare) that are either, in Parent&#146;s discretion, (A)&nbsp;substantially comparable in the
aggregate to those provided to such Continuing Employee immediately prior to the Closing Date or (B)&nbsp;no less favorable in the aggregate than those provided to similarly situated employees of Parent or any Subsidiary of Parent, in each case,
subject to the same exclusions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) From and after the Closing Date, Parent shall use reasonable best efforts to cause the service of each
Continuing Employee to be recognized for purposes of eligibility to participate, levels of benefits and vesting under each compensation, severance, retirement, vacation, paid time off, fringe or other welfare benefit plan, program or arrangement of
Parent, the Surviving Corporation or any of their Subsidiaries, but not including any equity compensation plans, programs, agreements or arrangements (collectively, the &#147;<B>Parent Benefit Plans</B>&#148;) in which any Continuing Employee is or
becomes eligible to participate, but solely to the extent service was credited to such employee for such purposes under a comparable Company Employee Plan immediately prior to the Closing Date; <U>provided</U>, that in no event shall service be
credited under this <U>Section</U><U></U><U>&nbsp;6.06(b)</U> (i)&nbsp;to the extent such credit would result in a duplication of benefits or (ii)&nbsp;for purposes of any Parent Benefit Plan that is a defined benefit pension plan, a frozen plan or
that provides benefits to a grandfathered population. Parent shall assume any and all vacation and paid time off balances of Continuing Employees, and shall assume all costs and notice obligations incurred in connection with terminations of <FONT
STYLE="white-space:nowrap">non-Continuing</FONT> Employees. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) From and after the Closing Date, with respect to each Parent Benefit Plan
that is an &#147;employee welfare benefit plan&#148; as defined in Section&nbsp;3(1) of ERISA providing group health benefits in which any Continuing Employee is or becomes eligible to participate in the year in which the Closing Date occurs, Parent
shall use reasonable best efforts to cause each such Parent Benefit Plan to (i)&nbsp;waive all limitations as to <FONT STYLE="white-space:nowrap">pre-existing</FONT> and <FONT STYLE="white-space:nowrap">at-work</FONT> conditions, waiting periods,
required physical examinations and exclusions with respect to participation and coverage requirements applicable under such Parent Benefit Plan for such Continuing Employees and their eligible dependents to the same extent that such <FONT
STYLE="white-space:nowrap">pre-existing</FONT> conditions, waiting periods, required physical examinations and exclusions would not have applied or would have been waived under the corresponding Company Employee Plan in which such Continuing
Employee was a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
participant immediately prior to his or her commencement of participation in such Parent Benefit Plan; <U>provided</U>, <U>however</U>, that for purposes of clarity, to the extent such benefit
coverage includes eligibility conditions based on periods of employment, <U>Section</U><U></U><U>&nbsp;6.06(b)</U> shall control; and (ii)&nbsp;provide each Continuing Employee and their eligible dependents with credit for any <FONT
STYLE="white-space:nowrap">co-payments</FONT> and deductibles paid in the calendar year that, and prior to the date that, such Continuing Employee commences participation in such Parent Benefit Plan in satisfying any applicable <FONT
STYLE="white-space:nowrap">co-payment</FONT> or deductible requirements under such Parent Benefit Plan for the applicable calendar year. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Prior to the Effective Time, if requested by Parent in writing no later than 10 Business Days prior to the Effective Time, the Company and
each of its Subsidiaries shall adopt resolutions and take all such corporate action as is necessary to properly terminate each 401(k) plan maintained, sponsored or contributed to by the Company or any of its Subsidiaries (collectively, the
&#147;<B>Company 401(k) Plans</B>&#148;), in each case, effective as of the day immediately prior to the Closing Date, and the Company shall provide Parent with evidence that such Company 401(k) Plans have been properly terminated, the form of such
termination documents shall be subject to the reasonable approval of Parent. To the extent the Company 401(k) Plans are properly terminated pursuant to Parent&#146;s request, the Continuing Employees shall be eligible to participate in a 401(k) plan
maintained by Parent or one of its Affiliates on, or as soon as administratively practicable following, the Closing Date, and such Continuing Employees shall be entitled to effect a direct rollover in cash of any eligible rollover distributions (as
defined in Section&nbsp;402(c)(4) of the Code) and any outstanding loan balances to such Parent Benefit Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Prior to making any
written or oral communications intended for broad-based or general distributions to Continuing Employees pertaining to compensation or benefit matters that are affected by the transactions contemplated by this Agreement, the Company shall provide
Parent with a copy of the intended communication (or, for oral communications, a written summary of the intended talking points), Parent shall have a reasonable period of time to review and comment on the communication, and the Company shall
consider any such comments in good faith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Nothing in this <U>Section</U><U></U><U>&nbsp;6.06</U> or otherwise contained in this
Agreement shall be deemed to: (i)&nbsp;guarantee employment for any period of time or preclude the ability of Parent, the Surviving Corporation or their respective Subsidiaries to terminate the employment of any Continuing Employee; (ii)&nbsp;amend
or establish any Parent Benefit Plan or Company Employee Plan; (iii)&nbsp;require Parent, the Surviving Corporation or any of their Affiliates to continue or amend any particular benefit or compensation plan before or after the consummation of the
transactions contemplated in this Agreement, and any such plan may be amended or terminated in accordance with its terms and Applicable Law or (iv)&nbsp;create a third party rights in any current or former employee or other service provider of the
Company or its affiliates (or any beneficiaries or dependents thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.07 <I><U>State Takeover Laws</U></I>. If any
&#147;control share acquisition,&#148; &#147;fair price,&#148; &#147;<B>moratorium</B>&#148; or other anti-takeover Applicable Law becomes or is deemed to be applicable to the Company, Parent, Acquirer, Merger Sub, Merger Sub II, the Mergers or any
other transaction contemplated by this Agreement, then the Company Board shall grant such approvals and take all such actions as are necessary or advisable so that the transactions contemplated by this Agreement may be consummated as promptly as
practicable on the terms contemplated by this Agreement and otherwise act to render such anti-takeover Applicable Law inapplicable to the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.08 <I><U>Obligations of</U></I><I><U> Acquirer,</U></I><I><U> Merger Sub and
Merger Sub II</U></I>. Parent shall cause each of Acquirer, Merger Sub and Merger Sub II to perform its obligations under this Agreement and to consummate the Mergers and the other transactions contemplated hereby on the terms and conditions set
forth in this Agreement. Without limiting the foregoing, immediately after the execution and delivery of this Agreement, Parent, in its capacity as the sole stockholder of Acquirer and Merger Sub, and Clearwater Analytics, LLC, in its capacity as
the sole member of Merger Sub II, shall execute and deliver to Acquirer, Merger Sub, Merger Sub II and the Company a written consent adopting this Agreement in accordance with the DGCL or the DLLCA, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.09 <I><U>Director and Officer Liability</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For six years after the Effective Time, the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to, maintain
officers&#146; and directors&#146; liability insurance in respect of acts, errors or omissions occurring prior to the Effective Time covering each such person currently covered by the Company&#146;s and the Company&#146;s Subsidiaries&#146;
officers&#146; and directors&#146; liability insurance policy on terms with respect to coverage and amount no less favorable than those of such policy in effect on the date hereof; <U>provided</U>, <U>however</U>, that in satisfying its obligation
under this <U>Section</U><U></U><U>&nbsp;6.09(a)</U>, neither Parent nor the Surviving Corporation shall be obligated to pay annual premiums in excess of 300% of the amount per annum the Company paid in its last full fiscal year prior to the date
hereof (the &#147;<B>Current Premium</B>&#148;) and if such premiums for such insurance would at any time exceed 300% of the Current Premium, then the Surviving Corporation shall cause to be maintained policies of insurance that, in the Surviving
Corporation&#146;s good faith judgment, provide the maximum coverage available at an annual premium equal to 300% of the Current Premium. At its election, Parent may require the Company to satisfy the provisions of the immediately preceding sentence
by requesting the Company to obtain prepaid &#147;tail&#148; or &#147;runoff&#148; policies prior to the Effective Time, which policies provide such persons currently covered by such policies with coverage for an aggregate period of six years with
respect to claims arising from acts, errors or omissions that occurred on or before the Effective Time, including in respect of the transactions contemplated by this Agreement. The Company (with the prior written consent of Parent) may also purchase
prepaid &#147;tail&#148; or &#147;runoff&#148; policies for any other &#147;claims-made&#148; liability insurance coverage, including employment practices liability, professional liability and cyber and data security liability coverages;
<U>provided</U><I>.</I> that such premiums for such insurance do not exceed 300% of the amount per annum the Company paid in its last full fiscal year prior to the date hereof with respect to each such coverage. If any such prepaid policies
described in this <U>Section</U><U></U><U>&nbsp;6.09(a)</U> have been obtained by the Company (with the prior written consent of Parent) prior to the Effective Time, the Surviving Corporation shall (and Parent shall cause the Surviving Corporation
to) maintain any and all such policies in full force and effect for their full term, and continue to honor the obligations thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) From and after the Effective Time, the Surviving Corporation shall: (i)&nbsp;indemnify
(including advancement of expenses within five Business Days of receipt by the Surviving Corporation of a <I>bona fide</I> request therefor) and hold harmless each individual who at the Effective Time is, or at any time prior to the Effective Time
was, a director or officer of the Company (each an &#147;<B>Indemnified Party</B>&#148;) for all reasonable, documented and documented costs and expenses (including fees and expenses of legal counsel; <U>provided</U>, that the Indemnified Party
shall have made an undertaking to repay such expenses if it is ultimately determined that such Indemnified Party was not entitled to indemnification), judgments, fines, penalties or liabilities (including amounts paid in settlement or compromise)
imposed upon or incurred by such Indemnified Party in connection with or arising out of any action, suit or other Proceeding (whether civil or criminal) in which such Indemnified Party may be involved or with which he or she may be threatened
(regardless of whether as a named party or as a participant other than as a named party, including as a witness) (an &#147;<B>Indemnified Party Proceeding</B>&#148;) by reason of the fact that such Indemnified Party is or was a director or officer
of the Company or, while serving as a director or officer of the Company, is or was serving at the request of the Company as a director, officer, employee, agent, trustee or fiduciary of any Subsidiary of the Company or another Person, in each case,
at or before the Effective Time, whether or not the Indemnified Party continues in such position at the time such Indemnified Party Proceeding is brought or threatened (including any Indemnified Party Proceeding relating in whole or in part to the
transactions contemplated by this Agreement or relating to the enforcement of this provision or any other indemnification or advancement right of any Indemnified Party), to the fullest extent permitted under Applicable Law and to the extent such
Indemnified Party is entitled to indemnification from the Company on the date hereof pursuant to the organizational documents of the Company or any indemnification agreement in effect as of the date hereof; and (ii)&nbsp;fulfill and honor in all
respects the obligations of the Company pursuant to: (x)&nbsp;each indemnification agreement in effect as of the date hereof between the Company and any Indemnified Party that is set forth in <U>Section</U><U></U><U>&nbsp;6.09</U> of the Company
Disclosure Schedule; and (y)&nbsp;any indemnification provision (including advancement of expenses) and any exculpation provision set forth in the certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company as in
effect on the date hereof. The Surviving Corporation&#146;s obligations under the foregoing clauses (i)&nbsp;and (ii) shall continue in full force and effect for a period of six years from the Effective Time; <U>provided</U>, <U>however</U>, that
all rights to indemnification, exculpation and advancement of expenses in respect of any claim asserted or made within such period shall continue until the final disposition of such claim. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) During the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the Surviving Corporation
shall (and Parent shall cause the Surviving Corporation to) cause the organizational documents of the Surviving Corporation to contain provisions with respect to indemnification, exculpation and the advancement of expenses that are at least as
favorable to those subject to those provisions as the indemnification, exculpation and advancement of expenses provisions set forth in the organizational documents of the Company as of the date hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the Surviving Corporation or any of its successors or assigns (i)&nbsp;consolidates with or merges into any other Person and shall not
be the continuing or surviving corporation or entity of such consolidation or merger or (ii)&nbsp;transfers or conveys all or substantially all of its properties and assets to any Person, then, and in each such case proper provision shall be made so
that the successors and assigns of the Surviving Corporation shall assume the obligations set forth in this <U>Section</U><U></U><U>&nbsp;6.09</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The provisions of this <U>Section</U><U></U><U>&nbsp;6.09</U> are (i)&nbsp;intended to
be for the benefit of, and shall be enforceable by, each Indemnified Party, his or her heirs and his or her Representatives and (ii)&nbsp;in addition to, and not in substitution for, any other rights to indemnification or contribution that any such
individual may have under any certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws,</FONT> by contract or otherwise. The obligations of Parent and the Surviving Corporation under this <U>Section</U><U></U><U>&nbsp;6.09</U> shall
not be terminated or modified in such a manner as to adversely affect the rights of any Indemnified Party unless (x)&nbsp;such termination or modification is required by Applicable Law or (y)&nbsp;the affected Indemnified Party shall have consented
in writing to such termination or modification (it being expressly agreed that the Indemnified Parties shall be third party beneficiaries of this <U>Section</U><U></U><U>&nbsp;6.09)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10 <I><U>Reasonable Best Efforts</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, the Company and Parent shall use their respective reasonable best efforts to take,
or cause to be taken, all actions and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable under Applicable Law to consummate the transactions contemplated by this
Agreement as promptly as practicable after the date hereof and, other than in the case of clause (iv)&nbsp;below, in no event later than the End Date, including (i)&nbsp;the obtaining of all necessary actions or
<FONT STYLE="white-space:nowrap">non-actions,</FONT> waivers, consents and approvals from Governmental Authorities and the making of all necessary registrations and filings (including filings with Governmental Authorities, if any), (ii) the delivery
of required notices to, and the obtaining of required consents or waivers from, Third Parties (<U>provided</U>, that the Company shall not be obligated to make any payment or commercial concession to any Third Party, or incur any liability, as a
condition to (or in connection with) obtaining any such consent or waiver, unless such payment, concession or liability is requested by Parent and is conditioned and effective only upon the Closing), (iii) the execution and delivery of any
additional instruments necessary to consummate the Mergers and to fully carry out the purposes of this Agreement and (iv)&nbsp;the preparation and timely filing of any reports under Section&nbsp;13(a) or 15(d) of the Exchange Act as may be required
in connection with this Agreement and the transactions contemplated hereby, including the filing of a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> by Parent following the consummation of the Mergers to include financial
statements of the Company and other financial information (including pro forma financial information) in compliance with Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated by the SEC. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In furtherance and not in limitation of the foregoing, each of the Company (and its Affiliates, if applicable) and Parent (and its
Affiliates, if applicable) shall: (i)&nbsp;promptly, but in no event later than 10 Business Days after the date hereof (or in the event that the relevant Governmental Authority has suspended its acceptance of filings under the HSR Act for any
reason, five Business Days after the Governmental Authority resumes normal operating procedures), file any and all notices, reports and other documents required to be filed by such party under the HSR Act with respect to the Mergers and the other
transactions contemplated by this Agreement; <U>provided</U><I>.</I> that if there are any changes in the applicable regulations under the HSR Act between the date hereof and the date of filing pursuant to the HSR Act, then the Company and Parent
shall use reasonable best efforts to file or cause to be filed any and all required notification and report forms under the HSR Act as promptly as commercially practicable thereafter; (ii)&nbsp;as promptly as reasonably practicable, but in no event
later than 20 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Business Days after the date hereof, make all filings necessary to timely obtain all consents, permits, authorizations, waivers, clearances and approvals, and shall cause the expiration or
termination of any applicable waiting periods, as may be required under the Antitrust Laws or Foreign Investment Laws of the jurisdictions set forth on <U>Section</U><U></U><U>&nbsp;6.10(b)</U> of the Company Disclosure Schedule (to the extent
required or advisable); and (iii)&nbsp;as promptly as reasonably practicable provide such information as may reasonably be requested by the U.S. Department of Justice (the &#147;<B>DOJ</B>&#148;) or the Federal Trade Commission (the
&#147;<B>FTC</B>&#148;) under the HSR Act or by any other Governmental Authority under applicable Antitrust Laws or Foreign Investment Laws in connection with the Mergers and the other transactions contemplated by this Agreement, as well as any
information required to be submitted to comply with a request for additional information in order to commence or end a statutory waiting period. Parent shall pay all filing fees under the HSR Act and other applicable Antitrust Laws or Foreign
Investment Laws, and the Company shall not be required to pay any filing fees to any Governmental Authority in connection with any filings under the HSR Act or such other filings as may be required under applicable Antitrust Laws, in connection with
the Mergers or the other transactions contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Without limiting the generality of anything contained in this
<U>Section</U><U></U><U>&nbsp;6.10</U>, each party hereto shall use reasonable best efforts to: (i)&nbsp;give the other parties prompt notice of the making or commencement of any substantive request, inquiry or Proceeding by any Governmental
Authority with respect to the Mergers and the other transactions contemplated by this Agreement; (ii)&nbsp;keep the other parties reasonably informed as to the status of any such request, inquiry or Proceeding; (iii)&nbsp;promptly inform the other
parties of any substantive communication to or from the FTC, DOJ or any other Governmental Authority to the extent regarding the Mergers and the other transactions contemplated by this Agreement, or regarding any such request, inquiry or Proceeding,
and provide a copy of all substantive written communications; and (iv)&nbsp;in the case of Parent, pull and <FONT STYLE="white-space:nowrap">re-file</FONT> any notice under the HSR Act only after consulting in good faith with and the consent of the
other party (such consent not to be unreasonably withheld, conditioned or delayed). Subject to Applicable Law, in advance and to the extent practicable, each of Parent or the Company, as the case may be, will consult the other on all the material
information relating to Parent or the Company, as the case may be, and any of their respective Subsidiaries that appear in any filing made with, or written materials submitted to, any third party and/or any Governmental Authority in connection with
the Mergers and the other transactions contemplated by this Agreement and shall consider in good faith all comments reasonably proposed by Parent or the Company, as the case may be; provided, however, that either party may limit access to
information solely to those individuals acting as outside antitrust counsel for the other parties (provided that such counsel shall not disclose such information to such other parties and shall enter into a joint defense agreement with the providing
party) and that neither party shall be required to provide the other party or their counsel access to its filing(s) contemplated in <U>Section</U><U></U><U>&nbsp;6.10(b)</U>. In addition, except as may be prohibited by any Governmental Authority or
by any Applicable Law, in connection with any such request, inquiry or Proceeding in respect of the Mergers and the other transactions contemplated by this Agreement, each party hereto will permit authorized Representatives of the other party to be
present at each substantive meeting or conference relating to such request, inquiry or Proceeding and to have access to and be consulted in connection with any substantive document, opinion or proposal made or submitted to any Governmental Authority
in connection with such request, inquiry or Proceeding. Any disclosures, rights to participate or provisions of information by one party to the other under this <U>Section</U><U></U><U>&nbsp;6.10(c)</U> may be made on a counsel-only basis and
redacted for legal privilege to the extent required under applicable Law or to remove references concerning the valuation of the Company or confidential competitively sensitive business information of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In furtherance and not in limitation of the foregoing, Parent agrees to take promptly
any and all steps necessary to avoid, eliminate or resolve each and every impediment and obtain all clearances, consents, approvals and waivers under the Antitrust Laws that may be required by any Governmental Authority, so as to enable the parties
hereto to consummate the Mergers and the other transactions contemplated by this Agreement as soon as practicable (and in any event no later than the End Date), including (i)&nbsp;committing to or effecting, by consent decree, hold separate order,
trust, or otherwise, the sale, divestiture, license, transfer, assignment or other disposition of assets or businesses of the Company or its Subsidiaries and controlled Affiliates, (ii)&nbsp;terminating, relinquishing, modifying, transferring,
assigning, restructuring, or waiving existing agreements, licenses, collaborations, relationships, ventures, contractual rights, obligations or other arrangements of the Company or its Subsidiaries and controlled Affiliates and (iii)&nbsp;creating
or consenting to create or enter into any agreements, licenses, collaborations, relationships, ventures, contractual rights, obligations, behavioral undertakings or other arrangements (and, in each case, to enter, or offer to enter, into agreements
and stipulate to the entry of an Order or file appropriate applications with any Governmental Authority in connection with any of the foregoing and in the case of actions by or with respect to the Company or its Subsidiaries or its or their
businesses or assets, by consenting to such action by the Company; <U>provided</U>, <U>however</U>, that any such action must be conditioned upon consummation of the Mergers and the other transactions contemplated by this Agreement) (each action
contemplated by clauses (i)&nbsp;through (iii) a &#147;<B>Specified Action</B>&#148;); <U>provided</U>, further, that notwithstanding anything to the contrary in this Agreement (including pursuant to this <U>Section</U><U></U><U>&nbsp;6.10(d</U>)),
none of Parent, Acquirer, Merger Sub, Merger Sub II or any other Affiliate of Parent shall be required to take any actions (including any Specified Actions) or propose, negotiate, offer to commit or agree to any restrictions, conditions, restraints
or concessions (including any Specified Actions) that would result in a Burdensome Condition, and none of the Company or any of its Subsidiaries shall take any actions (including any Specified Actions) or propose, negotiate, offer to commit or agree
to any restrictions, conditions, restraints or concessions (including any Specified Actions) that would result in a Burdensome Condition without the prior written consent of Parent. Parent and the Company shall cooperate in good faith in any
proposal, negotiation, or offer to commit and to effect, by consent decree, hold separate order or otherwise, any and all Specified Actions (other than any Specified Action that would result in the imposition of a Burdensome Condition) as may be
required to resolve any Governmental Authority&#146;s objections to the Mergers and the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Subject to <U>Section</U><U></U><U>&nbsp;6.10(d)</U>, in the event that any Proceeding is commenced challenging the Mergers and the other
transactions contemplated by this Agreement and such Proceeding seeks, or would reasonably be expected to seek, to prevent consummation of the Mergers and the other transactions contemplated by this Agreement, each of the Company, Parent, Acquirer,
Merger Sub and Merger Sub II shall use reasonable best efforts to cooperate with each other to contest any such Proceeding and to have vacated, lifted, reversed or overturned any decree, judgment, injunction or other Order, whether temporary,
preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the Mergers and the other transactions contemplated by this Agreement, which reasonable best efforts shall not, for the avoidance of doubt, include
proposing, negotiating, offering to commit or agreeing to commit any Specified Action that would result in a Burdensome Condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) None of Parent, Acquirer, Merger Sub or Merger Sub II shall, nor shall they permit any
of their respective Subsidiaries or controlled Affiliates to, acquire or agree to acquire any rights, assets, business, Person or division thereof (through acquisition, license, joint venture, collaboration or otherwise), if such acquisition would
reasonably be expected to (x)&nbsp;impose any material delay in the obtaining of, or materially increase the risk of not obtaining any applicable clearance, consent, approval, waiver, waiting period expiration or termination, <FONT
STYLE="white-space:nowrap">non-action</FONT> or other authorization, (y)&nbsp;materially increase the risk of any Governmental Authority entering an Order prohibiting the transactions contemplated by this Agreement, or (z)&nbsp;materially delay the
consummation of the transactions contemplated by this Agreement to a date after the End Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Parent and the Company shall jointly
(i)&nbsp;direct, devise and implement the strategy for obtaining any necessary approval of, for responding to any request from, inquiry or investigation by, and in connection with all meetings and communications (including any negotiations) with,
any Governmental Authority that has authority to enforce any Antitrust Law and (ii)&nbsp;control the defense and settlement of any Proceeding brought by or before any Governmental Authority that has authority to enforce any Antitrust Law; provided
that, in the event of a dispute regarding the appropriate course of action regarding the foregoing or any matter contemplated by this <U>Section</U><U></U><U>&nbsp;6.10</U>, Parent shall be entitled to make the final determination after considering
in good faith the view of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11 <I><U>Transaction Litigation</U></I>. The Company shall as promptly as
reasonably practicable notify Parent in writing of, and shall give Parent a reasonable opportunity to participate in the defense and settlement of, any Transaction Litigation. For purposes of this Section&nbsp;6.11, &#147;participate&#148; means
that the Company shall keep Parent reasonably apprised of the proposed strategy and other significant decisions with respect to any Transaction Litigation, including by providing Parent copies of all documents relating to or arising out of any such
Transaction Litigation, including all correspondence among the parties or other participants thereto (to the extent that the attorney-client privilege is not undermined or otherwise adversely affected), and Parent may offer comments or suggestions
with respect to such Transaction Litigation which the Company shall consider in good faith. Without otherwise limiting or expanding the Indemnified Parties&#146; rights with regard to the right to counsel, following the Effective Time, the
Indemnified Parties shall be entitled to continue to retain Goodwin Procter LLP, Dechert LLP or such other counsel selected by such Indemnified Parties prior to the Effective Time to defend any Transaction Litigation. Notwithstanding anything to the
contrary herein, the Company may not compromise, settle or come to an arrangement regarding, or agree to compromise, settle or come to an arrangement regarding, any Transaction Litigation unless Parent has consented thereto in writing (which consent
shall not be unreasonably withheld, conditioned or delayed). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12 <I><U>Public Announcements</U></I>. The initial press
release relating to the execution of this Agreement shall be in a form agreed by the Company and Parent, and thereafter Parent and the Company shall communicate, cooperate and consult with each other before issuing any press release or making any
other public announcements, or scheduling a press conference or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conference call with investors or analysts, with respect to this Agreement or the transactions contemplated by this Agreement and shall not issue any such press release or make any such other
public announcement without the prior written consent of the other party, which shall not be unreasonably withheld, conditioned or delayed, except as such release or announcement may be required by Applicable Law or any listing agreement under which
or rule of any national securities exchange or association upon which the securities of the Company or Parent are listed, in which case the party required to make the release or announcement shall use reasonable best efforts to consult with the
other party about, and allow the other party reasonable time (taking into account the circumstances) to comment on, such release or announcement in advance of such issuance; <U>provided</U>, <U>however</U>, that notwithstanding the foregoing and for
the avoidance of doubt, neither the Company nor Parent shall be required to consult with each other before (A)&nbsp;issuing any press release or making any other public statement (x)&nbsp;(1) in the case of the Company, with respect to an Adverse
Recommendation Change effected in accordance with <U>Section</U><U></U><U>&nbsp;6.03</U> or (2)&nbsp;in the case of Parent, with respect to any Adverse Recommendation Change or an Acquisition Proposal that is publicly disclosed, or (y)&nbsp;as
otherwise expressly permitted under <U>Section</U><U></U><U>&nbsp;6.03</U>, (B) disseminating any communications so long as such communications are consistent with previous releases, public disclosures, public statements or other communications made
by the parties not in violation of this <U>Section</U><U></U><U>&nbsp;6.12</U> or (C)&nbsp;making any filing or other communication made as part of any Proceeding between the parties to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13 <I><U>Section 16 Matters</U></I>. Prior to the Effective Time, the Company shall take all such steps as may be reasonably
required to cause any dispositions of equity securities of the Company (including derivative securities) resulting from the transactions contemplated by this Agreement by each individual who is subject to the reporting requirements of
Section&nbsp;16(a) of the Exchange Act with respect to the Company to be exempt under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.14 <I><U>Confidentiality</U></I>. Parent and the Company hereby agree to continue to be bound by the letter agreement dated as
of October&nbsp;23, 2024 between Clearwater Analytics, LLC and the Company (the &#147;<B>Confidentiality Agreement</B>&#148;), except for Section&nbsp;8 of the Confidentiality Agreement, which shall be of no further force or effect upon the
execution and delivery of this Agreement; provided, that (a)&nbsp;with respect to the Debt Financing Sources, the provisions of the Confidentiality Agreement shall not apply and the applicable provisions of <U>Section</U><U></U><U>&nbsp;6.18</U>
shall instead govern with respect to the Debt Financing Sources and (b)&nbsp;any equity financing sources of Parent shall be deemed to be Representatives (as defined in the Confidentiality Agreement) of Parent for all purposes under the
Confidentiality Agreement. Subject to <U>Section</U><U></U><U>&nbsp;6.18</U>, all information provided by or on behalf of the Company or its Subsidiaries pursuant to this Agreement will be kept confidential in accordance with the Confidentiality
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.15 <I><U>Listing Matters</U></I>. Each of the Company and Parent agrees to cooperate with the other party and
use reasonable best efforts to take, or cause to be taken, all action necessary to delist the shares of Class&nbsp;A Common Stock from NYSE as promptly as practical after the Effective Time and terminate the Company&#146;s registration under the
Exchange Act as promptly as practical after such delisting. Parent shall use reasonable best efforts to cause the Parent Class&nbsp;A Common Stock to be issued pursuant to and in accordance with this Agreement to be approved for listing (subject, if
applicable, to notice of issuance) for trading on the NYSE prior to the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.16 <I><U>Tax Matters</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Transfer Taxes</U>. All transfer, documentary, sales, use, stamp, registration and other similar Taxes (including penalties and
interest) incurred in connection with the Mergers and imposed on the Company and its Subsidiaries shall be paid by or on behalf of Parent, the Surviving Corporation, Merger Sub or Merger Sub II, when due and payable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Intended Tax Treatment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Subject to <U>Section</U><U></U><U>&nbsp;6.16(b)(ii)</U>, for U.S. federal income tax purposes, the parties hereto intend
that (A)&nbsp;the Merger and Second Merger constitute a single integrated transaction that qualifies as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code and the Treasury Regulations promulgated thereunder,
(B)&nbsp;Parent, Acquirer, Merger Sub and the Company each be a party to the reorganization within the meaning of Section&nbsp;368(b) of the Code, and (C)&nbsp;this Agreement constitutes a &#147;plan of reorganization&#148; for purposes of Sections
354, 361 and 368 of the Code and within the meaning of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-2(g)</FONT> (subclauses (A)&nbsp;through (C) collectively, the &#147;<B>Intended Tax Treatment</B>&#148;). In this
regard, each party acknowledges that it has not sought and will not seek any rulings from the Internal Revenue Service or any other Governmental Authority regarding the Tax treatment of the Corporate Mergers and that there can be no assurance the
Internal Revenue Service, any other Governmental Authority or a court will not take a contrary position to the Intended Tax Treatment for the Corporate Mergers. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding anything to the contrary contained in this Agreement, none of Parent, Acquirer or any of their respective
direct or indirect Subsidiaries shall be required to consummate the Second Merger unless each of the Second Merger Conditions shall have been satisfied as of the Closing Date, but prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Cooperation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Each of Parent, Acquirer, Merger Sub, Merger Sub II, and the Company shall (and shall cause its respective direct or
indirect Subsidiaries to) use commercially reasonable efforts and shall cooperate with one another to obtain the Closing Tax Opinions regarding the U.S. federal income tax treatment of the transactions contemplated by this Agreement, which
cooperation shall include, for the avoidance of doubt, the delivery by Parent, Acquirer, Merger Sub, Merger Sub II and the Company of duly executed certificates containing such representations, warranties and covenants as may be reasonably necessary
or appropriate to enable such counsel to render any such opinion(s) (each, an &#147;<B>Officer</B><B>&#146;</B><B>s Certificate</B>&#148;), but which shall exclude, for the avoidance of doubt, making any material amendments to this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Subject to <U>Section</U><U></U><U>&nbsp;6.16(b)(ii)</U>, none of
Parent, Acquirer, Merger Sub, or Merger Sub II shall take any action or fail to take any action, and shall cause their direct or indirect Subsidiaries not to take any action or fail to take any action, in each case, that would reasonably be expected
to cause the Corporate Mergers to fail to qualify for the Intended Tax Treatment (including, for the avoidance of doubt, an action or inaction that would cause it to be unable to deliver the applicable Officer&#146;s Certificate described in
<U>Section</U><U></U><U>&nbsp;6.16(c)(i)</U>). Each party shall (and shall cause its direct or indirect Subsidiaries to) report the transactions contemplated by this Agreement in a manner consistent with the Intended Tax Treatment, except as
otherwise required pursuant to a &#147;determination&#148; under Section&nbsp;1313 of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Each party hereto
shall use reasonable best efforts to comply with requests made by the other parties to determine the qualification of the Corporate Mergers for the Intended Tax Treatment. Such efforts shall include, if applicable, providing an executed version of
the applicable Officer&#146;s Certificate described in <U>Section</U><U></U><U>&nbsp;6.16(c)(i)</U> to permit the applicable party&#146;s tax counsel to deliver the Closing Tax Opinions, provided that such Officer&#146;s Certificate may be modified
to reflect any alterations to the transactions since the date hereof, but provided that a party shall only be required to deliver an applicable Officer&#146;s Certificate to the extent the applicable party believes in good faith such representations
and warranties are true and correct. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Each party acknowledges and agrees that their respective specific obligations to
effect the Second Merger are subject to (A)&nbsp;the qualification of the Corporate Mergers for the Intended Tax Treatment, and (B)&nbsp;the delivery of the Closing Tax Opinions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) Each party acknowledges and agrees that their respective specific obligations to effect the Merger and the LLC Merger are
not subject to any condition or contingency with respect to (A)&nbsp;the qualification of the Corporate Mergers for the Intended Tax Treatment, or (B)&nbsp;the delivery of the Closing Tax Opinions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) The provisions of this <U>Section</U><U></U><U>&nbsp;6.16(c)</U> (other than clause (v)&nbsp;and (vi)) shall no longer
apply if the parties are unable to jointly determine in good faith, after consultation with their respective tax advisors, that the Corporate Mergers will qualify for the Intended Tax Treatment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Closing Date Rule Methodology</U>. Solely in connection with the delivery of the Closing Date Opinions, the parties hereto acknowledge
and agree that for purposes of determining the value of the Final Parent Stock Price to be received by stockholders of the Company pursuant to the transactions contemplated by this Agreement under Revenue Procedure
<FONT STYLE="white-space:nowrap">2018-12,</FONT> <FONT STYLE="white-space:nowrap">2018-6</FONT> I.R.B 349 (&#147;<B>Rev. Proc. <FONT STYLE="white-space:nowrap">2018-12</FONT></B>&#148;), (i) the &#147;Safe Harbor Valuation Method&#148; within the
meaning of Rev. Proc. <FONT STYLE="white-space:nowrap">2018-12</FONT> will be the Average of the Daily Volume Weighted Average Prices as described in Section&nbsp;4.01(1) of Rev. Proc. <FONT STYLE="white-space:nowrap">2018-12;</FONT> (ii) the
&#147;Measuring Period&#148; within the meaning of Section&nbsp;4.02 of Rev. Proc. <FONT STYLE="white-space:nowrap">2018-12</FONT> will be the <FONT STYLE="white-space:nowrap">ten-trading</FONT> day period ending on the second to last trading day
prior to the Closing Date; (iii)&nbsp;the &#147;specified exchange&#148; within the meaning of Section&nbsp;3.01(4)(a)(ii) of Rev. Proc. <FONT STYLE="white-space:nowrap">2018-12</FONT> will be NYSE; and (iv)&nbsp;the &#147;authoritative reporting
source&#148; within the meaning of Section&nbsp;3.01(4)(a)(ii) of Rev. Proc. <FONT STYLE="white-space:nowrap">2018-12</FONT> will be Bloomberg L.P (or, if not available, in another authoritative source mutually selected by the Company and Parent).
Solely in connection with the delivery of the Closing Date Opinions, the parties further agree that the valuation of Parent Class&nbsp;A Common Stock by reference to the methodology described in this <U>Section</U><U></U><U>&nbsp;6.16(d)</U> is
intended to qualify for the &#147;Safe Harbor Valuation Method&#148; within the meaning of Section&nbsp;4.01 of Rev. Proc. <FONT STYLE="white-space:nowrap">2018-12,</FONT> and no party shall take any position for Tax purposes inconsistent therewith,
except to the extent otherwise required pursuant to a &#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.17 <I><U>Parent Financing</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of Parent and Clearwater LLC shall use its reasonable best efforts to, and shall cause each of its Subsidiaries and Representatives
to use reasonable best efforts to, take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable to arrange, obtain and consummate the Debt Financing on the terms and subject only to the conditions
described in the Debt Commitment Letter and/or the Debt Fee Letter as promptly as reasonably practicable but in any event prior to the Closing Date, including using reasonable best efforts to: (i)&nbsp;maintain in full force and effect the Debt
Commitment Letter until the Closing or earlier funding of the Debt Financing contemplated thereby and, to the extent entered into prior to the Closing, the Definitive Agreements in accordance with the terms and subject to the conditions thereof,
(ii)&nbsp;satisfy (or, if deemed advisable by Parent, obtain the waiver of) on a timely basis all conditions to funding in the Debt Commitment Letter that are applicable to the Parent and its Affiliates that are within its or their control,
(iii)&nbsp;negotiate and enter into definitive agreements with respect to the Debt Financing (&#147;<B>Definitive Agreements</B>&#148;) consistent with the terms and conditions contained therein (including, as necessary, the &#147;flex&#148;
provisions contained in any Debt Fee Letter) and (iv)&nbsp;consummate the Debt Financing at or prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent and
Clearwater LLC shall not, without the prior written consent of the Company,&nbsp;permit, consent to or agree to any termination of or amendment, restatement, replacement, supplement or modification to be made to, or grant any waiver of any provision
under, the Debt Commitment Letter if such amendment, restatement, replacement, supplement, modification or waiver (i)&nbsp;reduces (or would reasonably be expected to have the effect of reducing) the aggregate amount of the Debt Financing to an
amount less than, when taken together with cash on hand of Parent and the Company, the Required Amount, (ii)&nbsp;imposes new or additional conditions precedent to the funding of the Debt Financing, or otherwise expands any of the existing
conditions precedent to the funding of the Debt Financing, in each case that would reasonably be expected to materially delay or prevent the Closing, (iii)&nbsp;would reasonably be expected to materially delay or prevent the Closing or make less
likely to occur the funding of the Debt Financing (or satisfaction of the conditions to the Debt Financing) on the Closing Date or (iv)&nbsp;would reasonably be expected to have a material adverse impact on the ability of Parent (or its Affiliate
party thereto) to enforce its rights against other parties to the Debt Commitment Letter (the effects described in <U>clauses (i)</U>&nbsp;through <U>(iv)</U>, collectively, &#147;<B>Prohibited Modifications</B>&#148;). Notwithstanding the
foregoing, any amendment, amendment and restatement, supplement or modification to effectuate any &#147;market flex&#148; terms contained in the Debt Commitment Letter or the Debt Fee Letter or to add any additional agents or other financial
institutions thereto as provided for therein shall be permitted and shall not require written consent of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Upon prior
written request by the Company, Parent shall keep the Company informed on a reasonably current basis and in reasonable detail of the status of the Debt Financing. Parent shall promptly notify the Company in writing if at any time prior to the
Closing Date (i)&nbsp;the Debt Commitment Letter is terminated for any reason, (ii)&nbsp;any Person party to the Debt Commitment Letter indicates in writing that it will not provide, or it refuses to provide, all
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or any portion of the Debt Financing, (iii)&nbsp;Parent (or its Affiliate party to the Debt Commitment Letter) or, to the knowledge of Parent, any other Person party to the Debt Commitment Letter
materially defaults or materially breaches any of the terms or conditions set forth in the Debt Commitment Letter or (iv)&nbsp;Parent (or its Affiliate party to the Debt Commitment Letter) receives any written notice or other written communication
with respect to any (A)&nbsp;early termination of, repudiation by any Person party to or material default or material breach under the Debt Commitment Letter or (B)&nbsp;material dispute or disagreement between or among any Persons party to the Debt
Commitment Letter with respect to the obligation to fund the Debt Financing at the Closing in an amount necessary to fund the Required Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If any portion of the Debt Financing becomes unavailable on the terms and conditions (including any applicable market &#147;flex&#148;
provisions) contemplated by the Debt Commitment Letter and such portion is necessary to fund the Required Amount (after taking into account the amount of cash on hand of Parent and the Company), Parent shall promptly notify the Company in writing
and Parent shall use its reasonable best efforts to arrange and obtain, as promptly as practicable, alternative financing from the same or alternative sources in an amount sufficient to fund the Required Amount (after taking into account the amount
of cash on hand of Parent and the Company) (&#147;<B>Alternative Debt Financing</B>&#148;), which Alternative Debt Financing (i)&nbsp;shall be on terms (taken as a whole) not materially less favorable to Parent (or its Affiliates party thereto) than
those set forth in the Debt Commitment Letter and (ii)&nbsp;shall not add any conditions to the funding of such Alternative Debt Financing that are not contained in the Debt Commitment Letter or include any conditions to the funding of such
Alternative Debt Financing that are more onerous than the conditions set forth in the Debt Commitment Letter; <U>provided</U>, that in no event shall Parent be required to pay any fees in excess of those contemplated by the Debt Commitment Letter
and the Debt Fee Letter (including any applicable market &#147;flex&#148; provisions), each as in effect on the date hereof. Parent shall deliver to the Company true and complete copies of any commitment letters (including related fee letters,
subject to redaction of pricing, fee amounts, &#147;price flex&#148; and other customary &#147;market flex&#148; none of which redacted provisions would be reasonably expected to adversely affect the conditionality, availability, aggregate principal
amount or termination of the Alternative Debt Financing) with respect to any Alternative Debt Financing. For purposes of this Agreement, references to (A) &#147;Debt Financing&#148; shall include the financing contemplated by any Alternative Debt
Financing and (B) &#147;Debt Commitment Letter&#148; shall include any commitment letter or other binding documentation with respect to any Alternative Debt Financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.18 <I><U>Financing Cooperation</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Closing, the Company shall use its reasonable best efforts to, and shall cause its Subsidiaries and Representatives to use
their reasonable best efforts to, provide such cooperation as is customary, required and reasonably requested by Parent in connection with the obtaining and arranging of the Debt Financing, including using reasonable best efforts to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) participate (and cause management of the Company, with appropriate seniority and expertise, to participate) in a reasonable
number of meetings (including meetings with existing or prospective Debt Financing Sources), presentations, road shows, due diligence sessions and sessions with rating agencies, at reasonable and mutually agreed times and with reasonable advance
notice; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) provide reasonable and customary assistance with the preparation of
(A)&nbsp;bank information memoranda and similar documents reasonably requested by Parent as required for any portion of the Debt Financing, (B)&nbsp;materials for rating agency presentations and (C)&nbsp;any confidential information memoranda,
marketing materials, lender presentations and similar documents reasonably requested by Parent as required in connection with the Debt Financing, including customary authorization and representation letters duly executed on behalf of the Company
and/or its Subsidiaries authorizing the distribution of information relating to the Company and its Subsidiaries to prospective lenders and containing representations with respect to the presence of or absence of material <FONT
STYLE="white-space:nowrap">non-public</FONT> information relating to the Company and its Subsidiaries and the accuracy of the information relating to the Company and its Subsidiaries contained therein (which authorization and representation letters
will become effective before the Effective Time), in each case, in form and substance reasonably acceptable to Parent and the Company (such authorization letters, the &#147;<B>Authorization Letters</B>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) to the extent reasonably requested by Parent, facilitate the pledging of, granting security interest in and obtaining
perfection of security interests in, collateral, effective no earlier than the Effective Time; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) cooperate with the
marketing efforts of Parent and its Debt Financing Sources; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) furnish to Parent as promptly as reasonably practicable
following the delivery of a written request therefor to the Company by Parent (which notice shall state with specificity the information requested)&nbsp;(A) the Required Financial Information and (B)&nbsp;such financial and other pertinent
information regarding the Company and its Subsidiaries as is reasonably requested by Parent or the Debt Financing Sources in connection with the Debt Financing, including any such information necessary for Parent to prepare pro forma financial
statements required in connection with the Debt Financing, in each case, as is customarily required in connection with financings of a type similar to the Debt Financing (<U>provided</U> that none of the Company, its Subsidiaries and their
respective Representatives shall be required to provide or prepare the pro forma financial statements or required to provide or prepare, or provide any assistance or information relating to, (x)&nbsp;the proposed post-Closing debt and equity
capitalization of the Company and its Subsidiaries and (y)&nbsp;any post-Closing or pro forma cost savings, synergies or other pro forma adjustments desired to be incorporated into any information used in connection with the Debt Financing); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) following Parent&#146;s request, cause directors and officers who will continue to hold such offices and positions from
and after the Effective Time to execute and provide resolutions or consents of the Company and its Subsidiaries with respect to entering into the Definitive Agreements and otherwise as necessary to authorize consummation of the Debt Financing;
<U>provided</U> that no such resolution or consent shall become effective until the Effective Time; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) furnish to Parent at least two (2)&nbsp;Business Days prior to the
Closing Date, all documentation and other information required by regulatory authorities under applicable &#147;know your customer&#148; and anti-money laundering rules and regulations, including the PATRIOT Act 31 C.F.R. &#167;1010.230, relating to
the Company or any of its Subsidiaries, in each case as reasonably requested by Parent at least ten (10)&nbsp;Business Days prior to the Closing Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) assist in providing information regarding the Company and its Subsidiaries necessary for the preparation of, and
executing, the Definitive Agreements (including one or more credit agreements, security agreements, mortgages and/or guarantees and the schedules and exhibits thereto) in connection with the Debt Financing or other customary certificates or
documents and <FONT STYLE="white-space:nowrap">back-up</FONT> certificate for legal opinions in connection with the Debt Financing as may reasonably be requested by Parent as required in connection with the Debt Financing, in each case, to be held
in escrow pending release by the Company at, and subject to the occurrence of, the Effective Time; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) deliver notices
(within the time periods required by the Company Credit Agreement) required for the prepayment of all obligations under, and the termination and the release of guarantees and liens granted under, the Company Credit Agreement and take action required
by <U>Section</U><U></U><U>&nbsp;2.09</U>; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) to the extent reasonably requested by Parent, provide reasonable
cooperation with the existing or prospective Debt Financing Sources&#146; due diligence to the extent customary in connection with financings similar to the Debt Financing and to (A)&nbsp;ensure that the syndication efforts with respect to the Debt
Financing benefit materially from the existing lending and investment banking relationships of the Company and (B) cooperate with Parent in satisfying the conditions precedent to the Debt Financing (to the extent related to the Company and its
Subsidiaries and to the extent the satisfaction of such condition requires the cooperation of, and is within the control of, the Company or its Subsidiaries). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything herein to the contrary, (i)&nbsp;no directors, managers or officers of the Company or its Affiliates (other than
any director, manager or director who is continuing as a director, manager or officer of any the Company or its Subsidiaries following the consummation of the transactions contemplated hereby) shall be required to pass resolutions or consents to
approve or authorize the execution or delivery of the Debt Financing or to execute, deliver or enter into, or perform any obligations under, any agreement, certificate, arrangement, document or instrument with respect to the Debt Financing (other
than the Authorization Letters to be delivered pursuant to <U>Section</U><U></U><U>&nbsp;6.18(a)(ii)</U> and prepayment and termination notices to be delivered pursuant to <U>Section</U><U></U><U>&nbsp;6.18(a)(ix)</U>), (ii) no obligation of the
Company, its Affiliates or any of their respective Representatives arising in connection with the Company&#146;s, its Affiliates&#146; or any of their respective Representatives&#146; cooperation undertaken pursuant to the foregoing shall be
effective until the Closing other than the Authorization Letters to be delivered pursuant to <U>Section</U><U></U><U>&nbsp;6.18(a)(ii)</U> and prepayment and termination notices to be delivered pursuant to
<U>Section</U><U></U><U>&nbsp;6.18(a)(ix)</U>, and (iii)&nbsp;none of the Company, its Affiliates or any of their respective Representatives shall be required to (A)&nbsp;pay any commitment or other similar fee in connection with the Debt Financing
or incur any other cost or expense that is not promptly reimbursed by Parent in connection with the Debt Financing, other than, with respect to the Company and its Subsidiaries, obligations under the Debt Financing effective from and after the
Effective Time<U>,</U> (B)&nbsp;take any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
actions to the extent such actions would unreasonably interfere with the ongoing business or operations of the Company or any of its Affiliates, (C)&nbsp;take any actions that would conflict with
or violate the Company&#146;s or any of its Affiliates&#146; organizational documents or in any material respect any Applicable Law, (D)&nbsp;give to any other Person any indemnities in connection with the Debt Financing that are effective prior to
the Closing, (E)&nbsp;disclose or provide any information that is subject to attorney-client privilege or could reasonably be expected to result in the disclosure of any trade secrets or the violation of any confidentiality obligation or
(F)&nbsp;take any actions that would cause any representation or warranty in this Agreement to be breached or that would cause any closing condition set forth in <U>ARTICLE VII</U> to fail to be satisfied or that would otherwise cause a breach of
this Agreement. Nothing contained in this <U>Section</U><U></U><U>&nbsp;6.18</U> or otherwise shall require the Company or its Affiliates to be an issuer or other obligor with respect to the Debt Financing prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In no event shall the receipt or availability of any funds or financing (including the Debt Financing) by Parent or any of its Affiliates
or any other financing or other transactions be a condition to any of obligations of Parent, Acquirer, Merger Sub or Merger Sub II under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent shall, promptly upon request by the Company, reimburse the Company for all reasonable and documented
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred by the Company, its Affiliates or their respective Representatives in connection with such cooperation by the Company or any of
its Affiliates contemplated by this <U>Section</U><U></U><U>&nbsp;6.18</U>; <U>provided</U>, that, that the Company, and not Parent, shall be responsible for (i)&nbsp;fees, costs and expenses incurred by, or on behalf of, the Company or any of its
Affiliates in connection with their ordinary course financial reporting requirements and (ii)&nbsp;fees, costs and expenses incurred in connection with the preparation of historical financial statements that are or would be prepared in the ordinary
course of business regardless of the Debt Financing. Parent shall indemnify and hold harmless the Company, its Affiliates and their respective Representatives for and against any and all liabilities, losses, obligations, damages, costs and expenses
of any kind (whether direct or indirect, known or unknown, asserted or unasserted, absolute or contingent, accrued or unaccrued, liquidated or unliquidated, due or to become due and whether in contract, tort, strict liability or otherwise) suffered
or incurred by them in connection with the arrangement of the Debt Financing, including the cooperation of the Company and its Subsidiaries contemplated by this <U>Section</U><U></U><U>&nbsp;6.18</U>, except, in each case, (i)&nbsp;with respect to
any financial statements or information provided by or on behalf of the Company, its Affiliates or their respective Representatives, (ii)&nbsp;to the extent resulting from the breach of this Agreement by the Company, its Affiliates or their
respective Representatives or from the bad faith, gross negligence, fraud or willful misconduct of the Company, its Affiliates or their respective Representatives or (iii)&nbsp;with respect to any material misstatement or omission of a material fact
in information provided hereunder in writing by or on behalf of the Company, its Affiliates or their respective Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) All <FONT
STYLE="white-space:nowrap">non-public</FONT> or otherwise confidential information regarding the Company or its Affiliates obtained by Parent, Acquirer, Merger Sub or Merger Sub II or their Representatives pursuant to
<U>Section</U><U></U><U>&nbsp;6.18(a)</U> shall be kept confidential in accordance with the Confidentiality Agreement, except that Parent and its Representatives shall be permitted to disclose such information to existing or prospective Debt
Financing Sources, investors and rating agencies, subject to such Debt Financing Sources, investors and rating agencies entering into customary confidentiality undertakings with respect to such information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company hereby consents to the use of its and its Subsidiaries&#146; logos in
connection with the Debt Financing; <U>provided</U>, that such logos are used solely in a manner that is not reasonably likely to harm or disparage the Company or its Subsidiaries in any respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Solely to the extent that the Closing Date occurs on or after May&nbsp;30, 2025, prior to the Closing, the Company shall promptly deliver
(or cause to be delivered) to Parent the consolidated financial statements of the Company and its Subsidiaries included in its Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ending March&nbsp;31,&nbsp;2025.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.19 <I><U>Conduct of Parent</U></I>. Except for matters (a)&nbsp;required, expressly permitted or expressly contemplated by
this Agreement, (b)&nbsp;set forth in <U>Section</U><U></U><U>&nbsp;6.19</U> of the Parent Disclosure Schedule, (c)&nbsp;required by Applicable Law or (d)&nbsp;undertaken with the prior written consent of the Company (which consent shall not be
unreasonably withheld, conditioned or delayed and provided that the failure of the Company to respond to a request in writing for consent within five Business Days after receipt thereof shall be deemed to constitute consent), Parent shall not, and
shall cause each of its Subsidiaries not to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) amend Parent&#146;s certificate of incorporation or <FONT
STYLE="white-space:nowrap">by-laws</FONT> in a manner that would (A)&nbsp;materially and adversely affect the holders of Class&nbsp;A Common Stock or holders of Common Units or (B)&nbsp;materially and disproportionately adverse to the holders of
Class&nbsp;A Common Stock or holders of Common Units relative to the treatment of existing holders of Parent Common Stock; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) (A) declare, set aside or pay any dividends on, or make any other distributions (whether in cash, stock or equity
interests, property or otherwise) in respect of any capital stock of Parent; or (B)&nbsp;modify or repeal the terms of any shares of the capital stock or voting interest of Parent; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) split, combine, adjust, subdivide or reclassify any capital stock or other equity interest or voting interest of Parent;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) with respect to Parent, agree to a complete or partial liquidation or dissolution, merger, consolidation,
restructuring, recapitalization or other reorganization of Parent; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) authorize, resolve, or enter into any binding
commitment to take any of the foregoing action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.20 <I><U>Notice of Certain Events</U></I><I><U>.</U></I> Each of the
Company and Parent will give prompt notice to the other (and will subsequently keep the other informed on a reasonably current basis of any material developments related to such notice) upon its becoming aware of the occurrence or existence of any
fact, event or circumstance that (a)&nbsp;with respect to the Company, has had or would reasonably be expected have a Company Material Adverse Effect, (b)&nbsp;with respect to Parent, Acquirer, Merger Sub or Merger Sub II, has had or would
reasonably be expected to have a Parent Material Adverse Effect or (c)&nbsp;is reasonably likely to result in any of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the conditions set forth in <U>ARTICLE VII</U> not being able to be satisfied prior to the End Date. No notification given by any party pursuant to this <U>Section</U><U></U><U>&nbsp;6.20</U>
shall limit or otherwise affect any of the representations, warranties, covenants, obligations or conditions contained in this Agreement. Any failure to give notice in accordance with the foregoing shall not, in and of itself, be deemed to
constitute the failure of any condition set forth in <U>ARTICLE VII</U> or the basis for any condition set forth in <U>ARTICLE VII</U> not to be satisfied, or otherwise constitute a breach of this Agreement by the party failing to give such notice,
in each case unless the underlying breach would independently result in a failure of the conditions set forth in <U>ARTICLE VII</U> to be satisfied. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS
TO THE MERGERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01 <I><U>Conditions to the Obligations of Each Party</U></I>. Subject to Section&nbsp;7.01(e), the
obligation of each party hereto to consummate the Mergers is subject to the satisfaction or, to the extent permitted by Applicable Law, waiver by such party, at or prior to Closing, of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Stockholder Approval shall have been obtained; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) no Governmental Authority having jurisdiction over the transactions contemplated hereby shall have issued any Order or other action that
is in effect (whether temporary, preliminary or permanent) restraining, enjoining or otherwise prohibiting the consummation of the Mergers and no Applicable Law that makes consummation of the Mergers illegal or otherwise prohibited shall be in
effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the applicable waiting period (and any extension thereof) applicable to the Mergers under the HSR Act, and any agreement with
any Governmental Authority not to consummate the Merger, shall have expired or been validly terminated (the &#147;<U>Regulatory Approval</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) the Form <FONT STYLE="white-space:nowrap">S-4</FONT> shall have become effective under the Securities Act and no stop order suspending the
effectiveness of the Form <FONT STYLE="white-space:nowrap">S-4</FONT> shall have been issued; the Parent Class&nbsp;A Common Stock to be issued pursuant to and in accordance with this Agreement to be approved for listing (subject, if applicable, to
notice of issuance) for trading on the NYSE; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) solely with respect to the Second Merger, each of the Second Merger Conditions shall
have been satisfied (and for the avoidance of doubt, this <U>Section</U><U></U><U>&nbsp;7.01(e)</U> shall not be a condition to the consummation of either the Merger or the LLC Merger in accordance with the terms hereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02 <I><U>Conditions to the Obligations of Parent, Acquirer, Merger Sub and Merger Sub II</U></I>. The obligation of Parent,
Acquirer, Merger Sub and Merger Sub II to consummate the Mergers is subject to the satisfaction, or waiver by Parent, at or prior to Closing, of the following conditions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) the representations and warranties of the Company set forth in the first and second
sentences of <U>Sections 4.01</U> (<I>Corporate Existence and Power</I>), <U>Section</U><U></U><U>&nbsp;4.02</U> (<I>Corporate Authorization</I>), <U>Section</U><U></U><U>&nbsp;4.05</U> (<I>Capitalization</I>) (other than
<U>Section</U><U></U><U>&nbsp;4.05(a)</U> and <U>Section</U><U></U><U>&nbsp;4.05(b)</U>), <U>Section</U><U></U><U>&nbsp;4.24</U> (<I>Brokers</I><I>&#146;</I><I> Fees</I>), and <U>Section</U><U></U><U>&nbsp;4.26</U> (<I>Anti-Takeover Provisions</I>)
shall be true and correct in all material respects (disregarding for this purpose all &#147;Company Material Adverse Effect,&#148; &#147;materiality&#148; and similar qualifications contained in such representations and warranties) as of the date of
this Agreement and on the Closing Date as if made on such date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all
material respects only as of such earlier date), (ii) the representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;4.05(a)</U> and <U>Section</U><U></U><U>&nbsp;4.05(b)</U> (<I>Capitalization</I>) shall be true and
correct as of the date of this Agreement and on the Closing Date as if made on such date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be
true and correct only as of such earlier date), except where the failure to be so true and correct would not reasonably be expected to result in additional cost, expense or liability to Parent that would be more than <I>de minimis</I>,
(iii)&nbsp;the representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;4.09(b)</U> (<I>Absence of Certain Changes</I>) shall be true and correct in all respects as of the date of this Agreement and on the Closing
Date as if made on such date and (iv)&nbsp;the other representations and warranties of the Company set forth in <U>ARTICLE IV</U> shall be true and correct (disregarding for this purpose all &#147;Company Material Adverse Effect,&#148;
&#147;materiality&#148; and similar qualifications contained in such representations and warranties) as of the date of this Agreement and on the Closing Date as if made on such date (except to the extent that any such representation and warranty
expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct only as of such earlier date), except where the failure of such representations and warranties to be so true and correct would not,
individually or in the aggregate, have a Company Material Adverse Effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Company shall have performed in all material respects
or complied in all material respects with all obligations required to be performed or complied with by it under this Agreement at or prior to the Closing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent shall have received at the Closing a certificate signed on behalf of the Company by an authorized officer of the Company certifying
that the conditions set forth in <U>Sections 7.02(a)</U>, <U>Section</U><U></U><U>&nbsp;7.02(b)</U> and <U>Section</U><U></U><U>&nbsp;7.02(d)</U> have been satisfied; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) no Company Material Adverse Effect shall have occurred since the date hereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) (i) no Burdensome Condition shall be a condition to receipt of the Regulatory Approval, (ii)&nbsp;there shall not be in effect at or upon
the Closing any Order or Applicable Law resulting, individually or in the aggregate, in a Burdensome Condition and (iii)&nbsp;no Regulatory Approval shall contain, include or impose any Burdensome Condition; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) the TRA Amendment shall be in full force and effect in accordance with its terms and otherwise shall not have been amended, repudiated,
revoked or withdrawn. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03 <I><U>Conditions to the Obligations of the Company</U></I>. The obligation of the Company to
consummate the Mergers is subject to the satisfaction, or waiver by the Company, at or prior to Closing, of the following conditions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) the representations and warranties of Parent, Acquirer, Merger Sub and Merger Sub II
set forth in the first and second sentences of <U>Section</U><U></U><U>&nbsp;5.01</U> (<I>Corporate Existence and Power</I>), <U>Section</U><U></U><U>&nbsp;5.02</U> (<I>Corporate Authorization</I>), <U>Section</U><U></U><U>&nbsp;5.05(a)</U>
(<I>Capitalization</I>), <U>Section</U><U></U><U>&nbsp;5.14</U> (<I>Brokers</I><I>&#146;</I><I> Fees</I>) and <U>Section</U><U></U><U>&nbsp;5.20</U> (<I>Anti-Takeover Provisions</I>) shall be true and correct in all material respects (disregarding
for this purpose all &#147;Parent Material Adverse Effect,&#148; &#147;materiality&#148; and similar qualifications contained in such representations and warranties) as of the date of this Agreement and on the Closing Date as if made on such date
(except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects only as of such earlier date), (ii) the
representations and warranties of Parent, Acquirer, Merger Sub and Merger Sub II set forth in <U>Section</U><U></U><U>&nbsp;5.18</U> (<I>Absence of Changes</I>) shall be true and correct in all respects as of the date of this Agreement and on the
Closing Date as if made on such date and (iii)&nbsp;the other representations and warranties of Parent, Acquirer, Merger Sub and Merger Sub II set forth in <U>ARTICLE V</U> shall be true and correct (disregarding for this purpose all &#147;Parent
Material Adverse Effect,&#148; &#147;materiality&#148; and similar qualifications contained in such representations and warranties) as of the date of this Agreement and on the Closing Date as if made on such date (except to the extent that any such
representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct only as of such earlier date), except where the failure of such representations and warranties to be so true
and correct would not, individually or in the aggregate, have a Parent Material Adverse Effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent, Acquirer, Merger Sub and
Merger Sub II shall each have performed or complied in all material respects with all obligations required to be performed or complied with by it under this Agreement at or prior to the Closing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Company shall have received at the Closing a certificate signed on behalf of Parent by an authorized officer of Parent certifying that
the conditions set forth in <U>Sections 7.03(a)</U>, <U>Section</U><U></U><U>&nbsp;7.03(b)</U> and <U>Section</U><U></U><U>&nbsp;7.03(d)</U> have been satisfied; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) no Parent Material Adverse Effect shall have occurred since the date hereof. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01 <I><U>Termination</U></I>. This Agreement may be terminated, and the Mergers may be abandoned at any time prior to the
Closing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by mutual written agreement of the Company and Parent (notwithstanding any approval of this Agreement by the stockholders of
the Company); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by either Parent or the Company, upon written notice to the other party, if the Closing has not occurred on or before
11:59 p.m., New York City time, on July&nbsp;9, 2025 (such time, the &#147;<B>End Date</B>&#148;); <U>provided</U> that, the right to terminate this Agreement under this <U>Section</U><U></U><U>&nbsp;8.01(b)</U> shall not be available to any party
whose material breach of any provision of this Agreement has been the proximate cause of, or has proximately resulted in, the failure of the Mergers to be consummated by the End Date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by either Parent or the Company, upon written notice to the other party, if any
Governmental Authority of competent jurisdiction shall have issued a final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> permanent Order or taken any other action permanently enjoining, restraining or otherwise prohibiting the
consummation of the transactions contemplated by this Agreement and such action shall have become final and <FONT STYLE="white-space:nowrap">non-appealable;</FONT> provided, however, that the right to terminate this Agreement under this
<U>Section</U><U></U><U>&nbsp;8.01(c)</U> shall not be available to any party whose material breach of any provision of this Agreement has been the proximate cause of, or has proximately resulted in, such Order or other action; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by either Parent or the Company, upon written notice to the other party, if the Stockholder Approval has not been obtained at the
Stockholder Meeting (as may be adjourned or postponed thereof in accordance with <U>Section</U><U></U><U>&nbsp;6.04)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by Parent,
upon written notice to the Company, in the event of a breach by the Company of any representation, warranty, covenant or other agreement contained herein that (i)&nbsp;would result in any condition set forth in <U>Section</U><U></U><U>&nbsp;7.02</U>
not being satisfied and (ii)&nbsp;has not been cured prior to the earlier of the End Date or the 30th day following Parent&#146;s delivery of written notice describing such breach to the Company; provided, however, that Parent shall not be entitled
to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.01(e)</U> if either Parent, Acquirer, Merger Sub or Merger Sub II is in breach of its obligations under this Agreement that would result in any condition set forth in
<U>Section</U><U></U><U>&nbsp;7.03</U> not being satisfied; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by the Company, upon written notice to Parent, in the event of a breach
by Parent, Acquirer, Merger Sub or Merger Sub II of any representation, warranty, covenant or other agreement contained herein that (i)&nbsp;would result in any condition set forth in <U>Section</U><U></U><U>&nbsp;7.03</U> not being satisfied and
(ii)&nbsp;has not been cured prior to the earlier of the End Date or the 30th day following the Company&#146;s delivery of written notice describing such breach to Parent; provided, however, that the Company shall not be entitled to terminate this
Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.01(f)</U> if the Company is in breach of its obligations under this Agreement that would result in any condition set forth in <U>Section</U><U></U><U>&nbsp;7.02</U> not being satisfied; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) by Parent, upon written notice to the Company, at any time prior to receipt of the Stockholder Approval, (A)&nbsp;if the Company Board,
acting upon the recommendation of the Special Committee, shall have effected an Adverse Recommendation Change or (B)&nbsp;the Company has committed a material breach of its obligations under <U>Section</U><U></U><U>&nbsp;6.02</U> or
<U>Section</U><U></U><U>&nbsp;6.03</U>; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) by the Company, upon written notice to Parent, at any time prior to receipt of the
Stockholder Approval, if (i)&nbsp;the Company has received a Superior Proposal and (ii)&nbsp;the Company Board or any committee thereof, acting upon the recommendation of the Special Committee, shall have determined to terminate this Agreement in
accordance with <U>Section</U><U></U><U>&nbsp;6.03(b)</U> in order for the Company to enter into a definitive agreement with respect to the applicable Superior Proposal (with such definitive agreement being entered into substantially concurrently
with the termination of this Agreement (but in no case prior to the termination of this Agreement)); provided, however, that the Company shall pay the Company Termination Fee to Parent pursuant to <U>Section</U><U></U><U>&nbsp;9.04</U>, concurrently
with and as a condition to such termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02 <I><U>Effect of Termination</U></I>. If this Agreement is validly
terminated pursuant to <U>Section</U><U></U><U>&nbsp;8.01</U>, this Agreement shall become void and of no effect without liability of any party (or any Representative or <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party of such party) to
each other party hereto; provided, however, that the provisions of (i)&nbsp;this <U>Section</U><U></U><U>&nbsp;8.02</U>, (ii) the last sentence of <U>Section</U><U></U><U>&nbsp;6.05</U>, (iii) the last sentence of
<U>Section</U><U></U><U>&nbsp;6.10(b)</U>, (iv) <U>Section</U><U></U><U>&nbsp;6.14</U> and (v)<U>&nbsp;ARTICLE IX</U> shall survive any termination hereof pursuant to <U>Section</U><U></U><U>&nbsp;8.01</U>. Notwithstanding the foregoing or any other
provision of this Agreement to the contrary, nothing in this Agreement will relieve Parent, Acquirer, Merger Sub, Merger Sub II or the Company from any liability for any fraud or Willful and Material Breach of this Agreement. The parties acknowledge
and agree that any such liability payable by Parent, Acquirer, Merger Sub or Merger Sub II shall not be limited to reimbursement of expenses or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and
may include the benefit of the bargain lost by the Company or the Company&#146;s equity holders due to the Company&#146;s equity holders not receiving their applicable portion of the Aggregate Merger Consideration that such holders would be entitled
to receive pursuant to the terms of this Agreement if the Mergers were consummated in accordance with the terms hereof. Parent, Acquirer, Merger Sub and Merger Sub II expressly acknowledge and agree that, in accordance with Section&nbsp;261(a)(2) of
the DGCL, the Company, at or after the time at which the Agreement is adopted by the stockholders of the Company pursuant to Section&nbsp;251 of the DGCL, shall, in its sole discretion and as a representative of the stockholders of the Company, have
the sole, exclusive and irrevocable authority to take action on behalf of the stockholders of the Company to enforce the rights of such stockholders pursuant to this Agreement. For the avoidance of doubt, the Confidentiality Agreement shall survive
the termination of this Agreement and shall remain in full force and effect in accordance with its terms. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.01 <I><U>Notices</U></I>. Any notices or other communications required or permitted under, or otherwise given in connection
with, this Agreement shall be in writing and shall be deemed to have been duly given (i)&nbsp;when delivered if delivered in person, (ii)&nbsp;on the fifth Business Day after dispatch by registered or certified mail, (iii)&nbsp;on the next Business
Day if transmitted by national overnight courier or (iv)&nbsp;on the date delivered if sent by <FONT STYLE="white-space:nowrap">e-mail</FONT> (provided that no &#147;<B>bounce back</B>&#148; or similar message indicating nondelivery is received with
respect thereto within two hours of dispatch), in each case as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">if to Parent, Acquirer, Merger Sub or Merger Sub II, to:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">777 W. Main Street, Suite 900</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Boise, ID 83702</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Alphonse Valbrune</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">*****</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">with a copy to (which shall not constitute notice):</TD></TR></TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Kirkland&nbsp;&amp; Ellis LLP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">601 Lexington Avenue</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">New York, NY 10022</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Constantine N. Skarvelis, P.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Marshall P. Shaffer, P.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Jimin He</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">*****</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">*****</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">*****</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">if to the Company, to:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Enfusion, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">125 South Clark Street, Suite 750</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Chicago, Illinois 60603</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Matthew R. Campobasso</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">*****</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">with a copy to (which shall not constitute notice):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Dechert LLP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1095 Avenue of the Americas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">New York, NY 10036</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Mark E. Thierfelder</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Eric S. Siegel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Michael S. Darby</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Sarah Kupferman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">E-Mail:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">*****</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">*****</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">*****</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">*****</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">and</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwin Procter LLP</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">620 Eighth Avenue</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, New York 10018</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Attention:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joshua M. Zachariah</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gregg L. Katz</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Ding</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-Mail:</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">*****</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">*****</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">*****</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.02 <I><U>Survival of Representations and Warranties</U></I>. None of the representations,
warranties or covenants in this Agreement or in any certificate delivered pursuant to this Agreement shall survive the Effective Time, except that this <U>Section</U><U></U><U>&nbsp;9.02</U> shall not limit any covenant or agreement of the parties
which by its terms contemplates performance after the Effective Time, which shall survive to the extent expressly provided for herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03 <I><U>Amendments and Waivers</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Any provision of this Agreement may be amended or waived prior to the Effective Time if, but only if, such amendment or waiver is in
writing and is signed, in the case of an amendment, by each party to this Agreement or, in the case of a waiver, by each party against whom the waiver is to be effective; provided, however, that without the further approval of the Company&#146;s
stockholders, no such amendment or waiver shall be made or given after the Stockholder Approval that requires the approval of the stockholders of the Company under the DGCL unless the required further approval is obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any
single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. Except as otherwise expressly provided in this Agreement, the rights and remedies herein provided shall be
cumulative and not exclusive of any rights or remedies provided by Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.04 <I><U>Fees and Expenses</U></I>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise provided in this Agreement, all costs and expenses incurred in connection with this Agreement shall be paid by
the party incurring such cost or expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) this Agreement is validly terminated pursuant to <U>Section</U><U></U><U>&nbsp;8.01(g)</U> (Adverse Recommendation Change; <FONT
STYLE="white-space:nowrap">Non-Solicit</FONT> Breach); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) this Agreement is validly terminated pursuant to
<U>Section</U><U></U><U>&nbsp;8.01(h)</U> (Superior Proposal); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) this Agreement is validly terminated pursuant to
(x)<U>&nbsp;Section</U><U></U><U>&nbsp;8.01(b)</U> (End Date), (y) <U>Section</U><U></U><U>&nbsp;8.01(d)</U> (No Stockholder Approval) or (z)<U>&nbsp;Section</U><U></U><U>&nbsp;8.01(e)</U> (Company Material Breach) and, in each case of clauses (x),
(y) and (z), (A) after the date hereof and prior to the termination of this Agreement, a <I>bona fide</I> Acquisition Proposal is publicly disclosed and not irrevocably withdrawn at least three (3)&nbsp;Business Days prior to the Stockholder Meeting
and (B)&nbsp;within 12 months after the date of such termination, the Company enters into any Acquisition Proposal or consummates any Acquisition Proposal (provided that for purposes of this subsection (iii), each reference to &#147;20% or
more&#148; or &#147;80% or less&#148; in the definition of Acquisition Proposal shall be deemed to be references to &#147;more than 50%&#148; or &#147;less than 50%&#148;, respectively); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then the Company shall pay to Parent the Company Termination Fee by wire transfer of <FONT STYLE="white-space:nowrap">same-day</FONT> funds (x)&nbsp;in the
case of <U>Section</U><U></U><U>&nbsp;9.04(b)(i)</U>, within two Business Days after such termination, (y)&nbsp;in the case of <U>Section</U><U></U><U>&nbsp;9.04(b)(ii)</U>, substantially concurrently with the termination of this Agreement pursuant
to <U>Section</U><U></U><U>&nbsp;8.01(h)</U> and (z)&nbsp;in the case of <U>Section</U><U></U><U>&nbsp;9.04(b)(iii)</U>, substantially concurrently with the entry into a definitive agreement with respect to such Acquisition Proposal or the
consummation of such Acquisition Proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The parties acknowledge and agree that in no event will the Company be required to pay
the Company Termination Fee on more than one occasion, whether or not the Company Termination Fee may be payable pursuant to more than one provision of this Agreement at the same or at different times and upon the occurrence of different events.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event that this Agreement is validly terminated pursuant to <U>Section</U><U></U><U>&nbsp;8.01</U> and Parent receives payment
of the Company Termination Fee pursuant to <U>Section</U><U></U><U>&nbsp;9.04(b)</U> (and the Parent Enforcement Costs, if due and payable), the Company shall have no further liability, whether pursuant to a claim at law or in equity, to Parent,
Acquirer, Merger Sub, Merger Sub II or any of their respective Affiliates or any other Person in connection with this Agreement (and the termination hereof), the transactions contemplated by this Agreement (and the abandonment thereof) or any matter
forming the basis for such termination, and none of Parent, Acquirer, Merger Sub, Merger Sub II or any Parent Related Party shall be entitled to bring or maintain any Proceeding against the Company or any of its Subsidiaries or Affiliates for
damages or any equitable relief arising out of or in connection with this Agreement, any of the transactions contemplated by this Agreement or any matters forming the basis for such termination; <U>provided</U>, that if the Company fails to pay the
Company Termination Fee and Parent, Acquirer, Merger Sub and/or Merger Sub II commences a Proceeding which results in a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment against the Company for the Company Termination Fee or any
portion thereof, then in addition to the payment of the Company Termination Fee, the Company shall pay Parent its reasonable and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses
(including reasonable and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> attorneys&#146; fees) incurred in prosecuting such Proceeding, together with interest on the Company Termination Fee and such
costs and expenses at the &#147;prime rate&#148; (as published in <I>The Wall Street Journal</I>, Eastern Edition, in effect on the date such payment was required to be made) plus 5%, calculated from the date such payment was required to be paid
through the date of payment (calculated daily on the basis of a year of 365 days and the actual number of days elapsed, without compounding) (such amount, the &#147;<B>Parent Enforcement Costs</B>&#148;); provided, that in no event shall Parent
Enforcement Costs exceed $2,000,000. Notwithstanding the foregoing, this <U>Section</U><U></U><U>&nbsp;9.04(d)</U> will not relieve the Company from any liability for fraud. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The parties hereto acknowledge and agree that the agreements contained in this <U>Section</U><U></U><U>&nbsp;9.04</U> are an integral part
of the transactions contemplated hereby, and that, without these agreements, the parties hereto would not enter into this Agreement. Each of the parties hereto further acknowledges that the payment of the Company Termination Fee is not a penalty,
but is liquidated damages in a reasonable amount that will compensate the Parent, Acquirer, Merger Sub and Merger Sub II in the circumstances in which the Company Termination Fee is payable for the efforts and resources expended and the
opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the consummation of the transactions contemplated hereby, which amount would otherwise be impossible to calculate with precision.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.05 <I><U>Assignment; Benefit</U></I>. This Agreement shall not be assigned by any of the parties hereto (whether by
operation of law or otherwise) without the prior written consent of the other parties, except that Parent, Acquirer, Merger Sub and Merger Sub II will have the right to assign all or any portion of their respective rights and obligations pursuant to
this Agreement (i)&nbsp;to any of their respective Affiliates or (ii)&nbsp;to any Debt Financing Source of Parent, Acquirer, Merger Sub or Merger Sub II for purposes of creating a security interest herein as collateral in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect of the Debt Financing, it being understood that, in each case of clauses (i)&nbsp;and (ii), such assignment will not relieve Parent, Acquirer, Merger Sub or Merger Sub II of any of its
obligations hereunder. Notwithstanding anything contained in this Agreement to the contrary, nothing in this Agreement, express or implied, is intended to confer on any Person other than the parties hereto or their respective heirs, successors,
executors, administrators and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except for (a)&nbsp;the rights of the Indemnified Parties as set forth in <U>Section</U><U></U><U>&nbsp;6.09</U> and
<U>Section</U><U></U><U>&nbsp;6.11</U>, (b) the rights of the <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Parties pursuant to <U>Section</U><U></U><U>&nbsp;9.16</U>, (c) the rights of the Debt Financing Related Parties pursuant to
<U>Section</U><U></U><U>&nbsp;9.17</U>, (d) if the Effective Time occurs, the right of the holders of the Class&nbsp;A Common Stock or the Common Units to receive the Merger Consideration and (e)&nbsp;if the Effective Time occurs, the right of the
holders of Company Equity Awards to receive such amounts as provided for in <U>Section</U><U></U><U>&nbsp;2.06</U>.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.06
<I><U>Governing Law</U></I>. This Agreement and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated hereby, including the applicable statute of limitations, shall be governed by and construed
in accordance with the laws of the State of Delaware, without regard to the conflicts of law rules that would cause the application of law of any jurisdiction other than those of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.07 <I><U>Jurisdiction</U></I>. The parties hereto agree that any Proceeding seeking to enforce any provision of, or based on
any matter arising out of or in connection with, this Agreement or the transactions contemplated by this Agreement shall be brought and determined exclusively in the Delaware Court of Chancery or, if that court does not have subject matter
jurisdiction, the state or federal courts in the State of Delaware, and any appellate court therefrom (the &#147;<B>Delaware Courts</B>&#148;). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts in
respect of any legal or equitable Proceeding arising out of or relating to this Agreement or the transactions contemplated by this Agreement, or relating to enforcement of any of the terms of this Agreement, and hereby waives, and agrees not to
assert, as a defense in any such Proceeding, any claim that it is not subject personally to the jurisdiction of such court, that the Proceeding is brought in an inconvenient forum, that the venue of the Proceeding is improper or that this Agreement
or the transactions contemplated by this Agreement may not be enforced in or by such courts. Each party hereto agrees that notice or the service of process in any Proceeding arising out of or relating to this Agreement or the transactions
contemplated by this Agreement shall be properly served or delivered if delivered in the manner contemplated by <U>Section</U><U></U><U>&nbsp;9.01</U> or in any other manner permitted by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.08 <I><U>Waiver of Jury Trial</U></I>. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY
IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH OF THE PARTIES HERETO HEREBY (A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS
REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)&nbsp;ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED
BY THIS AGREEMENT, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION 9.08</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.09 <I><U>Specific Performance</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The parties hereto agree that irreparable harm would occur in the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms or were otherwise breached, and that money damages or other legal remedies would not be an adequate remedy for any such harm. The parties hereto agree that unless and until this Agreement is validly terminated in
accordance with <U>Section</U><U></U><U>&nbsp;8.01</U> and any dispute over the right to termination has been finally resolved through a Final Judgment, (i)&nbsp;the parties hereto shall be entitled to seek an injunction or injunctions, specific
performance and other equitable relief from a court of competent jurisdiction as set forth in <U>Section</U><U></U><U>&nbsp;9.07</U> to prevent breaches (or threatened breaches) of this Agreement and to enforce specifically the terms and provisions
of this Agreement without bond or other security being required, this being in addition to any other remedy to which they are entitled pursuant to <U>Section</U><U></U><U>&nbsp;8.02</U> or <U>9.04</U>, at law or in equity, and (ii)&nbsp;the right of
specific enforcement is an integral part of the transactions contemplated by this Agreement, including the Mergers, and without that right, none of the Company, Parent, Acquirer, Merger Sub or Merger Sub II would have entered into this Agreement.
Each of the parties hereto agrees that it will not oppose the granting of an injunction, specific performance or other equitable relief on the basis that any other of such parties has an adequate remedy at law or that any such injunction or award of
specific performance or other equitable relief is not an appropriate remedy for any reason. For the avoidance of doubt, (A)&nbsp;while the Company shall have the right to seek both (x)&nbsp;an injunction, specific performance or other equitable
remedies in accordance with this <U>Section</U><U></U><U>&nbsp;9.09</U> and (y)&nbsp;the payment of monetary damages from Parent pursuant to the terms hereof, in no event shall the Company be entitled to both specific performance to cause Parent to
consummate the Closing and the payment of monetary damages from Parent pursuant to the terms hereof, and (B)&nbsp;while Parent shall have the right to seek both (x)&nbsp;an injunction, specific performance or other equitable remedies in accordance
with this <U>Section</U><U></U><U>&nbsp;9.09</U> and (y)&nbsp;the payment of the Company Termination Fee, in no event shall Parent be entitled to both specific performance to cause the Company to consummate the Closing and the payment of the Company
Termination Fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything herein to the contrary (including <U>Section</U><U></U><U>&nbsp;6.17</U> and
<U>Section</U><U></U><U>&nbsp;9.09(a)</U>), it is acknowledged and agreed that neither Parent nor the Company shall be entitled to seek the remedy of specific performance with respect to Parent&#146;s rights under the Debt Commitment Letter against
the Debt Financing Sources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The parties hereto further agree that, except as set forth in <U>Section</U><U></U><U>&nbsp;9.09(a)</U>,
(i) by seeking the remedies provided for in this <U>Section</U><U></U><U>&nbsp;9.09</U>, a party shall not in any respect waive its right to seek any other form of relief that may be available to a party under this Agreement (including monetary
damages) for breach of any of the provisions of this Agreement or in the event that this Agreement has been validly terminated or in the event that the remedies provided for in this <U>Section</U><U></U><U>&nbsp;9.09</U> are not available or
otherwise are not granted, and (ii)&nbsp;nothing set forth in this <U>Section</U><U></U><U>&nbsp;9.09</U> shall require any party hereto to institute any Proceeding for (or limit any party&#146;s right to institute any Proceeding for) specific
performance under this <U>Section</U><U></U><U>&nbsp;9.09</U> prior or as a condition to exercising any termination right under <U>ARTICLE VIII</U> (and pursuing damages after such termination), nor shall the commencement of any Proceeding pursuant
to this <U>Section</U><U></U><U>&nbsp;9.09</U> or anything set forth in this <U>Section</U><U></U><U>&nbsp;9.09</U> restrict or limit any party&#146;s right to validly terminate this Agreement in accordance with the terms of <U>ARTICLE VIII</U> or
pursue any other remedies under this Agreement that may be available at any time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything herein to the contrary and for the avoidance of doubt, nothing
in this <U>Section</U><U></U><U>&nbsp;9.09</U> nor <U>Section</U><U></U><U>&nbsp;9.04</U> shall limit in any way the remedies of the parties under the Confidentiality Agreement, as modified hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10 <I><U>Severability</U></I>. If any term, provision, covenant or restriction of this Agreement is held by a court of
competent jurisdiction or other Governmental Authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected,
impaired or invalidated so long as the economic or legal substance of the transactions contemplated by this Agreement is not affected in any manner materially adverse to any party. Upon such a determination, the parties hereto agree to negotiate in
good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in an acceptable manner, in order that the transactions contemplated by this Agreement be consummated as originally contemplated to
the fullest extent possible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11 <I><U>Parent Guarantee</U></I>. Parent shall cause each of Acquirer, Merger Sub and Merger
Sub II to comply in all respects with each of the representations, warranties, covenants, obligations, agreements and undertakings made or required to be performed by Acquirer, Merger Sub and Merger Sub II in accordance with the terms of this
Agreement, the Mergers, and the other transactions contemplated by this Agreement. As a material inducement to the Company&#146;s willingness to enter into this Agreement and perform its obligations hereunder, Parent hereby unconditionally
guarantees full performance and payment by Acquirer, Merger Sub and Merger Sub II of each of the covenants, obligations and undertakings required to be performed by Acquirer, Merger Sub and Merger Sub II under this Agreement and the transactions
contemplated by this Agreement, subject to all terms, conditions and limitations contained in this Agreement, and hereby represents, acknowledges and agrees that any such breach of any such representation and warranty or default in the performance
of any such covenant, obligation, agreement or undertaking of Acquirer, Merger Sub or Merger Sub II shall also be deemed to be a breach or default of Parent, and the Company shall have the right, exercisable in its sole discretion, to pursue any and
all available remedies it may have arising out of any such breach or nonperformance directly against any of Parent, Acquirer, Merger Sub and Merger Sub II in the first instance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12 <I><U>Entire Agreement; No Reliance; Access to Information</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement, the Confidentiality Agreement, the exhibits and schedules to this Agreement, including the Company Disclosure Schedule,
and constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, among the parties with respect thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent, Acquirer, Merger Sub and Merger Sub II agree that, except for the
representations and warranties contained in <U>ARTICLE IV</U> or the certificate delivered pursuant to <U>Section</U><U></U><U>&nbsp;7.02(c)</U>, the Company makes no other representations or warranties and hereby disclaims any other representations
or warranties made by itself or any of its Representatives, with respect to the execution and delivery of this Agreement or the transactions contemplated by this Agreement, notwithstanding the delivery or disclosure to any other party or any other
party&#146;s Representatives of any document or other information with respect to any one or more of the foregoing. Without limiting the generality of the foregoing, and notwithstanding any otherwise express representations and warranties made by
the parties in this Agreement, each of Parent, Acquirer, Merger Sub and Merger Sub II agrees that none of the Company or any of its Subsidiaries make or has made any representation or warranty with respect to (i)&nbsp;any projections, forecasts,
estimates, plans or budgets or future revenues, expenses or expenditures, future results of operations (or any component thereof), future cash flows (or any component thereof) or future financial condition (or any component thereof) of the Company
or any of its Subsidiaries or the future business, operations or affairs of the Company or any of its Subsidiaries heretofore or hereafter delivered to or made available to it, or (ii)&nbsp;any other information, statements or documents heretofore
or hereafter delivered to or made available to it, including the information in the electronic data room of the Company, with respect to the Company or any of its Subsidiaries or the business, operations or affairs of the Company or any of its
Subsidiaries, except to the extent and as expressly covered by a representation and warranty made in <U>ARTICLE IV</U> or the certificate delivered pursuant to <U>Section</U><U></U><U>&nbsp;7.02(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent, Acquirer, Merger Sub and Merger Sub II each acknowledges and agrees that it (a)&nbsp;has had an opportunity to discuss the
business of the Company and its Subsidiaries with the management of the Company, (b)&nbsp;has had reasonable access to (i)&nbsp;the books and records of the Company and its Subsidiaries and (ii)&nbsp;the documents provided by the Company for
purposes of the transactions contemplated by this Agreement, (c)&nbsp;has been afforded the opportunity to ask questions of and received answers from officers of the Company and (d)&nbsp;has conducted its own independent investigation of the Company
and its Subsidiaries, their respective businesses and the transactions contemplated hereby, and has not relied on any representation, warranty or other statement by any Person on behalf of the Company or any of its Subsidiaries, other than the
representations and warranties of the Company contained in <U>ARTICLE IV</U> or the certificate delivered pursuant to <U>Section</U><U></U><U>&nbsp;7.02(c)</U>. Each of Parent, Acquirer, Merger Sub and Merger Sub II hereby acknowledges that there
are uncertainties inherent in attempting to develop estimates, projections, forecasts, business plans and other forward-looking information with which Parent, Acquirer, Merger Sub and Merger Sub II are familiar, that Parent, Acquirer, Merger Sub and
Merger Sub II are taking full responsibility for making their own evaluation of the adequacy and accuracy of all estimates, projections, forecasts, business plans and other forward-looking information furnished to them (including the reasonableness
of the assumptions underlying such estimates, projections, forecasts, business plans and other forward-looking information), and, for the avoidance of doubt, that Parent, Acquirer, Merger Sub and Merger Sub II will have no claim against the Company
or any of its stockholders, directors, officers, employees, Affiliates, advisors, agents or other Representatives with respect thereto, except as set forth in the representations and warranties of the Company contained in <U>ARTICLE IV</U> or the
certificate delivered pursuant to <U>Section</U><U></U><U>&nbsp;7.02(c)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13 <I><U>Rules of Construction</U></I>. Each of the parties hereto
acknowledges that it has been represented by counsel of its choice throughout all negotiations that have preceded the execution of this Agreement and that it has executed the same with the advice of said independent counsel. Each party and its
counsel cooperated and participated in the drafting and preparation of this Agreement and the documents referred to herein, and any and all drafts relating thereto exchanged among the parties shall be deemed the work product of all of the parties
and may not be construed against any party by reason of its drafting or preparation. Accordingly, any rule of law or any legal decision that would require interpretation of any ambiguities in this Agreement against any party that drafted or prepared
it is of no application and is hereby expressly waived by each of the parties hereto, and any controversy over interpretations of this Agreement shall be decided without regard to events of drafting or preparation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14 <I><U>Disclosure Schedule</U></I>. The parties hereto agree that any reference in a particular Section of the Company
Disclosure Schedule or the Parent Disclosure Schedule, as applicable, shall be deemed to be disclosed and incorporated by reference in each other Section of the Company Disclosure Schedule or the Parent Disclosure Schedule, as applicable, if the
relevance of such reference as a disclosure or exception to such other Section is reasonably apparent on its face. Certain items and matters may be listed in the Company Disclosure Schedule or the Parent Disclosure Schedule for informational
purposes only and may not be required to be listed therein by the terms of this Agreement. Except as expressly set forth in the Company Disclosure Schedule or the Parent Disclosure Schedule, as applicable, in no event shall the listing of items or
matters in the Company Disclosure Schedule or the Parent Disclosure Schedule, as applicable, be deemed or interpreted to broaden, or otherwise expand the scope of, the representations and warranties or covenants contained in this Agreement. The mere
inclusion of an item in the Company Disclosure Schedule or the Parent Disclosure Schedule, as applicable, as an exception to a representation or warranty (a)&nbsp;shall not be deemed an admission that such item represents a material exception or
material event, circumstance, change, effect, development or condition or that such item would have a Company Material Adverse Effect or Parent Material Adverse Effect, as applicable, and (b)&nbsp;shall not be construed as an admission or indication
by the Company or Parent, as applicable, of any <FONT STYLE="white-space:nowrap">non-compliance</FONT> with, or breach or violation of, any third party rights (including any Intellectual Property), any Contract or agreement or any Applicable Law or
Order of any Governmental Authority, such disclosures having been made solely for the purposes of creating exceptions to the representations made herein or of disclosing any information required to be disclosed under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.15 <I><U>Counterparts; Effectiveness</U></I>. This Agreement may be signed in any number of counterparts, each of which shall
be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each party hereto shall have received a counterpart hereof signed by all of the other parties
hereto. Until and unless each party has received a counterpart hereof signed by each other party hereto, this Agreement shall have no effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written
agreement or other communication). Signatures to this Agreement transmitted by facsimile transmission, by electronic mail in PDF form, or by any other electronic means designed to preserve the original graphic and pictorial appearance of a document,
will be deemed to have the same effect as physical delivery of the paper document bearing the original signatures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.16 <I><U><FONT STYLE="white-space:nowrap">Non-Recourse</FONT></U></I>. This
Agreement may only be enforced against, and any claim, action, suit or other legal proceeding based upon, arising out of, or related to this Agreement, or the negotiation, execution or performance of this Agreement, may only be brought against the
entities that are expressly named as parties hereto and then only with respect to the specific obligations set forth herein with respect to such party, except for claims that the Company or any of its Subsidiaries may assert in accordance with the
Confidentiality Agreement. Except as set forth in this Agreement or the Confidentiality Agreement, no former, current or future officers, employees, directors, partners, direct or indirect equity holders, managers, members, attorneys, agents,
advisors or other Representatives of any party hereto (each, a &#147;<B><FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party</B>&#148;) shall have any liability for any obligations or liabilities of any party hereto under this Agreement or for
any claim or proceeding (whether in tort, contract or otherwise) based on, in respect of or by reason of the transactions contemplated by this Agreement or in respect of any written or oral representations made or alleged to be made in connection
herewith. In furtherance and not in limitation of the foregoing, each party covenants, agrees and acknowledges that no recourse under this Agreement or any other agreement referenced herein or in connection with any transactions contemplated by this
Agreement shall be sought or had against any <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party, except for claims that any party may assert (A)&nbsp;against another party solely in accordance with, and pursuant to the terms and conditions
of, this Agreement or (B)&nbsp;pursuant to the express terms of the Confidentiality Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.17 <I><U>Debt Financing
Related Parties</U></I>. Notwithstanding anything in this Agreement to the contrary, the Company, on behalf of itself and its Subsidiaries and controlled Affiliates, hereby: (i)&nbsp;agrees that any Proceeding, whether in law or in equity, whether
in contract or in tort or otherwise, by or against any Debt Financing Related Party, arising out of or relating to, this Agreement, the Debt Financing, the Debt Commitment Letter or the Definitive Agreements or any of the transactions contemplated
hereby or thereby or the performance of any services thereunder shall be subject to the exclusive jurisdiction of any federal or state court in the Borough of Manhattan, New York, New York, so long as such forum is and remains available, and any
appellate court thereof and each party hereto irrevocably submits itself and its property with respect to any such Proceeding to the exclusive jurisdiction of such court, and such Proceeding (except to the extent relating to the interpretation of
any provisions in this Agreement as provided in the Debt Commitment Letter) shall be governed by the laws of the State of New York (without giving effect to any conflicts of law principles that would result in the application of the laws of another
jurisdiction), (ii) agrees not to bring or support any Proceeding of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against any Debt Financing Related Party in any way arising out of or relating
to, this Agreement, the Debt Financing, the Debt Commitment Letter, the Definitive Agreements or the performance of any services under such documents, (iii)&nbsp;agrees that service of process upon the Company in any such Proceeding shall be
effective if notice is given in accordance with <U>Section</U><U></U><U>&nbsp;9.01</U>, (iv) irrevocably waives, to the fullest extent that it may effectively do so, the defense of an inconvenient forum to the maintenance of such Proceeding in any
such court, (v)&nbsp;knowingly, intentionally and voluntarily waives to the fullest extent permitted by applicable Law trial by jury in any Proceeding brought against the Debt Financing Related Parties in any way arising out of or relating to, this
Agreement, the Debt Financing or any of the transactions contemplated hereby or thereby or the performance of any services thereunder, (vi)&nbsp;agrees that none of the Debt Financing Related Parties will have any liability to the Company, its
Subsidiaries and controlled Affiliates relating to or arising out of this Agreement, the Debt Financing, the Debt Commitment Letter, the Definitive Agreements or any of the transactions contemplated hereby or thereby or the performance of any
services thereunder, whether in law or in equity, whether in contract or in tort or otherwise, (vii)&nbsp;agrees that the Debt Financing Related Parties are express third party </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
beneficiaries of, and may enforce, <U>Section</U><U></U><U>&nbsp;9.05</U> and this <U>Section</U><U></U><U>&nbsp;9.17</U>. To the extent any amendments to any provision of
<U>Section</U><U></U><U>&nbsp;9.05</U> or this <U>Section</U><U></U><U>&nbsp;9.17</U> (or, solely as they relate to such Sections, the definitions of any terms used herein and therein) are materially adverse to the Debt Financing Sources, such
amendments will not be enforceable against the Debt Financing Sources without their prior consent. Notwithstanding anything in this Agreement to the contrary, nothing in this <U>Section</U><U></U><U>&nbsp;9.17</U> will in any way affect the
Company&#146;s and its Subsidiaries&#146; rights and remedies in any way relating to or arising out of any binding agreement to which a Debt Financing Source is a party, including the Debt Commitment Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by
their respective authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ENFUSION, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Oleg Movchan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Oleg Movchan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ENFUSION LTD. LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Oleg Movchan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Oleg Movchan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Agreement and Plan of Merger </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CLEARWATER ANALYTICS HOLDINGS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jim Cox</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jim Cox</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>POSEIDON ACQUIRER, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jim Cox</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jim Cox</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Treasurer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>POSEIDON MERGER SUB I, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jim Cox</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jim Cox</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Treasurer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>POSEIDON MERGER SUB II, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jim Cox</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jim Cox</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Agreement and Plan of Merger </I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d921635dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>E<SMALL>XECUTION</SMALL> V<SMALL>ERSION</SMALL> </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUPPORT AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
Support Agreement, dated as of January 10, 2025 (this &#147;<B><I>Agreement</I></B>&#148;), is made and entered into by and between Clearwater Analytics Holdings, Inc., a Delaware corporation (&#147;<B><I>Parent</I></B>&#148;), and [&#9679;]
(&#147;<B><I>Stockholder</I></B>&#148;, and together with Parent, the &#147;<B><I>Parties</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RECITALS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as of the date hereof, Stockholder is the beneficial owner (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT>
under the Exchange Act) of (a) [&#9679;] shares of Class&nbsp;A Common Stock, par value $0.001 per share (the &#147;<B><I>Class A Common Stock</I></B>&#148;) of Enfusion, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), (b)
[&#9679;] shares of Class B Common Stock, par value $0.001 per share of the Company (the &#147;<B><I>Class B Common Stock</I></B>&#148;, together with the Class A Common Stock, the &#147;<B><I>Common Stock</I></B>&#148;) and (c) [&#9679;] Common
Units of Enfusion Ltd. LLC, a Delaware limited liability company (the &#147;<B><I>Operating Company</I></B>&#148;) (all such shares and units beneficially owned by Stockholder, collectively, the &#147;<B><I>Subject Shares</I></B>&#148;);<SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution hereof, Parent, Poseidon Merger Sub I, Inc., a
Delaware corporation and a wholly-owned subsidiary of Parent (&#147;<B><I>Merger Sub</I></B>&#148;), Poseidon Acquirer, Inc., a Delaware corporation and direct, wholly-owned subsidiary of Parent (&#147;<B><I>Acquirer</I></B>&#148;), Poseidon Merger
Sub II, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Parent (&#147;<B><I>Merger Sub II</I></B>&#148;), the Company and the Operating Compay, are entering into an Agreement and Plan of Merger, dated as of the date hereof
(as it may be amended from time to time, excluding any Prohibited Amendment (as defined below), the &#147;<B><I>Merger Agreement</I></B>&#148;), which provides for, among other things, at the Effective Time, the merger of Merger Sub with and into
the Company (the &#147;<B><I>Merger</I></B>&#148;), at the LLC Merger Effective Time, the merger of Merger Sub II with and into the Operating Company (the &#147;<B><I>LLC Merger</I></B>&#148;), and, subject to the satisfaction of each of the Second
Merger Conditions as of the Closing Date but before the Effective Time, the merger of the Surviving Corporation with and into Acquirer (the &#147;<B><I>Second Merger</I></B>&#148;, and together with the Merger, the &#147;<B><I>Corporate
Mergers</I></B>&#148;, and the Corporate Mergers together with the LLC Merger, the &#147;<B><I>Mergers</I></B>&#148;), in each case, upon the terms and subject to the conditions set forth in the Merger Agreement (capitalized terms used but not
otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as a condition
to their willingness to enter into the Merger Agreement, Parent, Acquirer, Merger Sub and Merger Sub II have required that Stockholder, and as an inducement and in consideration therefor, Stockholder (in Stockholder&#146;s capacity as the beneficial
owner of the Subject Shares) has agreed to, enter into this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the
respective representations, warranties, covenants and agreements set forth below and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending to be legally bound, do
hereby agree as follows: </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Note to Draft: Agreement modified for each Stockholder based on the Subject Shares held by the Stockholder.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE I. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Agreement</U>.
Upon the terms and subject to the conditions of this Agreement, Stockholder hereby undertakes and agrees that, unless and until this Agreement shall have been validly terminated in accordance with <U>Section</U><U></U><U>&nbsp;5.2</U>, Stockholder
shall, at any annual, special or other meeting of the Company&#146;s stockholders or the Operating Company&#146;s equity holders called, and at every adjournment or postponement, and in connection with any action proposed to be taken by written
consent of the stockholders of the Company or the equity holders of the Operating Company thereof, (A)&nbsp;affirmatively vote (including via proxy), or deliver via a written consent, all of the Subject Shares and any other Company Common Stock and
Common Units owned by Stockholder, in favor of, and shall not withdraw or modify any such vote with respect to, approving and adopting the Merger Agreement and the transactions contemplated thereby, and/or (B)&nbsp;except as otherwise permitted
herein, vote against (including via proxy), and shall not deliver any written consent with respect to, (x)&nbsp;any action or agreement which would reasonably be expected to (I)&nbsp;impede, materially delay or adversely affect the consummation of
the Mergers or result in any of the conditions to the Company&#146;s obligations to consummate the Mergers set forth in <U>Article 7</U> of the Merger Agreement not being fulfilled on or before the End Date, (II)&nbsp;result in a breach of any
covenant, representation or warranty or any other obligation or agreement of the Company contained in the Merger Agreement, or of such Stockholder contained in this Agreement or (III)&nbsp;change in any manner the voting rights of any class of
shares of the Company or the Operating Company (including any amendments to the Company&#146;s certificate of incorporation or bylaws or the Operating Company&#146;s operating agreement), and (y)&nbsp;any Acquisition Proposal. Stockholder agrees to
be, or shall cause the record holder on any applicable record date to be, present, in person or by proxy, at every meeting of the Company&#146;s stockholders or the Operating Company&#146;s equityholders, including any postponement or adjournment
thereof, or in any other circumstance, however called, to vote on the matters contemplated by this <U>Section</U><U></U><U>&nbsp;1.1</U> so that all of the Subject Shares will be counted for purposes of determining the presence of a quorum at any
such meeting, or otherwise cause the Subject Shares to be counted as present threat for purposes of establishing a quorum.&nbsp;For the avoidance of doubt, other than with respect to the matters contemplated by this
<U>Section</U><U></U><U>&nbsp;1.1</U>, Stockholder does not have any obligation to vote the Subject Shares in any particular manner and, with respect to such other matters, Stockholder shall be entitled to vote the Subject Shares in its sole
discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Conditional Power of Attorney</U>. To secure Stockholder&#146;s obligations in accordance with
<U>Section</U><U></U><U>&nbsp;1.1</U> of this Agreement, Stockholder hereby appoints Parent as the Stockholder&#146;s attorney in fact and proxy with full power of substitution and resubstitution, and grants Parent the power to affirmatively vote
(including via proxy), and to execute written consents with respect to, all of the Subject Shares in favor of, and not withdraw or modify any such vote with respect to, approving and adopting the Merger Agreement and the transactions contemplated
thereby if, and only if, the Stockholder fails to comply with the provisions of <U>Section</U><U></U><U>&nbsp;1.1</U>. Such appointment will be irrevocable for the term of this Agreement and is coupled with an interest, including for purposes of
Section&nbsp;212 of the DGCL. The appointment will survive the merger or reorganization of the Stockholder. The proxy and power of attorney granted hereunder shall terminate upon the termination of this Agreement in accordance with
<U>Section</U><U></U><U>&nbsp;5.2</U>. Notwithstanding the foregoing, Parent may terminate this proxy at any time in its sole discretion by written notice provided to the Stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE II. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND
WARRANTIES OF STOCKHOLDER </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder represents and warrants to Parent that: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Organization; Authorization; Binding Agreement</U>. To the extent that Stockholder is
an entity, Stockholder is duly organized and validly existing under the laws of the jurisdiction of its formation or incorporation and Stockholder has duly authorized its execution, delivery and performance of this Agreement. Stockholder has full
power and authority to execute, deliver and perform this Agreement. This Agreement has been duly and validly executed and delivered by Stockholder, and constitutes a legal, valid and binding obligation of Stockholder enforceable against Stockholder
in accordance with its terms (except insofar as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other Applicable Laws of general applicability relating to or affecting creditors&#146; rights, or by
principles governing the availability of equitable remedies, whether considered in a Proceeding at law or in equity). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U><FONT
STYLE="white-space:nowrap">Non-Contravention</FONT></U>. The execution and delivery of this Agreement by Stockholder does not, and the performance by Stockholder of Stockholder&#146;s obligations hereunder and the consummation by Stockholder of the
transactions contemplated hereby will not, (a)&nbsp;conflict with, or result in any violation or breach of, or constitute a default on the part of the Stockholder under, any Applicable Law applicable to Stockholder or Stockholder&#146;s Subject
Shares and, to the extent that such Stockholder is an entity, the organizational or governing documents of such Stockholder, (b)&nbsp;conflict with or result in a violation or breach of, or constitute a default on the part of Stockholder under, any
contract, trust, commitment, agreement, understanding, arrangement or restriction of any kind to which Stockholder is a party or by which Stockholder or its assets are bound, or (c)&nbsp;except as may be required by Applicable Laws, require any
consent, approval, order, authorization or other action by, or filing with or notice to, any Person (including any Governmental Authority) under any Applicable Law, in case of each of clauses (a), (b) and (c), except as would not reasonably be
expected to prevent, impair or materially delay Stockholder&#146;s timely performance of its obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3
<U>Ownership of Subject Shares</U>. Stockholder is, and (except with respect to any Company Common Stock, other Company Securities or Common Units Transferred in accordance with <U>Section</U><U></U><U>&nbsp;4.1</U> hereof) will remain, the
beneficial owner (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> under the Exchange Act) of the Subject Shares (together with any shares of Company Common Stock, other Company Securities or Common Units which such Stockholder
may acquire at any time in the future during the term of this Agreement, the &#147;<U>Stockholder Securities</U>&#148;). Other than the Subject Shares, Stockholder does not hold or have any beneficial ownership interest in any other shares of
Company Capital Stock, Common Units or any option, warrant, call, proxy, commitment, right or other Company Securities convertible, exchangeable or exercisable therefor or other instrument, obligation or right the value of which is based on any of
the foregoing (each, an &#147;<U>Equity Interest</U>&#148;). The Subject Shares and the certificates, if any, representing the Subject Shares owned by the Stockholder are now, and, subject to <U>Section</U><U></U><U>&nbsp;4.1</U>, such Subject
Shares and any additional Stockholder Securities such Stockholder may acquire in the future during the term of this Agreement will be, held by Stockholder or by a nominee or custodian for the benefit of such Stockholder, free and clear of all Liens,
subscriptions, options, warrants, calls, proxies, commitments, restrictions and contracts of any kind, except for any such Liens arising hereunder, any applicable restrictions on transfer under the Securities Act and any Liens that would not impair
the Stockholder&#146;s ability to timely perform his/her/its obligations hereunder (collectively, &#147;<U>Permitted Liens</U>&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <U>Voting Power</U>. Subject to this Agreement and any agreement of Stockholder or any
of its Affiliates made available to Parent prior to execution of this Agreement for any borrowed money, advance or extension of credit or the pledge, hypothecation or other granting of a security interest in any Subject Shares to one or more banks
or financial institutions as <I>bona fide</I> collateral or security for any such loan, advance or extension of credit (each such agreement, a &#147;<U>Loan Agreement</U>&#148;), Stockholder has full and sole power and authority to direct the voting
of, and full and sole power of disposition with respect to, all of the Subject Shares. Other than any Loan Agreement, none of the Subject Shares are subject to any stockholders&#146; agreement, proxy, voting trust or other agreement or arrangement
with respect to the voting of the Subject Shares with respect to the Merger Agreement that would adversely affect Stockholder&#146;s ability to comply with this Agreement, except as provided hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 <U>Proceedings</U>. As of the time of execution of this Agreement, there is no Proceeding pending or, to the knowledge of Stockholder,
threatened against Stockholder at law or equity before or by any Governmental Authority that would reasonably be expected to prevent, impair or materially delay Stockholder&#146;s timely performance of its obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE III. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND
WARRANTIES OF PARENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Parent represents and warrants to Stockholder that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Organization; Authorization</U>. Parent is duly organized and validly existing and in good standing under the laws of the jurisdiction
in which it is organized (in the case of good standing, to the extent the concept is recognized by such jurisdiction). The consummation of the transactions contemplated hereby are within Parent&#146;s corporate powers and have been duly authorized
by all necessary corporate action on the part of Parent. Parent has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the transactions contemplated thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Binding Agreement</U>. Parent has duly executed and delivered this Agreement, and this Agreement constitutes a legal, valid and binding
obligation of Parent, enforceable against Parent in accordance with its terms (except insofar as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other Applicable Laws of general applicability relating to
or affecting creditors&#146; rights, or by principles governing the availability of equitable remedies, whether considered in a Proceeding at law or in equity). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>No Other Representations</U>. Parent hereby acknowledges and agrees that, except for the representations and warranties of Stockholder
expressly set in <U>ARTICLE II</U> of this Agreement, none of Stockholder, its Affiliates, any Representative of any of the foregoing or any other Person has made, and neither Parent or any other Person has relied on, any representation or warranty
regarding Stockholder, the sufficiency of the representations and warranties set forth herein or any other matter in connection with the entry by Stockholder into this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ADDITIONAL COVENANTS OF STOCKHOLDER </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>No Transfer; No Inconsistent Arrangements</U>. Except as provided hereunder or under the Merger Agreement or any Loan Agreement, from
and after the date hereof and until the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.2</U>, Stockholder shall not, directly or indirectly, (a)&nbsp;create any Lien on any or all of the Stockholder Securities,
except for any Permitted Liens, (b)&nbsp;transfer, sell, assign, gift, exchange, tender, hypothecate, hedge, pledge or otherwise dispose of (collectively, &#147;<B><I>Transfer</I></B>&#148;) any of the Stockholder Securities, (c)&nbsp;grant or
permit the grant of any proxy or power of attorney with respect to any of the Stockholder Securities to the extent inconsistent with such Stockholder&#146;s obligations hereunder, or (d)&nbsp;deposit or permit the deposit of any of the Stockholder
Securities into a voting trust or enter into a voting agreement or arrangement with respect to any of the Stockholder Securities, in each case except as may be necessary or advisable in connection with Stockholder&#146;s performance of its
obligations hereunder. Notwithstanding the foregoing, Stockholder may Transfer any of the Stockholder Securities to any Affiliate of Stockholder under common control with Stockholder, only if such transferee of such Stockholder Securities takes and
holds such Stockholder Securities subject to all of the restrictions, liabilities and rights under this Agreement, which shall continue in full force and effect until the termination of this Agreement in accordance with
<U>Section</U><U></U><U>&nbsp;5.2</U> (a &#147;<U>Permitted Transfer</U>&#148;); provided, that no such Transfer shall relieve Stockholder of any of its obligations under this Agreement. To the fullest extent permitted by law, if any involuntary
Transfer of any of the Stockholder Securities shall occur (including, but not limited to, a sale by Stockholder&#146;s trustee in any bankruptcy, or a sale to a purchaser at any creditor&#146;s or court sale), the transferee (which term, as used
herein, shall include any and all transferees and subsequent transferees of the initial transferee) shall take and hold such Stockholder Securities subject to all of the restrictions, liabilities and rights under this Agreement, which shall continue
in full force and effect until the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2
<U>Adjustments</U>. In the event of any stock split, stock dividend, merger, reorganization, recapitalization, reclassification, combination, exchange of shares or similar transaction with respect to the capital stock of the Company that affects the
Subject Shares, the terms of this Agreement shall apply to the resulting securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>No Solicitation</U>. From and after the date
hereof until this Agreement shall have been validly terminated in accordance with <U>Section</U><U></U><U>&nbsp;5.2</U>, Stockholder, solely in its capacity as a stockholder of the Company, shall not, and shall not authorize or permit any of its
Representatives to and it shall direct its Representatives not to, directly or indirectly (other than with respect to Parent, Acquirer, Merger Sub and Merger Sub II), (A) solicit, assist, initiate, propose, induce the making, submission or
announcement of or otherwise knowingly encourage or facilitate any inquiries, proposals or offers that constitute, or that would reasonably be expected to constitute or lead to, an Acquisition Proposal, (B)&nbsp;authorize, engage in, continue or
otherwise participate in any discussions or negotiations with any Third Party regarding any inquiries, proposals or offers that constitute, or that would reasonably be expected to constitute or lead to, an Acquisition Proposal, (C)&nbsp;furnish to
any Third Party any information or provide to any Third Party access to the businesses, properties, assets, books, records or personnel of the Company or any of its Subsidiaries, in each case for the purpose of encouraging or facilitating any
inquiries, proposals or offers that constitute, or that would reasonably be expected to lead to, an Acquisition Proposal, (D)&nbsp;approve, endorse or recommend an Acquisition Proposal, or publicly propose to accept, approve, endorse or recommend
any publicly announced Acquisition Proposal or (E)&nbsp;approve, recommend or enter into, or propose to approve, recommend or enter into, any letter of intent, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
memorandum of understanding, merger agreement, acquisition agreement, or other similar Contract with respect to an Acquisition Proposal; or (F)&nbsp;propose, resolve, authorize, agree or commit
to do any of the foregoing. Notwithstanding anything to the contrary in this Agreement, solely to the extent the Company or its Representatives is permitted to take certain actions set forth in <U>Section</U><U></U><U>&nbsp;6.02</U> of the Merger
Agreement or participate in discussions or negotiations with respect to an Acquisition Proposal, Stockholder may (and may permit its Affiliates and Representatives to) take such actions and participate in discussions and negotiations with any Person
making an Acquisition Proposal (or its Representatives) with respect to such Acquisition Proposal solely to the extent permitted by the Special Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Dissenter&#146;s Rights</U>. Stockholder forever and irrevocably waives and agrees that it/he/she will not exercise any
dissenter&#146;s or appraisal rights available to Stockholder with respect to the Merger pursuant to Section&nbsp;262 of the DGCL or any other Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U>Formation of Groups</U>. Unless and until the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.2</U>,
Stockholder agrees that it shall not, and shall cause each of its controlled affiliates not to, become a member of a &#147;group&#148; with respect to any Stockholder Securities (as defined under Section&nbsp;13(d) of the Exchange Act) for the
purpose of opposing or competing with or taking any actions in opposition to or competition with the transactions contemplated by the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MISCELLANEOUS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Notices</U>. All notices and other communications hereunder shall be in writing and shall be deemed given (a)&nbsp;when delivered
personally by hand (with written confirmation of receipt), (b) when sent by email (provided that no &#147;bounce-back&#148; or similar notice is received by the electronic mail sender within two (2)&nbsp;hours thereafter indicating that such
electronic mail was undeliverable or otherwise not delivered) or (c)&nbsp;one (1)&nbsp;Business Day following the day sent by an internationally recognized overnight courier (with written confirmation of receipt), in each case, at the following
addresses and email addresses (or to such other address or email address as a Party may have specified by notice given to the other Party under this provision): (i)&nbsp;if to Parent, in accordance with the provisions of the Merger Agreement and
(ii)&nbsp;if to Stockholder, to Stockholder&#146;s address or <FONT STYLE="white-space:nowrap">e-mail</FONT> address set forth on a signature page hereto, or to such other address or <FONT STYLE="white-space:nowrap">e-mail</FONT> address as
Stockholder may hereafter specify in writing for the purpose by notice to Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Termination</U>. This Agreement shall terminate
automatically, without any notice or other action by any Person, upon the first to occur of (a)&nbsp;the valid termination of the Merger Agreement in accordance with its terms, (b)&nbsp;the Effective Time, (c)&nbsp;the date of any Prohibited
Amendment that is effected without Stockholder&#146;s prior written consent or (d)&nbsp;the written consent of Stockholder and Parent. Upon termination of this Agreement as to any Party, such Party shall not have any further obligations or
liabilities under this Agreement; <I>provided</I>, <I>however</I>, that the provisions of this <U>ARTICLE V</U> shall survive any termination of this Agreement. A &#147;<B><I>Prohibited Amendment</I></B>&#148; means any one or more amendments or
modifications of any provision of the Merger Agreement (as in effect on the date hereof) in a manner that (i)&nbsp;reduces the amount of the Aggregate Consideration Per Share or imposes any material restrictions on or additional material conditions
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on the payment from and after the Effective Time of the Aggregate Consideration Per Share (excluding, for the avoidance of doubt, as a result of any changes to the total number of Class&nbsp;A
Common Stock plus Common Units outstanding immediately prior to the Effective Time), (ii) changes the form of any consideration payable thereunder (excluding, for the avoidance of doubt, as a result of any election by the holders of Eligible
Shares), (iii) changes the relative amount of cash and number of shares of Parent Class&nbsp;A Common Stock payable under the Merger Agreement, including any amendment, modification or waiver of any of the definitions set forth or referenced in
<U>Section</U><U></U><U>&nbsp;2.03(a)</U> of the Merger Agreement that would have the effect of, or otherwise result in, a change to the relative amount of cash and number of shares of Parent Class&nbsp;A Common Stock payable upon the consummation
of the Merger or (iv)&nbsp;amends or modifies <U>Article II</U> of the Merger Agreement, or <U>Sections 4.15(m)</U>, <U>5.21</U>, <U>5.22</U>, or <U>6.16(b) </U>of the Merger Agreement in a manner that would reasonably be expected to prevent
(A)&nbsp;the Corporate Mergers, taken together, from qualifying as a reorganization within the meaning of Section&nbsp;368(a) of the Code, (B)&nbsp;the delivery to Parent on the Closing Date, but before the Effective Time, of the First Closing Tax
Opinion or (C)&nbsp;the delivery to the Company on the Closing Date, but before the Effective Time, of the Second Closing Tax Opinion; provided, that any amendments, modifications or waivers of any provision of the Merger Agreement resulting from
any stock split, stock dividend, merger, reorganization, recapitalization, reclassification, combination, exchange of shares or similar transaction with respect to the capital stock of the Company or any other changes to the capitalization of the
Company shall be deemed not to be a Prohibited Amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Amendments and Waivers</U>. Any provision of this Agreement may be
amended or waived only if such amendment or waiver is in writing and is signed, in the case of an amendment, by each Party to this Agreement or, in the case of a waiver, by each Party against whom the waiver is to be effective. No failure or delay
by any Party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or
privilege. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Expenses</U>. All fees and expenses incurred in connection herewith and the transactions contemplated hereby shall be
paid by the Party incurring such fees or expenses, whether or not the Mergers are consummated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>Binding Effect; Benefit;
Assignment</U>. Except as otherwise expressly provided herein, the Parties hereby agree that their respective representations, warranties and covenants set forth herein are solely for the benefit of the other Party, in accordance with and subject to
the terms of this Agreement, and this Agreement is not intended to, and does not, confer upon any Person other than the Parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth
herein, except as provided in <U>Section</U><U></U><U>&nbsp;5.16</U> (which will be to the benefit of the Persons referred to in such Section); provided, that the Company may rely upon this Agreement and enforce the provisions hereof as an intended
and express third-party beneficiary. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the Parties (whether by operation of Applicable Law or otherwise) without the prior written consent of
the other Party; provided that, solely in connection with a Permitted Transfer, the Stockholder may assign this Agreement to any Affiliate of Stockholder under common control with Stockholder to whom Stockholder has made such Permitted Transfer. No
assignment by any Party shall relieve such Party of any of its obligations hereunder. Subject to the limitations regarding assignment herein, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their
respective successors and permitted assigns. Any purported assignment not permitted under this <U>Section</U><U></U><U>&nbsp;5.5</U> shall be null and void <I>ab initio</I>. </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>Governing Law; Venue</U>. This Agreement and all disputes or controversies arising
out of or relating to this Agreement or the transactions contemplated hereby, including the applicable statute of limitations, shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts
of law rules that would cause the application of law of any jurisdiction other than those of the State of Delaware. The Parties agree that any Proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection
with, this Agreement or the transactions contemplated by this Agreement shall be brought and determined exclusively in the Court of Chancery of the State of Delaware or, if that court does not have subject matter jurisdiction, the state or federal
courts in the State of Delaware (the &#147;<B><I>Delaware Courts</I></B>&#148;). Each Party hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts in respect of any legal or equitable Proceeding arising out of or relating to
this Agreement or the transactions contemplated by this Agreement, or relating to enforcement of any of the terms of this Agreement, and hereby waives, and agrees not to assert, as a defense in any such Proceeding, any claim that it is not subject
personally to the jurisdiction of such court, that the Proceeding is brought in an inconvenient forum, that the venue of the Proceeding is improper or that this Agreement or the transactions contemplated by this Agreement may not be enforced in or
by such courts. Each Party agrees that notice or the service of process in any Proceeding arising out of or relating to this Agreement or the transactions contemplated by this Agreement shall be properly served or delivered if delivered in the
manner contemplated by <U>Section</U><U></U><U>&nbsp;5.1</U> or in any other manner permitted by law. EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH OF THE PARTIES HEREBY (A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE
EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)&nbsp;ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS
AND CERTIFICATIONS IN THIS <U>SECTION 5.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U>Enforcement of Agreement</U>. The Parties agree that irreparable harm would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, and that money damages or other legal remedies would not be an adequate remedy for any such harm. It is
accordingly agreed that the Parties shall be entitled to an injunction or injunctions, or any other appropriate form of specific performance or equitable relief, to prevent breaches or threatened breaches of this Agreement and to enforce
specifically the terms and provisions of this Agreement in any court to which the Parties have submitted under <U>Section</U><U></U><U>&nbsp;5.6</U>, without bond or other security being required, this being in addition to any other remedy to which
they are entitled at law or in equity. Each of the Parties agrees that it will not oppose the granting of an injunction, specific performance or other equitable relief on the basis that any other of such parties has an adequate remedy at law or that
any such injunction or award of specific performance or other equitable relief is not an appropriate remedy for any reason. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <U>Counterparts</U>. This Agreement may be executed in several counterparts, each of
which shall be deemed an original and all of which shall be one (1)&nbsp;and the same instrument. Delivery of an executed counterpart hereof by facsimile or other electronic transmission (including email or any electronic signature complying with
the U.S. federal ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com) shall be effective as delivery of an original counterpart hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9
<U>Entire Agreement</U>. This Agreement, together with the other documents and instruments referred to herein, constitute the entire agreement, and supersede all prior agreements and understandings, both written and oral, among the Parties hereto
and their Affiliates, or any of them, related to the subject matter hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10 <U>Severability</U>. If any term or other provision of
this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule or law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full
force and effect. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the
Parties as closely as possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent possible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11 <U>Headings</U>. The Section headings contained in this Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.12 <U>Interpretation</U>. Unless the context otherwise requires, as used in this
Agreement: (a) &#147;or&#148; is not exclusive; (b) &#147;including&#148; and its variants mean &#147;including, without limitation&#148; and its variants; (c)&nbsp;words defined in the singular have the parallel meaning in the plural and vice
versa; (d)&nbsp;words of one gender shall be construed to apply to each gender; and (e)&nbsp;the terms &#147;Article,&#148; &#147;Section&#148; and &#147;Schedule&#148; refer to the specified Article, Section or Schedule of or to this Agreement; and
(f)&nbsp;neither the Company nor any of its Subsidiaries shall be construed to be a Subsidiary or Affiliate of Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.13
<U>Capacity as Stockholder</U>. Notwithstanding anything herein to the contrary, (a)&nbsp;Stockholder signs this Agreement solely in Stockholder&#146;s capacity as a beneficial owner of the Subject Shares, and not in any other capacity and this
Agreement shall not limit or otherwise affect the actions of Stockholder, any Affiliate thereof or any of their respective Representatives or designees in its capacity, if applicable, as an officer, director, employee or agent of the Company, and
(b)&nbsp;nothing herein shall in any way restrict a director, officer, employee or agent of the Company in the taking of any actions (or failure to act) in his or her capacity as such, or in the exercise of his or her fiduciary duties as a director
or officer of the Company or otherwise, or prevent or be construed to create any obligation on the part of any director, officer, employee or agent of the Company from taking any action in his or her capacity as such. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.14 <U>No Agreement Until Executed</U>. This Agreement shall not be effective unless and until (i)&nbsp;the Special Committee has approved,
for purposes of any applicable anti-takeover laws and regulations, and any applicable provision of the DGCL, the certificate of incorporation, the bylaws or any similar organizational document of the Company, the Merger Agreement, the Support
Agreements and the transactions contemplated by the Merger Agreement and the Support Agreements, including the Mergers, (ii)&nbsp;the Merger Agreement is executed by all parties thereto and (iii)&nbsp;this Agreement is executed and delivered by all
Parties. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.15 <U>No Ownership Interest</U>. Nothing contained in this Agreement shall be deemed to
vest in Parent or any other Person any direct or indirect ownership or incidence of ownership of or with respect to the Subject Shares. All rights, ownership and economic benefits of and relating to the Subject Shares shall remain vested in and
belong to Stockholder, and Parent shall not exercise any power or authority to direct Stockholder in the voting of any of the Subject Shares, except as otherwise expressly provided herein. This Agreement shall in no way be deemed to constitute a
transfer of any Stockholder Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.16 <U><FONT STYLE="white-space:nowrap">Non-Recourse</FONT></U>. Notwithstanding anything that
may be expressed or implied in this Agreement, or any document, certificate or instrument delivered in connection herewith or otherwise (together, the &#147;<B><I>Transaction Documents</I></B>&#148;), each Party acknowledges and agrees, on behalf of
itself and its respective Related Persons (as defined below), that all Proceedings that may be based upon, in respect of, arise under, out of, by reason of, be connected with, or relate in any manner to (a)&nbsp;this Agreement or any Transaction
Document or the transactions contemplated hereby or thereby, (b)&nbsp;the negotiation, execution or performance of this Agreement or any other Transaction Document (including any representation or warranty made in, in connection with, or as an
inducement to, any of the foregoing documents), (c) any breach or violation of this Agreement or any other Transaction Document or (d)&nbsp;the failure of the transactions set forth on this Agreement or any Transaction Document to be consummated, in
each case may be made only against (and are those solely of) the Persons that are expressly identified parties to such Transaction Document. In furtherance and not in limitation of the foregoing, each Party acknowledges and agrees, on behalf of
itself and its respective Related Persons, that no recourse under this Agreement or any other Transaction Document or in connection with any transactions contemplated hereby or thereby shall be sought or had against any such other Person and no such
other Person shall have any liabilities (whether in contract or in tort, in law or in equity or otherwise, or granted by statute or otherwise, whether by or through attempted piercing of the corporate, partnership, limited partnership or limited
liability company veil or any other theory or doctrine) of any nature whatsoever arising under, out of, in connection with or related in any manner to the items in the preceding clauses (a)&nbsp;through (d), it being expressly agreed and
acknowledged that no liabilities whatsoever shall attach to, be imposed on or otherwise be incurred by any direct or indirect, past, present or future shareholder, equity holder, controlling person, member, partner (limited or general), manager,
director, officer, employee, lender, financing source, Affiliate, agent or other representative of any Person or any Affiliate of such Person (collectively, with such Person&#146;s assignees, successors and assigns, the &#147;<B><I>Related
Persons</I></B>&#148;), through the Company, its Subsidiaries or otherwise, whether by or through attempted piercing of the corporate, partnership, limited partnership or limited liability company veil, by or through a claim by or on behalf of any
party hereto, as applicable, by the enforcement of any assessment or by any legal or equitable actions, suits, claims, investigations or proceedings, by virtue of any Applicable Law, or otherwise. The Parties acknowledge and agree that the Related
Persons are intended third-party beneficiaries of this <U>Section</U><U></U><U>&nbsp;5.16</U>. Nothing in this Agreement precludes the Parties or any Related Persons from exercising any rights under the Merger Agreement or any other agreement to
which they are specifically a party or an express third-party beneficiary thereof, and nothing in this Agreement shall limit the liability or obligations of any Related Person under any other agreement to which they are specifically a party. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.17 <U>Special Committee Approval</U>. Notwithstanding any provision to the contrary, no
amendment or waiver of any provision of this Agreement shall be made without first obtaining the approval of the Special Committee. The Special Committee shall direct enforcement of the Company&#146;s third-party beneficiary rights under this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the undersigned Parties has executed this Agreement on the date
set forth in the introductory clause above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CLEARWATER ANALYTICS HOLDINGS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[STOCKHOLDER]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">E-Mail</FONT> Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>d921635dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g921635dsp001.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">


<IMG SRC="g921635dsp001a.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FOR IMMEDIATE RELEASE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Clearwater Analytics to Acquire Enfusion for $1.5 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Billion Expanding its Investment Management </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Platform with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Front-to-Back</FONT></FONT> Capabilities </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Investor Conference Call Scheduled for Today at 8:30 a.m. ET </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BOISE, Idaho and CHICAGO, Illinois &#150; January</B><B></B><B>&nbsp;13, 2025 &#150; </B><U>Clearwater Analytics</U> (NYSE: CWAN) (&#147;Clearwater&#148;)
and Enfusion, Inc. (NYSE: ENFN) (&#147;Enfusion&#148;) today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">software-as-a-service</FONT></FONT></FONT> (SaaS) solutions for the investment management and hedge fund industry. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock.
Additionally, Clearwater will pay $30&nbsp;million to terminate Enfusion&#146;s tax receivable agreement (TRA). This equates to a purchase price of approximately $1.5&nbsp;billion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Today&#146;s announcement is about creating a future where our clients benefit from the synergy of two highly complementary, innovative software
leaders, paving the way for a unified, cloud-native <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">front-to-back</FONT></FONT> platform that&#146;s primed to serve institutional investors like never before. We expect to accelerate
growth based on our increased <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-to-win,</FONT></FONT> higher <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">back-to-base</FONT></FONT> sales, greater presence
across key geographies and increased Total Addressable Market (TAM). Coupled with our operating rigor and use of Generative AI, we have high confidence that we can drive meaningfully improved unit economics at Enfusion while also growing its
emerging managed services business,&#148; said Sandeep Sahai, CEO of Clearwater Analytics. &#147;Most importantly, this acquisition enables seamless data management from the front office to the back office, unlocking powerful network effects that
amplify client value.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Strategic Rationale </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
acquisition of Enfusion accelerates Clearwater&#146;s vision of building the first cloud-native <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">front-to-back</FONT></FONT> platform for the entire investment management industry:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Front-to-Back</FONT></FONT> Platform Leadership: </B>Enfusion&#146;s front-office
capabilities&#151;including IBOR, portfolio and order management&#151;will be integrated with Clearwater&#146;s middle and back-office solutions and client reporting capabilities to enable a unified, cloud-native platform that seamlessly integrates
with other technologies. This will allow clients to avoid the error-prone data handoff that happens between the front, middle and back office, which in turn creates major reconciliation issues resulting in inefficiencies, inaccuracies and increased
risk. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Enhanced Right to Win in Asset Management</B>: Approximately <FONT STYLE="white-space:nowrap">two-thirds</FONT> of Clearwater&#146;s core TAM
comes from the asset management industry, but the company derives only <FONT STYLE="white-space:nowrap">one-third</FONT> of its revenue from it. Enfusion has developed a next-generation platform for asset managers, starting its innovation in the
front office. Clearwater, on a parallel journey, has built a disruptive platform focused on the middle and back office, specifically in data ingestion, aggregation, accounting, compliance, regulatory reporting, and comprehensive client reporting. By
combining both sets of solutions and engineering expertise, Clearwater aims to significantly enhance its right to win with asset managers across various segments, geographies, and sizes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g921635dsp001.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Expanded Capabilities for Clients:</B> With very high levels of client satisfaction, as reflected in
Clearwater&#146;s high NPS score, the company has consistently been asked to do more in adjacent segments of its workflow. With this combination, Clearwater&#146;s clients in the insurance, asset management, and asset allocator
sectors&#151;including corporations, governments, pensions, endowments, foundations and REITs&#151; will, in due course, benefit from seamlessly integrating Enfusion&#146;s IBOR and its portfolio and order management software with the Clearwater
platform. We expect this to accelerate Clearwater&#146;s journey from 1 basis point to 4 basis points (bps) journey and improve net revenue retention. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Increased TAM and Hedge Fund Leadership:</B> The acquisition positions Clearwater to expand into the hedge fund industry. Enfusion has an outstanding track
record and wide acceptance as the leading <FONT STYLE="white-space:nowrap">end-</FONT> <FONT STYLE="white-space:nowrap">to-end</FONT> platform for hedge funds and more broadly, liquid alternatives. By adding dedicated engineering, product, and
client operations teams, Clearwater aims to accelerate growth and drive greater innovation within the industry. This expansion is expected to increase the company&#146;s TAM by $1.9&nbsp;billion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Global Growth Opportunities:</B> The international markets make up approximately 50% of Clearwater&#146;s TAM but the company derives less than 18% of its
revenue from outside the U.S. Enfusion&#146;s strong international presence, with 38% of its revenue generated in Europe and Asia, is expected to accelerate Clearwater&#146;s global adoption strategy. Having a significantly higher presence across
these geographies will strengthen Clearwater&#146;s ability to expand internationally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Significant Synergy Opportunity:</B> The combination presents
significant synergy opportunities across multiple fronts. Clearwater believes it will help accelerate Enfusion&#146;s growth based on the increased <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-to-win,</FONT></FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">back-to-base</FONT></FONT> sales, greater presence across geographies, and increased TAM. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Secondly, Clearwater has built a highly robust execution infrastructure across New Delhi, Edinburgh and Boise that operates effectively and at scale. Over the
past few years, Clearwater&#146;s operating rigor and its ability to harness Generative AI has allowed the company to aggressively improve gross margin while improving customer satisfaction. Clearwater expects to bring those skills to Enfusion and
has very high confidence of driving meaningfully improved unit economics, while also growing their emerging managed services business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">And thirdly,
Clearwater expects considerable efficiencies in general and administrative expenses, yielding about $20&nbsp;million in cost savings, which we believe will be delivered over the first two and a half years after close. In the Enfusion business
specifically, Clearwater expects to deliver 400 bps in Adjusted EBITDA margin expansion in the first year after close and an additional 400 bps in the second year after close. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#148;This transaction marks an exciting new chapter for all of Enfusion&#146;s key stakeholders. Since our inception, we have proven that the versatility,
scale, and depth of our solutions captures the hearts and minds of both traditional and alternative investment managers. Together with Clearwater, our shared passion for building innovative technologies and enriching every aspect of the client
journey will now accelerate and enhance our combined ability to support our clients&#146; evolving needs&#150;whether they are expanding into new strategies, asset classes, or geographies. That commitment will ensure our clients remain on the
cutting edge of investment management technology,&#148; said Oleg Movchan, CEO of Enfusion. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g921635dsp001.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael Spellacy, Chair of the Enfusion Board and a member of the Enfusion Special Committee, said, &#147;Our
agreement with Clearwater represents the culmination of a comprehensive process to determine the best path to maximizing value for all Enfusion shareholders. Our review of potential strategic alternatives for Enfusion was led by a Special Committee
composed of independent directors and advised by independent legal and financial advisors. We are pleased to have reached an agreement that will both deliver significant and immediate value to Enfusion&#146;s shareholders, and, together with
Clearwater, provide our shareholders and employees with the opportunity to participate in meaningful potential upside.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The merger agreement has
been unanimously approved by a Special Committee of the Board of Directors of Enfusion, consisting of directors independent of Enfusion&#146;s TRA holders, as well as by the Boards of Directors of both companies. Certain shareholders of Enfusion
affiliated with FTV, ICONIQ and Mr.&nbsp;Movchan, collectively holding approximately 45% of Enfusion&#146;s total voting power, have entered into voting and support agreements in favor of the transaction. The transaction is anticipated to close in
Q2 of 2025, subject to approval by Enfusion shareholders, the receipt of required regulatory approvals, and customary closing conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Building
on the momentum of our strong Q3 2024 results, we continue to see strong business momentum in Q4, and we are confident in our ability to meet and exceed the guidance provided for the fourth quarter and full year 2024. This outstanding ARR growth
allows us to look ahead to 2025 with high confidence. These achievements reflect the durability of our business model and our disciplined approach to growth, which positions us to execute this transformative acquisition effectively. With Enfusion,
we are taking a bold step forward, uniting two innovative platforms that will redefine investment management, deliver meaningful efficiencies, and expand our global reach,&#148; said Jim Cox, CFO of Clearwater Analytics. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Enfusion management expects preliminary full year 2024 revenue of approximately <FONT STYLE="white-space:nowrap">$201-202&nbsp;million,</FONT> representing <FONT
STYLE="white-space:nowrap">15-16%</FONT> year on year growth, and preliminary Annual Recurring Revenue (ARR) as of December&nbsp;31, 2024, of approximately <FONT STYLE="white-space:nowrap">$210-211&nbsp;million,</FONT> representing <FONT
STYLE="white-space:nowrap">13-14%</FONT> year on year growth. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transaction Details </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the merger agreement, Enfusion shareholders will receive consideration equal to $11.25 per share consisting of $5.85 per share in cash and
$5.40 per share in Clearwater Class&nbsp;A Common Stock. This represents a 13% premium over the January&nbsp;10, 2025, closing price of Enfusion Stock and a 31.6% premium over the undisturbed closing price of Enfusion Stock on September&nbsp;19,
2024, the last trading day prior to media rumors about a potential sale of Enfusion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exchange ratio will be determined at close with reference to a
10% collar around a Clearwater Class&nbsp;A Common Stock price of $27.79. If the volume weighted average price of Clearwater Class&nbsp;A Common Stock for the <FONT STYLE="white-space:nowrap">10-trading</FONT> day period ending on the second to last
trading day prior to the closing date (the &#147;Final Parent Stock Price&#148;) is below $25.01, then Enfusion shareholders will receive 0.2159 shares of Clearwater Class&nbsp;A Common Stock per share of Enfusion Stock. If the Final Parent Stock
Price is above $30.57, then Enfusion shareholders will receive 0.1766 shares of Clearwater Class&nbsp;A Common Stock per share of Enfusion Class&nbsp;A Common Stock. If the Final Parent Stock Price is greater than or equal to $25.01, but less than
or equal to $30.57, then Enfusion shareholders will receive a number of shares of Clearwater Class&nbsp;A Common Stock determined by dividing $5.40 by the Final Parent Stock Price. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g921635dsp001.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Enfusion shareholders will be able to elect to receive the mixed cash/stock consideration described above, or
<FONT STYLE="white-space:nowrap">all-cash</FONT> or <FONT STYLE="white-space:nowrap">all-stock</FONT> consideration, subject to proration to the extent cash or stock is oversubscribed. Regardless of the mix elected, the value per share will be
equalized ahead of closing, such that the value of each election choice will be substantially the same. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clearwater is expected to pay a total of
approximately $760&nbsp;million in cash and issue between approximately 23&nbsp;million and 28&nbsp;million new shares to Enfusion shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
connection with the transaction, an additional $30&nbsp;million will be paid to retire Enfusion&#146;s TRA. This payment represents an approximately 78% reduction to the contractual early termination obligation otherwise due under the TRA in
connection with a change of control, representing an approximately $105&nbsp;million benefit to Enfusion&#146;s shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clearwater has obtained
committed financing to support the transaction, which is expected to be funded, together with cash on hand, with a $800&nbsp;million Term Loan B to fund the transaction and refinance certain existing debt. Clearwater has also secured commitments for
a $200&nbsp;million revolving line of credit. Gross leverage at closing is expected to be approximately 3.7 times adjusted pro forma EBITDA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advisors
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC is serving as financial advisor to Clearwater Analytics. Committed financing for the transaction has been provided by
JPMorgan Chase Bank, N.A. Kirkland&nbsp;&amp; Ellis LLP is serving as legal advisor to Clearwater Analytics. Goldman, Sachs&nbsp;&amp; Co. LLC is serving as exclusive financial advisor to Enfusion&#146;s Special Committee. Dechert LLP is serving as
legal advisor to Enfusion&#146;s Special Committee, while Goodwin Procter LLP is serving as legal advisor to Enfusion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conference Call and Webcast
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clearwater Analytics will host an investor conference call to discuss the transaction on <B>January</B><B></B><B>&nbsp;13, 2025, at 8:30 a.m. ET</B>.
A live webcast of the call will be accessible via Clearwater&#146;s Investor Relations website at <U>investors.clearwateranalytics.com</U>. A replay of the webcast will also be available on Clearwater&#146;s Investor Relations website shortly after
the call. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Clearwater Analytics </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clearwater
Analytics (NYSE: CWAN), a global, industry-leading SaaS solution, automates the entire investment lifecycle. With a single instance, multi-tenant architecture, Clearwater offers award-winning investment portfolio planning, performance reporting,
data aggregation, reconciliation, accounting, compliance, risk, and order management. Each day, leading insurers, asset managers, corporations, and governments use Clearwater&#146;s trusted data to drive efficient, scalable investing on more than
$7.3 trillion in assets spanning traditional and alternative asset types. Additional information about Clearwater can be found at <U>clearwateranalytics.com</U>. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g921635dsp001.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Enfusion </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Enfusion&#146;s investment management
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">software-as-a-service</FONT></FONT></FONT> platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one
system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over
850 investment managers from 9 global offices spanning four continents. For more information, please visit <U>www.enfusion.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Enfusion&#146;s
ARR </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Enfusion calculates Annual Recurring Revenue (ARR) by annualizing platform subscriptions and managed services revenues recognized in the last
month of the measurement period. Enfusion believes ARR provides important information about its future revenue potential, its ability to acquire new clients and its ability to maintain and expand its relationship with existing clients. ARR is
included in a set of metrics Enfusion calculates monthly to review with management as well as periodically with its board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
&#147;forward-looking statements&#148; within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the beliefs and assumptions of Clearwater&#146;s and
Enfusion&#146;s management and on information currently available to them. Forward-looking statements include information concerning the following factors in reference to Clearwater and/or Enfusion: the timing of the consummation of the acquisition
and the ability to satisfy closing conditions, possible or assumed future results of operations, possible or assumed performance, business strategies, technology developments, financing and investment plans, competitive position, industry, economic
and regulatory environment, potential growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as &#147;anticipate,&#148;
&#147;believe,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;aim,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;seek,&#148;
&#147;should,&#148; &#147;will,&#148; &#147;would&#148; or similar expressions and the negatives of those terms, but are not the exclusive means of identifying such statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond Clearwater&#146;s and Enfusion&#146;s
control, that may cause their actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include,
but are not limited to, the ability to successfully close the acquisition, Clearwater&#146;s ability to successfully integrate the operations and technology of Enfusion with those of Clearwater, retain and incentivize the employees of Enfusion
following the close of the acquisition, retain Enfusion&#146;s clients, repay debt to be incurred in connection with the Enfusion acquisition and meet financial covenants to be imposed in connection with such debt, risks that cost savings, synergies
and growth from the acquisition may not be fully realized or may take longer to realize than expected, the finalization and audit of Enfusion&#146;s 2024 fiscal year financial results which could potentially result in changes or adjustments to the
preliminary financial results presented herein, as well as other risks and uncertainties discussed under &#147;Risk Factors&#148; in Clearwater&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended
December&nbsp;31, 2023 filed with the US Securities and Exchange Commission (the &#147;SEC&#148;) on </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g921635dsp001.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
February&nbsp;29, 2024 and in Enfusion&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 filed with the SEC on March&nbsp;12,
2024, as well as in other periodic reports filed by Clearwater and Enfusion with the SEC. These filings are available at www.sec.gov and on Clearwater&#146;s website, investors.clearwateranalytics.com, and Enfusion&#146;s website, ir.enfusion.com.
Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent management&#146;s beliefs and assumptions only as of the date of this press release and should not be relied
upon as representing Clearwater&#146;s or Enfusion&#146;s expectations or beliefs as of any date subsequent to the time they are made. Each of Clearwater and Enfusion does not undertake to and specifically declines any obligation to update any
forward-looking statements that may be made from time to time by or on behalf of Clearwater or Enfusion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Enfusion&#146;s financial results for and as of
the year ended December&nbsp;31, 2024, presented in this press release are preliminary, unaudited, and based on currently available information. Enfusion has provided estimated ranges because financial closing procedures for the quarter are not yet
completed and final results may therefore vary from these estimates. These preliminary estimates have not been audited by Enfusion&#146;s independent registered public accounting firm. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Offer or Solicitation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release is not
intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section&nbsp;10 of the
Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information and Where to Find It </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the acquisition, Clearwater will file with the SEC a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (the
&#147;Registration Statement&#148;) to register the shares of Clearwater&#146;s common stock to be issued pursuant to the acquisition, which will include a prospectus of Clearwater and a proxy statement of Enfusion (the &#147;proxy
statement/prospectus&#148;). Each of Clearwater and Enfusion may also file other documents with the SEC regarding the acquisition. This press release is not a substitute for the Registration Statement, proxy statement/prospectus or any other
document which Clearwater or Enfusion may file with the SEC in connection with the acquisition. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER
RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE
TRANSACTION, THE RISKS RELATED THERETO, AND RELATED MATTERS. After the Registration Statement has been declared effective, the definitive proxy statement/prospectus (if and when available) will be mailed to Enfusion&#146;s security holders.
Investors and security holders will be able to obtain free copies of the Registration Statement and proxy statement/prospectus, as each may be amended or supplemented from time to time, and other relevant documents filed by Clearwater and Enfusion
with the SEC (if and when available) through the website maintained by the SEC at www.sec.gov. Copies of documents filed with the SEC by Clearwater, including the proxy statement/prospectus (when available) will be available free of charge from
Clearwater&#146;s website at investors.clearwateranalytics.com/overview. Copies of documents filed with the SEC by Enfusion, including the proxy statement/prospectus (when available) will be available free of charge from Enfusion&#146;s website at
ir.enfusion.com. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g921635dsp001.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participants in the Solicitation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clearwater, Enfusion and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in
respect of the Transaction. Information about Clearwater&#146;s directors and executive officers is available in Clearwater&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 filed
with the SEC on February&nbsp;29, 2024, its definitive proxy statement for its 2024 annual meeting of stockholders, which was filed with the SEC on April&nbsp;29, 2024, and in the proxy statement/prospectus (when available). Information about the
directors and executive officers of Enfusion is available in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 filed with the SEC on March&nbsp;12, 2024, its definitive proxy statement
for its 2024 annual meeting of stockholders, which was filed with the SEC on April&nbsp;26, 2024, and in the proxy statement/prospectus (when available). Other information regarding the participants in the solicitations and a description of their
direct and indirect interests, by security holdings or otherwise, will be contained in the Registration Statement, the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the Transaction when they become
available. Investors should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. Copies of the documents filed with the SEC by Clearwater and Enfusion will be available free of
charge through the website maintained by the SEC at www.sec.gov. Additionally, copies of documents filed with the SEC by Clearwater, including the proxy statement/prospectus (when available) will be available free of charge from Clearwater&#146;s
website at investors.clearwateranalytics.com/overview. and copies of documents filed with the SEC by Enfusion, including the proxy statement/prospectus (when available) will be available free of charge from Enfusion&#146;s website at
ir.enfusion.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact
for Clearwater Analytics </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joon Park | +1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">415-906-9242</FONT></FONT> |
<U>investors@clearwateranalytics.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact for Enfusion </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bill Wright | <U>investors@enfusion.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact
for Clearwater Analytics </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Claudia Cahill | +1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">703-728-1221</FONT></FONT> |
<U>press@clearwateranalytics.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact for Enfusion </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mollie Applegate | <U>media@enfusion.com</U> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cwan-20250110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 1/13/2025 4:43:46 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:cwan="http://clearwater-analytics.com/20250110"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://clearwater-analytics.com/20250110"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cwan-20250110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cwan-20250110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cwan-20250110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 1/13/2025 4:43:46 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cwan-20250110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 1/13/2025 4:43:46 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cwan-20250110.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g921635dsp001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g921635dsp001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  K ,\# 2(  A$! Q$!_\0
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MSY;FE? XCZS0MS6:U2::DFFFGW3-\PRZCC*'U:K>VCT=FFG=-,_/[2OV?_\
M@H9%JMJUQ\;OA2;=9T:8'2T8% PW J+%2>,\!E)]1UKZV_;%^">H_M'?LI^/
M? FFW=G9:IXJT2XTZVN+D-Y$<KIA2^T%@N>N 2!V->FT5OBLZJUZM.LJ<(.#
MNN2$8ZW3UMOMU,,-D].C2G1<YS4U9\TG+NM+[;GDO["?P"U/]EO]D/P%\/\
M6KNRO]6\,:8MK=SV>XP/(79VV%@&*@M@$@9QG Z5XMXJ_P"";?B/P-_P46M/
MC?\ ";Q)I'A2Q\1V5S;^-=)NHI'CU*5HVV31QH-K%I1$[AF7#1EP2785]AT5
MG3SG%4ZU6O%ZU5)2T5GS:O3;?5=G8TJ93AIT:5&2TI\KCKJN7;7TT?=!1117
MEGI!1110!\7?\%)_C?;ZC\1M)\#VGC73_!UUX4L'\7/<7$_EB[U"/_CPL_\
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M#XIUNRLQ!JGB-K5]1G\QV^TF&+RX_E)*KA>/E SWR:K"XOV5.<+;K3R>U_\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g921635dsp001a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g921635dsp001a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  Z *D# 2(  A$! Q$!_\0
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M!5E#V$9>T]]Q4DF[I6^):/?W=K[B2?0_1JBO.?VKOB+XK^%/P+UG7/!6A?\
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D$ CCJ!7Y"?\ #.WP_P#^A%\'?^"6V_\ B*ZLOG:D_7_(#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46220761670336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 10, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001866368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 10,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Clearwater Analytics Holdings, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-1043711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">777 W. Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boise<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">ID<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">83702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">433-1200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class&#160;A common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CWAN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "M-2U:/49G:FT$  !#$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V877/B-A2&_XK&[?0JP1\0("DP0TC237<WRP3:3-OIA; %:")+KB2'\.][
M9!.;;LTQ-V 9G]>/I*/W2(QV2K^:+6.6O*="FK&WM3:[\7T3;UE*34=E3,(O
M:Z53:J&I-[[)-*-)$90*/PJ"OI]2+KW)J+@WUY.1RJW@DLTU,7F:4KV_94+M
MQE[H?=QXYINM=3?\R2BC&[9@]K=LKJ'E5RH)3YDT7$FBV7KL3<.;V^C*!11/
M_,[9SAQ=$]>5E5*OKO&8C+W $3'!8NLD*'R]L1D3PBD!QS\'4:]ZIPL\OOY0
M?R@Z#YU94<-F2KSPQ&['WM C"5O37-AGM?O$#ATJ &,E3/%)=N6SO< C<6ZL
M2@_!0)!R67[3]\- ' =<GPB(#@%1P5V^J*"\HY9.1EKMB'9/@YJ[*+I:1 ,<
MEVY6%E;#KQSB[.1.Q3D,LB54)N1>6F[WY%&6LPVC-O(MO,0]ZL<'P=M2,#HA
M^"N5'1(&%R0*HJO_AOO 5@%&%6!4Z'5/Z,W4&]/DK^G*6 U3^'<34:G0:U9P
M>7UC,AJSL0>):YA^8][DIQ_"?O SPM>M^+J8^F0*HY<4(_@@Z*:)#H]?4V$8
MPM&K.'JHSF'N9D"BJ8 Y3-@[^<SV342X4A $X;#?[_:'"-95A76%BE7YM=QG
MK(D%#Q]>?D8@^A5$_SR(.=-<N3Q/"*R61AY<J<KNMO0>5&B#<Z;MF6VX2W!@
M?*)I(QBN,Q.,ZAWT29.II&)O>6S()R42+C?F M(A[B"TPXIV> XMJ"F=*5U8
M!%E8>"V9J1PR#Q)0)8WXN/#=/4)W7=%=GT/WP 4C3WFZ8KH)!-> W+_L!<,N
MEOMA4)MK< [1DKZ3QP02D*]Y7 [::;X6R>'@,@QZW4$88H1']A^>0SA-$K!&
M2)3#!?D"SY%OLG$J6R0'@P%YZ9"OL"6 W-!0F3#2N@Z$J(WCI,N=:B3%)1<Y
MA\R]#@(,L"X$(>[DWP/.7$MILE2[YCJ*R]TJCA:&L*X,X5FEH0(K%RR0S;5Z
MXS)NGF1<\_$.0ZNK0XC[^_=H<V4L5*\_>7;22%H4A]U!$&%L==$(<:\OYF\*
M6]W3*+A %* N4I>($/?V+RJ&,9EOE<1\K46DU^U>AA&>ZG49"'&[?M'<6B9A
M8-(TEP=/,XU4N)#5.9KCM?6'N&\OE. QMU#MP'B@"G(J&G%PE;;-6%0[?X3;
M]%RS8G08+*]R_P/;1"C.W];KYNEKT6LEJQT_PNWY?V2/QN1 U@J(R[8"'FWX
M6UR9Q;EV:R^,5F3)K6A<>RTB,T&-*3?Y4Q)#=Z'FPF$J?KT@&=7DC8J<D1^#
M#M1[DD&WS99J%+\N Q'NVTM-W::++/;I2C4F88O [&7ZA)'4OA_A'ET-Y/U[
MO*5RPT[N+5N$GOY88/NSJ+;[Z"R[OT^9WK@Q^@44[-:E8T9EXU&E1?!DUOE'
M1V+W]\)7ZMYHB&!K$ HZ ]#5Y8F];%B5%:?DE;)PYBXNMXS"BG /P.]KI>Q'
MPQV\J_]-)O\"4$L#!!0    ( *TU+5J?H!OPL0(  .(,   -    >&PO<W1Y
M;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KK
MI[-L)VEU9=V'L<VAR=T]NKM'=R>9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8
M^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L
M*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:
ML!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI
M\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF
M X?)8Q1\V .7\@%:^*VZBMU7)/3B4PEM(+#52?2$1C&$"0K$OXP68E^$O?VM
ML*01C\9][/QN]*!_[XSC]Y97HA_TOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;
M_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2
M]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=
MV_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>
M;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*
M(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D
M>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8
MJ;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P
M!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( *TU+5J7BKL<P    !,"
M   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8
M$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*N
MU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I
M2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3
MZ:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ K34M6APX
M9>H_ 0  / (   \   !X;"]W;W)K8F]O:RYX;6R-4<MNPD ,_)75?D 34(M4
M1+B4/I"J%I6*^Y)UB,4^(J\#+5]?)U%4I%YZ\GILC6=F%^=(QWV,1_7E74B%
MKIF;>9:EL@9OTDUL(,BDBN0-2TN'+#4$QJ8:@+W+IGD^R[S!H)>+D6M#V743
M&4K&& 3L@!W".?W.NU:=,.$>'?)WH?NW ZT\!O1X 5OH7*M4Q_-+)+S$P,9M
M2XK.%7HR#'9 C.4?>-N)_#3[U"-L]A]&A!1ZE@MAA92XW^CYC6@\@2P/7<OQ
M"1T#K0S#,\6VP7#H:,1%=F6CSV&L0XAS^D^,L:JPA%4L6P^!AQP)7"<PI!J;
MI%4P'@H]KB@3K'H,+"&I=1BH9+=S*J?7=G#-(O<J0YJC#&AM!^&C6@L5!K!O
M<B )+LF5&U)=Z7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0    ( *TU
M+5HD'INBK0   /@!   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.U
MD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.
MGV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S
M9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H
M,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04
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MYHOA/UY_ 5!+ 0(4 Q0    ( *TU+5H'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ K34M6HXJ"L[O
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ K34M6IE<G",0!@  G"<  !,              ( !S0$  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "M-2U:/49G:FT$  !#$0
M&               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ K34M6I^@&_"Q @  X@P   T              ( !L0P  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " "M-2U:EXJ[',     3 @  "P
M        @ &-#P  7W)E;',O+G)E;'-02P$"% ,4    " "M-2U:'#AEZC\!
M   \ @  #P              @ %V$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ K34M6B0>FZ*M    ^ $  !H              ( !XA$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ K34M6F60>9(9 0
MSP,  !,              ( !QQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      D "0 ^ @  $10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d921635d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cwan-20250110.xsd</File>
    <File>cwan-20250110_lab.xml</File>
    <File>cwan-20250110_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d921635d8k.htm">d921635d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d921635d8k.htm": {
   "nsprefix": "cwan",
   "nsuri": "http://clearwater-analytics.com/20250110",
   "dts": {
    "schema": {
     "local": [
      "cwan-20250110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cwan-20250110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cwan-20250110_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d921635d8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-01-10_to_2025-01-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921635d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-01-10_to_2025-01-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d921635d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://clearwater-analytics.com//20250110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-25-004935-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-004935-xbrl.zip
M4$L#!!0    ( *TU+5H7'XM<1@,  &0+   1    8W=A;BTR,#(U,#$Q,"YX
M<V2]5M]OVS80?B_0_^&FIPV81,MV"D2(4[1+ P1(L\)-A[T5-'5VB%*D1E)Q
M_-_O2%F.8B>NFQ3UBVG>?7??_:1/WMY5"F[1.FGT),FS00*HA2FE7DR2QJ7<
M"2F3MZ>O7YW\EJ9P=GYQ!2G<>%^[@K'E<IF5<ZF=48TG"RX3IF*0IIW^7]=?
MX)_6>@%35,@=0L6=1POO&ZG*8C@8CO-\.,SR/LPB#_:@Y!X+R%D^8J1X!.-B
M/"K&;^#31_@0K6BXEA7VH:9>6;FX\?"[^ ,BZ,QHC4KA"LZEYEI(KN!SQ_A/
MN- B@W=*P33 '-%T:&^QS-96[UQ9.'&#%7_]"H#RI5VAR61339*0B'4>[F96
M9<8N6.DM\ZL:&2FEI(56BJ0'_3YN!T.%"!*W <ZYFT50)PGI&?<08LGU1EM0
MWNV24FE3KKE:>2G:2H7T#/)\T .6*#>X2,VAR!;FEI%@VTF0R\>#&0X&(T:-
MX2G?V(,HJ;_M003QC'JD[V0'LAQ%0'Y\?,RB=(M2Z1]&L+9^Q%IAU.;>6SEK
M/)X;6YWAG#>*4(W^K^%*SB6648L:MD+M'^@\U/#<+M!?\0I=S04^*^748(_%
M1Y1S]N_'R\^Q]Y+3  "([2BKVE@/;5=>&A&'94]:PZ^TJT8:KM)\F([RC(PE
MH'?8[RDEL!<3Z8K\+"*;#CF8B'NJD\,A#8>GO#_>_\_.P/: A_B/0_SYFX/B
MWUD0/X&)T5<O)=/;<L^OB>8T(&U5XO'PNMPC7]2;W78(>3C:ZWA[G:R]1I]<
M:^.CHSX37M=2S\WZBBY#$Q==)T]Q#G&-%=P*:Q3N7W:LMJ9&ZR4M_?MA: W<
M6)Q/DK#[TV[/?%5\EM&>Z51V'#P<KR!F!$%U>4^OPWKI _@RB"'(Z?7D:F,Z
MM,,D<91WU1O/7QQN;?%'PR6(HRT?R_9TU)]Z6C\<?/!S31H0#E^F%]]_)S8/
M!?/\SFA3K5JR9T8TX4WJOM_I\H,FBJL+ZC!;17H)2'I1IJ3^]2#U#=F.;HGT
MIT[&-LX'X4/_^3H+_2/7);3FH&?OA&T;V;;?."S_UJ?Q++@2C=HD?PU>:^P#
M;I?M<.0]LZ=QZ]NN<-TXL^UY7M_TY[Z]:O<._?P?4$L#!!0    ( *TU+5KV
M(=Z\>P8  +E&   5    8W=A;BTR,#(U,#$Q,%]L86(N>&ULS9QO;]LV$,;?
M%^AWN'EO-J"R:R<;4*-ID3E)$2QM@L;=A@U#(4N,34PB#5*.[6\_4G\:.:9D
M*CQ5>=%6D>Z>NT?YG<I(<MZ^W\01W!,A*6<GO6'_=0\("WA(V?RDMY*>+P-*
M>R 3GX5^Q!DYZ6V)[+U_]_+%VQ\\#\XN+C^!!XLD6<KQ8+!>K_OA'6621ZM$
M2<I^P.,!>%X1/YE^@3^R<F/X3"+B2P*Q+Q,BX+<5C<+QZ/7H>#@<C?K#<IH@
MOM:#T$_(&(:#X=% !?X"Q^/CH_'QKW#S$<Y3%093&I-R*E]N!9TO$O@I^!G2
MI#/.&(DBLH4+RGP64#^"VZ+C5W#)@CZ<1A%\UFE2M2F)N"=A/U>-*/MOK/^:
MZ>;AY0L =1:93/>=]/2YR$_%9B:B/A=SU>OKHT&1TGO(V.REK(_2A.&;-V\&
MZ=%RM*2F6"4^'/SU\>HV6)#8]]395]^M("\CZ5BF^Z]XD)Y"BP:A,D)_Y15A
MGM[E#4?>T;"_D6'OG2Z8GQU_1J(KM06IA['@$:DIK ^GU7MY?+)=JGBR20@+
M2:[\39L'>=1"D+M,5;.72DH2].?\?A 2J@$YUAN>WM =_JB^^#KA"O?3F4R$
M'R2[]2)]BK@H=J8F3GJ&I,%N0SKN5 0[6KX("AVU><!_'C$(N/J^+1,O52S2
M[P2/C5WDY;CAX-=H%AG;U"2I+3W=A'E?;@]YS83*Q@21?"447DV^M:F?=ZDR
M_%-H__MV\%#[N;2J+B&27#7MUPW)TUAAKOXD%Y$_MT7R45)'2)I;YX:#+D@:
MA)"0_*8,6MH9R!8:+0-IVZT;CN<LH<EVHLH(/[I4%^#-[V1KBV5%<D=XUEOA
M-4$NN-8((F&;58"\!*0U0!5Q!KC%ULL@-^_?#>DS'JSTW$Q5][8D[^9T!+"Q
M<;Y_S 77?1TD2@MAT,K.:.*W62;2LE<<#&^(H#P\9^&9^G&F*8^/DCL&TVR%
MUP1AH&H0Q&8V*P&J!N@B:/BVT+J18^O^,18+G\F<ZD4R2S[YL371YMQ.EPH5
M1GAUC/M"P:2'NTYXJ "Z!-(JH8V^#8L$Z^8Q0+YD 1=++M););>)&IP)7ZE%
MRG;"PX9<'Y#J%',[F]PZQ7T(+.1Q9V*G(*05(2\)NB;2D'P'7X:9>;HYC"&Z
MH!'YM(IG1#2;F')>I^-A,,#-Q]W!?ZR%2[E6ATP>"6CL?@WT6C6- >K4WUR&
M:K%$[VAV<_PIU%:*=(KP(6O<(M@=[EIA7-)5*=BMA<M]JU8,0_ $/Q@C<1J&
MRH#,_[FBC R;C8-1H--1J+/$#P2ZCT"E*"[^N?ZK8@-T);AF6.N8UFP8T'^"
MEW;0'[FB/WIVZ(]LT1^U@?[H^Z$_7?/6T$>R88U^K1=$]"=J\UI,^9H]"?QR
M^G/ WF#'!/U#&!KRCR5; EZ7 2Y %\*%'=M '>IV+A Q3W\>OA8W@M]3%C2\
MK5.E\1R KS)FHOY1+!KZ1MV6^,]N;"ATBFJX0]"*E;I):. '<1QNN$S\Z&^Z
M;'Z/TZSP'$;!;,HT"#N1:&-@4&UI"+)*H$IAWK=LST;= %A[<7P'4!L4Q&\"
M_&Y.5V\ FAKG^\><WO_;TT$"-_U_7BOC<(K?Y\Z[?Y;-NH&H7\J-;A:<-;Q?
MOI_7$9"5!KCYN N89BTD.%-Q2-6Q[ANVTV\9TB9-NX'ZIZ!)0MB$Q_&*Y?<C
MI2VM%<D=(5MOA=<$N<!;(XA$<%X!=DLX4]QBXV64FW;OAO,MCVA $\KF']6*
M6U _LF79E-D1R#4F>%6$"\)5:DC\/LA#H>\,;ULME\EMU+<;MC>"Z/D@"HOT
M34C]Z1AQ?7=GOW"H4^@(8PM3_%"D"]:'5)'P5F6@7 >R0I!6<@:];1-EX)_H
M!!7]2RE71+@/@$'G>8Q!M4'S,.S%(XY$A79;@Y&5:W4^6G)4.R6-;#DN;TBP
M4NNI[7 TF](DLK['L9_7U=*FR@ W'W=:UABUL!8UN3@H=4CEW=<TK?2[LZ)I
MT+0;J%/AZX^:WV[C&;=>@C]*Z@A1<^O<<- %3H,0$IFY,F32SE2VT&@92=MN
M<:Z;YYM@H=R2)A]F,.=V?/TT&N'5,1C7T7T][&MI40'GPPSM]6V\IEHVC_%\
M[SPF8JZFYH/@ZV2A%B-+GS7\(&^%1*=/^.IM\8.A[L_X:F216,\?C!6%(*L$
M>2FD9WPMVC \Y+/U4MYQI;;TKUS)=]'L%X^H/?\#4$L#!!0    ( *TU+5K'
MJBX0R00  $\L   5    8W=A;BTR,#(U,#$Q,%]P<F4N>&ULU9I=C^(V%(;O
M5]K_X*8WK=00 LRV@X99469FA3H?"-BVZLW*) >PZMC(-@/\^QX'O.4CS,+L
MMHJY@.#X/7Y]'L=@)U?OEQDGSZ TDZ(5Q)5J0$ D,F5BT@KF.J0Z82P@VE"1
M4BX%M((5Z.#]]=LW5]^%(;FYZSZ2D$R-F>EF%"T6BTHZ9D)+/C<84E<2F44D
M#%W]SO C^7W=7)/T@0/50#*J#2CRZYSQM%FKUAIQ7*M5XFV9 FKCD90::)(X
MBNL15KP@C6:CWFR\([T'<IM'$63(,MB6RME*L<G4D!^2'TDNNI%" .>P(G=,
M4)$PRLG .?Z)=$52(6W.2=_*--K4H)XAK6RB<B;^;MJWD35/WKXA^,(\"IV7
MM@*;C4TREB/%*U)-T&VU'CE1L*U9'H@6]5P27UY>1OG9W?J:%=7&!N+HSX?[
M03*%C(;( )DE>TVAF]1\5F^;NXC6)UU]S9HZCW0ODSSU)W2+'*UAOX6N6FB+
MPK@6UN/*4J?!M6URG54E.?1A3.SGQW[W<YL)#A2U0/8JI(+RE6')>FCEHZ :
MQ]7(T*44,EM%5AO=R&2>@3#NLRW26V&8677%6*HL[U% \N0VIPK&K2!94!&Z
M:-;7]WT,].F<0&8UP^M#LVS&(2#15K]F"L>0,'GM>RS8$<#2@$@A=6%L!_[C
MGE^O*6^&LDQV,N$NYARAAJ0RD<]1"LRVV+ '-DV-/$7XY5-'XOS1'FFC:&)V
M4\'MV)'*%7(Z MX*"D31MS34QFZGMNMWG$Y.-;0GVC6TC:^MDIV05"4N'![N
ML#N\#C8UHAE5&"],ICCC.?58R:PP.9O69*%1J5)0K0#G2[S^ S)33"J$C24!
MF6OT(F?6->7V'(Q!*4COU]T^ZC*WB"-.0U[S&^-9C\8.]D!1WL6!O_P-5J=B
M.B(N+ZXCAAVVNC?8W'PRQ#2>2FM74UY(NSX=FPOOV/0 O>)TG][@#\:YD/;$
MY:>U9]AA>^<-MO7<T(<)LQT5YI%F)U,KUI876K%?Q^QGSYCA$D&JF51Y:@>8
M8>C(.4[QJXY,ST3XA5!E)_H%^P[P+YX!OF,<'N?9"-1Y-+=U94>W[=5QNO2,
MTY NNRFF@8W9>IGZ&FA'@Y2=X%'C&YSUJF<XVVF*2=:;#UPI0WP>RL( 9<=8
M:-HAC+U'6/M:A#4?$=;^1>C;VGS3BPX>/JFA7(A7 =R6>X)OV[*#Y\\*?:<K
M^5^Q)]53\IG9;>#7$#R(X0G& ]^.9<-/ECVI#>5_L=GYJXOB")YPW'/M*/JS
M+V/GD[8">@ZW74UY2>WZ=&S\V7RQ][5X;RK%F>N\0UUY&1UZ=9S\V7#Y _T9
M$!V997.Q6>;H4V$=$9>7V!'##IL_VR@#R5G"#!.3!WOSDEEKIS$K4I876)%;
M1\N?S92> COD /\MY?=![/UH]30>GSXMOA2AO/1><KVAV/!G#V6O-UVMYZ"^
MGF5!'&^(%GAW7/W96!E ,K<6X]IHR P_^:_DH:Z\W Z].D[^[)X,%;4/S@U6
MV4B>_'.W)RHOH3VC#H\_^R-NB-TNDRD5$SCG=FNQMKRPBOTZ9K[M@]QFH"8X
M]CXHN3!3G-]G5)SYR-"1$.4E^*)M!_)_V JYB@Y2<X\%]D'8]1G[9A_KQ))_
M %!+ P04    " "M-2U:FEC7!<0H  #2W@  #@   &0Y,C$V,S5D.&LN:'1M
M[3UI=]I(MM_S*^JXIV><.8 !.XOMQ.\0C#M,.\;/D*3[?9E32 6H(R1&BVWF
MU[][;U5)I0WP[G2GSYF)T5++W=?2N_^YGKOL4@2AXWOO_]%J-/_!A&?YMN--
MW_^C,^SV^__XGZ,7[V81/ :/>N&!+9SW6[,H6ASL[%R/ [<1"JLQ]2]WX,9.
MN]G>VU(/QF$]6BY$F#P]X>&XX0?3'7TG\[CG>UX\3QZ^NKIJT/#X@AT%._C&
M#CQ4AZ=$X%CZO6O7\;YE7KO:I9=:^_O[.W17/UIX,IF@W6SN[N#M,0^%?MRZ
MXE[RN.4*'ESQ2 1U[G%W&3E6V+#\.>[A5;/5:B;K"9VRU< ,K9W?/IT.K9F8
M\[KCA1'WK&2N. HJ5[:_ W?U@T[H[[5;;U9L0SV1O'!=]6P+GO5@T^*W#Q>G
MZ>-1^?/IHSM1P+UPX@=S'@'9X$BOZLUVO?W:&*0.9)$92)/)NG'>UG=;"2QA
M<F?55G-0Q+MVCCS5PZ]WY$WU:#7!(*EO(<D+;L,_D1.YXNAM_==W._+/%^_F
M(N(,7Z^+_\3.Y?NMKN]%PHOJ(R#1+6;)7^^W(G$=[=!P._#6CAR0,?9N[-O+
MHW>V<\G":.F*]UNV$RY<OD0>$%M'[)US?8!/BT#][=BV\.3?\,B99 #F\3F^
M*YR#SEQX-OPO.G'Y5*W@.KH0$[@=!P3=?R.=UINM>JOY[\@W?FTQQWZ_Y5Q?
MUG??O-HZFG W%.]V,C,59L8W/M*B_@W3_[OG 6B679@_X&[?L\7UKV*Y9:RO
MXH&;K?.H"2ST]O7KW==OB^O;R8$I$!,1@"03(?Q&QCX(B?%@KH>4&S032JKW
M6Z$S7[C)M5F FT2)4M<"HW$=VOHV#ZS 1TI8/\F.VFUFA_0[].- _B2^.5#@
M)6QM %[]FB!D)3\=&R],'!$P J$HY>IN_]<L@O(OXZI+QU\ !GT[^0D,'43'
M(&>/TK7I-]-[Z5KMBF?UG63:9)Z=#'02:*;0VS'9;P?8%/XQF!7?JG/7F7H'
M%NQ%!%O9^U>.'<T.WC9>.=ZA\:PK)M'AG =3QZOCWP>,QY&OKP3.=*8NX7 +
M/1C*ROI,T%W0SHMDB,A?'!@_QWX4^7.Z,O8#6+J^TEI<L]!W'9O]U*3_MH[^
M_E/K=?/PW<ZB:J+=]1.U;SV1,>P>#,**&V 30$T]=/XK#EIOD]\3/G?<Y<'(
MF8N0G8DK=N'/N7=(]Z[DNL>^:Q^6H.?S67_4.V;#46?4&U8OI_E(RQGVNI\O
M^J-^;\@Z9\>L]UOW8^?LEQ[K#CY]Z@^'_<'9G=;8OH\U?NT,/_;/?AD-SFKL
MN-%ML';SU=Y^;EWII&\W(,PL/:QCJ%+"?'TKPFPTX;$L;1Y*)FVW?BYN?D,F
M33>C9409OMX^$DV=#"X^L7?A@GN)&)HYD:C#%4N JKP*^&+KJ-* ./:M&.T'
MPX*YA?WP]O66M)2RVOG=#J[KZ ?Q/ #QW NS@SBZZ)V-V$7O?' Q>GKA<QX'
M8<R]B$4^&PH+R4\"K+7+_("U7FW;+Y]^E?Z$13.!"XP#)W+@_=ZU->/>5+".
M%3&XW=K?W:M>YV-A%\T@7,V%6/A!Q+;U;_!G75AUQ,0E/,D"NBWLEP?5?H86
M$^=D2_6DB75C>2$]/I09T8$- \SA]9G-ETM8D?!,>?)FZ^A?W(MYL&2M9HWA
M($7A\D.JW+=4:>_=!]U54I'T!B_$U DQ A"=P9T[*)VW(,"2X SKZ. ,^PCK
M<KQI6&-]SVJLH9N;R8_F?<!GNW?-04X@7"1[:G@P'K+A0ECH-]G,\5@_"EEW
M!KZ/"/)R[P>]E]/['>#RXEW$QZY@EG!=-)\P%+H%%(>_%]RV]6\UD]JIY;LN
M7X3B0/^QFD!8=H$2%JUF\V<%N8.F6N5!4SN%L*Z _M_.>IJ[>S]C4,"\<2D"
M8 'N*J#*C>8?4F^W-WM;+['PM#G,NQVUQ$#?7?"IJ(\#P;]AR-.QQ0&_]($(
M-H9.B]"3F9$9],(R!'- I,)R&P"T@S0R;>,\>ZX55B!!_ #T(TFE8022INO'
M7A0LN[Y])P6(85*,:T1B$?B7.&U6 ^Z#_A8NOP+-6&E61_8FV$](//_X@X#S
MUIZ(A/>)XPJX-P9!=&O%L$\APU9]K_EVMQ Q3(#WYX7AB%_W5?C-(J#=&: M
M<._>P+6]W3>MU@80?0!Q\/9^I,%M-?^]^.K;)$#0DQF  Q&P?X'_$-H.^3DW
M,DM:#[ XL$0RPNZE5*]/P1]/BZ2N/Y\[8?@<<(+2D$GN_<NBHW\Q9+WYPO67
M(GARA&3E*COS&RE>2.C!_Z$-^9U:I.3?/*%)NGNGMUM_:DNT8]N!"$/USREX
M9JT[:/3VUM&;-V_8UP;[Q,'1'$:!$-%#&9HEP-@(S3<;\"^$^?8=,+^[=32,
MP:9D^\WF#X3?/\+U5NX%YUWX<Q",_"OO#AC?VSKZX#O%XHY:=;PWLPBR6@?!
M.?BI#M7</)C7N_\*52R?^8]$F.7JY(%MJGLED',?H.G^G[.X53PB!3PF\';?
M--NK /]\O;HUH-Q6P,)HZWD -.PLN,MZU\**(^=2L,$$+#H1OGRVXN]!@ )$
MPY!J7A9P7&+$WBQ]=2]A\C0N_O>?WK9;;PY#-A*N6,Q\3SM%%.%W8[2#60?(
MD/:S(HV%XA2?NR.SO-DZ:C=+:M%N';<Y]0%WY[BQ.X=JWFX=[>WNUEOM%=K]
M#HG)>\'LF1^QSF+A L4"F=TE(7,_+N8)*"@1L#-*R 1,_51"H\:<"29AO*FP
MV1 5(#OE8:2RJC_2,@]1W+".RK:.NC-A?:,T/%^ *;$('(RLC?UK-A:N?X4X
MPYN(RO5\2:4KQ!MLXK@H3)R0.5C,:P/.(Y^%SCQV(^X)/P[=)0N!'</)DF90
M+_AC )<,"JCR@"!-Z\4P3L"XM]3W)N"8^U?X'II!#L::PH-*2GI]V[#!O88%
MDEA &A\H!B)R@8J-K(6M,F=^[^?#4IU6)4&_!DX$^,+87>RI\$QX9TMU[/ON
MF .N(J L4\KN([SWW^R]/BP*V0VL 1//+(M:=F<)G"L]W3I2L %@F,!A"Z/8
MYB(&<MEKOU*DFBMOP:J6[=8;UCVY8.W=9@,>O$G8ZP?]KJ??(8AB"Z#M33]A
M-8/#W8<BWCU9H O$N_<]$&\*&!A:0J9(N6LE?&N/@TFDA7Q*Y)G"+4WB:T=K
M[S4;<L27ADWU@QONC1O. X&2')L<J#@5%7$ 7MHM+..-N:+U/7'%6A(%"-8M
M X2:]-?I@ TXR:ZWM\<O[Y>7Y)@_N.DQN*D?AK$('H6GVC]X:B.>VA7UO6WK
M?GE*C;DQ3SU!', P,:6W) +PMQ:51> H([0+!0"I]IB>?:+U1^G?/4>%-XAO
M5&RQA'^>M,1@A,W&LDS?FC'+Y6'X.*4?MP7A$Q>(C *.[/GDI2'#Y1QN;8>/
M5*CSG6+K3!6]$W$+I=V>''>^QT .P(I2-935E\\NR[PFFB 5Z[+5'I,XN74^
M8:^YBTT6((,DH7;(V/'1^O"M;S6VX &[Y&XLV-^:0((MML!N\5EIT?*35-I6
M04A)#<FT=P#/'H#G:^?LF>]6TX,V)V_5>).W^I%[\QG\O>8KX'&@^=_]X!L;
M(I&D-NSI:;<43H]CD6X=]3T;C73!QDMF4?X 1OP&G"^H&C<7M'="!E8V&/HX
MZ91- _\JFB'Y+S"0ST-FBXGCR3X=&3YMOF+%UL"T(W"7;2.VWQQ*G%,@5;\"
MDP&0%MCG@QFH#=V&]KB>Q+0V:TI</VAVC>A(%&8Q%MMXT&3BUE&O'/Q__^EM
M:Q^<RM4E$OKE7^C=KGSUX9S=URN<W0<%4G^R@E)K0)^E9.\4TE0S(&KA@L<%
M1.WYY'_%H:"G %XJ&88G]SB4YY+G:B!\:"YWB9-?.3 U,H@'ZX,[@;AT0G@/
M6(5[%@9ON65A!PT^C&?XV#RP0YD&LU<Z?[O;/''^3-)N*&)(8%_A$[8V.4-C
M@S,RON/#.&165N5F7[PHI<B6F!<H$B\91L]8 ,[!Z'&O^#)$>Q*&?O%NEMA'
MX W[P<%/^_3?H=[-XMKT>.E4+=2",_(M7ZQ)?M_O,2LO\E' #X.+X]Y%O3LX
M/>V<#WL'^H_G' 5LM4K#@(S^!$HJQK2*-4#]2,RQN*;9.@2R;C6*!5#F:$\5
MJ5MEP<MM]K C#S/V/N-,)]#8,2IHARJ\.M- 4,R.W20.]KI".IM4MO?SW3:S
M=92N#:0A.W<YE1!\ FD.1DFUZJA:' $'9#X,>-/%;1T-/);ONZ^Q#9JLV3:*
M922E=O.PFRCI=KMUB%I WT@&4O=>,N)O,J(0=QY;"0QS$G4I>3X9D330N1\*
MQP8EU;'^$SN!JA1KU( \=%<E,WJ=:#+.;'C2BFI@$?JNNZS[5VC>A?$8.-%!
MD"CMH_:'YAPM1<^AEU!+IU>K',9CUM]@"3><.!U]S=0P-QC?F:E=9^Z@HG<=
M/G9<L)92TQ9AX9'9@."XT3I@JG0I/6\28VG+FHWK4?3CZ0"X$GV5G49VXX:[
MR*X\&2D_(1N *</)(LF2[LO&"OZ39W3<-P.. +QYTM;6$? :!]][RGSEKR#_
MT49A#X@78*5YJ'?^!^(.F IO@,EK.S([H5"8GZ,&5WG$MIV7TES(H!1XRG49
MVI="&WB*8\D8JP1CAF$!=6K6%,$TV)HQPCBX="[Q"CZ8CH(N&-^08PYA8R4[
MJ]Q62BH%B9-;?/)D=IG&$E-.<I<;,[@Q[3 9N)LRC5[%(:T9-J=WET.\K%3C
MEBY,H[!;ZBH"6>BE=E,2V<XZMV7D\A*WIA?M^B$NCXZ7&<<1D_:A]!LF$S3B
M00-'C@S\I:/5Y"K*MK>:X+2\S8+)W(T"CY0@D3^5#GY";>;\B<Z2D^N;878(
MPDWNB9*!4^K,#)X=4I-.LHTLZ631<@,B;[!^&6)M'R0,NG.^9<6PKO3X2$TD
MI:O$*![A@&<H0$,CW>GCR\A.I#S7<*&(*TMF84+I<H4'^17>7_G ]^@XM'^N
M#COJ)]9[%D[CF7D)!:> *(!BT:FDJ@AD9\P#/XXH,($,*:6<,Y\+&PN,08(O
M L</ULHVMBVN+;&@$WU(6U\YH4BC')52E>3>F!0VPD\84H\\6!!'DO@I3F-4
M&X.$P)H!^!7&R;;-8 H^!/-;PHZ!<5@H(HS<@!BJ6$L-7P*M)8B_'))SB76
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M9>0"+_*D"Y"Y_*ID]71ESK\!!E8-!8)23&&QI6L1-@#1,NA&7"^<5-I@U 1
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MI*,7^G-QX\!6:![ 6JI55,A-P=8,6S\<P,[QA.3H3O!JJ$2MD01^P5[\M?/
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M]T*9U71@@S0JJ!6AAL1GQ^"739Q$9!B1J'()@G&LK#JC#B#M0TIKFR* *CZ
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MHCOXU&.=+YW^:>?#:0\O=#[#H'2W.S@;=6 4F/EK']:D?_<_G0\N1KBO_AE
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M9+N8J_R?-0 HL:YT+DJ'7DN 7NJM2:LJPD9R=81L M>2/EGJ=5RS. N,9YF
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MY,(&"46,@TB]N[3 N0/MX6A"44$K@\<??2FZ#'!&&N,BI9Z9!"]M/AV,*LQ
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MZ=^.#@X/>+^6^3PG^4C'NG[99??D%,\(-!_H_,=7COOL*]./A4?J\5Q-^_#
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M]R@O]17W:1:S>L8'B 2F,$';;@K]4Y28E P74<7+]..9%+GX5VG/9$$HQ';
M@$25N_AGK[NY6/4O6X_4'[IC3NV.<6"-Q8!'_&"P0TGV6#R2!_-:6,]G[[P\
M1?)[!MZ_@!-S*5Q'QKU5&.*8P(,Q539XY/YY_*#J=MP38%[O='<=HY@6^T.G
M<V4U+C$X"*X"@1L)_GQ'A)1*@$VM=DVB 22PB%^:%69N2Y&0%PP+P?NEU$?^
M^2DF_7YNTI4$Z,=-L%H>J=N$^+:JV& ,310(]>VM<1J:RCC\NO+DU('MTYB6
MWS-"K<,L"C>(Y :N5;'8%%%.L88TG*%"@A@IIJ +896TVHU(,N6HT\/4_O$=
MI78^L.99$&*H7LX2U-(P$XA6!L+@"]VK2M 3TNM,0!E,=*X$%2/I#18J7B.Z
M4SX#O+2<W9!2#S]Y8CPKY>;7X>+_T/7[R+O%*5KWSD$VWQI6)? N-0X8Y^R*
M2XLE?K^]A;CV092SHD):*"*+&4@QDLJ4FX^?:G'<J\X';%A8@6!'[D)U^PF6
MYXR7)YT6=':SPQ $YM2LC\I!R3,>!+96AIY3C3U*$0]7D(#R ,864% 9U=>Y
M:+#NAU*5.M?3/(^"9._S%^+F@./%9WD6J#C:N\(<B(*_1W!;D"6%0)?8X7%R
M ML6N2/>1J!>(F0=#N\NC>&OE-QB:9: K$-'7)RF(=8Q*C#-1_^>!E_H]WR:
MP*K!7^-IF,=@Q6"]$B8)J,PD3I W$C7C"?P.FC$:5# *^M-US"]M+'9R^=O9
MZ=[AZUU?MQ(#^^QV2F%E7C^A$"=6Q#$CYJ'=@\@-.HU"CV<897SB)UB=P]S+
M8]C>>F 4P!-[XP!SMGD,F#"!(7?:)UQV_2$-JP8G*!&YTBD\&H!8*T#J:Y1S
M/8OQ5Y;.3QS8#S]"_[XKMG<48SI8)1*!( 1*%64E)S65T'S&$ !.D;/W&?O3
M1F,VQAT;VA=?I(81ZD_#6\71&]2001X7C*&<FIQO#)3C@@VH_H]RX[&E!SD"
MT$F%*4+ K_?&&\ 9-ZXYY;H)Q]3DCNL6>1\B>1>$7DK^J5W?T3(JN=':Y<[6
MG<=#S\U!7+YGDD6<=Z5M*=B#TS%[,*WH?#A!U )Y$RI$7L"&]4S?3OHNGI&I
MAXZ!W/"A$#AW*:EQX+03X>_B1!@'LW6ZJWT8)N$&LG>K.F8)+]B0(#FR,5+G
MG*-.[>,W'16/VB05[XU$+067'34)!-^(>;UW3A!R]!3_Z>(_I**&'IPNOD!M
M88A>O)B/7F@Y.DBBVV3-I<N/^PW#+G/^Z<J(/(GRK![D65Y.CGW)<U*",X)+
M*! SZP^I$@]RCEQ*JE,IH2M& *9B2B<3X7L-HDF06"C*;[="?7L+TYY6E1XY
MR'167'7*:$ $2/$TDS\QI>O'$']S,X5^:?TR:XVV/Y#H4)<ELB"[(>7D&>UX
MSG2>(6-E/B*YH0'Y!YC@5%^F7)L$C";"'0,Z+3%]0&<EMPMY4$OXNI(.CTO$
M^Q6C=3A2DQRC\[M)[@@F-[:L +&&=SI*CL ,WBG6,UUWM-537:7H-I5PQUCA
M['2BPCT(EUOTM\/#;'.G4MH89[\W@&37"M3Z^31\TN*H<Q3^O#H2=Q/*.*Y[
MGQ_!A-X?R8/;6TN8$-OISK&7)\"E' (70%^PG-$L+.5[ZRRE5;G,LTSVM"1Q
M4R7K::,["J>V'& )/5::^X_WLRV8>VVQ"P[ZZ.#HL)Q*R@X+4_%PQ=GR!EF.
MX5RXX86M)5 67!^U?NU:A:_9F4?,F/)_:WJKXCZF9+@&B*0;6\#@O5?S)5CH
MTAF3IJ?^C4<I3.M_7QSYSXY>( ;+TY*<\T%JQ:G >GD:U<O60P2VM@]+BJD4
MA[&FE&#VCT$ON TP74\*];"SNO:NQPIWRP[E)4[[]&D7\[XHJ=*7LI_4:3^3
M(J"9Z8@GN&I18>J5!(8T041!^;(?BZ.S5+>!%XL=+8)1/)E?8.Q/*W<J#8>7
M5?W:?":3L-S#(+6NOWO*R:SL\A-GVP*X@0Q,J;LHF^;,*JL[$HT?4?R15:^=
MNI-&(*P*38MR4J'[YJ4OW9E[*]B"B@(J&AEX.,VX\DQ[2HFWC:\4U)!<?,$8
MT4C'3TFZ4]4OO/?L4X,Q78NS5SQCM82JW-)+8=<J+B\HIZ2Y&4+,LE'F_&6O
MW-ZREXJ7T7F,J2^R94>^F^Y&=;WX7XZ%Y4XBV[639W*G$<#Y[?ET@!AC^GKN
M!R>=4L" RZO1,M%]V+T09;H7N\ RH)^E0604FLS+E* @#BT(2)8=.;)X+#-+
M:8+D@(/C2XOETM)2=EBDI!8<G45H+(UE$5%+8H^:4S1*HIOZ25K?GRIU_;5]
M3N<;]_J<=JT#H)F!S*C,O5(CH%NC2OH1)N4XIPE,MBA$I))CR(R N])0>;CS
MG4IN=5<)OA-C*73 8'31M%\T0/AR/N*JIJ@5V FBFY9]RN4O!4],T#A8QR@M
M4GEE"AU0>XH^N);]/IR<+Y 5<4!5&1\D7T2?>P)5_J2#/C\_Z<R-VHSX7'!O
MSDW)H5;_.MKG]C3C[MIF"["@-;BW=6D(J<#UNLF6$U PIKJ)$(76R"V<?5&9
M4ZN<8YDMIQ[ EBZ8[RB4HP-NP-\L;W3@V&D'43V*R2&]:&QN=BP^!^8]Q:11
MTC!'L$>Y/PYE<*,CRL?B)$'-E>IW."=("T4';2JQ;'BL8B^^S\EP$X9&P$ 7
MCNEC\)\@"],I.PHH*75S?:JO6I_J>G8=(B_4RCB-%X&N*%WL?L;MV7J<2#ES
M6AX\USK(]A8".?.1Z@)KN[C,)-WI>'E"JY=F[M5UP!);2A+%K>QQ-(29%%85
MZ2T'.?"L0C,082OH MT4$T,EN)$9.2;P4$>.35U#M@J,QO/#YSM]#,H-\)\Q
M0]"F+JJJ1E_+*C<>'!S"G3N'%H7C225\[^KJH<)>'90FSXQA/W'C:!OZF[PR
MGG;*;&]MC%>FJY.;.S5^#;&3=3JS>RUOR&=F0Q*PNA1%-WM#FDF@\OX@3!-!
MGG.SLOD^@5)L0;4)E/Y%;1A)I)7>,(==#(R $09&2-%'IAM*#FQW]G(YQ1.N
M&EH(L??W:7A;7JOM+0WW.Z0KEGH DC39@\4"!0DGJ+T _Y('/PB@3WL&],OA
M-*XD-M]1EH63DN>2Z^'BB]?[![]P"4<]F-+3R##=;L>(IUK_LEN67;K2Q"4<
M( YW23!$5@I:()-1?Q7J\$=Q=L+^* QZ\UR:N-9IT4S-%^,7H2WK9AA8V"-3
MES[)(EC(**;LPCP*33%IZ7U-(,<9U082H]:V-L$=7FVYY*KENJ=(9)^CR_RU
MP:_Q9#)U%\%(V%"@1AIP[FN%*&64I 2/G( ,:6T\F"Y,IH!EWA=@R\UT[_*A
MU![86RA55S>]#6SG61N-*>_ X<)M^Y1TPR3_.2))\841M*@RV?1_8,8$>#56
M)AFF,5Q8O[X/-^.X-?=HYX^&CI)^-]3$9<^P#6;"$R(4[%DV"KE72Z!?1ZD,
M4NAJ*KM DF"B4^XDXU?;5-RZ@X='_'L:Y-%>Z5M^-_K4!OA?F[>?JWBX)TH%
MINN7.AA7/%98:[5;%^4(R NAHS2D/<?L:Y,&V@99#S.W8L2#B,GQZ6]OP?%$
MW<Y,XQ@>114C<3A-!L8WS@F6A:3<8V_)$BDJS1VL"P$8\(Z0:+-^5*"#@."I
M))N4"A4PGXXZ$>&CW&W8-.9D"M4X4A_L+!3'.KB%2;+D6<9XC@7"QP<$B+'(
M)=HYN0M1Y09%"D[P,M*)QBL+2D,2ZN"C=ZF4?JQA?@AD+R&7O/HZB3(G8]Q!
M7C/5HS"00M)&$.[7:1KDNGLK+Y=>/R#QJ8$> F>&E8X_J @A$_<MC);[*YD7
MA$SV0*V+:9/NWCF2<F.-I#45$,__'@2MUZT/9RT[O,;15ZN1LF,T2 H&4 AP
MSR3DQ/@*$LY8/+!C1^:)]U@]@%Y*_84&1W&_L[?"=D-P(#4=\T:6#WOT/A:X
M@H"$-GP?\1QR]T?[]*7V"FSL/6VE<#7S;!A/TRP-XB^SV!V3_#H8Q; %$\;$
MB"8CE<QB\B3$"$H8PK0I.UMW)Z'C!#[LE/+TG<<:F!@JE,FY#XAL; OHAZYF
M4[A(!T2"T]=IM-$8:][#76>[SSG"G_+TD(Y^M3;X1U!%]GH#>.?>=0HR/75:
M IYA+]4[D;?63?BR[)5XR$N(Z"@-\$HLY<.E%YS!.$>*>VF:3 'FVTIJXH(\
MK<"K2^<2S*;$:DE<IV$;G-N^=GEN;<4K+/NCWT^P%*6F#?G3<-I90NF=-+4K
M5+48N=<ZF^L-.TE[KS/P*CVVJGE 4C!YQP7:M].('("[^MA_R.%AXJKVC:0*
MNUHH/E A'G=NZUS</$X70!2AY#C3A_4-U"(ULO0B/0 ?HKU@E0I15FC+S<"E
MD >7U7<B7G[9>"5/39Z+%YHUDP SJ UM7/,A30AOO*^PL46::<2L(LIU0&M
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MW(1=X4H///HW8;GA6H(JA9L'[')&S<)FE+C "$31CZ<*4Y4*AJ6[1]0J4J=
M@U/(OH+:3<RO;O6TT2I+B]D$,W47,1_KM3UBL K_ ?NQ#@RL)XU3Z&3A7%:W
M:8ID5.4+6=QM]E)Y"0BM>I5#<[N4@%(2A*$P^^HUZ5DGA&>Y238B%4P3.[^R
M:5+N=W@7Q(IPAIPQ5)B],A*;%6>2*.%U2S4CJ=HV:9DF"<_8&+!WA4^?6LG,
M[ABYKWM7EROM=#.9I)A5B-E0@=-W1K>C<7K.D"APH.P? I+GO/(%8/(V.W&%
M-N!U4%DHHE"D:*!4DXF-HCU72@LN#?#E:^.AASC+5)?'I9M*P LYC<M"UY2!
M@&O1[G$KI;Q:DBI.TQ;D,;I$]W9!OJ<^%6E\I[N^F"X:I8-)]V)!V'S@V5SQ
M%=X<02L1O$P-5#219H:,[BJIHE<&KY=CBY3WE)6_)B[&/"AI+5+RV6$)N:2L
M6HN#.UN\H<"9,XR'^YIX3]/6Y(V^\P_L\4!)E6Z3!^^_H\=#78>5-Z7PJ-NJ
M*A*5A.:DXJ&!]U^,#.FM# R)?CX4P%ZU!X1I5X9#<= 6-3;@_-0=3$@[$==\
M1OH%4SH9&.64)F@ #0>2"T%F2IR*CX>=. )**[P+IY$B!M#&8=D?BG++*0:G
MQIP&$68.!Y*23MVX\U"']"NK/I=',"+49JRMX*PE4(!6PSBE0-EC0$Z=OE4(
MAKNI#MC#U@'[/8BBH* U!MW6T_T/)<-7L:JXPUPK>7@R1&Z=(*,$E253NGHZ
MW/4$1+P.+OZ;I9/WD-0Q&IECO7B,L&ESYM8@DJ1L: 69](3Y=F>)R?(@Q)+Q
M@EI N-3#3P::BFL$<)W 3(C$4R+M"=BE(D#Y#Y0.!FXR-B.F<$)6A1NIC[H-
M(SB97)3;-'03NW4P4'M"ZOV\9"2E#\!5#J2(F"J,2%57H:E)<H968 EV_=@T
M]&\ZS3BQJ6:4HKQRA<E<TW.A3,&=%YZ02_X!1D&LPEM=D;:])4M0FZ@:\%I^
M<6]B\#O63BP:<&Y3O,+E_:$.]P\.;8FB)<.I<5QXO<%(A=/8U?F-&:.L-CX4
MO8QS$K%/!\9@GM*T+*TPZ[9_[-K"M!ZUN*)?_S>L[7FDYK)\ZVMOC(=%E_WQ
M>6-AZ6)X%/J4<.E]EC$XXV&488LL."&RZK?H2AU.<\RQ9WL/?^&42^DAGZ-9
M8&#LR%ZFDPZ.O&A,'H,,7V;R!$HMN1*PCOJ95$XS[">*#.KDRU/3@F=N;D])
MDD^H=G3N@DBJG^<X/1#4\<C-%-%X1F(\\ZE^'^2.U<ZN6:QIU _7J2B][HG7
M/?W0N38.21#<!:$*%M[AD3=".5UV5YC6HO-6MI@1)O%4Q5B(Q:>7-4WY+RWL
M*SABWET4E+)R8<!DA@#!.3[!]?'P'+P2!T2I3 @<CG[4+"5H!:K>XX6]8B/#
MNP*M*0KYE,$UM<7/4DT%T@"SB./A'.)M0DDW>52H106SC^E\^NWK^[3,J7-0
MKTC7K17$O.5%&:;<,E2D$&I]Y_ 7G:F,>B)74GK'VC=W"@8+!PXYL4C8$Y<P
MH\!BR0,%6C1V3O5(.9;O/Z%C7J3V*Q_Q.UZPE[?OW!CJ7LXXB!0T-"*1M0PH
M\4[PPHS?IM:Y*,G.=$"3DR7!V))DS>+PWR.7+D_H/-C[APY3:$5J!M,32V)[
MZU0-*">0Y_#LD&;VW$+8#Z.8(W)>V3LF,P5>DUF8.[1[D=YUK9LLO3=KX*2A
M+7)'[GQUWE1E#'%0*G0;<,,Y32X:4^HV#:C@RT6YVW2;IV7E1LF7)6]AR#M=
M!RF*+WN%".ZALAE%:13__VSY+,#Z"7'OA=P^@%LW:$9%Z@_]\NZEJ@FEMR])
MZR6;8'O+W06R>?R2 $+:245(H(N!#:OJ$#QG@N9T$B8:3UEP:4Q+S0K*#4H%
M=HD"FT]#K'^@E^D6"LKICZ(',\;2*O-<\DLNV#_+O.W8D=#NHN7L6&T?\1BZ
M:9+I_BDX'BSJCW775+N>9J<(+841RUG>2X;J])B0?$HBQC#F#LS55\Z;4$S)
M6NIPFJ:3[:@]X2'GX^ @E-DX'#_@6:&GF-=;]]!U!T$Y";!P&^M8.VH=:]_G
M6-,M]_:]LZ&+9UIB3MY@I>8V(-WO5(G3'G'(E$4=NIQ$;W2TQL X3C )=R"U
M0O ZZ8*S0RY!/"_O1]@1IM"#RCT"^=?[F#:>/'ZV6R=/G!I]?(D9RM)IF.TC
M<D>?%20$$/HF)YM3%!LZ"J41*XL_&IK,3HN;I<)-7L+PL'PBK?*":J:4R$19
M;/@-4Y2P[149@U5"YW-G$\I8N\CT>EEC?0PL6;L (<\%A6X(*K&W\UP.RK*&
M:!VD$H0DL$QWZ<25Z 2@9"CY B8J-6RKXRE6\G737(*:(I:1#D4[^>Z*DZQ;
M-6,B[2X,_5+Y+.LM3M\R3+63@]E=:UJ*RC3A/JM$U2@!NG^=P^YS2Z77HN9V
MXHJAU1.6'HQZ4YBYSR7NX4ZBS*!,$;B**KG72LY,<E* X9X5WS."FL6'+P1L
MO!R')_OCSCU9HY*^9%=;[V)-\QVT#UW_D&A%[G;;]>K(RGF5R^2/]/3"35B6
M H1,:+MW,?+TPOWR@.#1K4FD1U%%TI5D$$M:>/%3VJP(]U-KI^+%_TRS+Q+_
MU9A\3SG62]#T!%S<I"W55IKKE'PL+7<3;!FN#7,JR4,BG!3EOD$1$XR+7!#>
M0)0 @X4F5QO&DZB,'EOME;1K,&5L2I5YO(,49]&EM._.@BT9+&XN)4BHQ>]0
M9>(?"BB DN(J\*1\>*=2I0J$"1;0#PN=*(:_XT^\1/I;"OK;KYTLDV+F9I[J
M$:)OH9(5P3"F<=3/,&0AU[G-9CY<V*I 7;^I?97XVSDF[64++SGNG=H/G0E(
M/DMS^\-Y'(P#ZP-%!KGNG)W;;SKH6DT7ON53^A\0I,'<]YSZ@*X%FVV%@N@4
MDV&C/ON>S-7=01Q-L/2Y\A2"%\1X$/IQ^)&Y2X$ ,[.%!&;$I8"L-F3G2>*V
M&=DM^Q3M[0\PF"1$D;@4<\EV7"*5 8E( -=N$W**:[F+@ >J)HO#Y23;G-<[
M+5RLC];<:,9GOHFCY MF31/R/J()T+%!J<]]C?UBQB$75AX*TG>GH]VL'(W
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M:^U]I\@#,0&6-(VW9::L0O#=NCFQL<^7=:C7B238EFT\4:$#-1F3@SZ8<14
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MYER&W0+!^ZCY56&NR /'>6D:NU#[^13VL"I'%_#;RH.YCE9JHUG:5_"5'TD
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M8_*A4$7IV^)_]@V2 ([1_49]0RE)>/+D:/C1WK!.XB:>1=60&AOT&>(*@-W
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M<'(>(TS1=T+,KBRR*T@H;\T8MBJM6E8-&"[F/Y?F'JZ*!FD:5DPC9G96G),
MW&#M4K4 QQS@R<S (,AKU*DYMBOCI-X$%#HR/^4VJJG&=9G:8_"K;\))7K29
M69YM3JTR5'N@<)CD>^;;R9$U+;K[U4-G'GF6:L'<Z401<9V+86W7!3)0KPL!
ML,#[HS.=4H=M9Z,,8%GVCS*@J> JGFE2(&[MHID-"5I-63'!EW4OVR0-+UJ6
M#-_-.C=:2'N0>.N8=(C';;Y3?=Y[W(\U!/GL]'L(\FY,8_M9TR25X(XOZNP:
M&&]V?'^))U%+$P11L3P?+\\ ;6=.?]4VA.>K&H3Y$,JC>_.H]ZYW3YJ^M!K=
MF 4;!>$5IN;/EH<UZ)484<[6N)3.A<X2R6;F>Y5H6?YBO-FC:_*(?7P[OA"8
MZSQP1J#Y.@HTI%W=1B^O*#E1*E,DD\'* ,FMW :W,,(N4% ="6/7^;:MUTZ9
M:-!*T\Z@NZ%K+KD2M1F>VAW.P;RJ$-."/\<,+4I:T$>VY]UZ7;7KN;S+ >QB
MAQI[:I._9O;E[-3\H4Z6^;4$-9$2RE=Y.Z[),8=F5HQ'FH&//7<&" X6-KR4
M?*\?PK?M(JL:@4#QY3#J\Y.?0.R!QU'^.I@^[.1 U(&M9NMU+8H&VL9PO8/%
M[@ <!;UMV!Z7[(2C+,G=6@"?<AF4R5I10QDQYC/B8S+O AJ6>@&)=J"T@7CU
M(B>>9:Y3\&6!0PE? .?H,@-/"7 QC8-R="9*[RC$MUV!H5FK4STK7+6J\=ML
MM_C?J[5"(/D4OU'NVM M=0G,]8*7KIH9'6%;-Z*$NL$/*%4CX#%:!&9N\9;@
M,*5PP?E3?G6PY!V/G(Z>G".+ ^@]CWH_6#K)P1OM*M96-\00CK<*1.XHM:PA
M>:!SX$"T#  N&3+]R5V7)C%BQ[?GBFWGGO>O<])9YK@:M!>8@W0P=!=&XPZ[
M_O*%<Q\J-9T<1;5*&C 9]*U:\"//BW/0?HJ,]AKKYE>W"<9;VI(_AR,Y)+0%
M@M ??D#P3K.ULE_*$>S#U4/9S[-=#22(X$,EX]K@3H>D]]I1E!^GL=JT6SZC
M66,UMXX_\8#,BWE:=XIVV;H/:GYL7^_!SUDH$]ZML'Q_P1*I$/4]H4*PN$*?
MTL.4F?Z3O//MI=G)I,\K#]DA/$P"=<2,[+^N#:1<]Y2JMCG4&8L1?YVU[B)P
M!$=$8.Q1! V-64PSW.OFVR"[A:6/IH^]TSV*KF.0 N[--S!;,UUHSQ!)TX+E
MDOP&IO>?8&A'B,'^^B_TE]!A"*A^6=0,T5I-CBR_M9^QCB\]@*"?:E(QXZ4:
M^>+S!NUDTHJ_,3I]_<*=&>^0X1%^T%DQHGC\D>MA'F,$Z.Q[!&C@.KZ^\W4\
M-[IKIUUD1!!MOC:0?& "&4O2QH>$^3W*L@B Y<ZR[.Z+]]-T($\/=CW9B82\
M<SHQ=OE39USRBFCH;>0'@+N*(2R*6JQR6$62.+T/28YSV\ D[!R--,C0,>K"
MG(%+"2-8RXR-MD2A%B ?9>0R)-"0G;<#TA)<S%\$.4K8U'OGLF]RG/YR:!/L
M=LM1-V-@6DY6+"3BNB+\_+J02K'"3D*B=,A^B);JO*R:G""6&E?9(S[] ]T9
MZ+T?:>D+<M!C_7;:>TS9/:PI3-:W*K(3>R^*\8\[FN[PU)S%+IOE5S"S[V:S
M#!";_G_*9G&(&7OC>-,]B^6.>WX?>A'O?73.=[CT\+P 0?KFX',=K<:*NM'*
M;(3E8'X^WG+ =T'UG@5@3T/5&34L@M1\GR+=.=AJ.6ZL$,?K&4B,>V(?/7V/
M8^Q;J]@0!]6V<9NLWL;[,%Y?)P=2U_%A[GUQ)T=#XLQIZT->7J.L[_<6F@L(
MU.+V!O9>.]\6N*<E'S:0O@'"=VB-TF<+_(P<VW]6WT,7N\P CXV\)VP!V,69
M=4 X7JBZ$% )K_WGK+J2VEKLG;+9E#>^0+AG/1XA?>WU?<<XV>O%N$OZ-:[4
MHXP-/?T>&[H+.F@(\!\@!@(&FU3^ $0"6'?W98OP(H1.<W;GW.;H)D>_9M>$
M/]&M/B6-); ,ES^(U(9$XPZ4&8HD,()DY'"K4\4ST"E14V7*75P'Y?PD[6B^
MZ4D9J:Q :=1TDG'[0,(')B]IL>[(<6X[,R'#<TAN,P5H:+[''.Z<*KLS,<$+
M(290#$AA[0JL\SL%89.NQP,4!0_<C!@(6?I@Z,$E,;H14?UO,8UJ#&Y4#G_6
M;;-U1+*_GYR?(- ,Z;C:.6QM54\M=Z^EF,@H00B<56#[4[D-83BX6&->7:S-
M1!9)\!O=JTSE: <QU8)V"F'RGO.JR]4$]B8L< A(QB\[EKB>RW$<(7)W#$3[
M,;GO2<1#W9NG/BV8QP:V'VPB6"X-OE2+U26'P[*AR^H:* T56QSRYN?+W$QZ
MCN5UD!&&J>UX [H+KHV85."H1X% JJK/3\PLZQO+M]0(545#<$.%_Z>B],MB
M$^281RS*R>"=,=Z?OC2HMX5.)SS)F4+82.6#A_4;<Z8534<0B[%G.+NAPH:!
M IZ>MA&Z8T!/EWNADJ/Y,@P7 ;T>.* BMAD&Z?8.V@%.J<S<CCH."8AM5R?3
M?[>&WJESN:#RPH8FK&]C"<G'7&A:AWEMWKQU61.B("KSQ05S>''/1E7F034O
M).A@G_3KH)C&G7Y[CJS?UNW4I@(W4+R6W01QE^&R:38?C,J^EW85MQ1ROFSZ
MR(?\EW:]\"J>_Z1-)6,S902'!?72@8S83V"K&#.(H)UPB]=0WP6ZRLCR%AE\
MP I%!I<E,Z33=34;;-Y V3 C $LDTRAJ5?%,4.<Q]S+D]',8::Q7(CBB.3W(
MLU][=XV_LE#?85AX64&.CB@_+:0,Y]14#,O219$% -ZA:S<"M1!K:_X)+.\<
M 0#)SE/USQ5.EL#*-%5&Q.F]4D23QB]M!J%X1)JD-7]/N9*MV%ES/2(]6\J[
MH/@+;5W@:10LF-$0A9F#+#B&D%=(XD?%!#(%MYT*C!9TL4%F5@=QHCO7PU!E
M:R=A- CF39F,40XJ'"T>LG<:CD,9>]G'&K>MIN[L",=)YFC=8?,MB5,(MV49
MY69A 74T*,U0$5EOA:==95N/GG6.7(I0Q&'K[DKHG"LKS660 !SM@&U]8+H*
MZ03O;_0!,_]MCOT3\" 56MHZ:Z N@*L#*:Z8>E2-N8+^N@KE_^P4&OU2\8JM
MJX!C01LXR^:?W6D&IY<QY6@?H@8PCTS5FXE;JZ&*MG6.X%E0@>;Z0H0-R5RK
M%;Y/*##IOY%]AR)S/(#^55"ENMZ! :]$-;SHN:?<.!(AJR+VN+<!6<KTR_@Q
MY&.K"F/V.+X9T0Z9LUE?L&N5?]D8046I' $ ;B_97(_9%@7"2=>ZTM_W2L99
M%WL858)U%C$[_/1''%9[]CVL]A7Z^8W@]NK'Z$JK#:BJ00F[KB9'I0/_16J2
M1@)^C4&TZ)KX79T-U0WX52$B'B+8&^./QDEP 4S1V\C.$CZ;OY3@+:& X/=B
MH<2]];3;H^L*&$Q0*H3R \K;(01J-+'F]D#5Q(ZAM_UA:9?R!J5=,FZ,\4R8
M)\NF5FU!I>/CP>4"VQ"=BZ)!^E)0[23KD-R:S4]CP:?$EH!TX%3;H8HT=:D^
M5^?K2 08+%C$7/CT/FRJKJB@"JTK5EJ6*6T,G<R+XYQ=@SA1"T5U6JK#ISH*
M_OR$R-!N?2QQ>5W)T)T.E-N8"*WT"%5C&^?LF(,-"TF=N=JJ="2OX'%'Q%SW
M%A-,4SHTQ\Y0$R+Y.&L 4G5[@]I6%U2O11P]1"EAJ^*->V)&<V5D]@*8)I ^
M )K)1.]9#]&4=_6VTLX1V;]<,;W9B@T;PNQ_8CA'>+U6D ._R#ET%7=F@KAG
MCB3XX&!*V:T,%ZX28R^"1ZRR&T5E:"D;IV*O(U0#UU#%!O3UW+N""@2YQLRD
M[N;W[J":I)  6LI)-7CT5X5R,KID)V88V\*HG@HRO'QRR+N52:&#Z[BZU-&Q
M+AX?^5X]1S8MB#J;<@)I%[W!^)+8983J3F>@*\.[P.&:<X?M+BJ[3Y?6*(]T
M65 3Q*L=SNTPK3S?DQNHH@C]HDD<.5P "(3:@M2M)7WDC'-#HHQT]!JKN['C
MG]IPO:T%2*:+ @AV8.\+M=J9HV&WK$1BL_LQ@KS 8?2<&:I,IQ)&RUYC+1^O
M#T!A-2*&X#SF&I\Z7,V6C[VM()8QL@+G+@ZQ>,A:7V=IGO%G]L4%**#FD9U'
M5S8N:]"_#VY)M48,EP>:?S00D"[,^952?3%,^BMQ'9T,#-5R&\CE(&H%G#=<
MB ,Q1T%A53Q44T0[H51!\Y/!%@'<'<0>+Y?8  MB<N36 VP_"!N$RXJRC.K6
MS&F#*)S*;-RQ,)9Z@%"(4=L'G?W'&!7B+"$:W.LWH!)UDUU79DHUGC<Z9K64
M;1N+C4_SF"#_KFE4.K!NKXE''!6/-0B5N.XOUWVZNC!VT%O;ZBN*WG1LN(VQ
M2$JT<)'%@$D?4WC4PDQ9#/)!AK!!E\<?+B#(TGZ-M\>3TBX%E#LC83PI7%5_
M18VQYC_9_%8Y)5Y; ['2%\-Y5UV-8EMR[D$HFFI&43^@>PB&YMPJV:Y2<JX&
MQ/*Q,UR9KRUS674#VM#**9]V=A\';')D17R?7:9B;VB]6@PH!3:-$27<."A!
M%!4%LJ6EUA=S]X,CS6SVCCQ0X4E%CD_,%^!'EI$MR2XRL/)Q9>=E5JQ()3$'
M.@2;H5Z(OE-LNVP-@1R,UKTC2AG3CJG75V,I9G_OMG4?/0# $26A@HS[:P K
M\<&;&!3YN)!>IHRX1X;NS*.,93[_'LN\;Y*!\ZZSX&47&'<&6<7&'"N\F$[D
MQ)+_R(JR^W0#S\Y-GM7]"E 98@&-853TL& UX@0=8H]A0LC*+RNT;+$]G%5>
MNZ\EQ_$L^:"O[D(.^7"F?1".W7$SS%DJ:P-BA6YET(*CU2N-_<0>\9"VEQR)
MWT(8D9R[LR:'T+474P;S=0"1#IP7 E]W!WLITCL&4>H0*L;%WQ^B0I 1Z:>>
M6:^MVX;#.YK0G)"<C.R*^/>R1;5Q5]3+LF+H=BVV'K?E=.1W&%='C+Z*6@)^
M)2L:#FO+JYT[35U3,7)GO\E^C=64O'R1P^T#,E\^E4/U[F]O?_6SE7X\-D5N
M-JOK(!8_/CH[P_:#QCO.%O%(;7#">6(Y!B9;Q]XF15)[SDOC5Q2U7J-+$V[1
M(^Q8/86L#HNKB=R( >!?$L7]%=K_F!R%/@;%"/%X+K.B%#[M)=INN7RY=!R3
MV&%& KW7F?FP85A'WJBGB<5K=]>>LM1+VPP>)(A)+#&:9-Q6^ 3LYQR!Z_]J
MZZ)9%)HVS'':N3@'S0S(&56[4*MC$':R=)Z+N<##!R!,(^]N@JIPVD3D=>/(
M_E4+/8=9]X7++7(8WJGF9ACCY"4I5R^RTHD\=$,4-GJ&ZT(0!)_O44 OG,9D
M!%; @$LD?1O&>A!7'FCYIL.-*P_'<+&57;O-DQ2?JKA2-9R&7F8M"HZ:LYW!
M0T2X!^0H4,AT+!9YYY"RV.?HLUE6"LUW)H-<.K9MOE$.U2%84/12X6G5!DR_
MEMPO3#+R08(>ST8[;3"6N\:XUCJ_,#,5CC!X)KCJB,/K-@-6R[8#ENNMCE4.
MKHD[!07@]W(F6-LI!*-.K5H@S-IE,>B@0].0U 6?*5J,P*9\,4VEY8E%.85S
MHK0Z1HB(%'=)"3+Z4QJ>%D(?(9 862^YSS#MHFWL\@WT<7S)%I;LP<] 87>3
MG%]G]:)YD_S\Z>/' _=J5(,C ?H!;:&&JS#'HH7E1*E6Y1R'@=/>Q_FICB?2
MPFFOAW"*2\YM:?LP-MZHW/=XRP[*BD&6-I8U3HX&"AMW5CZ^-\.^S)_\9J[8
MC>V!1+6./=L()POS_#N??=\O3RW3*$%<<8M;QKNF8=A33+4Q,().EVQW &T&
MDLZ/&817/WO+0MX=7JRJ]T(I=8"=9DMFK.\4%B$#MQ' 7'0F_G('(KZZXM""
MN#3P1J.M-]AT75H$JP5YR.7P<?+\QZ "334'43NHVEZ@9C/R"!--V9>\><3A
MO1??PWM?GZSQ_>Z#//(+@\+C0[M]4BW[+L3#*82=7[C%0"='H48WIVN9%](!
MQ&D+L,;#'M\'2)W//",*>%?)=NJI'$-S1GW;CWWM)\4QX^)%/N[!$DOZ#+$!
MX^K0I+#FXD7X;^$PO/\O/.O=3^]B?^!J.BTW @9/ "W1B:.,B,B0]SL=O@KD
MQ\%C[JP&4PSAL;.UTB3;#+BU=>Y>':,U!R)[%=2Z]'>_'$>"_2VPW]"Y_$L*
MO'P)8:5P[',%Z&J:=M6I^@[.*,*=ML;V@K\T)$0A[I!DX&<FQYDJ-;:_-*_1
MI=\=COJH]2M5C?K<QNSK-*DK2),";D@^6N<9&N;7YC!PNC;MM\//;V&'(PN.
M)EZ(KNT^)O)/:A0VV_T'W)L3^#?3@3H\G$\,.B8-]=+H#S@J%#AFY:#VR)X
M?]_#RK 1+2OUFQS#_K98M[G L%(5+)_E2AJD#'1;"9R+1T/1GL;"$%Q,;E[5
M<)HJ4FMWV8@#-0I7.OWC7CK=?#NYO4IG!.2#*?4K])5UM7!(*)-K54 2Q9;P
M>PP#%+)6JX#U@'OH5\!BC&1GOY-ZM=%$/5@,^L)J1--N6.] )S]:C'-L445J
ML2"=8_0C/D5=%H8^FB%#Z>T".1*1ADO^,,L:AY3>N0PQI%?_CH45Y*R*/_:;
M!02!]ZL0X!$QG]HFP?NLC9228>'K=5ST/KST<]I]N[E0>2! ##[Z4]KQ1<6<
M/7@1XIL[>!Y&NBG(]./C]J*)I\-@?XVP$V#*1VMWL<@;51/C$PR\+:N&.JO#
M9BL<RX/'@4A3Q>Q-OT(AR'!U\+ >%&9[::R;"SH$F^RFK@"M?&-> 2THY2^(
M<@5CH$[UC>@_Z1T3[-M9K%3QKY8WPFM3!Z(=CWB/?3+"$"(+"$F/B5:"\?SZ
M>N]5=XA/# N# ,57W>1Y,]3SU2M'L-7X-K5-.&B&$2,S!'27U1<@$"#<R<@F
MOK86%B\%@\HL(H23B*X.Q-/7U19XBC+QJBI(_!8K9/@0Y+SC/."J>2,F&<;H
M9:R>G[X^=T-:Y(\XW/GR>[CSOH'9 '8%9\2"I7P9\K',UE9E1'5;2*V&G@W5
MK'8?Q>>3LL_P4=21IEIF0I*E"7=H\"N=1H"#YQ7A"03^BS:3X^8?]'\U$0B5
MVVE^KK@;;7.><>B*<;/0=Z;:"LZ$#_K@9'YZ7< 7_VJ%!4,<<!H)FF@W&T7[
M,$U#.I'N1/0F_51A6 %2\  ,0A[+W-E5L7G, N(RVG5ZD!G'.\2L5[6>X#$K
M867I=5]VF.9AYH W%1EQHVN$UU6"+ 0P<VB6^@)I5*9A#W#QR[K(C:TTE,ND
M2-YK1HCDTEH;*#8CSW)&;,I\CF"C>=YW4S69T-K,'B$9V",.24_FET@?;_Y4
M+1J+B,\1T6"#"\;EA3<H$)PW18] !]YA@3%P:&>YXDBUKB(^OV?)@C-,6K*@
M2@SOT=((%9X%%1!@_AO%6!,\$/GF)8#91=_@\@TM!I0^$ T2>W P2&,%XRA/
MDE^H$ SU^JT/47*7,Z2,&#E*7)O,!<E"VR7P,3I"L86 )?S1#];99/""46M0
MH7XSM&1JQ9Q7I":BL!WP_*PN"T>U4-6%N=[&LNF\E^<I[Q7/%#\F@&:3O"0R
MH_@"!I[R+_B:G^4U[\P7/><4>D-@' (6!6HY[8D32*9Q(MM52T4DR ]<S%I:
M_^@%$L8AV E9L1V*;+ $4VXZ7B'[S\BT$J@C"^Q,<T5V#R90:*-',P@MLHMA
M%$@K^H3-=+O$UB=39UZ6/7#1@CMT&I#!^(9\9'58T+QU9WYRI';-]BO7U[\_
M_+?@;Y*=$_$=4%239Z;+2 DP;M?F GFX$'5G >;AJ=K:D@9J"K_C+,DVVTA4
M9"T$].CAK:,QE'U2:^.Y.GO"T1T@_X'**T9C,ZU%10@<9\<1]-'9/=D"^1>W
M)--Z+.?*;?K4!I2AR(&NC=GTJFR=P[\5<*9H ]>LPK,G</PMB4].!6O0?Q3C
M:,4NW?/;105TJU/*0W0+[CT&'?.W/UJC0$= *<Y>SIX\0PH=BHM K*LM+[Q"
M/UWI.-\>PN:\'&-S>I++B&(*PK',8J,:71K'7!7S)<"9<K0<KFQ;4-M>>JJQ
MQKUE3[!7\]//;T%T0(_UW;&L3T]^2'5K%1PH#!/-R!J*>4I%GH(,3E5-SHVP
M<M*\;>T$RG1).7MU]Y8BF>P$HQ J2M1P5L";(-7G^2D=&2  \6L ) [V\NMQ
MVI;(_  78LZ+;6T8BX9FY@ZV'1]M-.;5]VC,UX29OV*8^;ES^AVL''@0%JW5
M%VQSS_+M-93"!#8OT4G!'X?H$4 ED3QD5TI?CK)881:D++)948(JF+-F$&RN
M-?X^;%"[*TPW$\R S0/1&.869LEC; 2H^Z&*&(S$F[]DFV)K=N+?4J8*N(=F
M8]ZKM0:0K=9-KCZ=4FW?:E80_7ZJ^3"A4,X%4.#U+?%M,/=G3BIN 1*%;?B!
MLG6_M(6 RXTE/QK@>'6!%&<00!8&1Y8KXF+GJ'&2/C?&4+4JYLJOBC6: +);
M>9FU2HDC[BJ7)F%$JFI^:^8/;[1OA]&E,384LFF7WI-F_:;=GD?4F11['4M5
MH\1GAGE2 O/ESB>0GMI[!-7'G3.8#!U!*53D,TC/611(HK;8??PF1]_>^4N^
M^O$SMWK$^3MT5Y4?6'[_4Z6Z_D /SXEQ!(LIH,?Y' W>VH=\N/^>'+U_G_9G
M,=TM\DD\/$O;;[QX;BR<LB 2'%CP"[2UCS'FH2!F>A)$?*)Q9M'R8>/40U$&
MF57T:]I8S-SY10=;B[5RE,Z8*\-738Z&SC/&]OG\9PUQO'L1K]A 8G$OHDCO
MT(N1PT"EB.9&-(63'"J*#11@97:=8#6,_,!!:K38$Z$DF\5$,GKMZ)3S" +B
M?_;D9,9 225S9)B"U.[1CM:.KBZ(O)LQPX3/V^UE58/N@Y)[,[#N9J?^,G?J
MLCI<@XI.1=&;-P!(0PX=2PS&H[*$>9;C%M;8Q4^Z0Z+T+=</+HCHTMMC6RQX
M2"'PFH7 Q^RF6B[=Q6?,F6 J@E8K9N,[31!@M5+V[^!9W"KPC8,G6F;<>+VP
M>8PD83+)"&V3,L^PKJI#<NI'M+3?B8X1]G79D@.WQ!C2HC;26C&BP!A_)<92
MC*W-^*7ZN6$%/7668;K3>;6YB3YO:%N?/O\*KHX1@(X1Z'T"HN\VH:<[#N'/
MO_^<?/KKCW^\_\?[W_^6O/WPQ\</?YS_^?[#[[<>T/T=]6<GIV=2%JN9%9<8
M*>!VL<$G[]=SI[HZ5V/ 54$%XCT+H!K\FEXWA,FSQ'KI#=X.O)C# Q@Z:-?"
MAF,#![.<<!B=X26=T?E\,BWRP;I0KDVR[D0",B"IT;T?WIE'GO?"6HV,ORKJ
M;6N3A#37V*HBL$01E7E,-VB9C%O1WN#_V%=&C1V PYME\]*@PZ''ER=GI\Q9
MWK^^KFUC\FMV;9?Q$UB_BPY"M%@.?*J]CCM%NJ?^ME&>G=^Y[_8Y$W/<YD6G
M=IL]I.?$[=;.3NZ"OM]J*Q]MI.V'[Y&VKZFYGK+F E%L[]R;$2V+?[IY8FS^
MQJ(PQZNPCA1VW^7.5KT!-^=45$LEC!/P#.^LX3BQI#39R(%TE9J?:/?65ON.
M#R#$$QW^'&@#.#D:H2)W'HJ9=RB^DM:\Y2B^*])QBO26R_LU=.MM=WI W3[0
MAA_4]S9B_9EE0F0<(N5!/D!.+Z]5%$X586KW&6UZ!ZY2L"J(J:A\K<NHXQ<)
M636"4-R:_0'^J0"6I0QHG.N\,4K21J57U140;=7NEWXPSW8IIB%"4Y')D?08
MAK% 5:?M0A.[1H.6'#SA/@4//M _-:D/\5UH"*G2=;N%)LER_RIY3^L=51IT
M-ZCXO(0YA;V*_V0(X</ZUR4 />H?>DJ_.PXCU7;H^;%C,@_X&K<C>CEZ9.%^
M=P2BA[>X),FW<4>&/*1=5V5RY)UNT41[ZIY=]V77"/MOSKT,J'-2\2>3HYY[
M['?X>1@+8Q"4]M6#D_\X5&SRCY\__O'S)^/_84#R4W+^^[ODG^=__''^^Y_O
M?_Z4?/@E@>CEVP^_?3S__?\<)E[)I?TN^ U=>)LY4*W:[M46=_?SV^2=;?*T
M;.LU]0TPIW592-'SIIV9ZPBYTZNL*/%:-@4<F?_.UJV1=_2:LS1Y>OKT::*P
MK!YD/CE6+3B*M8L4"IP9<JQ$I^#ZC54E7!\>-#:ZHQYZ0*LQMR?3*X?VIN2J
M:OPB<6JUZL; -6[X-'A#BPEV:46?!G>>4>WFYP 3? (4VYBDMS] AI'^4246
MHPCYM60-_6ISF]:XP1YZC+3.9E YOVSQ&PMHV%QM\!G3,"&RKJ"-V\78O9;R
M(-?*9E4MH.^@V7K2#-Q#2PA;%;^GF34@=HN W617+.LY\Y:G.XQP\[W7Q[.I
MM&7>]>6GK^2;-O4RVMY_?7+VG.W]IDL=("OWCI84MN#3W%R/MO01L%0?,5/L
MMMXZ-2XE%<]\XY=]8Z=# /D8PWFOOX?SOIK?]UPEHM@6 #@$%NHR+_+'ZIHX
MO<G[^U/;] U6ORE/&<U#9^)!0:+KR\AU2%S1<U%5P-3#T"2',RZ1YINMCRU;
MC>_R$@H2:43 )4_553+B#8R1(1DV/:]!#7-SAVX B0OUZC-)W"(G/=XT;">Y
M5J  \YOJ>IUBPI?X>#%!EE/!.Q+9@^1*N0J!?.6L,9>_Z:P1+HJSDXFM5P\B
M0\)><R"2T#8NFNY2B9WFL9!?4[<M4!;\ICG7##2Z,P_K,>HO :WV]$,:?@IP
ML:,JP4QZ4ZFQ7V/C=FS4YC=QA([<<^X&130ZYGP",*O%G#>R5U,R[L+8?A<$
MZ[>+]!L4HT"O@O,%(<3(WO17$K;]-T QG%L#PB7II1DH6YPUF.**TGN,(S(B
M@AWW1&S&U &'L$818C^BJ;FA*(# L.IP2P:)8,,";Y&:X<$7KHJJM(DA'U6S
M98N([8B5K"$[;X>F?G[N,@5.M#!XYM]!$OL@M,^")HN!C+JH7!$Z*%4:<S1"
M\1-('W,T7:-)T 7,4V:^Q.3M20 _U9&4H%85P?),('<.0,0K(%[?$O%CNUI)
M00II?U=QPK8R=*J3B,,.#&(02V'Z'I1ZE;'?+]A^@Z.'(INN*(%0T(NTG6'1
MYE?L/^9=N5MQQY+?O^0=;]%^UTX;[D' 6[+C>?>P2)X8)?8V@>W&-\IU;:,8
M(Y^2?W/;%B2_EZB/.U5QDJOAJ>IT#5 +R+@6;2YG4S"Z=L_TF8PMNN7=&VMV
MIL$3B/=G6VQ;Q$V214#,6 47DX2YL=V;F8/?-<^)WXF[MHW[Y1"5D=U:*82Q
MKZ%D'E<(2Y;/+,TL6W^NV\UVCO+?N)I7QG*Z22='*]A%L]XMA>[HE#7FAV56
M=S)N%%XQ@YP;@Z4 UY0J-Z7(\2)?FVF )L5ENY$_0$QH/2^,ZD,UQZ!\/Y?X
MLS\%<NR)!]?F%0\A@F=32')ER2K/<>K4U#NS+&G43\$+>KDSVSFFC/.%OO%F
M6=[::L%VG:V+5=4VB-JN-K!MJOIO<F0KMX5(@.X,>M'=%_!!OX. !2-V850X
M=UW-BCIAO< 6T@Q8N#IU(N&Y#@I\&R=XFM21-M8Y41 LU*24[*6:RZ!WS6.=
M-BE@K/'$_T+QFW>U['W,)RB [BQSR-.&BB#45+CZL2)8\UMS>L,E]!E(HBN@
M0='0Y LSMM "@"#'TN1KRX$&;,F2H\SB^F.:1>)HH/P%QL6-Z&2WUOE^J^@7
MM=*NH$G!T+[(ZJC^IO9NNZ&+K<RYZE <I+OD@3/:'I4XL%>Z1QXX5AL\ ^R%
MT[;1!.]_;ATV$DJ0]*PGDZTRV<D>9QWS=W#8DY%GG:DZOY'3'BAK2^SD'>B.
MIGZ,@;SGI]\#>??-T&MLNQ:# 7]]2LY2P(B?8"(/#-IYMLGFV'F+^BF;'V47
M</A6N11G1PUD8[N"L]L1A)(BH)*A0>G4-;I1H)DOT+L;\!/GQA"&_,+6"4#B
M;++.<J<^#C(5\%3ICZI2]CUI2$1W.XWALI*^AXTNBF0I700?9$>Q?A,D;OC^
M+P*3=+<;U;\T':>V@W/</8=D8 J'L.\74XP-8-=8E,]5G3C""L6(.E2+:FL]
ML>B42 %J#NH-_TX3=PCW1T3Y8DRRO_MIMP^Q<5BR?U&,AU]I)H?\6A@%$DZF
M6-GMX(@[QIOHLU1>@)%BJ"L"&CA<#FK?"5\.285C@8BN%CE@;%#@9G\#WL$U
MK#6$?^/AP8$0T^0HB#'I%;U= (FW91\KCE,-P$[$)WPF,6]7GY=R/AQ;N!:
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M];N;;>CT3%5>P:BL"-A]1F,60]IO+K@JO[XL6RWY,Q4O#Y.%"GG=]R7;VJ^
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M=JGA-DLR&*_-.ZL7B:_R0/DL]B&@&2T>C23MLFWBHP:"%'_8=2[V*^0%@>O
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MI1__T=AUYME3\_#U0J*O_@5^^'CGQ51Q14EO=;I%7G=3*KRRHH4DD#]X2AU
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MR6-8I3WR..CA#Z[UR.[^A[A'6P_#]6N.L+P_<JKV(;YVWDJ?Q)U# R0B*3@
M_XW]S$$ETH-\PR % 'C6^*@357&BRF]]8)\?@$>D36<R#N#7.2\']]^>GEK_
M;9MC*+=5"_P-T6(^/;T5+>8=W$5,)M Z?00IM%4- 54Y(1\:JAU([#=5-<%O
M6?UYS&_Y>U1/8G_]MMK<,&0"S<Y=3W'?=W2"A*NU_8?(X$4M)]V"[')^@'LR
M.8H>A\3OR_&N K68_)ZM$%$5?U[T07X "U\9_R*^T7L/EPY7N^N7]SHQ9DD
MKC]KN(!@7/&!U_=U:!I&L;@^\/D:O0SP'OR%0("A2D#8\U=0IX2F*MDW 7K_
M!F.=YJ48M<!]%JK_SH;&A]5)'.5[X?.HI?ANHW1G1"-%O15=($$+^<VJZ*MB
MB;Q?4\+P_<?D5V.2K!M,H4)' =TMF3_J/]N\QMD**07:QIWE?517V+1Q"=0"
M*'I*((3C2!1V7?.H=(..;(^X O'E]U#(?=O?YX#?[B@CU!<<7+,Z8E"N>V(
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M@6D&;[\J:F@1XNI;;1X)?MUNK-*E*3'Z(W0#&EDFIB&F;NYV9)19B5TUYMW
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M6X3_H L#S1IW)[('K8C'&/A[_3WP=^_]BP]FWNTTFPE8A !N1F]E0SY ZC<
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MR;;D!BMKRMHA?I<&QY-/>8"JM;CX@P"\(UME531-$;>R85"_Y?4%3%%:QG"
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MNS'[Y5?P:[!L^3>DW*2?/(DX(#JMF\ORVM^NCG*8SB#$)ZZ?\Q)UGE^7$"K
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MD'L%$^6+U\8.L6<>-&(@H-)S L=PE #5PA^VB.HPA?2PA<Z@P$U<K0/W$^
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M[J4A"48O<PSRJD4-HF8P8I>H3E4C4E31PK0#,A/I[L,%U)8NXXWSW"?/'Y\
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M\W3</'$H$ S $@!V_=IW4(" (-#2E!2K0N^;Z_.H.&5GB]GU#99)J'?:X1A
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M39%^< ?S\"%(IK[^]1Z&@Y,+)/-#L-UW9ZN[[M^^\$=(#8!,UUDJUF-**I:
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M6@@\&8%TF0^BO?I_IPWXR<^^&>0_UEYKZ(!_\U4A,?Z+G>N^QI@49%US(9\
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MS-XK0(Z_ E^7TJSPXODJ+Z_H_ E[)5@+$*"0 "\J:=0H^-D\7.*Z@.@IQN<
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M2R)=%9DY3;\*\ =#WB4&4C0]4$ 9F7)@B+FEQ<40BD._)[>=H^GWXAL@ 98
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MS<1VHOP8S[4>\(T/# F1UM@;D=)PE*FZP=6!2@($\5RAB0A93])?E$,%JGE
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MPR=/"A6[*V"Y.VI@+'Y@;2BK'U2IW?<1,KVIW#I"":LNY,%+F++@)!EKR6^
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MX_!'B$, W![7/@#44Y;OI9;:.<6S@0@NB%*XXK"(D/4KG'*E62NH"QUK7Z&
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MW.F>,^)&5^N6T$$?D\.KBPNN!Y5C1#UYPN01_PI/2M>K,N*SA\ DQCQP6QC
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MHF?10.'EA&N %Q"FKX%W_=H)$D^":$*L&C;UV(\LHG\44$1GC!,U=QS$Z-6
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M#"\KI'):E1^YAV8UGV_K_=/%PTCJ38 +RY9&3(GSJ19F6(\<\@TJ'P>=\=S
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M ^MKR_3@$C$FRTE>(7B@(V=>_69M =ADK1;O1(DW\"S*LD4YP5<9WVFCG \
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MD)2&L6(@Y=(;[)18RZDK)G#'5@^F)"4WH(;(S>V"'21#X" \NX0+]B899]0
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MZ;>I>2'C8/PBN;"6?YW\P$H[VBR<9APCZ7F&=ST-"I0:>E*<Y] )@$>R%Y;
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M"V_(!45$RGX3IZ1_3IP? U^-S6]RA*[*!/&#NG_TVVEO$4K Y\OAD6ASFT\
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M+BG"/ H/4U*,T@3Q) A9'_]@8$9'C.5)EP@)"(ZPJ?-!QB8"+G<P5%3ZP10
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M9@(56OY2$CEVIS&L,@CX$W$;5H"TI#GOD@S3-G*'SE\\9C?:RR<WVGW3JG1
ML47 5H);RGH^ <M9D=8W_@K8K"#[ I:IALB#__&"G3SN SAN#%I^D:N5CA?Y
MO%;$;Z: <%:=#UN?YWP3/$24I^0"GX(V,:)[:$JP6VS*.01=8992]"?W*$U,
M_1!FZK#%"/L<]H\3E'*E">1,C?./+UE?BWQ;\7*M!C;KM&7E>)/7]AC)BX:U
MAZ8V 2L/A6]4]L)FVG(C$Y(1[&%U_CA(0;_I;!<SU'>+2U(:LT\2T&&LO-3
MJ*RO+8FH*(0;#*CGE91D=S2"7I!69U$@D_>$G;2$R\#-4!.I4N9A%8X?UYJ0
MZ DN/#>G/81;9HI E1CS43#+/AS@FA3.IG[ :CE'UE8$HL37R=*?Y-QI1D)U
M.F1ND/7[E:!I(FH:^DCY]U4YR'.FS!,W=(2?*(N#T2UX=5T,BZR2*)]9GQ'J
MPL/L$FX-MUBT(TC^$-(F&#P5>SW14<T>Q85+F)K-L=)B!<M!_5MB.1HD=>)=
MCY#JT<-;BS1G#:/K8'NAT(VE^+<&'"<[3U#9S^P"<8R0V0<HL"H46^EM^;5^
MGPW/6=*W+'T,-]ZXJ"KV-"OJI4-6)ZT?>S?T@-?LJ;MI8W&,VFT33SC-LM%Q
M&X)2 L>?41"7H=.Z'QQ2Y[-$-@Y"(\4U^:)]@;U<5I/\IN803C+*D4/;NE!A
M[X+].ILZ3ZC?/BB9SUF6,Q8B0;BCGW0R=YV5V0S5Z(;[5E0$MCFO*HR^881"
MK%&DG2)/1'W!W?O[P4^H4_V*B\KEO\D_D(TJ&Z,W(TUZ&8+:39(>[QSVLPCP
MM0&=$YAGWDZ?L@;[,D:I-I.K\:Q.7OPU!7-E/)BQG""\WJ7;04<S:FM5.3N_
M"-P6^J,-T_80I,*-]I-E# 7];O*,#-=O7KY YI7:4;.")$.>T\GLLL^F+7T+
MDORJQ@"?AO20<:^<$33RIE!N9I?PP30BW>S2 @(23A\_;*BN@F8A[/"-9BBU
M H;YOW?2[>UM_,\"Y.9TR02,;]6'1[HS8^PR,/,22,N$LOP0L;X\- \$37".
ME4 KKM=3;;B%-%BR',L 7*+8-!W?\RH;4P^<@ME]0V('^S?*"XQPO"9D7-NN
MI3:_10?FN.(MYT0, ]MSD-:-W[M0K9^@VL_+<E<#ZNK8@RP!Z9.-0=E<7R/>
MB!HV!1S<H1Q#5D+H?K3BF<Z,1LLI&G6)4HP).^:C@+= 'JLKI*@&LTL\  -^
MI\<AGC,*M<OTC@49![>HACEK$(G8&DG9H;AN2<THK_"VG:%+A'4N.&F@.L([
MQXCQ>5Y.BTPX+1N@N= W/%>,SMM(RB($?[&5_D#].Z!!68T=4[<:3X7,.V\@
M'RM$A%60:W5=")^DDZ1\/6%TF@S3NQN.=X[!OM 4FAI30W"^?DQ>,PAY)R5W
M2)Q9<TZ)I@*TGY$-M;4PMLFQ?IEOL;+<[&T&^1[LE5=B'EPK<Y8\^P&\*<R/
M6W''TZ$A2]$%YLD8I+%1?%=T[A '/33I3#S?4B<%@:/8['(,#.62EJ)A!.*?
M[.?]:?(&#N%D@*?CE [8(HNK"9,?APP&(%XX<2A!K8O0N)U:)5D*1",UQGV-
MPIK(^QZMB_&[)Q?C7<(A'GQ8T>2#;0G:KM(K4=)//2U+O:L[XXVZT94(2Y/=
MG*1J:E6W(E!D#P"()7-H77I24Q&$GS#U1E/-N0U?1ZH90^0S@'NFH/P\B@SR
M%8D72#FA$)$X-MA'Q.*/W)TM$I>OWU"4X-\U32/<P75987)S_@<:5?AOL&KA
M,B^05AK_%K!_G.S:9!>E+K<H#<1<Z5UKV O.[2HK1O3.ZO:PKXAL%#X;F6$Z
M\V#]^-<!M'4Y813P]^JSKE?A)'RYM?U*/9F+TA9>;CT7;B#,=&GVYM8T/I2.
MM8(W]/E+Z<:@K1N1W+=>LNA%BP8,;_I.WC3<5']0E'=*#O#:Y*UI-^(,QS'L
M&*'8(6:Y<L+!=$-7@I]]F%!*N:< F5YT<(G0Z<]#6L4E.[>^9GJG*FN/>4]V
M/V75,.B!L3YI>P6IZ MWV,[6-BW7UD,K="]AN4FC8YY[W!N'V:=.78X..4A1
MQ(6?3;7" :06_KJFD];P;%:XUT@5;TD-7E*!]FXF29[5S$20LP0-A:HAEBM(
M%89W_)[3N%3A'#*<5#5#2ID._A=0,=T&/9V*FV,?!@%[(/?&(C+:5$,CND?0
M)SYPJ*16L[':=:SP,Y>[Z7Z@TO+=\CMH3O6P$/H2*[#+.N_LT]V-_CMOH^_$
M+OB'&8#=1$WW0$C?9'R[=9Y_E-VBA"Q9E!M/E!;]#'-YD+W">[>7\JLWB"X6
M[L*F3]UMKSYYQ/A@&!),EVL[OE'[6%<+1,NLHMYA,N" N(4KH;G/F&=BF@S+
MG"U\LC+J6?]W5)8THF*W"<NQ>BK,QJ-\2.HU-5/KNUNV,9UDF#CTA9-2+F\F
MYS6YF#8"GUK8?>M*$V^'I963<QMD6,$@+D6*LVVMV<CAIA^U3!;7)AB5D;Q?
M</[(T/+!%1O"N5<QU-@ :=QB;IR$7E'4@%L+.Q6O@,P39;#7J7>4\>+C90P7
M9%[ATS5G@:"W6:O&&GYMJM6B@"3[-*?J*-(=Q%PKE'0BZQ#/OF0-SZJI(0(T
M$PL-ZIZG7J!H+B?7^:3 H<,DS"[-#P-4N; 54%XK-.UY]AOA:%"P5S^6&.QW
M5-JT($-FC<5G_<CJMBTK\R[$*T3I*SV !;@NV$J^PB'4==(2,[SCAJ/<G*5$
M#D\;GBCH%Y<"=9/KX&M 8D_RJC%W"[VLSX6>64?+%Y*TYEF&H*FQU@<\Z"7T
MO5Q"7-"%JP#7T4URADFK_C+J[>[]G!R_2<Y^[B7OD8FJ=YK\W#OIG1W3_[S^
M+3DX.>G]<KRW^_KPM^37W8-?X('=H]_@/_M@5Q\F)X@!DL#C9R<'NX<)_. ?
M'TY^6U\[.*+'#GMOX=/W)\=[O1XBYR>[)P>G^+_''\[PO<<GR4GO</>LMT]M
M_'P K;\]Z?7>@:V.7V*_SDYVCTYW]\X.CH].DSTP"7KOWO-/X&WA3Y89D.,9
MW^O!UV_P@;.?=\^2HV/HRON3WBFTLWL& P53^*UT8_?L[/CDJ/>;MGP,_W5"
M[?^6_+Q[NK[F?MG;3Y/>?^$?IS!A\%-Z]->#4VB.7G/Z 3MH?O_K\8?#?7C[
M69K I&'KO5_HM6^2PX.S@[>[./ T.>WU_HESU#MZ<WRRUZ,'X5^]M\<XG;0R
M)[0J+LUV=^^?1\>_'O;VW^H0#\ZPM\GK7N\(WK7_88^GG?PB\$%S!;"]N4NP
MOM98 Y@V^.O]^\,#W#0P[->_P4?OCG'1:=CP^-';TY0:?O?A[ -L$.[^*;U/
MEF5OE]]&<P+MXP'M40\2W-U,$?IX?6;?/_G,/J?T>Z4%[4C4/BH&Z/?1<NL'
MKFV=K_^CD@C?D@9WD567&B!!,UVO,).U9J,& 3]Q3&R+=)^H#$C9.=V'3?IY
M]GK5.FFBK57\<Q.DH9H']+5IV! S^?.;Q&3Z\/W(>JFKJ//APCY%*[,AZ*NH
M;M,3GB27^4]A^(O,)2G_I(3#R;08Q^-N3^-K&_H*Z7S80['YB1,O#'P$.66@
MJ!(3("7DC&\HBC>^IEH#SA[(R \UALN9<VY2RRS=&'EK!A?:B*Q[_CZ;B.I:
MF;_0 2 KNKX6P Y,)/+63,GBL+I80>A8QJ HX0T$*O)JGD0TC6D2,46JXETL
M6ZDF[F\L,H$%(@>%?+[9P?5I#&(='"ORSLC@,AH]$Q(*C]B>V7G1+R=#OV5=
MR(9][IK[(88R?QBE,9F"5]['&!G7@.\-A>;=@JV40KJC2B=\J)'^M#V_4CW]
MD2.8.'/=@;:&&;+@1OD"MTBHB[U1PB_,_?'12*SXYEK@B8$+<;P*J\4>6(J0
M,X N)#K1S;R#];4YB0?6P"E,- 1#Z>*9.B?@$K1B1N'Q\N<I0/%P.ZAQFH+D
M'R^WZ6%+3T_]R^HVR>C7/&3Y#@\]N@F&X9(OUT--H9APT?Q55;1(98Y%S*?U
M==HU)Q\TD_::D6*27W#%7OABG-M--WI%Y*)I]68NDTSC0AV^0B?*1,&;;II5
M_K(C62E95NULW)H"V4RKLO,3)^;BC+2.G+(BT'^JI5*EJ661.1^7M4)7W%__
MPRH^6F#YW6=?VZ1]:9FM]][6=FX":E=2W"T6SKZ'0Y1++I[YX?I:U,.'*6?O
M#/%*HD,4S4U,DNS"6.)WR\8=<7%!M\;/-E/Q])F4LJ'W)2J9<%[0_I(5G$1)
MS=UZ%NUN%HLHN=M6.2Y$XW<(O(I&(@V,"08C,;173&F5#W-VWG/NM1#>MR6J
MS&4K_TP+/FBU7UP6GU/,77AZ90U1UQ'KI8M-<E5J#.3"2($XPKB"!,"*Z2M3
M$$'5SQ.YX7C5R 7-2>6!)//7-JXV[@"Y/]D&$E2BZZR@?'JNB>%7Z7I'*4SN
M+*A4=M42FS0R5H,C)_I<2Z]L,Q.C9YQ9TF(;=?S^?J:>5&%2--P<88&(MRSU
M>]*]U,#T:JUF@@1;:I7W\XJ+3F_@=V0CP_\7CF G\FE3H@5E:B@0'/TT.->+
M&MCLL,3,[EAR()S<AXI937;:Q%LC$8Z0M4>YD_PV3%P\.3O8.^PEOQP<'/C2
M,=(!\->J(+37,&^F!ER(13R7I]BPCQE^4&B\RE!9^[SCPF/N754,ILD2*]@X
M%0VO0GNLW 6WVJ86]SE-01Z;BS[E)TZ$:A4JHOUCI>5C=H"^>G* WG=1ZZJJ
M&![VT1Q;3J0MY8:L<M8F[+!8IFJ!I0<?2+F#/W'QG#\;D0'O-:>]<H*()P0<
M0'E))IQ<PXTZY+0WDX_XT%&YY]OJET:,/BE8\?[H@Y&3V*F_Y=, <50%67MM
M=H$ZV9CS>YSW#JW#5O>=,[,XWPE;R,;)[FQZ49('C,N=B@D)Q#0A9%_XS6PB
M?B241ZDN5E9PVJ()])M!U'X4KIY!Q]&FQNA%C<WBSAC-X$]-@!EJ]1<5H=&3
M;)Q]$F%)WX+Z %L7%'HJW2)=A09":DY=)N,2SPAC!^9P*,I+4.1+]5D+*,4@
MOX53S+E3I!^ZM25:?"G807#%9(*,)4Y$NH^VD@]8.\\Y=2Z/QL#@M+O#2U?I
MD9.#^QS3A$<974XEGX9F&+VD"2AU/JDR .Y!<DE3$FT,;.M>"G.  $(X!E )
MM6"#LR#@<@3=GVXK'G+*B0=\<$6?7&4^^Z;6!*VYVO62 4/\;[E0(*?]@NGV
M@I*K'7QPX+[GST4"B.7Y=I:1JFNB4H%+A?T%:@0L*,E87Q,/*?D48$HHWXH/
M$ADV-2LKN?&+QI#-B4=L-D<VR%=.;<$:AUY@9:<96FFUPP*-BR9=X*E_LT(Q
MU5P]"W?)^EH$#1EXH*>NU&6%[;:5[*)2K<<4NC&<#8+<]! RE;S','9"_:'
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M%20MYUK4Q=07MZ.$N\@PER/Q@#?DI,:+:\8L, C](_C+T5(3V$V\:YQ/"88
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MG4V@H7W$9D X$T=01BT4=-)4DK8JFW >]$WH4OZ$?#9Y SG-I+]YM[@=H>8
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M 4"I_]:V*:: \\->$LQ;N//#0[ZHKWUZ;J>/?/M$IB<[C^A@]Z9_ +EY"M^
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M7[9)\\0GB^ 7#UZ>'/X.7[X9_7:T_[]02P,$%     @ K34M6GKQD,NJ)0
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MI2-ETX*['/QW+26*NUR@8VX5@7Z2L7FY"N.U(A=6APP+AX[0>85I(R]8(44
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M-\L "NV9@DW#T!3M8EP*:J)I 7O<;-1N,D>^F(=\=(J>X!6VS]X%&+ [ ['
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M[S7MD$%ZWJIM$0(Q0H?%E]C&H=>*&JATCKK<,UKNB,+QG*XH.G]BDYNSA(T
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M/P$/N"7.1L-_?2DN/(6_QV?]P\E''AT)&,+SHV8#O[?Q4P]$X6AX^!'O'</
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ME"=Q& 8*OP$6&_,!FXDSZ=B]>JZL#S4 J<.C+W#QP^3D>/__ %!+ 0(4 Q0
M   ( *TU+5H7'XM<1@,  &0+   1              "  0    !C=V%N+3(P
M,C4P,3$P+GAS9%!+ 0(4 Q0    ( *TU+5KV(=Z\>P8  +E&   5
M      "  74#  !C=V%N+3(P,C4P,3$P7VQA8BYX;6Q02P$"% ,4    " "M
M-2U:QZHN$,D$  !/+   %0              @ $C"@  8W=A;BTR,#(U,#$Q
M,%]P<F4N>&UL4$L! A0#%     @ K34M6II8UP7$*   TMX   X
M     ( !'P\  &0Y,C$V,S5D.&LN:'1M4$L! A0#%     @ K34M6L%Q]8I+
MN $ <O\* !               ( !#S@  &0Y,C$V,S5D97@R,2YH=&U02P$"
M% ,4    " "M-2U:+*(BMN\R  "YT@  $0              @ &(\ $ 9#DR
M,38S-61E>#DY,2YH=&U02P$"% ,4    " "M-2U:>O&0RZHE  "HBP  $0
M            @ &F(P( 9#DR,38S-61E>#DY,BYH=&U02P4&      < !P"]
) 0  ?TD"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>d921635d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cwan-20250110.xsd" xlink:type="simple"/>
    <context id="duration_2025-01-10_to_2025-01-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001866368</identifier>
        </entity>
        <period>
            <startDate>2025-01-10</startDate>
            <endDate>2025-01-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-375">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-01-10_to_2025-01-10"
      id="Hidden_dei_EntityCentralIndexKey">0001866368</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-386">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-387">2025-01-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-388">Clearwater Analytics Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-389">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-390">001-40838</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-391">87-1043711</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-392">777 W. Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-393">Suite 900</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-394">Boise</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-395">ID</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-396">83702</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-397">208</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-398">433-1200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-399">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-400">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-401">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-402">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-403">Class&#160;A common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-404">CWAN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-405">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-01-10_to_2025-01-10" id="ixv-406">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
